0001834494-22-000109.txt : 20221107 0001834494-22-000109.hdr.sgml : 20221107 20221107163203 ACCESSION NUMBER: 0001834494-22-000109 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 84 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221107 DATE AS OF CHANGE: 20221107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MeridianLink, Inc. CENTRAL INDEX KEY: 0001834494 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 824844620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40680 FILM NUMBER: 221365933 BUSINESS ADDRESS: STREET 1: 3560 HYLAND AVE STE 200 CITY: COSTA MESA STATE: CA ZIP: 92626 BUSINESS PHONE: 866-417-3274 MAIL ADDRESS: STREET 1: 3560 HYLAND AVE STE 200 CITY: COSTA MESA STATE: CA ZIP: 92626 FORMER COMPANY: FORMER CONFORMED NAME: Project Angel Parent, LLC DATE OF NAME CHANGE: 20201202 10-Q 1 mlnk-20220930.htm 10-Q mlnk-20220930
2022Q3false0001834494--12-310.5http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent00018344942022-01-012022-09-3000018344942022-11-04xbrli:shares00018344942022-09-30iso4217:USD00018344942021-12-31iso4217:USDxbrli:shares00018344942022-07-012022-09-3000018344942021-07-012021-09-3000018344942021-01-012021-09-300001834494us-gaap:CommonStockMember2021-12-310001834494us-gaap:AdditionalPaidInCapitalMember2021-12-310001834494us-gaap:RetainedEarningsMember2021-12-310001834494us-gaap:RestrictedStockMemberus-gaap:CommonStockMember2022-01-012022-03-310001834494us-gaap:RestrictedStockMember2022-01-012022-03-310001834494us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonStockMember2022-01-012022-03-310001834494us-gaap:CommonStockMember2022-01-012022-03-310001834494us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-3100018344942022-01-012022-03-310001834494us-gaap:RetainedEarningsMember2022-01-012022-03-310001834494us-gaap:CommonStockMember2022-03-310001834494us-gaap:AdditionalPaidInCapitalMember2022-03-310001834494us-gaap:RetainedEarningsMember2022-03-3100018344942022-03-310001834494us-gaap:RestrictedStockMemberus-gaap:CommonStockMember2022-04-012022-06-300001834494us-gaap:RestrictedStockMember2022-04-012022-06-300001834494us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonStockMember2022-04-012022-06-300001834494us-gaap:CommonStockMember2022-04-012022-06-300001834494us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-3000018344942022-04-012022-06-300001834494us-gaap:RetainedEarningsMember2022-04-012022-06-300001834494us-gaap:CommonStockMember2022-06-300001834494us-gaap:AdditionalPaidInCapitalMember2022-06-300001834494us-gaap:RetainedEarningsMember2022-06-3000018344942022-06-300001834494us-gaap:RestrictedStockMemberus-gaap:CommonStockMember2022-07-012022-09-300001834494us-gaap:RestrictedStockMember2022-07-012022-09-300001834494us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonStockMember2022-07-012022-09-300001834494us-gaap:CommonStockMember2022-07-012022-09-300001834494us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001834494us-gaap:RetainedEarningsMember2022-07-012022-09-300001834494us-gaap:CommonStockMember2022-09-300001834494us-gaap:AdditionalPaidInCapitalMember2022-09-300001834494us-gaap:RetainedEarningsMember2022-09-300001834494mlnk:SeriesARedeemableConvertiblePreferredStockMember2020-12-310001834494us-gaap:CommonStockMemberus-gaap:CommonClassBMember2020-12-310001834494us-gaap:CommonStockMember2020-12-310001834494us-gaap:AdditionalPaidInCapitalMember2020-12-310001834494us-gaap:RetainedEarningsMember2020-12-3100018344942020-12-310001834494us-gaap:RetainedEarningsMember2021-01-012021-03-3100018344942021-01-012021-03-310001834494us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-01-012021-03-310001834494mlnk:SeriesARedeemableConvertiblePreferredStockMember2021-01-012021-03-310001834494us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001834494mlnk:SeriesARedeemableConvertiblePreferredStockMember2021-03-310001834494us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-03-310001834494us-gaap:CommonStockMember2021-03-310001834494us-gaap:AdditionalPaidInCapitalMember2021-03-310001834494us-gaap:RetainedEarningsMember2021-03-3100018344942021-03-310001834494us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-04-012021-06-3000018344942021-04-012021-06-300001834494us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001834494us-gaap:RetainedEarningsMember2021-04-012021-06-300001834494mlnk:SeriesARedeemableConvertiblePreferredStockMember2021-06-300001834494us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-06-300001834494us-gaap:CommonStockMember2021-06-300001834494us-gaap:AdditionalPaidInCapitalMember2021-06-300001834494us-gaap:RetainedEarningsMember2021-06-3000018344942021-06-300001834494mlnk:SeriesARedeemableConvertiblePreferredStockMember2021-07-012021-09-300001834494us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-07-012021-09-300001834494us-gaap:CommonStockMember2021-07-012021-09-300001834494us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001834494us-gaap:RetainedEarningsMember2021-07-012021-09-300001834494mlnk:RestrictedStockUnitsFormerlyClassBUnitsMemberus-gaap:CommonStockMember2021-07-012021-09-300001834494us-gaap:AdditionalPaidInCapitalMembermlnk:RestrictedStockUnitsFormerlyClassBUnitsMember2021-07-012021-09-300001834494mlnk:RestrictedStockUnitsFormerlyClassBUnitsMember2021-07-012021-09-300001834494us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonStockMember2021-07-012021-09-300001834494mlnk:SeriesARedeemableConvertiblePreferredStockMember2021-09-300001834494us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-09-300001834494us-gaap:CommonStockMember2021-09-300001834494us-gaap:AdditionalPaidInCapitalMember2021-09-300001834494us-gaap:RetainedEarningsMember2021-09-3000018344942021-09-300001834494us-gaap:CapitalUnitClassAMember2022-01-012022-09-300001834494us-gaap:CapitalUnitClassAMember2021-01-012021-09-300001834494us-gaap:CapitalUnitClassBMember2022-01-012022-09-300001834494us-gaap:CapitalUnitClassBMember2021-01-012021-09-3000018344942021-07-27xbrli:pure0001834494us-gaap:CapitalUnitClassAMember2021-07-272021-07-270001834494us-gaap:CapitalUnitClassBMember2021-07-272021-07-270001834494us-gaap:CapitalUnitClassAMember2021-07-2800018344942021-07-302021-07-300001834494us-gaap:IPOMember2021-07-302021-07-300001834494us-gaap:IPOMember2021-07-3000018344942021-08-262021-08-2600018344942021-07-2800018344942021-07-162021-07-1600018344942022-01-010001834494mlnk:LendingSoftwareSolutionsMember2022-07-012022-09-300001834494mlnk:LendingSoftwareSolutionsMember2021-07-012021-09-300001834494mlnk:LendingSoftwareSolutionsMember2022-01-012022-09-300001834494mlnk:LendingSoftwareSolutionsMember2021-01-012021-09-300001834494mlnk:DataVerificationSoftwareSolutionsMember2022-07-012022-09-300001834494mlnk:DataVerificationSoftwareSolutionsMember2021-07-012021-09-300001834494mlnk:DataVerificationSoftwareSolutionsMember2022-01-012022-09-300001834494mlnk:DataVerificationSoftwareSolutionsMember2021-01-012021-09-300001834494mlnk:LendingSoftwareSolutionsMember2022-07-012022-09-300001834494mlnk:LendingSoftwareSolutionsMember2021-07-012021-09-300001834494mlnk:DataVerificationSoftwareSolutionsMember2022-07-012022-09-300001834494mlnk:DataVerificationSoftwareSolutionsMember2021-07-012021-09-300001834494mlnk:LendingSoftwareSolutionsMember2022-01-012022-09-300001834494mlnk:LendingSoftwareSolutionsMember2021-01-012021-09-300001834494mlnk:DataVerificationSoftwareSolutionsMember2022-01-012022-09-300001834494mlnk:DataVerificationSoftwareSolutionsMember2021-01-012021-09-300001834494mlnk:SubscriptionFeesMember2022-07-012022-09-300001834494mlnk:SubscriptionFeesMember2021-07-012021-09-300001834494mlnk:SubscriptionFeesMember2022-01-012022-09-300001834494mlnk:SubscriptionFeesMember2021-01-012021-09-300001834494mlnk:ProfessionalServicesMember2022-07-012022-09-300001834494mlnk:ProfessionalServicesMember2021-07-012021-09-300001834494mlnk:ProfessionalServicesMember2022-01-012022-09-300001834494mlnk:ProfessionalServicesMember2021-01-012021-09-300001834494us-gaap:ServiceOtherMember2022-07-012022-09-300001834494us-gaap:ServiceOtherMember2021-07-012021-09-300001834494us-gaap:ServiceOtherMember2022-01-012022-09-300001834494us-gaap:ServiceOtherMember2021-01-012021-09-300001834494us-gaap:ComputerEquipmentMember2022-09-300001834494us-gaap:ComputerEquipmentMember2021-12-310001834494us-gaap:LeaseholdImprovementsMember2022-09-300001834494us-gaap:LeaseholdImprovementsMember2021-12-310001834494us-gaap:OfficeEquipmentMember2022-09-300001834494us-gaap:OfficeEquipmentMember2021-12-310001834494us-gaap:OfficeEquipmentMember2022-07-012022-09-300001834494us-gaap:OfficeEquipmentMember2021-07-012021-09-300001834494us-gaap:OfficeEquipmentMember2022-01-012022-09-300001834494us-gaap:OfficeEquipmentMember2021-01-012021-09-300001834494us-gaap:CustomerRelationshipsMember2022-09-300001834494us-gaap:DevelopedTechnologyRightsMember2022-09-300001834494us-gaap:TrademarksMember2022-09-300001834494us-gaap:NoncompeteAgreementsMember2022-09-300001834494us-gaap:CustomerRelationshipsMember2021-12-310001834494us-gaap:DevelopedTechnologyRightsMember2021-12-310001834494us-gaap:TrademarksMember2021-12-310001834494us-gaap:NoncompeteAgreementsMember2021-12-310001834494us-gaap:CustomerRelationshipsMember2022-01-012022-09-300001834494us-gaap:DevelopedTechnologyRightsMember2022-01-012022-09-300001834494us-gaap:TrademarksMember2022-01-012022-09-300001834494us-gaap:NoncompeteAgreementsMember2022-01-012022-09-300001834494mlnk:CapitalizedSoftwareMember2022-01-012022-09-300001834494us-gaap:CostOfSalesMember2022-07-012022-09-300001834494us-gaap:CostOfSalesMember2021-07-012021-09-300001834494us-gaap:CostOfSalesMember2022-01-012022-09-300001834494us-gaap:CostOfSalesMember2021-01-012021-09-300001834494us-gaap:GeneralAndAdministrativeExpenseMember2022-07-012022-09-300001834494us-gaap:GeneralAndAdministrativeExpenseMember2021-07-012021-09-300001834494us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-09-300001834494us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-09-300001834494us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012022-09-300001834494us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-09-300001834494us-gaap:SellingAndMarketingExpenseMember2022-07-012022-09-300001834494us-gaap:SellingAndMarketingExpenseMember2022-01-012022-09-300001834494mlnk:RelatedPartyMember2022-09-300001834494mlnk:ThirdPartyMember2022-09-300001834494srt:ScenarioForecastMember2022-10-012022-12-310001834494srt:ScenarioForecastMember2023-01-012023-12-310001834494srt:ScenarioForecastMember2024-01-012024-12-310001834494mlnk:RelatedPartyMember2021-12-310001834494mlnk:ThirdPartyMember2021-12-310001834494us-gaap:ResearchAndDevelopmentExpenseMember2021-07-012021-09-300001834494us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-09-300001834494us-gaap:SellingAndMarketingExpenseMember2021-07-012021-09-300001834494us-gaap:SellingAndMarketingExpenseMember2021-01-012021-09-300001834494us-gaap:SecuredDebtMembermlnk:A2021TermLoanMember2022-09-300001834494us-gaap:SecuredDebtMembermlnk:A2021TermLoanMember2021-12-310001834494us-gaap:SecuredDebtMembermlnk:A2021TermLoanMember2021-11-100001834494us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembermlnk:A2021RevolvingCreditFacilityMember2021-11-100001834494us-gaap:LetterOfCreditMembermlnk:A2021RevolvingCreditFacilityMember2021-11-100001834494mlnk:VariableRateComponentOneMemberus-gaap:BaseRateMembermlnk:A2021TermLoanMember2022-01-012022-09-300001834494mlnk:VariableRateComponentTwoMembermlnk:A2021TermLoanMembermlnk:AdjustedEurocurrencyRateMember2022-01-012022-09-300001834494mlnk:A2021TermLoanMember2022-09-300001834494mlnk:A2021TermLoanMember2021-11-100001834494mlnk:FirstLienMember2021-11-100001834494mlnk:A2021TermLoanMember2022-07-012022-09-300001834494mlnk:A2021TermLoanMember2022-01-012022-09-300001834494us-gaap:RevolvingCreditFacilityMembermlnk:A2021RevolvingCreditFacilityMember2021-11-100001834494us-gaap:RevolvingCreditFacilityMembermlnk:A2021RevolvingCreditFacilityMember2022-01-012022-09-300001834494us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembermlnk:A2021RevolvingCreditFacilityMember2022-09-3000018344942022-05-310001834494mlnk:TwoThousandTwentyOneStockOptionAndIncentivePlanMember2021-07-260001834494mlnk:TwoThousandTwentyOneStockOptionAndIncentivePlanMember2021-07-262021-07-2600018344942021-01-012021-12-310001834494us-gaap:EmployeeStockOptionMember2022-07-012022-09-300001834494us-gaap:EmployeeStockOptionMember2021-07-012021-09-300001834494us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001834494us-gaap:EmployeeStockOptionMember2021-01-012021-09-300001834494us-gaap:RestrictedStockMember2022-01-012022-09-300001834494us-gaap:CapitalUnitClassBMember2022-09-300001834494us-gaap:CapitalUnitClassBMember2022-07-012022-09-300001834494us-gaap:RestrictedStockMember2021-07-012021-09-300001834494us-gaap:RestrictedStockMember2021-01-012021-09-300001834494mlnk:CarriedEquityUnitsMember2022-09-300001834494us-gaap:RestrictedStockUnitsRSUMember2021-12-310001834494us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001834494us-gaap:RestrictedStockUnitsRSUMember2022-09-300001834494us-gaap:RestrictedStockUnitsRSUMember2022-07-012022-09-300001834494us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-09-300001834494us-gaap:RestrictedStockUnitsRSUMember2021-07-012021-09-300001834494us-gaap:EmployeeStockMember2022-09-300001834494us-gaap:EmployeeStockMember2022-07-012022-09-300001834494us-gaap:EmployeeStockMember2022-01-012022-09-30mlnk:Property0001834494mlnk:LeasedPropertyFromRelatedPartyMember2022-07-012022-09-300001834494mlnk:LeasedPropertyFromRelatedPartyMember2021-07-012021-09-300001834494mlnk:LeasedPropertyFromRelatedPartyMember2022-01-012022-09-300001834494mlnk:LeasedPropertyFromRelatedPartyMember2021-01-012021-09-300001834494mlnk:AdvisoryServicesAgreementMember2021-07-012021-09-300001834494mlnk:AdvisoryServicesAgreementMember2022-01-012022-09-300001834494srt:AffiliatedEntityMember2022-07-012022-09-300001834494srt:AffiliatedEntityMember2022-01-012022-09-300001834494srt:AffiliatedEntityMember2021-07-012021-09-300001834494srt:AffiliatedEntityMember2021-01-012021-09-300001834494srt:AffiliatedEntityMember2022-09-300001834494srt:AffiliatedEntityMember2021-12-310001834494mlnk:OptionsToPurchaseCommonStockOutstandingUnexercisedMember2022-01-012022-09-300001834494mlnk:OptionsToPurchaseCommonStockOutstandingUnexercisedMember2021-01-012021-09-300001834494mlnk:RestrictedStockAwardsUnvestedMember2022-01-012022-09-300001834494mlnk:RestrictedStockAwardsUnvestedMember2021-01-012021-09-300001834494mlnk:RestrictedStockUnitsUnvestedMember2022-01-012022-09-300001834494mlnk:RestrictedStockUnitsUnvestedMember2021-01-012021-09-300001834494us-gaap:EmployeeStockMember2022-01-012022-09-300001834494us-gaap:EmployeeStockMember2021-01-012021-09-300001834494mlnk:StreetSharesMember2022-04-012022-04-010001834494mlnk:StreetSharesMember2022-04-010001834494us-gaap:CustomerRelationshipsMembermlnk:StreetSharesMember2022-07-012022-09-300001834494us-gaap:DevelopedTechnologyRightsMembermlnk:StreetSharesMember2022-07-012022-09-300001834494mlnk:StreetSharesMember2022-07-012022-09-300001834494us-gaap:CustomerRelationshipsMembermlnk:StreetSharesMember2022-04-012022-04-010001834494us-gaap:DevelopedTechnologyRightsMembermlnk:StreetSharesMember2022-04-012022-04-010001834494us-gaap:TrademarksMembermlnk:StreetSharesMember2022-04-012022-04-010001834494us-gaap:SubsequentEventMembermlnk:BeanstalkNetworksLLCMember2022-11-042022-11-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022
or
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______ to_______
Commission file number: 001-40680
____________________________
MeridianLink, Inc.
(Exact Name of Registrant as Specified in its Charter)
______________________________
Delaware82-4844620
(State or Other Jurisdiction of
Incorporation or Organization)
(I.R.S. Employer
Identification No.)
3560 Hyland Avenue, Suite 200, Costa Mesa, CA
92626
(Address of Principal Executive Offices)(Zip Code)
(714708-6950
(Registrant’s Telephone Number, Including Area Code)
______________________________________________
Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.001 per shareMLNKThe New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes  x    No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes  x    No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated fileroAccelerated filero
Non-accelerated filerxSmaller reporting companyo
Emerging growth companyx
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).   Yes  o    No  x
As of November 4, 2022 there were 80,917,710 shares of the registrant’s common stock, par value $0.001 per share, outstanding.


MeridianLink, Inc.
Table of Contents
Page
Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and 2021


PART 1. FINANCIAL INFORMATION
Item 1. Financial Statements
MERIDIANLINK, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)
As of
September 30, 2022
(unaudited)
December 31, 2021
Assets
Current assets:
Cash and cash equivalents
$115,752$113,645
Accounts receivable, net of allowance for doubtful accounts
32,03424,913
Prepaid expenses and other current assets
12,5429,398
Escrow deposit30,000
Total current assets
190,328147,956
Property and equipment, net5,0445,989
Right of use assets2,638
Intangible assets, net279,548298,597
Deferred tax assets, net10,7174,286
Goodwill571,554564,799
Other assets4,1704,266
Total assets
$1,063,999 $1,025,893
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
$2,173$2,335
Accrued liabilities
29,80724,667
Deferred revenue
22,65514,707
Current portion of long-term debt, net of debt issuance costs
3,3672,139
Total current liabilities
58,00243,848
Long-term debt, net of debt issuance costs423,599425,371
Long-term deferred revenue378
Deferred rent396
Other long-term liabilities1,527
Total liabilities
483,506469,615
Commitments and contingencies (Note 5)
Stockholders’ Equity
Preferred stock, $0.001 par value; 50,000,000 shares authorized; zero shares issued and outstanding at September 30, 2022 and December 31, 2021
Common stock, $0.001 par value; 600,000,000 shares authorized, 80,732,286 and 79,734,984 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively
12888
Additional paid-in capital614,222596,542
Accumulated deficit(33,857)(40,352)
Total stockholders’ equity580,493556,278
Total liabilities and stockholders’ equity$1,063,999$1,025,893
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
3

MERIDIANLINK, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
(in thousands, except share/unit and per share/unit data)
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Revenues, net$71,754 $67,367 $217,495 $203,652 
Cost of revenues:
Subscription and services
23,812 23,467 68,292 58,078 
Amortization of developed technology
4,003 3,219 11,287 9,190 
Total cost of revenues27,815 26,686 79,579 67,268 
Gross profit
43,939 40,681 137,916 136,384 
Operating expenses:
General and administrative
21,423 29,917 60,416 64,103 
Research and development
11,518 13,533 30,414 27,807 
Sales and marketing
6,311 5,994 16,519 13,817 
Acquisition related costs163  2,549 781 
Total operating expenses39,415 49,444 109,898 106,508 
Operating income (loss)4,524 (8,763)28,018 29,876 
Other (income) expense, net:
Other income(327)(9)(706)(39)
Interest expense, net
6,855 7,165 16,649 27,073 
Loss on debt repayment and extinguishment 4,351  4,351 
Total other expense, net6,528 11,507 15,943 31,385 
Income (loss) before provision for income taxes(2,004)(20,270)12,075 (1,509)
Provision for income taxes890 1,176 5,318 5,274 
Net income (loss)(2,894)(21,446)6,757 (6,783)
Class A preferred return (2,780) (20,944)
Net income (loss) attributable to common stockholders$(2,894)$(24,226)$6,757 $(27,727)
Net income (loss) per share:
Basic$(0.04)$(0.34)$0.08 $(0.47)
Diluted(0.04)(0.34)0.08 (0.47)
Weighted average common stock outstanding:
Basic80,659,320 71,697,083 80,353,399 58,495,073 
Diluted80,659,320 71,697,083 82,364,835 58,495,073 
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
4

MERIDIANLINK, INC.
CONDENSED CONSOLIDATED STATEMENTS OF PREFERRED UNITS AND STOCKHOLDERS’ EQUITY / MEMBERS’ DEFICIT
(unaudited)
(in thousands, except share/unit and per share/unit data)
Common StockAdditional Paid-in CapitalAccumulated DeficitStockholders’ Equity
SharesAmount
Balance at December 31, 2021
79,734,984$88$596,542$(40,352)$556,278
Vesting of restricted stock awards484,4013232
Vesting of RSUs76,937
Issuance of common stock due to exercise of stock options28,909179179
Share-based compensation expense3,8873,887
Net income7,4797,479
Balance at March 31, 2022
80,325,231120600,608(32,873)567,855
Vesting of restricted stock awards92,20966
Vesting of RSUs4,656
Issuance of common stock due to exercise of stock options1,00077
Issuance of common stock through employee stock purchase plan64,985922922
Repurchases of common stock(12,300)(193)(193)
Share-based compensation expense5,5485,548
Net income2,1722,172
Balance at June 30, 2022
80,475,781126607,085(30,894)576,317
Vesting of restricted stock awards11,49622
Vesting of RSUs259,868
Shares withheld related to net share settlement of RSUs(10,456)(184)(184)
Repurchases of common stock(4,403)(69)(69)
Share-based compensation expense7,3217,321
Net loss(2,894)(2,894)
Balance at September 30, 2022
80,732,286$128$614,222$(33,857)$580,493

5

MERIDIANLINK, INC.
CONDENSED CONSOLIDATED STATEMENTS OF PREFERRED UNITS AND STOCKHOLDERS’ EQUITY / MEMBERS’ DEFICIT
(unaudited)
(in thousands, except share/unit and per share/unit data)
Class A Preferred UnitsClass B Common UnitsCommon StockAdditional Paid-in CapitalAccumulated DeficitMembers’ Deficit / Stockholders’ Equity
SharesAmountSharesAmountSharesAmount
Balance at December 31, 2020319,913$319,91351,492,805$$$3,909$(30,338)$(26,429)
Payment of Class A units cumulative preferred return(12)(12)
Vesting of Class B carried equity units575,0043838
Repurchase of vested units(54)(54)(103,421)(38)(1,849)(1,887)
Unit-based compensation expense643643
Net income7,2317,231
Balance at March 31, 2021319,859319,85951,964,3882,703(23,119)(20,416)
Vesting of Class B carried equity units148,51699
Unit-based compensation expense665665
Net income7,4327,432
Balance at June 30, 2021319,859319,85952,112,90493,368(15,687)(12,310)
Effect of Corporate Conversion (Note 1)(319,859)(319,859)(52,112,904)(9)68,720,14069319,799(6)319,853
Issuance of common stock in connection with initial public offering, net of underwriters' discounts and commissions and issuance costs10,000,00010242,354242,364
Issuance of common stock due to exercise of stock options213,4081,3171,317
Vesting of restricted stock awards (formerly Class B carried equity units)573,3163838
Vesting of restricted stock units ("RSU")21,691
Share-based compensation expense25,57225,572
Net loss(21,446)(21,446)
Balance at September 30, 2021$$79,528,555$79$592,448$(37,139)$555,388
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
6

MERIDIANLINK, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
(in thousands)
Nine Months Ended September 30,
20222021
Cash flows from operating activities:
Net income (loss)$6,757$(6,783)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
39,74637,654
Amortization of debt issuance costs
1,7052,551
Share-based compensation expense16,50126,835
Loss on disposal of fixed assets164524
Loss on sublease liability
405
Loss on debt repayment and extinguishment4,351
Gain on change in fair value of earnout(162)
Other adjustments(18)
Deferred income taxes
5,1934,992
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable
(6,964)(2,033)
Prepaid expenses and other assets
(2,480)(6,179)
Accounts payable
(450)(961)
Accrued liabilities
(247)(2,271)
Deferred revenue
7,47210,016
Deferred rent
(71)
Net cash provided by operating activities67,23569,012
Cash flows from investing activities:
Acquisition, net of cash acquired – TazWorks, LLC(85,420)
Acquisition, net of cash and restricted cash acquired – Saylent Technologies, Inc.(35,945)
Acquisition, net of cash and restricted cash acquired – StreetShares, Inc.(23,138)
Escrow deposit(30,000)
Capitalized software additions
(6,323)(3,590)
Purchases of property and equipment
(889)(692)
Net cash used in investing activities(60,350)(125,647)
Cash flows from financing activities:
Repurchases of common stock(262)
Repurchases of Class A Units
(54)
Repurchases of Class B Units
(1,887)
Proceeds from initial public offering, net of underwriters’ discounts and commissions247,227
Proceeds from exercise of stock options1861,317
Payment due to effect of corporate conversion(6)
Proceeds from employee stock purchase plan922
Taxes paid related to net share settlement of RSUs(184)
Proceeds from long-term debt
100,000
Principal payments of long-term debt
(2,175)(202,590)
Payment of Regulation A+ investor note(3,265)
Payments of debt issuance costs
(1,970)
Payments of Class A cumulative preferred return
(12)
Payments of deferred offering costs
(4,435)
Payment to sellers of Teledata Communications, Inc(2,142)
Holdback payment to sellers of MeridianLink(25,665)
Net cash (used in) provided by financing activities(4,778)109,783
Net increase in cash, cash equivalents and restricted cash2,10753,148
Cash, cash equivalents and restricted cash, beginning of period113,64539,881
Cash, cash equivalents and restricted cash, end of period$115,752$93,029
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents$115,752$93,029
Restricted cash
Cash, cash equivalents, and restricted cash$115,752$93,029

7

MERIDIANLINK, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
(in thousands)

Nine Months Ended September 30,
20222021
Supplemental disclosures of cash flow information:
Cash paid for interest
$14,852$24,549
Cash paid for income taxes
1,179239
Non-cash investing and financing activities:
Regulation A+ investor note assumed in business combination$3,265$
Initial recognition of operating lease liability3,786
Initial recognition of operating lease right-of-use asset3,096
Share-based compensation expense capitalized to software additions25545
Shares withheld with respect to net settlement of RSUs184
Purchases of property and equipment included in accounts payable and accrued expenses2
Vesting of restricted stock awards and RSUs4085
Deferred offering costs included in accounts payable and accrued expenses423
Effect of corporate conversion (Note 1)320
Related party receivable net against holdback payment to prior shareholders4,335

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
8

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Note 1 – Organization and Description of Business
MeridianLink, Inc., and its wholly-owned subsidiaries, (collectively the “Company”) provides secure, cloud-based digital solutions that transform the ways in which traditional and emerging financial services providers engage with account holders and end users. The Company sells its solutions to financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies. The Company delivers its solutions to the substantial majority of its customers using a software-as-a-service (“SaaS”) model under which its customers pay subscription fees for the use of the Company’s solutions. The Company is controlled by its majority stockholder, which is represented by various investment funds of Thoma Bravo UBP, LLC and its affiliates (“Thoma Bravo”). The Company is headquartered in Costa Mesa, California.
Corporate Conversion
Prior to July 27, 2021, the Company operated as a Delaware limited liability company under the name Project Angel Parent, LLC (“Parent”), which directly and indirectly held all the equity interests in its operating subsidiaries. On May 31, 2018, a subsidiary of Parent acquired all the outstanding common stock of MeridianLink, Inc. (“MeridianLink”). Under the terms of the Amended and Restated Limited Liability Company Operating Agreement (“Agreement”), dated as of May 31, 2018, of Parent, the members were not obligated for debt, liabilities, contracts or other obligations of Parent. Profits and losses were allocated to members as defined in the Agreement.
On July 27, 2021, prior to the effectiveness of the registration statement for the Company’s initial public offering, MeridianLink, the then operating company and the indirect wholly owned subsidiary of Project Angel Parent, LLC, changed its name to ML California Sub, Inc, and Project Angel Parent, LLC converted into a Delaware corporation pursuant to a statutory conversion and changed its name to MeridianLink, Inc. As a result of the corporate conversion, MeridianLink, Inc. succeeded to all property and assets and debts and obligations of Project Angel Parent, LLC. Effective July 27, 2021, MeridianLink, Inc. is governed by its certificate of incorporation filed with the Delaware Secretary of State and its bylaws.
Upon its conversion into a corporation, the Company converted each of its outstanding Class A preferred units (“Class A Units”) into a number of shares of common stock equal to the result of the accrued preferred return price per Class A Unit divided by the per share of common stock conversion price determined by the board of directors to be $25.50. The preferred return price for each Class A Unit was equal to the future value of $1,000 at a 9% interest rate compounded quarterly over the time passed since the issuance of such unit. Upon the Company’s conversion into a corporation, the outstanding Class A Units converted into an aggregate of 16,607,235 shares of common stock and were reclassified into permanent equity. Additionally, all the outstanding Class B common units (“Class B Units”) converted into an aggregate of 53,646,668 shares of common stock on a one-for-one basis. At the time of the corporate conversion there were 1,533,763 of such shares that remained subject to future vesting and were not included in the outstanding shares. Following the Corporate Conversion, there were no units of Class A Units outstanding.
The effects of the events described in the preceding two paragraphs are collectively referred to as the “Corporate Conversion.”
Initial Public Offering and Reverse Stock Split
On July 30, 2021, the Company completed its initial public offering (“IPO”) through an underwritten sale of 13.2 million shares of its common stock, of which 10.0 million newly issued shares were sold by the Company at a price to the public of $26.00 per share. The Company received net proceeds of approximately $242.1 million after deducting approximately $17.9 million in underwriting discounts, commissions, and offering-related expenses.
The IPO also included the sale of 3.2 million shares of our common stock by the selling stockholders. The Company did not receive any proceeds from the sale of common stock by the selling stockholders. Additionally, the selling stockholders granted the underwriters an option, exercisable for 30 days after the effective date of the Prospectus, to purchase up to 2.0 million additional shares of common stock. The option was exercised for 1.2 million additional shares on August 26, 2021.
9

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
In connection with the listing of the Company’s common stock on the New York Stock Exchange (the “NYSE”), the Company entered into indemnification agreements with its directors and certain officers and employees that require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or services as directors, officers, or employees.
In advance of the IPO, on July 16, 2021, the Company effected a 1-for-2 reverse unit split of the Company’s Class B Units, whereby every two Class B Units converted into one Class B Unit. All Class B Unit and per unit information included in the accompanying condensed consolidated financial statements have been adjusted to reflect this reverse unit split for all periods presented. Following the Corporate Conversion, there were no units of Class B Units outstanding.
Note 2 – Significant Accounting Policies
Basis of Presentation
The unaudited condensed consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany balances and transactions have been eliminated in consolidation.
Unaudited Condensed Consolidated Financial Information
In the Company's opinion, the unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and include all adjustments, consisting of normal, recurring adjustments, necessary for a fair presentation. Certain information and disclosures normally included in the notes to the annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted from these unaudited condensed consolidated financial statements pursuant to the rules and regulations of the SEC. Accordingly, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (“Annual Report”). The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any other period.
Use of Estimates
The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the reported amounts of revenues and expenses. Significant items subject to such estimates include revenue recognition including determining the nature and timing of satisfaction of performance obligations and variable consideration; share-based compensation; the fair value of acquired intangibles; the capitalization of software development costs; the useful lives of long-lived intangible assets; impairment of goodwill and long-lived assets; and income taxes. In accordance with GAAP, management bases its estimates on historical experience and on various other assumptions that management believes are reasonable under the circumstances. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from those estimates.
Significant Accounting Policies
The Company’s significant accounting policies are discussed in Note 2, “Significant Accounting Policies” in the Company’s Annual Report. There have been no changes to the Company’s significant accounting policies described in the Company’s Annual Report that have had a material impact on its condensed consolidated financial statements and related notes, except for updates resulting from the adoption of ASU 2016-02, “Leases (Topic 842)” as discussed below.
10

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
Leases
Leases arise from contractual obligations that convey the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. At the inception of the contract, the Company determines if an arrangement contains a lease based on whether there is an identified asset and whether the Company controls the use of the identified asset. The Company also determines the classification of that lease, between financing and operating, at the lease commencement date. The Company accounts for and allocates consideration to the lease and non-lease components as a single lease component.
A right-of-use (“ROU”) asset represents the Company’s right to use an underlying asset, and a lease liability represents the Company’s obligation to make payments during the lease term. ROU assets are recorded and recognized at commencement for the lease liability amount, adjusted for initial direct costs incurred and lease incentives received, and adjusted for prepaid or accrued lease payments. Lease liabilities are recorded at the present value of the future lease payments over the lease term at commencement. The discount rate used to determine the present value is the incremental borrowing rate, unless the interest rate implicit in the lease is readily determinable. As the implicit rate for the operating leases is generally not determinable, the Company uses an incremental borrowing rate as the discount rate at the lease commencement date to determine the present value of lease payments. The Company determines the discount rate of the leases by considering various factors, such as the credit rating, interest rates of similar debt instruments of entities with comparable credit ratings, jurisdictions, and the lease term.
The Company’s operating leases typically include non-lease components such as common-area maintenance costs, utilities, and other maintenance costs. For real estate leases, the Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.
The Company’s lease terms may include options to extend or terminate the lease. The Company generally uses the base, non-cancelable, lease term when recognizing the lease assets and liabilities, unless it is reasonably certain that the Company will exercise those options. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
The Company’s ROU assets are included in right of use assets and the current and non-current portions of the lease liabilities are included in accrued liabilities and other long-term liabilities, respectively, on the condensed consolidated balance sheets. The Company does not record leases with terms of 12 months or less on the condensed consolidated balance sheets. Lease expense is recognized on a straight-line basis over the expected lease term.
The Company has entered into subleases, or has made decisions and taken actions to exit and sublease certain unoccupied leased office space. Sublease income is recorded as a reduction of rent expense straight-line over the term of the sublease. The Company tests ROU assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. For leased assets, such circumstances would include the decision to leave a leased facility prior to the end of the minimum lease term or subleases for which estimated cash flows do not fully cover the costs of the associated lease. No impairment of ROU assets was recorded during the nine months ended September 30, 2022.
Accounting Pronouncements Recently Adopted
The Company is an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and has elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies.
11

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
ASU 2016-02, “Leases (Topic 842)”
The new standard establishes a right-of-use model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the condensed consolidated statements of operations. The new standard provides for a modified retrospective approach which requires recognition at the beginning of the earliest comparative period presented of leases that exist at that date, as well as adjusting equity at the beginning of the earliest comparative period presented as if the new standard had always been applied. In July 2018, the FASB issued ASU 2018-11, which provides an additional transition method. Under the additional transition method, an entity initially applies the new lease guidance at the adoption date (rather than at the beginning of the earliest period presented). Therefore, an entity which elects the additional transition method would apply Topic 840 in the comparative periods and recognize the effects of applying Topic 842 as a cumulative adjustment to retained earnings as of the adoption date. If an entity elects the new transition method, it is required to provide the Topic 840 disclosures for all prior periods presented that remain under the legacy lease guidance.
The Company adopted the new standard on January 1, 2022, utilizing the optional transition approach to not apply Topic 842 in the comparative periods presented. Additionally, the Company elected the package of practical expedients to not (1) reassess whether any expired or existing contracts are considered or contain leases; (2) reassess the lease classification for any expired or existing leases; and (3) reassess the initial direct costs for any existing leases. The most significant impact upon adoption was related to its long-term office space leases that resulted in the recognition of right of use assets and related liabilities of approximately $2.6 million and $3.4 million, respectively, on the Company’s condensed consolidated balance sheets.
ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”
The amendments in this ASU require that an acquirer recognizes and measures contract assets and contract liabilities acquired in a business combination in accordance with Topic 606 rather than at fair value. The ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted.
The Company adopted the new standard on January 1, 2022, prospectively, for business combinations that occur subsequent to the adoption date. The adoption did not have a material impact on the Company’s condensed consolidated financial statements.
Recent Accounting Pronouncements Not Yet Adopted
ASU 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.”
Rather than generally recognizing credit losses when it is probable that the loss has been incurred, the revised guidance requires companies to recognize an allowance for credit losses for the difference between the amortized cost basis of a financial instrument and the amount of amortized cost that the company expects to collect over the instrument’s contractual life.
ASU 2016-13 is effective for the Company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years; early adoption is permitted. The Company intends to adopt the new standard as of January 1, 2023 as a cumulative effect adjustment to retained earnings. The Company does not expect the adoption of this guidance to have a material impact on its condensed consolidated financial statements and disclosures.
12

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”
The standard simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 related to the approach for intraperiod tax allocation and the recognition of deferred tax liabilities for outside basis differences and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard also improves consistent application of and simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance.
For the Company, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted. The Company intends to adopt the new standard as of January 1, 2023 and does not expect the adoption of this guidance to have a material impact on its condensed consolidated financial statements and disclosures.
ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”
ASU 2020-04 provides optional guidance for a limited time to ease the potential accounting burden associated with transitioning away from reference rates, such as the London Inter-Bank Offered Rate (LIBOR), which regulators in the United Kingdom are currently phasing out. The expedients and exceptions provided by ASU 2020-04 are for the application of U.S. GAAP to contracts, hedging relationships, and other transactions affected by the rate reform, and will not be available after December 31, 2022, other than for certain hedging relationships entered into before December 31, 2022. Companies can apply the ASU immediately. However, the guidance will only be available for a limited time. The Company is currently evaluating the impact of this guidance on its condensed consolidated financial statements and related disclosures.
Note 3 – Revenue Recognition
Disaggregation of Revenue
The following table disaggregates the Company’s net revenues by solution type (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Lending Software Solutions
$52,414 $44,657 $153,249 $133,034 
Data Verification Software Solutions
19,340 22,710 64,246 70,618 
Total$71,754 $67,367 $217,495 $203,652 
Lending Software Solutions accounted for 73% and 66% of total revenues for the three months ended September 30, 2022, and 2021, respectively. Data Verification Software Solutions accounted for 27% and 34% of total revenues for the three months ended September 30, 2022 and 2021, respectively.
Lending Software Solutions accounted for 70% and 65% of total revenues for the nine months ended September 30, 2022, and 2021, respectively. Data Verification Software Solutions accounted for 30% and 35% of total revenues for the nine months ended September 30, 2022 and 2021, respectively.
The following table disaggregates the Company’s net revenues by major source (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Subscription fees$61,861 $58,988 $188,860 $179,732 
Professional services7,293 5,706 21,070 16,812 
Other2,600 2,673 7,565 7,108 
Total revenues$71,754 $67,367 $217,495 $203,652 
13

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
Deferred Revenue
The deferred revenue balance consists of subscription and implementation fees which have been invoiced up front and are recognized as revenue only when the revenue recognition criteria are met. The Company’s subscription contracts are typically invoiced to its customers annually, and revenue is recognized ratably over the service term. Any fees invoiced up front for contracts that have a service term that extend multiple years, the portion of deferred revenue that will be recognized beyond 12 months from the date of the financial statements, are classified as long-term deferred revenue.

The changes in the Company’s deferred revenue as of September 30, 2022 and 2021 were as follows (in thousands):
Nine Months Ended September 30,
20222021
Deferred revenue, beginning balance$14,707 $10,873 
Billing of transaction consideration225,821 213,668 
Revenue recognized(217,495)(203,652)
Deferred revenue, ending balance$23,033 $20,889 
Deferred revenue, current$22,655 $20,889 
Long-term deferred revenue378  
Total deferred revenue$23,033 $20,889 
Assets Recognized from Costs to Obtain a Contract with a Customer
Sales commissions related to the Company’s customer agreements are capitalized and charged to expense over the expected period of customer benefit. Current costs are included in prepaid expenses and other current assets, and non-current costs are included in other assets on the accompanying condensed consolidated balance sheets. The following table represents the changes in contract cost assets (in thousands):
Nine Months Ended September 30,
20222021
Beginning balance$5,835 $3,207 
Additions2,114 2,832 
Amortization(1,856)(1,014)
Ending balance$6,093 $5,025 
Contract cost assets, current$2,835 $2,004 
Contract cost assets, noncurrent3,258 3,021 
Total deferred contract cost assets$6,093 $5,025 

Allowance for Doubtful Accounts
Allowance for doubtful accounts as of September 30, 2022 and December 31, 2021 was $0.2 million and $0.2 million, respectively.
14

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
Note 4 – Balance Sheet Components
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following (in thousands):
As of
September 30, 2022
As of
December 31, 2021
Prepaid expenses$8,309 $6,752 
Contract cost assets – current2,835 2,402 
Income tax receivable989  
Others409 244 
Total prepaid expenses and other current assets$12,542 $9,398 
Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
As of
September 30, 2022
As of
December 31, 2021
Computer equipment and software $8,795 $7,995 
Leasehold improvements3,015 2,994 
Office equipment and furniture1,250 1,378 
Total13,060 12,367 
Less: Accumulated depreciation(8,016)(6,378)
Property and equipment, net$5,044 $5,989 
Depreciation expense amounted to $0.6 million for both the three months ended September 30, 2022 and 2021, and $1.7 million for both the nine months ended September 30, 2022 and 2021. The Company disposed of office furniture that resulted in a loss of $0.0 million and $0.3 million during the three months ended September 30, 2022 and 2021, respectively, and $0.2 million and $0.5 million during the nine months ended September 30, 2022 and 2021, respectively. The losses are included in general and administrative expenses in the accompanying condensed consolidated statements of operations.
Intangible Assets, Net
Intangible assets, net consisted of the following (in thousands):
As of September 30, 2022
Gross AmountAccumulated AmortizationNet Carrying Amount
Customer relationships$329,100 $(123,870)$205,230 
Developed technology86,600 (37,375)49,225 
Trademarks24,275 (9,502)14,773 
Non-competition agreements600 (450)150 
Capitalized software17,481 (7,311)10,170 
Total intangible assets, net$458,056 $(178,508)$279,548 
15

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
As of December 31, 2021
Gross AmountAccumulated AmortizationNet Carrying Amount
Customer relationships$328,600 $(99,320)$229,280 
Developed technology74,800 (29,207)45,593 
Trademarks24,175 (7,474)16,701 
Non-competition agreements600 (225)375 
Capitalized software10,902 (4,254)6,648 
Total intangible assets, net$439,077 $(140,480)$298,597 
The weighted average remaining useful lives for intangible assets at September 30, 2022 were as follows:
Weighted Average Remaining Useful Life
Customer relationships6 years
Developed technology5 years
Trademarks6 years
Non-competition agreements1 year
Capitalized software3 years
Amortization expense related to intangible assets was as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Cost of revenues$4,003 $3,219 $11,287 $9,190 
General and administrative expense8,790 8,906 26,741 26,721 
Total amortization expense$12,793 $12,125 $38,028 $35,911 
The estimated future amortization of intangible assets as of September 30, 2022 was as follows (in thousands):
Years ending December 31,
2022 (remaining three months)
$13,003 
202350,531 
202448,584 
202542,750 
202638,794 
Thereafter85,886 
Total amortization expense$279,548 
16

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
Accrued Liabilities
Accrued liabilities consisted of the following (in thousands):
As of
September 30, 2022
As of
December 31, 2021
Accrued payroll and payroll-related expenses$9,056 $8,522 
Accrued costs of revenues6,135 2,217 
Accrued operating costs3,789 2,099 
Accrued bonuses4,174 6,708 
Sales tax liability from acquisitions2,939 2,939 
Lease liability – current1,401 233 
Other accrued expenses2,313 1,949 
Total accrued liabilities$29,807 $24,667 
Note 5 – Commitments and Contingencies
Legal Matters
The Company is, and from time to time may be, involved in legal proceedings and claims arising out of the Company’s operations in the ordinary course of business. Management is not currently aware of any legal proceedings or claims against it that could have a material adverse effect on the financial position, results of operations, or cash flows of the Company.
Other Contractual Commitments
The Company’s contractual commitments primarily consist of third-party cloud infrastructure agreements and service subscription arrangements used to support operations at the enterprise level. Future minimum payments under the Company’s non-cancelable purchase commitments as of September 30, 2022 are as follows (in thousands):
Contractual Commitments
Years ending December 31,
2022 (remaining three months)$ 
2023375 
2024395 
20257,911 
Total$8,681 
Note 6 – Leases
The Company leases office space and server equipment under various operating lease agreements that expire through December 2026. The Company recognizes the related rent expense on a straight-line basis over the term of each lease. Free rent and rental increases are recognized on a straight-line basis over the term of each lease.
As of September 30, 2022, the weighted average remaining lease term was three years and the weighted average discount rate was 5.7%. The Company does not have any finance leases as of September 30, 2022.
One lease is with a related party with a termination date of December 2022. The monthly payments during each of the nine months ended September 30, 2022 and 2021 were $0.1 million. The monthly payments are subject to annual increases.
17

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
The Company also has subleases of former office spaces which expire at various dates from 2022 to 2026. Sublease income from operating leases, which is recorded as a reduction of rental expense, was $0.1 million for both the three months ended September 30, 2022 and 2021, and $0.3 million and $0.2 million for the nine months ended September 30, 2022 and 2021, respectively. One of the subleases was entered into during March 2022 resulting in a total loss of $0.1 million from the disposal of related assets. The loss is included in general and administrative expense on the condensed consolidated statements of operations for the nine months ended September 30, 2022.
Rent expense, gross of sublease income, has been recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 (in thousands):
Three Months Ended
September 30, 2022
Nine Months Ended
September 30, 2022
Cost of revenues$201 $507 
General and administrative23 187 
Research and development170 387 
Sales and marketing66 163 
Total rent expense$460 $1,244 
The following table presents supplemental cash flow information about the Company’s leases (in thousands):
Nine Months Ended
September 30, 2022
Cash paid for amounts included in the measurement of lease liabilities$1,563 
Operating lease assets obtained in exchange for new operating lease liabilities1,082 
The following table presents supplemental balance sheet information about the Company’s leases (in thousands):
As of
September 30, 2022
Operating lease ROU assets$2,638 
Operating lease liabilities, current$1,401 
Noncurrent operating lease liabilities1,511 
Total operating lease liabilities$2,912 
As of September 30, 2022, remaining maturities of lease liabilities were as follows (in thousands):
Related PartyThird PartyTotal
Years Ending December 31,
2022 (remaining three months)$219 $226 $445 
2023 1,259 1,259 
2024 843 843 
2025 321 321 
2026 244 244 
Total operating lease payments (1)
219 2,893 3,112 
Less: imputed interest(1)(199)(200)
Total operating lease liabilities$218 $2,694 $2,912 
______________
(1)Presented gross of sublease income. The Company expects to receive sublease income of approximately $0.1 million in the remainder of the year ended December 31, 2022, $0.3 million in 2023, and $0.2 million thereafter.
18

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
As of December 31, 2021, prior to the adoption of Topic 842, the aggregate future non-cancelable minimum rental payments and expected sublease receipts were as follows (in thousands):
Related PartyThird PartySublease ReceiptsTotal
Years Ending December 31,
2022$875 $736 $(293)$1,318 
2023 753 — 753 
2024 722 — 722 
2025 319 — 319 
2026 244 — 244 
Thereafter  —  
Total future minimum lease payments$875 $2,774 $(293)$3,356 
Rent expense for the three and nine months ended September 30, 2021 was as follows (in thousands):
Three Months Ended September 30, 2021Nine Months Ended September 30, 2021
Cost of revenues$156 $608 
General and administrative41 153 
Research and development100 393 
Sales and marketing44 174 
Total rent expense$341 $1,328 
As of December 31, 2021, the Company had an accrued lease termination liability related to leased office space it ceased using during February 2021. The termination liability as of December 31, 2021 was $0.2 million. Upon adoption of Topic 842 on January 1, 2022, the termination liability was removed as an adjustment to the related right of use asset.
Note 7 – Long-Term Debt
Long-term debt consisted of the following (in thousands):
As of
September 30, 2022
As of
December 31, 2021
2021 Term loan
$432,825 $435,000 
Debt issuance costs
(5,859)(7,490)
Total debt, net
426,966 427,510 
Less: Current portion of long-term debt
2021 Term loan4,350 3,263 
Debt issuance costs
(983)(1,124)
Total current portion of long-term debt, net
3,367 2,139 
Total non-current portion of long-term debt, net
$423,599 $425,371 
Amortization of deferred financing fees was $0.3 million and $0.7 million for the three months ended September 30, 2022 and 2021, respectively. Total interest expense, excluding amortization of deferred financing fees, was $6.6 million and $6.4 million for the three months ended September 30, 2022 and 2021, respectively.

Amortization of deferred financing fees was $1.7 million and $2.6 million for the nine months ended September 30, 2022 and 2021, respectively. Total interest expense, excluding amortization of deferred financing fees, was $14.9 million and $24.5 million for the nine months ended September 30, 2022 and 2021, respectively.
19

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
2021 Credit Agreement
On November 10, 2021, the Company entered into a credit agreement (the “2021 Credit Agreement”), which provides for a term loan facility (the “2021 Term Loan”) in an aggregate principal amount of $435.0 million, and a revolving credit facility (the “2021 Revolving Credit Facility”) in an aggregate principal amount of $50.0 million, inclusive of a $10.0 million letter of credit sub-facility. The Company used the proceeds from the 2021 Term Loan to pay all outstanding amounts due under the Company’s previous 2018 First Lien plus certain fees and expenses. The 2021 Term Loan and 2021 Revolving Credit Facility mature on November 10, 2028 and November 10, 2026, respectively. The Company has not drawn on the 2021 Revolving Credit Facility as of September 30, 2022.
The obligations under the 2021 Credit Agreement are secured by a lien on substantially all tangible and intangible property of the Company, subject to customary exceptions, limitations, and exclusions from the collateral.
The 2021 Credit Agreement contains customary affirmative covenants, negative covenants and events of default, including covenants and restrictions that, among other things, require the Company to satisfy a financial covenant, and restricts or limits the ability of the Company to grant or incur liens, incur additional indebtedness, enter into joint ventures or partnerships, engage in mergers and acquisitions, engage in asset sales, and declare dividends on its capital stock, subject in each case to certain customary exceptions. A failure to comply with certain covenants could permit the lenders to declare the 2021 Term Loan, and any then outstanding borrowings on the 2021 Revolving Credit Facility, together with accrued interest and fees thereon, to be immediately due and payable. The Company was in compliance with all financial covenants of the 2021 Credit Agreement at September 30, 2022.
2021 Term Loan
Borrowings under the 2021 Term Loan bear interest at a variable rate, elected by the Company, equal to the Base Rate (as defined in the 2021 Credit Agreement) or the Adjusted Eurocurrency Rate (as defined in the 2021 Credit Agreement), plus, an initial margin based on the Company’s Consolidated First Lien Net Leverage Ratio (as defined by the 2021 Credit Agreement), which was 3.00% at September 30, 2022. Beginning in June 2022, the Company is required to make quarterly principal payments equal to 0.25% of the original principal, with the remainder due at maturity.
Debt issuance costs of $7.6 million were included as a reduction of the debt balance on the condensed consolidated balance sheets and are amortized into interest expense over the contractual life of the loans using the effective interest method. Included in the debt issuance costs were $4.8 million incurred in connection with the 2021 Term Loan, and $2.8 million carried forward from the Company’s previous 2018 First Lien. The Company recognized $0.3 million and $1.6 million of amortization of debt issuance costs for the 2021 Term Loan during the three and nine months ended September 30, 2022, respectively. The effective interest rate on the 2021 Term Loan was 6.2% as of September 30, 2022.
2021 Revolving Credit Facility
Borrowings under the 2021 Revolving Credit Facility bear interest, at the election of the Company, at a rate equal to the Base Rate (as defined in the 2021 Credit Agreement) or the Adjusted Eurocurrency Rate (as defined in the 2021 Credit Agreement), plus, in each case, the Applicable Rate (as defined in the 2021 Credit Agreement), which shall vary based on the Company’s Consolidated First Lien Net Leverage Ratio.
In connection with the 2021 Revolving Credit Facility, the Company incurred $0.5 million in debt issuance costs. Expenses associated with the issuance of the revolving credit facility are presented in the accompanying condensed consolidated balance sheets in prepaid expenses and other current assets and other assets, and are amortized to interest expense over the life of the 2021 Revolving Credit Facility using the straight-line method. The remaining unamortized debt issuance costs were $0.4 million and $0.5 million as of September 30, 2022 and December 31, 2022, respectively.
The 2021 Revolving Credit Facility also requires a quarterly commitment fee based on the Company’s consolidated first lien net leverage ratio. As of September 30, 2022, the applicable rate was 0.5%, which was applied against the $50.0 million unused revolving credit facility balance.
20

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
Future Principal Payments
Future principal payments of long-term debt as of September 30, 2022 were as follows (in thousands):
Years ending December 31,
2022 (remaining three months)$1,087 
20234,350 
20244,350 
20254,350 
20264,350 
Thereafter414,338 
Total$432,825 
Note 8 - Stockholders’ Equity
Stock Repurchase Program
In May 2022, the Company’s board of directors authorized a new stock repurchase program to acquire up to $75.0 million of the Company’s common stock, with no requirement to purchase any minimum number of shares. The manner, timing, and actual number of shares repurchased under the program will depend on a variety of factors, including price, working capital needs, general business and market conditions, regulatory requirements, and other investment opportunities. Shares may be repurchased through privately negotiated transactions, or open market purchases, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934. The repurchase program may be commenced, suspended, or terminated at any time by the Company at its discretion without prior notice.

The Company retires the repurchased shares, which shall automatically return to the status of authorized but unissued shares of common stock. During the three months ended September 30, 2022, the Company repurchased 4,403 shares of its common stock for approximately $0.1 million, including commissions and fees. During the nine months ended September 30, 2022, the Company repurchased 16,703 shares of its common stock for approximately $0.3 million, including commissions and fees. As of September 30, 2022, there was a total of $74.7 million remaining for repurchase under the stock repurchase program.
Note 9 – Share-based Compensation
2021 Stock Option and Incentive Plan
The 2021 Stock Option and Incentive Plan (the “2021 Plan”) was adopted by the board of directors and approved by the Company’s stockholders following the Corporate Conversion and became effective as of July 26, 2021. The 2021 Plan replaced both the Company’s 2019 Equity Option Plan (the “2019 Plan”) and the Project Angel Parent, LLC Equity Plan (the “2018 Plan”). Outstanding options to purchase Class B Units granted under the 2019 Plan were converted into options to purchase shares of common stock, and all outstanding Carried Equity Units granted under the 2018 Plan were converted into restricted stock awards (“RSAs”), both of which have been granted under the 2021 Plan.
The Company had initially reserved 13,171,588 shares of its common stock for the issuance of awards under the 2021 Plan. The 2021 Plan provides that the number of shares reserved and available for issuance under the 2021 Plan will automatically increase on January 1, 2022 and each January 1 thereafter, by 5% of the outstanding number of shares of common stock on the immediately preceding December 31, or such lesser number of shares as determined by the Company’s compensation committee. The number of shares reserved under the 2021 Plan is subject to adjustment in the event of a stock split, stock dividend, or other change in the Company’s capitalization.
The 2021 Plan provides flexibility to the Company’s compensation committee to use various equity-based incentive awards as compensation tools to motivate the Company’s workforce. The incentive awards that may be granted under the 2021 Plan include, but are not limited to, options to purchase common stock, stock appreciation rights, restricted shares of common stock, restricted stock units, and cash bonuses.
21

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
Stock Options
A summary of stock option activity during the nine months ended September 30, 2022 is as follows (in thousands, except options, price per option, and term amounts):
Number of OptionsWeighted Average Exercise PriceWeighted Average Remaining Contract TermAggregate Intrinsic Value
Outstanding – January 1, 2022
4,256,812 $13.05 
8.44
$42,429 
Granted
927,364 17.09 
Exercised(29,909)6.22 
Forfeited(331,781)21.04 
Outstanding – September 30, 2022
4,822,486 $13.32 
7.90
$26,811,786 
Vested and expected to vest in the future at September 30, 2022
4,822,486 13.32 
7.90
26,811,786 
Exercisable at September 30, 2022
2,833,199 $8.56 
7.15
$25,074,833 
The total fair value of options that vested during the three months ended September 30, 2022 and 2021 was $4.9 million and $10.6 million, respectively, and for the nine months ended September 30, 2022 and 2021 was $6.6 million and $12.1 million, respectively.

The total intrinsic value of options exercised during the three months ended September 30, 2022 and 2021 was $0.0 million and $4.2 million, respectively, and for the nine months ended September 30, 2022 and 2021 was $0.4 million and $4.2 million, respectively.
The Company recognized approximately $2.1 million and $11.8 million in share-based compensation expense related to time-based and performance-based stock options for the three months ended September 30, 2022 and 2021, respectively, and $5.1 million and $12.8 million for the nine months ended September 30, 2022 and 2021, respectively. Included in the amounts of share-based compensation for the three and nine months ended September 30, 2021, is the acceleration of stock-based compensation expense in the amount of $10.3 million related to 500,000 options to purchase common stock, which became fully vested upon the completion of the Company’s IPO.
During the three and nine months ended September 30, 2022 and 2021, performance-based options were probable of vesting and, therefore, were included as part of share-based compensation expense.
As of September 30, 2022, there was approximately $19.1 million of unrecognized share-based compensation expense related to stock options, which is expected to be recognized over a weighted-average period of approximately 2.86 years.
Restricted Stock Awards
The number of restricted stock awards that vested during the three and nine months ended September 30, 2022 was 11,496 and 588,106, respectively. The liability balance as of September 30, 2022, related to the unvested RSAs was $0.0 million. As of September 30, 2022, the number of unvested RSAs amounted to 75,102. There were a total of 0 and 27,146 RSAs cancelled or forfeited during the three and nine months ended September 30, 2022, respectively.
The Company recognized approximately $0.1 million and $0.2 million in share-based compensation expense related to the vesting of RSAs for the three and nine months ended September 30, 2022. The Company recognized $11.2 million and $11.5 million in share-based compensation expense related to the vesting of RSAs during the three and nine months ended September 30, 2021. Included in the amounts of share-based compensation for the three and nine months ended September 30, 2021, is the acceleration of stock-based compensation expense in the amount of $11.1 million related to 426,657 Carried Equity Units, which became fully vested upon the completion of the Company’s IPO.

Share-based compensation expense related to the excess of fair value per unit on date of issuance over the $0.06 per share purchase price paid by the participants, has been recognized as additional compensation expense attributable to the participants.
22

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
Restricted Stock Units
A summary of restricted stock unit (“RSU”) activity during the nine months ended September 30, 2022, is as follows:
Number of RSUsWeighted Average Grant Date Fair Value
Non-vested – January 1, 2022
1,073,529 $25.76 
Granted
2,708,097 17.94 
Vested(341,461)25.89 
Forfeited(266,138)21.42 
Non-vested – September 30, 2022
3,174,027 $19.44 
As of September 30, 2022, 3,174,027 RSUs are expected to vest. The Company recognized approximately $4.9 million and $11.0 million in share-based compensation expense related to RSUs for the three and nine months ended September 30, 2022, respectively. The Company recognized $2.3 million in share-based compensation expense related to RSUs for both the three and nine months ended September 30, 2021.
As of September 30, 2022, there was approximately $54.5 million of unrecognized share-based compensation expense related to RSUs, which is expected to be recognized over a weighted-average period of approximately 3.26 years.
Employee Stock Purchase Program
As of September 30, 2022, the Company has issued 64,985 shares of common stock pursuant to the 2021 Employee Stock Purchase Plan under its employee stock purchase program (“ESPP”). As of September 30, 2022, there was approximately $0.1 million of unrecognized share-based compensation related to the ESPP that is expected to be recognized over the remaining term of the current offering period. The Company recognized $0.2 million and $0.5 million of share-based compensation expense related to the ESPP for the three and nine months ended September 30, 2022, respectively.
Share-Based Compensation
Share-based compensation for share-based awards granted to participants has been recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021 as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Cost of revenues$1,352 $5,296 $3,567 $5,461 
General and administrative3,170 12,158 6,947 12,864 
Research and development (1)
2,092 6,194 4,457 6,358 
Sales and marketing639 1,879 1,530 2,152 
Total share-based compensation expense $7,253 $25,527 $16,501 $26,835 
______________
(1)Net of $0.1 million and $0.3 million additions to capitalized software on the Company’s condensed consolidated balance sheets during the three and nine months ended September 30, 2022, respectively, and $0.1 million during both the three and nine months ended September 30, 2021.
23

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
Note 10 – Income Taxes
In accordance with applicable accounting guidance, the Company is required to use an estimated annual effective tax rate to compute its tax provision during an interim period. The Company’s provision for income taxes reflected an effective tax rate of approximately (44)% and (6)% for the three months ended September 30, 2022 and 2021, respectively, and 44% and (350)% for the nine months ended September 30, 2022 and 2021, respectively. During the three and nine months ended September 30, 2022, the Company’s effective tax rate differs from the U.S. federal statutory rate primarily due to R&D credits, state taxes, permanent unfavorable differences related to share-based compensation expense, transaction expenses, certain employee remuneration under section 162(m) of the Internal Revenue Code and other expected permanent differences. During the three and nine months ended September 30, 2021, the Company’s effective tax rate differs from the U.S. federal statutory rate as ASC 740 generally requires providing for income taxes during interim periods based on the estimated annual effective tax rate (“AETR”) for the full fiscal year. For the three and nine months ended September 30, 2021, the Company calculated its income tax provision as though the interim year to date period was an annual period, referred to herein as the discrete method. The Company believes that the application of the AETR method was impractical at the time, given that normal deviations in the projected pre-tax net income (loss) for the Company due to certain employee remuneration limited under section 162(m) of the Internal Revenue Code and certain employee share-based remuneration that the Company recognized due to the Company becoming a public issuer of its securities in the three months ended September 30, 2021.
The Company has gross unrecognized tax benefits with respect to R&D credits of $2.3 million as of September 30, 2022 and $1.9 million as of December 31, 2021. There are no penalties or interest recorded on these liabilities as the credits have not yet been utilized.
The Company assesses whether a valuation allowance should be recorded against its deferred tax assets based on the consideration of all available evidence, using a “more likely than not” realization standard. The four sources of taxable income that must be considered in determining whether deferred tax assets will be realized are: (l) future reversals of existing taxable temporary differences (i.e., offset of gross deferred tax assets against gross deferred tax liabilities); (2) taxable income in prior carryback years, if carryback is permitted under the applicable tax law; (3) tax planning strategies; and (4) future taxable income exclusive of reversing temporary differences and carryforwards. Based on the evaluation of the evidence and sources of taxable income, the Company has determined that no valuation allowance is necessary as of September 30, 2022.
Note 11 – Related Party Transactions
The Company has leased one property from a related party. Rental expense for this property totaled $0.2 million for both the three months ended September 30, 2022 and 2021, and $0.5 million for both the nine months ended September 30, 2022 and 2021.
On May 31, 2018, the Company entered into an Advisory Services Agreement with Thoma Bravo, a private equity firm, that owns the majority of the Company through private equity funds managed by the firm. During the three and nine months ended September 30, 2021, the Company recorded $0.2 million and $1.2 million, respectively, in general and administrative expenses on the accompanying condensed consolidated statements of operations for management and advisory fees. The Advisory Services Agreement was terminated upon completion of the IPO.
During the three and nine months ended September 30, 2022, the Company recorded $0.4 million and $1.3 million, respectively, in cost of revenues for third party expenses with a Thoma Bravo affiliated company, and $0.4 million and $1.2 million, respectively, for the three and nine months ended September 30, 2021. As of September 30, 2022, the Company had prepaid expenses of $0.2 million, accounts payable of $0.1 million, and accrued liabilities of $0.3 million with a Thoma Bravo affiliated company. As of December 31, 2021, the Company had prepaid expenses of $0.1 million, accounts payable of $0.2 million, and accrued liabilities of $0.2 million with a Thoma Bravo affiliated company.
24

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
Note 12 – Net Income (Loss) Per Share
The following table presents the calculation of basic and diluted net income (loss) per share (in thousands, except share and per share data):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Basic and diluted net income (loss) per share
Numerator:
Net income (loss) attributable to common stockholders
$(2,894)$(24,226)$6,757 $(27,727)
Denominator:
Weighted average common stock outstanding:
Basic80,659,32071,697,08380,353,39958,495,073
Diluted80,659,32071,697,08382,364,83558,495,073
Net income (loss) per share:
Basic$(0.04)$(0.34)$0.08 $(0.47)
Diluted(0.04)(0.34)0.08 (0.47)
The following outstanding potentially dilutive securities were excluded from the calculation of diluted net income (loss) per share attributable to common stockholders because their impact would have been anti-dilutive for the periods presented:
As of September 30,
20222021
Options to purchase common stock outstanding, unexercised1,833,279 4,448,454 
Restricted stock awards, unvested 947,540 
Restricted stock units, unvested757,859 1,088,230 
Purchase rights committed under the ESPP  
Total2,591,138 6,484,224 
25

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
Note 13 – Business Combinations
Acquisition of StreetShares
On April 1, 2022, the Company acquired all of the outstanding stock of StreetShares, Inc. (“StreetShares”) for cash consideration of $28.0 million, $30.0 million in escrow for a contingent earnout that expires April 1, 2023, subject to adjustment as defined in the purchase agreement, and $1.6 million in acquisition costs. The $30.0 million is considered contingent consideration and accounted for separate from the business combination accounting. The acquisition was funded by the Company’s available cash. StreetShares is based out of Reston, VA, and is a financial technology company that provides digital small business lending technology to banks and credit unions. The acquisition is accounted for using the acquisition method of accounting whereby the acquired assets and liabilities are recorded at their respective fair values and added to those of the Company, including an amount for goodwill representing the difference between the acquisition consideration and the fair value of the identifiable net assets. Results of operations of StreetShares have been included in the operations of the Company beginning with the closing date of the acquisition. The acquisition was deemed immaterial to the Company’s operating results as a whole.
The table below summarizes the allocation of the purchase price of StreetShares based on the estimated fair value of the assets acquired and the liabilities assumed (in thousands):
Assets acquired:
Cash and cash equivalents$1,580 
Restricted cash (1)
3,265 
Accounts receivable157 
Prepaid expenses and other current assets561 
Property and equipment142 
Right of use assets613 
Deferred tax asset11,624 
Goodwill6,755 
Intangible assets12,400 
Other assets83 
Total assets acquired37,180 
Liabilities assumed:
Accounts payable368 
Accrued compensation and benefits3,585 
Accrued expenses738 
Contingent earnout162 
Notes payable to Regulation A+ investors (1)
3,265 
Deferred revenue854 
Other long-term liabilities225 
Total liabilities assumed9,197 
Fair value of assets acquired and liabilities assumed$27,983 
______________
(1)Prior to the acquisition, StreetShares was subject to Regulation A+ of the Securities and Exchange Commission and had offered StreetShares notes to investors. The notes were scheduled to mature during various dates through 2023. Subsequent to the acquisition, during April 2022, the Company used the $3.3 million restricted cash balance to repay the Regulation A+ payable in full.
26

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
During the three months ended September 30, 2022, the Company completed measurement period adjustments related to the fair value of identifiable intangible assets and final working capital adjustment, resulting in a reduction to the fair values of customer relationships and developed technology by $1.9 million and $1.5 million, respectively, an increase in deferred tax assets of $1.1 million, and an increase in goodwill of $2.3 million. The final working capital adjustment amounted to approximately $0.1 million being paid by the Company to the sellers of StreetShares. The working capital adjustment was settled in September 2022 and resulted in a corresponding adjustment to prepaid expenses and other current assets.

As of September 30, 2022, the Company is still finalizing the provisional purchase price allocation related to income tax effects. The goodwill recognized is attributable to the Company’s expected acceleration of its small business lending service capabilities. The StreetShares acquisition is treated as a stock purchase for income tax purposes; therefore, of the goodwill recorded, none is considered deductible for income tax purposes.
The fair value of the separately identifiable finite-lived intangible assets acquired and estimated useful lives are as follows (in thousands, except years):
Estimated Fair ValuesWeighted Average Amortization Life (years)
Customer relationships$500 5
Developed technology11,800 10
Trademarks100 2
Total acquisition-related intangible assets$12,400 9
The fair value estimates for intangible assets include significant assumptions in the prospective financial information, such as revenue growth and discount rates. The fair value of the intangible assets was primarily based on the income approach using various methods such as the relief from royalty, with-or-without, and excess earnings methods.
Goodwill Rollforward
A rollforward of the Company’s goodwill balance from January 1, 2022 to September 30, 2022 is as follows:
Nine Months Ended September 30,
2022
Beginning balance$564,799 
StreetShares acquisition6,755 
Ending balance$571,554 
Contingent Earnout Liability
The purchase price for StreetShares includes a potential earnout that will be measured over 12 months from April 2, 2022, through April 1, 2023, based on performance factors outlined in the acquisition agreement.
The contingent earnout liability is recorded at estimated fair value each reporting period using a Monte Carlo simulation based on the forecasted operating results over the earnout period, estimates for market volatility, discount rates, and the earnout formula specified in the acquisition agreement. As the fair value uses significant unobservable inputs, it is considered a Level 3 fair value measurement.
The contingent earnout liability is recorded in accrued liabilities on the Company’s condensed consolidated balance sheets. Changes to the fair value are recorded as an adjustment to general and administrative expenses on the condensed consolidated statements of operations. The fair value of the contingent earnout liability was $0.0 million as of September 30, 2022 and $0.2 million as of April 1, 2022.
27

MERIDIANLINK, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (CONTINUED)
Note 14 – Subsequent Events
Acquisition of OpenClose
On November 4, 2022, the Company acquired all of the outstanding stock of Beanstalk Networks, L.L.C. doing business as OpenClose (“OpenClose”) for cash consideration of $65.0 million, which includes approximately $1.4 million in acquisition costs. The acquisition was funded by the Company’s available cash. OpenClose is based out of West Palm Beach, Florida, and provides mortgage lending technology, with a particular focus on supporting depository institutions. The acquisition will be accounted for using the acquisition method of accounting whereby the acquired assets and liabilities will be recorded at their respective fair values and added to those of the Company, including an amount for goodwill representing the difference between the acquisition consideration and the fair value of the identifiable net assets.
Results of operations of OpenClose will be included in the operations of the Company beginning with the closing date of the acquisition. As of the date of issuance of these condensed consolidated financial statements, the initial acquisition and disclosures under ASC 805, Business Combinations, have not been prepared as the Company has not obtained all of the information necessary, nor has there been sufficient time, to complete the related activities.

28


Special Note about Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or Exchange Act, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. All statements other than statements of historical fact included in this Quarterly Report on Form 10-Q, including statements regarding our strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans, and objectives of management are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “may,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements described under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 and in this Quarterly Report on Form 10-Q. These forward-looking statements are based on management’s current beliefs, based on currently available information, as to the outcome and timing of future events. You should not rely upon forward-looking statements as predictions of future events. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, statements about:
our future financial performance, including our expectations regarding our revenue, gross profit or gross margin, operating expenses, ability to generate cash flow, revenue mix, and ability to achieve and maintain future profitability;
our ability to execute on our strategies, plans, objectives, and goals;
our ability to compete with existing and new competitors in existing and new markets and offerings;
our ability to develop and protect our brand;
our ability to effectively manage privacy and information and data security;
increases in spending by financial institutions on cloud-based technology;
anticipated trends and growth rates in our business and in the markets in which we operate;
our ability to maintain and expand our customer base and our partner network;
our ability to sell our applications and expand internationally;
our ability to comply with laws and regulations;
our ability to anticipate market needs and successfully develop new and enhanced solutions to meet those needs;
the impact of the novel coronavirus, or COVID-19, pandemic and other global financial, economic, and political events on our industry, business, and results of operations;
our ability to successfully identify, acquire, and integrate complementary businesses and technologies;
our ability to hire and retain necessary qualified employees to grow our business and expand our operations;
the evolution of technology affecting our applications, platform, and markets;
economic and industry trends;
seasonal fluctuations in consumer borrowing trends;
our ability to adequately protect our intellectual property; and
our ability to service our debt obligations.
We caution you that the foregoing list may not contain all of the forward-looking statements made in this Quarterly Report on Form 10-Q.
The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events, or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we, in the future, may file with the Securities and Exchange Commission, or SEC, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.

29


In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to unduly rely upon these statements.
In this Quarterly Report on Form 10-Q, the terms “MeridianLink,” “we,” “us,” and “our” refer to MeridianLink, Inc. and its subsidiaries, unless the context indicates otherwise.

30

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read together with our unaudited condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and the consolidated financial statements and related notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021 (our “2021 Annual Report on Form 10-K”), filed with the SEC on March 10, 2022. The following discussion and analysis contains forward-looking statements that involve risks and uncertainties. When reviewing the discussion below, you should keep in mind the substantial risks and uncertainties that could impact our business. In particular, we encourage you to review the risks and uncertainties described in the section titled “Risk Factors” included elsewhere in this Quarterly Report on Form 10-Q and our 2021 Annual Report on Form 10-K. These risks and uncertainties could cause actual results to differ materially from those projected in forward-looking statements contained in this report or implied by past results and trends. Our fiscal year ends on December 31. Our historical results are not necessarily indicative of the results that may be expected for any period in the future, and our interim results are not necessarily indicative of the results we expect for the full fiscal year or any other period.
Overview
We are a leading provider of cloud-based software solutions for financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies (“CRAs”). Financial institutions are undergoing digital transformation as they seek to transition business models, create new revenue streams, and increase customer engagement. We support our customers’ digital transformations by helping them create a superior consumer experience with our mission-critical loan origination software, or LOS, digital lending platform, and data analytics. Our solutions allow our customers to meet their clients’ financial needs across the institution, which enables improved client acquisition and retention. Additionally, our solutions allow our customers to operate more efficiently by enabling automated loan decisioning and enhanced risk management.
The effective delivery and management of secure and advanced digital solutions in the complex and heavily regulated financial services industry requires significant resources, personnel, and expertise. We provide digital solutions that are designed to be highly configurable, scalable, and adaptable to the specific needs of our customers. We design and develop our solutions with an open platform approach intended to provide comprehensive integration among our solution offerings and our customers’ internal systems and third-party systems. Our solutions are central to the financial institution’s technology ecosystem and help drive additional business volume for our customers both directly and indirectly through our Partner Marketplace. Our omni-channel borrowing experience seamlessly integrates all the touch points a borrower may have with the financial institution (remote via the web or an app, in person at a branch, or telephonically through an operator). In addition to our streamlined workflow, which has been refined over twenty years with input from across our customer base, our Partner Marketplace provides our customers optional integrations, the collective capabilities of which we believe further distinguish our solution from that of competitors.
The financial services sector is in the midst of a transition from offering primarily in-branch services to providing hybrid in-person and digital experiences for consumers. This transition has recently accelerated, leading to increased investment in software that enables digital capabilities. We are well-positioned to assist our customers to compete with tier 1 banks and digital market entrants. We enable mid-market financial institutions to leverage their cost of capital advantage and community presence by allowing them to execute faster. With the digital edge we provide, our customers can become more competitive in this evolving environment, which, in turn, can drive further volume on our platform.
We deliver our solutions to the substantial majority of our customers using a SaaS model under which our customers pay subscription fees for the use of our solutions as well as fees for transactions processed using our solutions. Our subscription fees consist of revenues from software solutions that are governed by pricing and terms contained in contracts between us and our customers. The initial term of our contracts is typically three years, but may range from one to seven years. Our customer contracts are typically not cancellable without penalty. Our contracts almost always contain an evergreen auto-renewal term that is often for a one-year extension after the initial term, but can extend the auto-renewal of the contract up to the length of the original term. Our subscription fee revenues include annual base fees, platform partner fees, and, depending on the product, fees per search or per loan application or per closed loan (with contractual minimums based on volume) that are charged on a monthly basis, which we refer to as volume-based fees. We earn additional revenues based on the volume of applications or closed loans processed above our customers’ contractual minimums.

31

As a result of this pricing approach, our revenues from our customers grow as our customers add additional transaction types, purchase more modules, utilize more of our partner integrations, or see increased transaction volume. We generally sell our solutions through our direct sales organization or channel partners and recognize our subscription fee revenues over the terms of the customer agreements.
Our revenues per customer vary from period to period based on the length and timing of customer implementations, sales of additional solutions to existing customers, changes in the number of transactions processed (including impacts from seasonality and cyclicality), and variations among existing customers and new customers with respect to the mix of purchased solutions and related pricing.
We seek to strengthen and grow our customer relationships by providing consistent, high-quality implementations and customer support services, which we believe drive higher customer retention and incremental sales opportunities within our existing customer base. We have invested in migrating our solutions onto a platform resident in a public cloud and driving further increases in customer cross-selling opportunities and retention. We believe that our increased focus on our go-to-market strategy and strategic partnerships will drive incremental opportunities for revenue and accelerate client cross-sell growth.
In addition, we believe there is untapped market potential in the loan origination and digital banking markets. We believe significant opportunity for additional customer acquisition and revenue growth exists as financial institutions continue to adopt online lending and account opening practices and require more efficient technologies. We provide these services to institutions of all sizes and complexities, but currently focus on the middle market. By focusing on better sales execution, providing and allocating resources where needed, and improving marketing efforts, we are confident in our ability to expand our customer base within our current target market.
We cater largely to financial institutions such as community banks and credit unions with assets under management between $100 million and $10 billion. In recent years, community banks have continued to compete with their typically larger non-community bank competitors, and the FDIC reported that, in 2019, net interest income accounted for over 78 percent of community bank net operating revenues. A large opportunity exists in expanding our target market to new customers with less than $100 million or greater than $10 billion in assets under management. In our down-market, smaller institutions commonly use spreadsheets or other inexpensive alternatives. These companies have a smaller volume of loans per month, but there is opportunity to alter our solutions to offer decreased pricing and functionality in order to lower implementation fees.
We have continuously invested in expanding and improving our solutions since they were first introduced two decades ago, and we intend to continue investing both organically and inorganically through acquisitions to expand our portfolio. We are focused on introducing new solutions and enhancing services and capabilities in areas including digital lending, data insights, and collections to further expand our reach into the consumer lending markets. In addition to developing our solutions organically, such as the combination of our capabilities to create our patented consumer debt optimization functionality, we may selectively pursue acquisitions, joint ventures, or other strategic transactions that provide additional capabilities or customers, or both. Acquisitions to date have included CRIF Lending Solutions (“CRIF”) in June 2018, and Teledata Communications, Inc. (“TCI”) in November 2020. TCI is the creator of DecisionLender, a SaaS loan origination solution. We believe that with the addition of TCI, our position as a vendor of choice is enhanced among financial institutions seeking solutions to manage their needs from initiation of client relationships to facilitating the extension of credit to their clients. In December 2020, we acquired all of the assets of TazWorks, LLC (“TazWorks”). TazWorks provides software and data solutions to CRAs focused on the employment and tenant screening market, a market that is adjacent and complementary to our current solutions for credit-focused CRAs. In April 2021, we acquired Saylent Technologies, Inc. (“Saylent”), a data analytics and marketing solution that offers insights to financial institutions that help drive account and credit and debit card usage and enabled us to more rapidly bring to market our MeridianLink Engage product. In April 2022, we acquired StreetShares, Inc. (“StreetShares”), a financial technology company that offers digital small business lending technology to banks and credit unions. The acquisition further strengthens our existing lending platform and accelerates our small business lending capabilities.
We have designed our Partner Marketplace to act as the gateway for third parties to access our customers, which allows our customers to leverage the capabilities from these third parties to enable an accelerated loan process with improved efficiency and reduced cost. We are able to capitalize on one-time service fees from our partners upon their integration into our Partner Marketplace and a revenue share from our partners as they derive revenues from our software solution. As we grow our business, we expect to add additional product partners and drive additional monetization opportunities. We also intend to cultivate and leverage existing and future partners to grow our market presence.

32

We believe that delivery of consistent, high-quality implementations and customer support services is a significant driver of purchasing and renewal decisions of our prospects and customers. To develop and maintain a reputation for high-quality service, we seek to build deep relationships with our customers through our customer support organization, which we staff with personnel who are motivated by our common mission of using technology to help our customers succeed and who are knowledgeable with respect to the regulated and complex nature of the financial services industry. As we grow and scale our business, we intend to continue to invest in and grow our internal services and support organization, as well as partner with high quality third-party organizations, to support our customers’ needs and maintain our reputation.
Global Considerations
Impact of the COVID-19 Pandemic
The COVID-19 pandemic has had widespread, rapidly-evolving, and unpredictable impacts on global societies, economies, financial markets, and business practices (including in California where our corporate headquarters are located). Federal and state governments have implemented various measures in an effort to contain the virus and different variants of the virus that have emerged, some of which have been subsequently rescinded or modified, have caused, and we expect will continue to cause, business slowdowns or shutdowns in affected areas, both regionally and worldwide.
Our focus remains on promoting employee health and safety, serving our customers, complying with regulations, and ensuring business continuity. We continue to assess local regulations and restrictions across the United States and the administration of vaccine programs to ensure that our return to work is thoughtful, prudent, and handled with an abundance of caution with the health of our employees being the top priority.
There continues to be uncertainty as to the duration and extent to which the COVID-19 pandemic, as well as the emergence of new variants, may adversely impact our business operations, financial performance, and results of operations, as well as macroeconomic conditions, at this time. See Part II, Item 1A. “Risk Factors” for further discussion of the impact and possible future impacts of the COVID-19 pandemic on our business.
Economic Uncertainty, Rising Inflation, and Increasing Interest Rates
We are also closely monitoring the recent volatility in capital markets and the increased economic uncertainty in the United States. These developments have lead to higher inflation and increased uncertainty about business continuity. Additionally, interest rates, including for mortgages and consumer lending, have risen from historic lows and may increase further in the future. These factors may adversely affect our business and our results of operations. As our customers react to global economic conditions and the potential for a global recession, we may see reduced spending on our products and take additional precautionary measures to limit or delay expenditures and preserve capital and liquidity.
Inflation rates, particularly in the United States, have increased recently to multi-year highs. Increased inflation may result in decreased demand for mortgages and consumer lending, increased operating costs (including our labor costs), reduced liquidity, and limitations on our ability to access credit or otherwise raise debt and equity capital. In addition, the United States Federal Reserve has raised, and may again raise, interest rates in response to concerns about inflation. Increases in interest rates, especially if coupled with reduced government spending and volatility in financial markets, may cause us to experience lower than expected volumes if there is a decrease in customer spending.
As economic conditions continue to change quickly and are subject to rapid and possibly material change, we will continue to actively monitor the volatility and may take actions that alter our business operations as we may determine are in the best interests of our customers and stockholders.

33

Components of Operating Results
We have one primary business activity and operate in a single operating and reportable segment.
Revenues
Our revenues consist of three components: subscription fees, professional services, and other revenues.
Subscription Fee Revenues
Our subscription fees consist of revenues from software solutions that are governed by pricing and terms contained in contracts between us and our customers. Our subscription fee revenues include annual base fees, platform partner fees, and, depending on the solution, fees per search or per application or per closed loan (with contractual minimums based on volume) that are charged on a monthly basis, which we refer to as volume-based fees.
Our software solutions are hosted in either colocation data centers or cloud-based hosting services and are generally available for use as hosted application arrangements under subscription fee agreements. Subscription fees from these applications are recognized over time on a ratable basis over the customer agreement term generally beginning on the date our solution is made available to the customer. Amounts that have been invoiced are recorded in accounts receivable and deferred revenues or revenues, depending on whether the revenue recognition criteria have been met. Revenue that is earned but not yet invoiced is recorded in accounts receivable. Additional fees for monthly usage above the levels included in the standard subscription fee are recognized as revenue in the month when the usage amounts are determined and reported.
Professional Services Revenues
We offer implementation, configuration, consulting, and training services for our software solutions and SaaS offerings. Revenues from services are recognized in the period the services are performed, provided that revenue recognition criteria have been met.
Other Revenues
We enter into referral and marketing agreements with various third parties, in which revenues are primarily generated from transactions initiated by the third parties’ customers. We may introduce our customers to a referral partner or offer additional services available from the referral partner via an integration with our solutions. We market our partners’ solutions to our customers as a way not only to generate revenue but also to ensure that our customers are leveraging the full benefit of our solution, which includes the capabilities offered through our partners. Revenues are recognized in the period the services are performed, provided that collection of the related receivable is reasonably assured.
Cost of Revenues
Cost of revenues consists primarily of salaries and other personnel-related costs, including employee benefits, bonuses, and share-based compensation for employees providing services to our customers. This includes the costs of our implementation, customer support, data center, and customer training personnel. Additional expenses include fees paid to third-party vendors in connection with delivering services to customers.
Cost of revenues also includes cloud-based hosting services, an allocation of general overhead costs, and the amortization of developed technology. We allocate general overhead expenses to all departments based on the number of employees in each department, which we consider to be a fair and representative means of allocation.
We capitalize certain software development costs related to programmers, software engineers, and quality control teams working on our software solutions. We commence amortization of capitalized costs for solutions that have reached general release. Capitalized software development costs are amortized to cost of revenues over their estimated economic lives.

34

We intend to continue to increase our investments in our implementation and customer support teams and technology infrastructure to serve our customers and support our growth. We expect cost of revenues to continue to grow in absolute dollars, after adjusting for one-time share-based compensation charges resulting from our Corporate Conversion and IPO, as we grow our business. For more information on our Corporate Conversion in connection with our IPO, see Note 1 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.
Gross Profit and Gross Margin
Gross profit is revenues less cost of revenues, and gross margin is gross profit as a percentage of revenues. Gross profit has been, and will continue to be, affected by various factors, including the mix of our subscription fees, professional service and other revenues, the costs associated with our personnel, third-party vendors, and cloud-based hosting services, and the extent to which we expand our implementation and customer support services. We expect that our gross margin will fluctuate from period to period depending on the interplay of these various factors. Our gross margin was 61.2% and 60.4% for the three months ended September 30, 2022 and 2021, respectively, and was 63.4% and 67.0% for the nine months ended September 30, 2022 and 2021, respectively.
Operating Expenses
General and Administrative
General and administrative expenses consist primarily of salaries and other personnel-related costs, including employee benefits, bonuses, and share-based compensation, of our administrative, finance and accounting, information systems, legal, and human resources employees. General and administrative expenses also include consulting and professional fees, insurance, franchise taxes, and travel.
General and administrative expenses include depreciation and amortization of property and equipment and amortization of acquired intangibles. Identifiable intangible assets with finite lives, such as customer relationships, trademarks, and non-competition agreements, are amortized over their estimated useful lives on either a straight-line or accelerated basis, depending on the nature of the intangible asset.
We expect to continue to incur incremental expenses associated with the growth of our business and to meet increased compliance requirements associated with operating as a public company through the fourth quarter of 2022. These expenses include costs to comply with Section 404 of the Sarbanes-Oxley Act and other regulations governing public companies, increased costs of directors’ and officers’ liability insurance, and investor relations activities, partially offset by the termination of sponsor-related costs. As a result, we expect our general and administrative expenses to increase in absolute dollars, after adjusting for one-time share-based compensation charges resulting from our Corporate Conversion and IPO, but to decrease as a percentage of revenues over the long term as we scale the business and continue to adjust to being a public reporting company.
Research and Development
Research and development expenses include salaries and other personnel-related costs, including employee benefits, bonuses, and share-based compensation. Research and development expenses also include third-party contractor expenses, software development costs, allocated overhead, and other related expenses incurred in developing new solutions and enhancing existing solutions.
Certain research and development costs that are related to our internal software development, which include salaries and other personnel-related costs attributed to certain programmers, software engineers, and quality control teams, are capitalized and are included in intangible assets, net on the condensed consolidated balance sheets.
We believe that continuing to improve and enhance our solutions is essential to maintaining our reputation for innovation and growing our customer base and revenues. We plan to continue investing in research and development by increasing the number of our software developers. As a result, we expect our research and development expenses to increase in absolute dollars, after adjusting for one-time share-based compensation charges resulting from our Corporate Conversion and IPO, over the long term as we scale the business, including through integration of our acquisitions.

35

Sales and Marketing
Sales and marketing expenses consist primarily of salaries and other personnel-related costs, including commissions, employee benefits, bonuses, and share-based compensation. Sales and marketing expenses also include expenses related to advertising, lead generation, promotional event programs, corporate communications, travel, outside consulting fees, and allocated overhead. Commissions related to software sales are generally capitalized and then amortized over the expected period of customer benefit.
Sales and marketing expenses are also impacted by the timing of significant marketing programs such as our annual client conference, which we typically hold during the second quarter. We plan to continue investing in sales and marketing by increasing our number of sales and marketing personnel and expanding our sales and marketing activities. As a result, we expect our sales and marketing expenses to increase in absolute dollars, after adjusting for one-time share-based compensation charges resulting from our Corporate Conversion and IPO. We believe these investments will help us build brand awareness, add new customers, and expand sales to our existing customers as they continue to buy more solutions from us.
Total Other (Income) Expense, Net
Total other (income) expense, net consists primarily of interest expense, net. Interest expense consists of interest attributable to our credit facilities and amortization of lender-related fees and other direct incremental costs of securing financing, partially offset by interest income from our interest-bearing cash accounts.
Provision for Income Taxes
Our income tax expense, deferred tax assets and liabilities, and liabilities for unrecognized tax benefits reflect management’s best estimate of current and future taxes to be paid. We are subject to federal income taxes in the United States and numerous state jurisdictions. Significant judgments and estimates are required in the determination of the consolidated income tax expense.
We recognize deferred tax assets to the extent that these assets are more likely than not to be realized. If they are not, deferred tax assets are reduced by a valuation allowance. In making such a determination, all available positive and negative evidence is considered, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If it is subsequently determined that deferred tax assets would be more likely than not realized in the future, in excess of their net recorded amount, an adjustment would be made to the deferred tax asset valuation allowance, which would reduce the provision for income taxes. After a review of the four sources of taxable income (as described above), and after consideration of our continuing cumulative income position, inclusive of impact from permanent differences, as of September 30, 2022, we have not recorded a valuation allowance on its deferred tax assets.
We have recorded an uncertain tax position with respect to our R&D credits. There are no penalties or interest recorded on these liabilities as the credits have not yet been fully utilized, and therefore the uncertain tax position is recorded primarily as a reduction of the deferred tax asset related to these credits.

36

Results of Operations
Condensed Consolidated Statements of Operations
The following table sets forth our condensed consolidated statements of operations data for each of the periods indicated:
Condensed consolidated statements of operations data
Three Months Ended September 30,Nine Months Ended September 30,
(in thousands, except share and unit and per share and per unit amounts)2022202120222021
Revenues, net$71,754 $67,367 $217,495 $203,652 
Cost of revenues:
Subscription and services (1)
23,812 23,467 68,292 58,078 
Amortization of developed technology4,003 3,219 11,287 9,190 
Total cost of revenues27,815 26,686 79,579 67,268 
Gross profit43,939 40,681 137,916 136,384 
Operating expenses:
General and administrative (1)
21,423 29,917 60,416 64,103 
Research and development (1)
11,518 13,533 30,414 27,807 
Sales and marketing (1)
6,311 5,994 16,519 13,817 
Acquisition related costs163 — 2,549 781 
Total operating expenses39,415 49,444 109,898 106,508 
Operating income (loss)4,524 (8,763)28,018 29,876 
Other (income) expense, net:
Other income(327)(9)(706)(39)
Interest expense, net6,855 7,165 16,649 27,073 
Loss on debt repayment and extinguishment— 4,351 — 4,351 
Total other expense, net6,528 11,507 15,943 31,385 
Income (loss) before provision for income taxes(2,004)(20,270)12,075 (1,509)
Provision for income taxes890 1,176 5,318 5,274 
Net income (loss)(2,894)(21,446)6,757 (6,783)
Class A preferred return— (2,780)— (20,944)
Net income (loss) attributable to common stockholders$(2,894)$(24,226)$6,757 $(27,727)
Net income (loss) per share:
Basic$(0.04)$(0.34)$0.08 $(0.47)
Diluted(0.04)(0.34)0.08 (0.47)
Weighted average common stock outstanding:
Basic80,659,320 71,697,083 80,353,399 58,495,073 
Diluted80,659,320 71,697,083 82,364,835 58,495,073 
______________
(1)Upon completion of our IPO in July 2021, 500,000 options to purchase common shares, and 426,711 Carried Equity Units became fully vested, and we recognized accelerated share-based compensation expense in the amount of $21.4 million during the three and nine months ended September 30, 2021. Share-based compensation is as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Cost of revenues$1,352 $5,296 $3,567 $5,461 
General and administrative3,170 12,158 6,947 12,864 
Research and development, net of amounts capitalized2,092 6,194 4,457 6,358 
Sales and marketing639 1,879 1,530 2,152 
Total share-based compensation expense$7,253 $25,527 $16,501 $26,835 

37

Comparison of the Three and Nine Months Ended September 30, 2022 and 2021
Revenues, net
Three Months Ended September 30,ChangeNine Months Ended September 30,Change
(in thousands)20222021$%20222021$%
Revenues, net$71,754 $67,367 $4,387 %$217,495 $203,652 $13,843 %
Revenues increased for both the three and nine months ended September 30, 2022 compared to the three and nine months ended September 30, 2021. For the three and nine months ended September 30, 2022, Lending Software Solutions made up 12% and 10%, respectively, of the increase in total revenue growth, primarily from new and ramping customers as well as volume and revenue increases from existing customers. Lending Software Solutions growth was partially offset by a decline in Data Verification Software Solutions revenue, driven primarily by the decline in mortgage refinance application volumes. For both of our solutions, we receive incremental revenues if customers exceed their minimum commitments for monthly transactions, which typically is based off of number of applications or closed and funded loans for Lending Software Solutions and credit, tenant, or employment verification reports for our Data Verification Software Solutions.

Cost of Revenues and Gross Profit
Subscription and services
Three Months Ended September 30,ChangeNine Months Ended September 30,Change
(in thousands)20222021$%20222021$%
Subscription and services$23,812 $23,467 $345 %$68,292 $58,078 $10,214 18 %
Subscription and services cost of revenues increased $0.3 million, or 1%, for the three months ended September 30, 2022 compared to the three months ended September 30, 2021. The increase was due to $2.1 million in additional cloud-based data storage costs, as well as higher compensation and benefits spend, largely from additional employee headcount. The increase was partially offset by a decrease of $3.9 million in share-based compensation related to the vesting of Carried Equity Units upon completion of the IPO which increased expense in the same period in the prior year.
Subscription and services cost of revenues increased $10.2 million, or 18%, for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021. The increase was partially due to $4.0 million in additional cloud-based data storage costs, as well as higher compensation and benefits spend, largely from additional employee headcount. The increase was partially offset by a decrease of $1.9 million in share-based compensation expense compared to the same period in 2021, primarily related to the vesting of options and equity grants upon the completion of our IPO.
Amortization of Developed Technology
Three Months Ended September 30,ChangeNine Months Ended September 30,Change
(in thousands)20222021$%20222021$%
Amortization of Developed Technology$4,003 $3,219 $784 24 %$11,287 $9,190 $2,097 23 %
Amortization of developed technology increased $0.8 million, or 24%, for the three months ended September 30, 2022 compared to the three months ended September 30, 2021. The increase was due to increased amortization for internally developed software and additional amortization on developed technology from the acquisition of StreetShares.
Amortization of developed technology increased $2.1 million, or 23%, for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021. The increase was due to increased amortization for internally developed software and additional amortization on developed technology from the acquisitions of Saylent and StreetShares.


38

Gross Profit
Three Months Ended September 30,ChangeNine Months Ended September 30,Change
(in thousands)20222021$%20222021$%
Gross Profit$43,939 $40,681 $3,258 %$137,916 $136,384 $1,532 %
Gross profit increased $3.3 million, or 8%, for the three months ended September 30, 2022 compared to the three months ended September 30, 2021. The increase was primarily due to an increase of revenues and lower share-based compensation, as described above, partially offset by an increase in cost of revenues due to an increase in cloud-based data storage costs and increased personnel-related expenses from increased employee headcount.
Gross profit increased $1.5 million, or 1%, for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021. The increase was primarily due to an increase of revenues and lower share-based compensation, as described above, more than offset by an increase in cost of revenues due to an increase in cloud-based data storage costs and increased personnel-related expenses from increased employee headcount.
Operating Expenses
General and Administrative
Three Months Ended September 30,ChangeNine Months Ended September 30,Change
(in thousands)20222021$%20222021$%
General and Administrative$21,423 $29,917 $(8,494)(28)%$60,416 $64,103 $(3,687)(6)%
General and administrative expenses decreased $8.5 million, or 28%, for the three months ended September 30, 2022 compared to the three months ended September 30, 2021. The decrease includes a $9.0 million reduction in share-based compensation expense, as prior year costs were higher due to the vesting of equity grants upon our IPO. Additionally, our losses due to disposal of assets decreased by $0.9 million, primarily related to the accounting for the termination of a lease in the same period in 2021. The decrease was partially offset by increased personnel-related expenses from increased employee headcount.
General and administrative expenses decreased $3.7 million, or 6%, for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021. The decrease includes a $5.9 million decrease in share-based compensation expense and a $1.8 million decrease in advisory services spend compared to the same period in 2021, as prior year costs were higher in connection with our IPO. Additionally, our losses due to disposal of assets decreased by $1.3 million, primarily related to the accounting for the termination of a lease and new sublease in the same period in 2021. The decrease was partially offset by a $2.2 million increase in insurance costs for director and officer insurance, as well as increased personnel-related expenses from increased employee headcount.
Research and Development
Three Months Ended September 30,ChangeNine Months Ended September 30,Change
(in thousands)20222021$%20222021$%
Research and Development$11,518 $13,533 $(2,015)(15)%$30,414 $27,807 $2,607 %
Research and development expenses decreased $2.0 million, or 15%, for the three months ended September 30, 2022 compared to the three months ended September 30, 2021. The decrease includes a $4.1 million reduction in share-based compensation expense, as prior year costs were higher in connection with equity grants vesting upon our IPO. The decrease was partially offset by increased personnel-related expenses from increased employee headcount on our research and development teams.

39

Research and development expenses increased $2.6 million, or 9%, for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021. The increase was primarily due additional personnel-related expenses from increased employee headcount on our research and development teams. The increase was partially offset by a $1.9 million decrease in share-based compensation expense, as prior year costs were higher in connection with our IPO.
Sales and Marketing
Three Months Ended September 30,ChangeNine Months Ended September 30,Change
(in thousands)20222021$%20222021$%
Sales and Marketing$6,311 $5,994 $317 %$16,519 $13,817 $2,702 20 %
Sales and marketing expenses increased $0.3 million, or 5%, for the three months ended September 30, 2022 compared to the three months ended September 30, 2021 primarily due to higher personnel-related expenses from increased headcount on our sales and marketing teams, and additional advertising spend. The increase was partially offset by a $1.2 million decrease in share-based compensation expense, as prior year costs were higher in connection with our IPO.
Sales and marketing expenses increased $2.7 million, or 20%, for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021, primarily due to higher personnel-related expenses from increased headcount on our sales and marketing teams, and additional advertising spend. The increase was partially offset by a $0.6 million decrease in share-based compensation expense, as prior year costs were higher in connection with our IPO.
Acquisition Related Costs
Three Months Ended September 30,ChangeNine Months Ended September 30,Change
(in thousands)20222021$%20222021$%
Acquisition Related Costs$163 $— $163 — %$2,549 $781 $1,768 226 %
Acquisition related costs increased for both the three and nine months ended September 30, 2022 compared to the three and nine months ended September 30, 2021. The increase was primarily due to higher acquisition costs for StreetShares during 2022 compared to Saylent during 2021, as well as additional professional services costs incurred while pursuing other strategic opportunities.
Total Other Expense, net
Three Months Ended September 30,ChangeNine Months Ended September 30,Change
(in thousands)20222021$%20222021$%
Total Other Expense, net$6,528 $11,507 $(4,979)(43)%$15,943 $31,385 $(15,442)(49)%
Total other expense, net decreased $5.0 million, or 43%, for the three months ended September 30, 2022 compared to the three months ended September 30, 2021. The decrease was due to the loss on debt repayment in 2021, and lower interest expense on debt during 2022 as a result of principal repayments and debt refinancing that occurred in 2021.
Total other expense, net decreased $15.4 million, or 49%, for the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021. The decrease was due to the loss on debt repayment in 2021, and lower interest expense on debt during 2022 as a result of principal repayments and debt refinancing that occurred in 2021.

40

Provision for Income Taxes
Three Months Ended September 30,ChangeNine Months Ended September 30,Change
(in thousands)20222021$%20222021$%
Provision for Income Taxes$890 $1,176 $(286)(24)%$5,318 $5,274 $44 %
Provision for income taxes decreased $0.3 million, or 24%, for the three months ended September 30, 2022 compared to the three months ended September 30, 2021. The decrease in the provision for income taxes was due to a discrete tax charge related to the tax impact of certain executive & employee share-based remuneration offset by a decrease in earnings before income tax.
Provision for income taxes was $5.3 million for the nine months ended September 30, 2022 compared to $5.3 million for the nine months ended September 30, 2021. The flat provision for income taxes was primarily due to a discrete tax charge related to the tax impact of certain employee share-based remuneration and an increase in permanent tax differences including acquisition related costs, offset by decreased earnings before income tax, and decreased certain employee remuneration under section 162(m) of the Internal Revenue Code, that are not tax deductible.
Liquidity and Capital Resources
Sources of Liquidity
We have financed our operations primarily through cash flows from operations, long-term debt, and, concurrent with the completion of our IPO on July 30, 2021, through proceeds from the issuance of our common stock. In connection with our IPO, we sold 10.0 million shares of our common stock at a price of $26.00 per share, before underwriting discounts and commissions, which generated net proceeds to us of approximately $242.1 million, after deducting $17.9 million in underwriting discounts and commissions and offering costs.

As of September 30, 2022, our principal sources of liquidity were cash and cash equivalents of $115.8 million and unused capacity under our revolving line of credit of $50.0 million. Additionally, $30.0 million is held in an escrow deposit account for a contingent earnout related to our StreetShares acquisition. The earnout period associated with the escrow amount ends on April 1, 2023. Based upon our current levels of operations, we believe that our cash flows from operations along with our other sources of liquidity are adequate to meet our cash requirements for at least the next twelve months.
Our primary uses of cash are funding operations, acquisitions, capital expenditures, debt principal and interest payments, and stock repurchases. Our use of cash is impacted by the timing and extent of the required payments for each of these activities.
Our future capital requirements will depend on many factors, including our growth rate, the timing and extent of spending to support research and development efforts, the continued expansion of sales and marketing activities, the introduction of new and enhanced solutions, the seasonality impacts on our business, the timing and extent of spending to support our growth strategy, the continued market acceptance of our solutions, the future acquisitions of solutions or businesses, and future stock repurchases. In the event that additional financing is required from outside sources, we may not be able to raise such financing on terms acceptable to us or at all. We continue to monitor our financing requirements and may pursue refinancing opportunities to potentially reduce interest rates and extend maturities. If we are unable to raise additional capital when desired, our business, operating results, and financial condition would be adversely affected.
Operating Leases
We lease office space and server equipment under various operating lease agreements that expire through December 2026. We recognize the related rent expense on a straight-line basis over the term of each lease. Free rent and rental increases are recognized on a straight-line basis over the term of each lease.
One lease is with a related party with a term date of December 2022. The monthly payments during each of the nine months ended September 30, 2022 and 2021 were $0.1 million.

41

Long-Term Debt
For a detailed description of our long-term debt, please see Note 7 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on 10-Q.
Cash Flows
The following table summarizes our cash flows for the periods presented (in thousands):
Nine Months Ended September 30,Change
(in thousands)20222021$%
Net cash provided by (used in):
Operating activities$67,235 $69,012 $(1,777)(3)%
Investing activities(60,350)(125,647)65,297 (52)%
Financing activities(4,778)109,783 (114,561)(104)%
Net increase in cash, cash equivalents, and restricted cash$2,107 $53,148 $(51,041)96 %
Cash Flows from Operating Activities
Our largest source of operating cash is cash collection from sales of subscriptions to our customers. Our primary uses of cash from operating activities are for personnel-related expenses, marketing expenses, and payments to third-party vendors.
Operating cash flow is derived by adjusting our net income (loss) for non-cash operating items, such as depreciation and amortization, amortization of debt issuance costs, share-based compensation expense, deferred income taxes, loss on disposal of fixed assets, and changes in operating assets and liabilities, which reflect timing differences between the receipt and payment of cash associated with transactions and when they are recognized in our results of operations.
For the nine months ended September 30, 2022, cash provided by operating activities was $67.2 million. Net income was $6.8 million, adjusted by non-cash charges of $63.1 million and an increase of $2.7 million in operating assets and liabilities. The non-cash charges consist primarily of depreciation and amortization of $39.7 million, share-based compensation of $16.5 million, and deferred income taxes of $5.2 million. Net cash outflows from changes in operating assets and liabilities of $2.7 million primarily consisted of increased accounts receivable of $7.0 million due to increased revenue and timing of cash receipts, increased prepaid expenses and other assets of $2.5 million, decreased accrued liabilities of $0.2 million, and decreased accounts payable of $0.5 million due to timing, mostly offset by increased deferred revenue of $7.5 million
For the nine months ended September 30, 2021, cash provided by operating activities was $69.0 million. Net loss was 6.8 million, adjusted by non-cash charges of $77.3 million and a decrease of $1.5 million in operating assets and liabilities. The non-cash charges consist primarily of depreciation and amortization of $37.7 million, share-based compensation of $26.8 million, deferred income taxes of $5.0 million, and loss on debt repayment of $4.4 million. The change in operating assets and liabilities was primarily the result of an increase in deferred revenue of $10.0 million, partially offset by a decrease of accrued liabilities of $2.3 million, an increase in accounts receivable of $2.0 million, and an increase in prepaid expenses and other assets of $6.2 million.
Cash Flows from Investing Activities
Net cash used in investing activities of $60.4 million for the nine months ended September 30, 2022 consisted of $23.1 million of cash paid for the acquisition of StreetShares, $30.0 million cash paid for an escrow deposit for contingent consideration as a part of the StreetShares acquisition agreement, $6.3 million for capitalized software additions, and $0.9 million for purchases of property and equipment.
Net cash used in investing activities of $125.6 million for the nine months ended September 30, 2021 included $85.4 million of cash paid for the acquisition TazWorks, $35.9 million of cash paid for the acquisition of Saylent, $3.6 million for capitalized software additions, and $0.7 million cash paid for purchases of property and equipment.

42

Cash Flows from Financing Activities
Net cash used in financing activities of $4.8 million for the nine months ended September 30, 2022 consisted of $3.3 million payment of the Regulation A+ investor note that we assumed as part of the StreetShares acquisition, $2.2 million principal payments of long-term debt, $0.3 million cash paid to repurchase our common stock, $0.9 million proceeds from our employee stock purchase plan, and $0.2 million of proceeds from exercise of stock options. Principal repayments on our term loan started in June 2022 and are payable quarterly.
Net cash provided by financing activities of $109.8 million for nine months ended September 30, 2021 consisted of $100.0 million in proceeds from issuance of long-term debt, partially offset by $25.7 million of payments on the financing obligation due to related party, $202.6 million of principal payments of long-term debt, $2.0 million of payments of debt issuance costs, $4.4 million payments of deferred offering costs, and $1.9 million of repurchases of units.
Recent Developments
On November 4, 2022, we acquired all of the outstanding stock of Beanstalk Networks, L.L.C. doing business as OpenClose for cash consideration of $65.0 million, which includes approximately $1.4 million in acquisition costs. The acquisition was funded by our available cash. OpenClose is based out of West Palm Beach, Florida, and provides mortgage lending technology, with a particular focus on supporting depository institutions. For more information on our acquisition of OpenClose, see Note 14 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.
Recent Accounting Pronouncements
See Note 2, “Significant Accounting Policies” to our unaudited condensed consolidated financial statements included in Part I, Item 1 included in this Quarterly Report on Form 10-Q for a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects on our results of operations, financial condition, and cash flows.
Emerging Growth Company Status
We are an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. We have elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our financial results may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. We expect to use the extended transition period for any other new or revised accounting standards during the period in which we remain an emerging growth company.
Critical Accounting Policies and Significant Judgments and Estimates
There have been no material changes to our critical accounting policies and estimates since December 31, 2021. For a full discussion of these estimates and policies, see “Critical Accounting Policies and Significant Judgments” within “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2021 Annual Report on Form 10-K.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
There have been no significant changes in our exposures to market risk since December 31, 2021. For a full discussion of our exposures to market risks, see “Quantitative and Qualitative Disclosures about Market Risk” within “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2021 Annual Report on Form 10-K.

43

Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15(d)-15(e) under the Exchange Act as of the end of the period covered by this Quarterly Report on Form 10-Q.
Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of September 30, 2022, our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2022 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls
Our management, including our Chief Executive Officer and Chief Financial Officer, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitation in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Due to inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

44

PART II. OTHER INFORMATION
Item 1. Legal Proceedings
We are not currently a party to any litigation or claims that, if determined adversely to us, would have a material adverse effect on our business, operating results, financial condition, or cash flows. We are, from time to time, party to litigation and subject to claims in the ordinary course of business. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.
Item 1A. Risk Factors
Investing in our common stock involves substantial risks. You should carefully consider the risks and uncertainties described below, together with all of the other information in this Quarterly Report on Form 10-Q, including the financial statements and the related notes, before deciding to invest in our common stock. Any of the risk factors we describe below could have a material adverse effect on our business, financial condition, results of operations, cash flow, and prospects. The market price of our common stock could decline if one or more of these risks or uncertainties develop into actual events, causing you to lose all or part of your investment. Other risks, events, and uncertainties that we do not currently anticipate or that we currently deem immaterial may also affect our business. Certain statements contained in the risk factors described below are forward-looking statements. See the section titled “Special Note Regarding Forward-Looking Statements” for more information.
Summary of Risk Factors
The following risk factor summary provides an overview of the inherent uncertainty investing in us presents. This summary does not contain all of the information that may be important to you, and you should read this risk factor summary together with the more detailed discussion of risks and uncertainties set forth following this section as well as elsewhere in this Quarterly Report on Form 10-Q. The risks and uncertainties to which our business is subject include, but are not limited to, the following:
Risks Related to Our Strategy and Industry
The mortgage lending market and the broader financial services industry in which our customers operate are subject to various economic factors, the deterioration of which would directly affect our performance.
Failure to retain or attract customers, expand our offerings, features, and functionalities, or increase brand recognition may limit both growth and profitability.
Opportunities to grow our business may be limited by inability to identify suitable partnerships, acquisitions, or new business opportunities, or to effectively integrate businesses we acquire.
Changing dynamics, such as pricing pressure, new entrants, and customer preferences, within our highly-fragmented and competitive landscape may adversely affect our operations.
Risks Related to Our Business and Operations
Any disruption in the performance or delivery of our software solutions, whether due to security compromises, third-party providers, or other unforeseeable circumstances, could affect brand perception, decrease demand, and subject us to substantial liability.
Integration or implementation challenges could affect the functionality of our software solutions and delay revenue recognition.
Challenges in measuring and tracking key operating metrics could affect our ability to consistently report results over time or develop long-term strategies.
The seasonal and cyclical nature of our business, including our usage and volume-based pricing and sales process, could result in volatility in our operating results.
Failure to retain or expand personnel, including management, sales, marketing, development, and support functions, to sustain our growth and infrastructure may result in operational disruptions, reduced sales opportunities, and increased expenses.
Our success is dependent on our ability to retain and attract product partners to drive further volume through our platform.

45

Risks Related to Legal and Regulatory Matters
Failures in data protection, privacy, and information security and intellectual property rights could critically impair our offerings and ability to conduct business.
Failure to comply with laws and regulations as a technology provider to our customers who operate in a highly regulated industry, as well as failure to create solutions that assist our customers to comply with their regulatory requirements, could disrupt our operations and result in significant expense to alter and update our solutions.
Changes in laws and regulations could affect our ability to compete, require us to change our pricing model, or result in additional charges booked to our balance sheet.
Risks Related to Finance and Accounting
Fluctuations in performance and our inability to accurately forecast results may affect our market perception.
Accounting treatments, such as revenue recognition or goodwill impairment, may cause fluctuations in earnings that do not fully reflect the underlying performance of our business.
High levels of indebtedness, as well as the terms of our existing debt, or our inability to effectively access capital markets may restrict our ability to compete, react to changes in our business, and fund future needs.
Changes in applicable tax laws, rules, or regulations could adversely affect our financial position.
Risks Related to Potential Conflicts of Interests and Related Parties
Thoma Bravo holds a controlling stake in our company, and their interests may conflict with ours and those of our other stockholders.
Risks Related to Our Common Stock and Governance Structure
Market conditions, issuances of additional or preferred stock, and payments of dividends may result in dilution or otherwise affect our stockholders’ return on investment.
The consummation, suspension, or termination of our capital allocation strategies, including any stock repurchases, may affect our stock price, stock volatility, or liquidity.
Delaware law and certain provisions in our charter and bylaws could restrict certain strategic activity or limit stockholder actions that may be beneficial or favorable to our stockholders.

46

Risks Related to Our Strategy and Industry
Mortgage lending volume is lower in 2022 than it was at the same point in 2020 or 2021 due to various economic factors, including increased mortgage interest rates, which could adversely affect our business.
Factors that adversely impact mortgage lending volumes include reduced consumer and investor demand for mortgages, more stringent underwriting guidelines, decreased liquidity in the secondary mortgage market, high levels of unemployment, high levels of consumer debt, lower consumer confidence, changes in tax, and other regulatory policies, including the recent expiration of the home buyer’s tax credit and other macroeconomic factors.
In addition, mortgage interest rates have risen from historic lows and many economists predict that mortgage interest rates will rise further in 2022. Mortgage interest rates are influenced by a number of factors, particularly monetary policy. The Federal Reserve Bank has been raising the Federal funds rate to combat higher than expected inflation in the United States and has signaled expectations to begin selling Fannie Mae and Freddie Mac mortgage-backed securities, each of which could cause mortgage interest rates to rise further. Further increases in mortgage interest rates could reduce the volume of new mortgages originated, in particular the volume of mortgages refinanced.
The lower levels of residential mortgage loan market volume in 2022 as compared to 2020 and 2021 levels have required us to increase either our share of loan volume, our revenues per loan effected through use of our solutions, or both, in order to maintain our financial performance. Any additional decrease in residential mortgage loan market volumes would exacerbate our need to increase either our share of loan volume, our revenues per loan effected through use of our solutions, or both. We cannot assure you that we will be successful in our efforts to increase either our share of loan volume, our revenues per loan effected through use of our solutions, or both, which could materially adversely affect our business.
In addition, increases in interest rates and supply chain shortages for goods subject to financing generally may also negatively impact consumer demand for loans other than mortgages. If demand for non-mortgage loans also decreases as a result of increased interest rates, our business and operating results could be materially adversely affected.
If we fail to increase the number of our customers or retain existing customers, our business may be harmed.
Our growth depends in large part on increasing the number of customers using our software solutions. To attract customers to our solutions, we must convince them that the utility of, and access to, our software solutions can assist them in their digital transformations, help create new revenue streams, and increase engagement with their customers. In particular, we must enhance the features and functionality of our software solutions and convince financial institutions of the benefits of our software solutions and encourage them to switch from competing loan origination, digital lending, and data analytics solutions or to forgo using more traditional processes and procedures, including (with respect to the loan origination business) paper, facsimile, courier, mail, and e-mail processing.
Due to the fragmented nature of the consumer lending (including mortgage) and consumer reporting agency industries, many industry participants may not be familiar with our software solutions and the benefits of our solutions. Any consolidation in our industry could also decrease our market advantage and may impact our competitive position. Some of our current and potential customers have developed, and may continue to develop, their own proprietary technologies and may one day become our competitors. In particular, some of our customers and potential customers have increasing market share in their respective markets that could be leveraged to introduce, directly or indirectly, alternative solutions to the use of our services in the short term with the potential to replace our solutions within their organizations in the long term. As our customers increase their spend with us, there may be internal pressure to evaluate and potentially create their own internal solutions as a cost-savings measure. We cannot assure you that we will be successful in attracting new customers or retaining existing customers, and increased competition from both competitors and any internal development efforts by our current customers could harm our business.

47

Additionally, with increased competition, existing customers may decide not to continue to use our software solutions in favor of other alternatives for financial or other reasons. Customer attrition could impact the performance of our business in the future. We have agreements in place with various product partners with respect to the integration between their businesses and our solutions, such as e-signing vendors, insurance providers, dealership integrators, credit card processors, home banking systems, and settlement service tools. Most of these contracts are not long term or are subject to termination rights. An unexpected termination, or a failure to renew, of a significant number of our agreements or relationships with these platform partners could have an adverse effect on our business as our customers may find our solutions less valuable without these integrations. If we lose existing platform partners due to terminations or failures to renew our agreements, we would also lose revenues associated with such platform partners, which could have a material adverse impact on our results of operations and financial condition.
In addition, our future development efforts are focused on our cloud-based offerings, and, as a result, we do not intend to invest in upgrading certain legacy products or developing added functionality for them, including legacy products acquired through past strategic transactions such as the acquisition of CRIF in 2018. As a result, customers using these legacy products may determine that these legacy offerings no longer satisfy their needs. If we are unsuccessful in transitioning these customers to our newer, cloud-based offerings, these customers may cease doing business with us. Therefore, we must continue to demonstrate to our customers that using our solutions is the most effective and cost-efficient way to maximize their results and if we are not successful our business and results of operations could be materially and adversely impacted.
We may not accurately predict the long-term rate of customer subscription renewals or adoption of our software solutions, or any resulting impact on our revenues or operating results.
Our customers have no obligation to renew their subscriptions for our software solutions after the expiration of the initial or current subscription term, and our customers, if they choose to renew at all, may renew for shorter subscription terms, or on less favorable usage-based or volume-based pricing terms. Since we have only been tracking our retention rates since November of 2020, we have limited historical data with respect to rates of customer subscription renewals and cannot be certain of anticipated renewal rates. Our renewal rates may decline or fluctuate as a result of a number of factors, including our customers’ satisfaction with our pricing or our software solutions or their ability to continue their operations or spending levels. Strategic acquisitions can further complicate our ability to predict customer subscription renewals. If our customers do not renew their subscriptions for our software solutions on similar pricing terms, our revenues may decline and our business could suffer.
Additionally, as the markets for our solutions develop, or as new or existing competitors introduce new solutions or services that compete with ours, we may experience pricing pressure and be unable to renew our agreements with existing customers, or we may be unable to attract new customers based on the same subscription models that we have used historically or at fee levels that are consistent with our pricing models and operating budget. Moreover, large or influential customers may demand more favorable pricing or other contract terms from us. In addition, our pricing strategy for new solutions may prove to be unappealing to our potential customers, and our competitors could choose to bundle certain solutions and services competitive with ours. If any of these were to occur, we may in the future be required to change our pricing model, reduce our prices, or accept other unfavorable contract terms, any of which could adversely affect our revenues, gross margin, profitability, financial position, cash flow, or growth prospects.
If we fail to expand our offerings, features, and functionalities or to respond to evolving technological requirements, our software solutions could become obsolete or less competitive and our revenue growth rate may be reduced.
The market for our software solutions is characterized by rapid technological advancements, changes in customer requirements and technologies, frequent new solution introductions and enhancements, and changing regulatory requirements. The life cycles of our software solutions are difficult to estimate. Rapid technological changes and the introduction of new products and enhancements by new or existing competitors or large financial institutions could undermine our current market position. Other means of digital or virtual consumer lending and banking may be developed or adopted in the future, and our software solutions may not be compatible with these new technologies. In addition, the technological needs of, and services provided by, the banks, credit unions, mortgage lenders, specialty lending providers, and CRAs that we endeavor to serve may change if they or their competitors offer new services to account holders. Maintaining adequate research and development resources to meet the demands of the market is essential. The process of developing new technologies and software solutions is complex and expensive. The introduction of new products by our competitors, the market acceptance of competitive products based on new or alternative technologies, or the emergence of new technologies or products in the broader financial services industry could render our solutions obsolete or less effective.

48

The success of any enhanced or new software solution depends on several factors, including timely completion, adequate testing, and market release and acceptance of the solution. Any new software solutions that we develop or acquire may not be introduced in a timely or cost-effective manner, may contain defects, or may not achieve the broad market acceptance necessary to generate significant revenues. In addition, we must continuously develop, market, and sell new features and functionalities to our existing software solutions that respond to the changing needs of our customers and offer better functionality than competing offerings from other providers. If we are unable to anticipate customer requirements or work with our customers successfully on implementing new software solutions or features in a timely manner or enhance our existing software solutions to meet our customers’ requirements, our business, growth prospects, and operating results may be adversely affected.
If we fail to develop, maintain, and enhance our brands, our ability to expand our business, operating results, and financial condition could be adversely affected.
We believe that maintaining and enhancing the brands associated with our solutions is important to support the marketing and sale of our existing and future solutions to new customers and to increase adoption of our solutions by existing customers. Successfully maintaining and enhancing our brands will depend largely on the effectiveness of our marketing and demand generation efforts, our ability to provide reliable solutions that continue to meet the needs of our customers at competitive prices, our ability to maintain our customers’ trust, our ability to continue to develop new functionality and solutions, and our ability to successfully differentiate our solutions from competitive products and services. Our promotion activities may not generate brand awareness or yield increased revenues, and even if they do, any increased revenues may not offset the expenses we incur in building our brand. If we fail to successfully promote and maintain our brands, our business, operating results, and financial condition could be adversely affected.
We have entered, and may in the future enter into, partnership agreements with third parties for reseller services, which may adversely affect our ability to generate revenues.
We have entered into and may seek to enter into additional collaborations or partnerships with third parties for reseller services. Should we seek to collaborate with a third party with respect to a prospective reseller program, we may not be able to locate a suitable partner or to enter into an agreement on commercially reasonable terms or at all. Even if we succeed in securing partners for reseller services, such as the arrangement we have entered into with Jack Henry & Associates, Inc., we have limited control over the time and resources that our partners may dedicate to such services. These partnerships pose a number of risks, including the following:
partners may not have sufficient resources or decide not to devote the necessary resources due to internal constraints such as budget limitations, lack of human resources, or a change in strategic focus; or
partners may decide to pursue a competitive product developed outside of the collaboration arrangement.
As a result of the foregoing risks and others, partnership agreements may not lead to successful reseller programs. We also face competition in seeking out partners. If we are unable to secure new partnerships that achieve the partner’s objectives and meet our expectations, we may be unable to generate meaningful revenues.

49

We may acquire or invest in companies, or pursue business partnerships, which may prove difficult to integrate, divert our management’s attention, or dilute stockholder value, and we may be unable to realize the expected benefits of such acquisitions, investments, or partnerships.
From time to time, we consider potential strategic transactions, including acquisitions of, or investments in, businesses, technologies, services, products, and other assets. For example, in November 2022, we acquired OpenClose, a mortgage lending technology, with a particular focus on supporting depository institutions, and in April 2022, we acquired StreetShares, a financial technology company that provides digital small business lending technology to banks and credit unions. We may also enter into relationships with other businesses to expand our products, which could involve preferred or exclusive licenses, additional channels of distribution, discount pricing, or investments in other companies. Negotiating these transactions can be time-consuming, difficult, and expensive, and our ability to close these transactions may be subject to approvals that are beyond our control. If an acquired business fails to meet our expectations, our operating results, business, and financial position may suffer. We may not be able to find and identify desirable acquisition targets, we may incorrectly estimate the value of an acquisition target, and we may not be successful in entering into an agreement with any particular target. We may not integrate an acquired company smoothly, successfully, or within our budgetary expectations and anticipated timetable. If we are successful in acquiring additional businesses, we may not achieve the anticipated benefits from the acquired business due to a number of factors, including:
our inability to integrate or benefit from developed technologies or services;
unanticipated costs or liabilities associated with the acquisition;
incurrence of acquisition-related costs;
difficulty, including unanticipated delays, costs, or inefficiencies associated with, integrating the operational and compliance policies and practices, technology, accounting systems, operations, and control environments of the acquired business and integrating the acquired business or its employees into our culture;
difficulties and additional expenses associated with supporting legacy products and infrastructure of the acquired business;
difficulty converting the customers of the acquired business to our software solutions and contract terms, including disparities in subscription terms;
additional costs for the support or professional services model of the acquired company;
diversion of management’s attention and other resources;
adverse effects to our existing business relationships with business partners and customers;
the issuance of additional equity securities that could dilute the ownership interests of our stockholders;
incurrence of debt on terms unfavorable to us or that we are unable to repay;
incurrence of substantial liabilities;
difficulties retaining key employees of the acquired business; and
adverse tax consequences, substantial depreciation, or deferred compensation charges.
Accordingly, we may fail to realize some or all of the anticipated benefits of the acquisition, such as increase in our scale, diversification, cash flows, and operational efficiency. In addition, a significant portion of the purchase price of companies we acquire may be allocated to acquired goodwill and other intangible assets, which must be assessed for impairment at least annually. In the future, if our acquisitions do not yield expected returns, we may be required to take charges to our operating results based on this impairment assessment process, which could adversely affect our results of operations.

50

The markets in which we participate are intensely competitive and highly fragmented, and pricing pressure, new technologies, or other competitive dynamics could adversely affect our growth, business, results of operations, and future prospects.
We have experienced growth in recent periods. In future periods, we may not be able to sustain net revenue growth consistent with recent history, or at all. We believe our net revenue growth depends on several factors, including, but not limited to, our ability to add new customers and to expand our existing customers’ usage of our solutions. The markets in which we compete, however, are highly competitive, fragmented, evolving, complex, and defined by rapidly changing technology and customer demands. We currently compete with providers of technology and products in the financial services industry, primarily point solution vendors that focus on building functionality that competes with specific components of our solutions. From time to time, we also compete with systems internally developed by financial institutions.
Many existing and potential competitors enjoy substantial competitive advantages, such as:
larger sales, development, support, and marketing budgets and resources;
the ability to bundle competitive offerings;
greater brand recognition and longer operating histories;
more extensive customer bases and broader customer relationships;
lower labor and development costs;
greater resources to make acquisitions;
larger and more mature intellectual property portfolios; and
substantially greater financial, technical, management, and other resources.
Further, one of our competitors may establish or strengthen a cooperative relationship with, or acquire one or more software application, data analytics, compliance, or network vendors. We may also face competition from new companies entering our markets, which may include large established businesses that decide to develop, market, or resell cloud-based banking technology, acquire one of our competitors, or form a strategic alliance with one of our competitors. In addition, new companies entering our markets may choose to offer cloud-based consumer lending and related products at little or no additional cost to the customer by bundling them with their existing products, including adjacent financial services technologies.
We expect competition to intensify in the future, and these competitive pressures in our markets or our failure to compete effectively may result in fewer customers, increased pricing pressure, reduced revenues and gross profit, increased sales and marketing expenses, and loss of market share. Any failure to meet and address these factors could materially and adversely affect our business, operating results, and financial condition.
If the market for cloud-based solutions develops more slowly than we expect or changes in a way that we fail to anticipate, our sales would suffer and our results of operations would be adversely affected.
We do not know whether our prospective customers will continue to adopt cloud-based financial products such as our software solutions or whether the market will change in ways we do not anticipate. Many potential customers have invested substantial personnel and financial resources in legacy software, and these institutions may be reluctant, unwilling, or unable to convert from their existing systems to our solutions. Furthermore, these potential customers may be reluctant, unwilling, or unable to use cloud-based financial solutions due to various concerns such as the security of their data and reliability of the delivery model. These concerns or other considerations may cause prospects to choose not to adopt cloud-based financial products such as ours or to adopt them more slowly than we anticipate, either of which would adversely affect us. Our future success also depends on our ability to sell additional solutions and functionality to our current and prospective customers. As we create new solutions and enhance our existing solutions to meet anticipated market demand, these solutions and enhancements may not be attractive to customers. In addition, promoting and selling new and enhanced functionality may require increasingly costly sales and marketing efforts, and if customers choose not to adopt this functionality our business and results of operations could suffer. If potential customers are unwilling or unable to transition from their legacy systems, or if the demand for our solutions does not meet our expectations, our results of operations and financial condition will be adversely affected.

51

We derive all of our revenues from customers in the financial services industry, and any downturn or consolidation or decrease in technology spend in the financial services industry could adversely affect our business.
All of our revenues are derived from customers in the financial services industry, an industry which has experienced significant pressure in recent years due to economic uncertainty, low interest rates, liquidity concerns, and increased regulation. In the past, financial institutions have experienced consolidation, distress, and failure. It is possible these conditions may reoccur. If any of our customers merge with or are acquired by other entities, such as financial institutions that have internally developed technology products or that are not our customers or use our software solutions less, we may lose business. Additionally, changes in management of our customers could result in delays or cancellations of the implementation of our software solutions. Consolidation could also produce a smaller number of large customers, which could increase their bargaining power and lead to lower prices or more favorable terms for our customers. Our business may also be materially and adversely affected by weak economic conditions in the financial services industry. Any downturn in the financial services industry may cause our customers to reduce their spending on technology or cloud-based financial products or to seek to terminate or renegotiate their contracts with us. Additionally, a prolonged economic slowdown may result in reduced consumer demands for loans and reduced application volume for credit, employment, tenant, or other forms of screening, which would negatively impact our revenues from existing customers due to the volume-based aspect of our customer agreements. Due to recent levels of inflation, the U.S. Federal Reserve has begun to increase interest rates, which could also reduce consumer demand for loans and materially and adversely impact our business. Moreover, even if the overall economy is robust, economic fluctuations caused by factors such as the U.S. Federal Reserve changing interest rates or otherwise managing market liquidity may cause potential new customers and existing customers to become less profitable and therefore forego or delay purchasing our software solutions or reduce the amount of spend with us, which would also materially and adversely affect our business.
Risks Related to Our Business and Operations
Uncertain or weakened economic conditions, including as a result of the COVID-19 pandemic, may continue to heighten many of our known risks and has affected, continues to affect, and may adversely affect our industry, business, and results of operations.
Our overall performance depends on economic conditions, which are beyond our control and may be difficult or impossible to forecast. The United States and other key international economies have experienced significant economic and market downturns, including recently in connection with the COVID-19 pandemic, and are likely to experience additional cyclical downturns from time to time, in which economic activity is impacted by falling demand for a variety of goods and services, restricted credit, poor liquidity, inflation, fluctuations in interest rates, reduced corporate profitability, volatility in credit and equity markets, bankruptcies, and overall uncertainty. Macroeconomic developments can arise suddenly, as did the conditions associated with the COVID-19 pandemic, and the full impact can be difficult to predict. These conditions affect the rate of technology spending generally and could adversely affect our customers’ ability or willingness to purchase our software solutions, delay prospective customers’ purchasing decisions, reduce the value or duration of their subscriptions or affect renewal rates, or impact the demand for our customers’ services, any of which could adversely affect our results of operations.
The COVID-19 pandemic continues to have widespread, evolving, and unpredictable impacts on global society, economies, financial markets, and business practices. Even as vaccines are introduced and administered, governmental restrictions are lifted, and economies gradually reopen, the ongoing economic impacts, including government economic stimulus, and health concerns associated with the pandemic, the emergence of more transmissible variants, and the global availability and efficacy of vaccines, there is substantial uncertainty in the pandemic’s continued and long-term effects. Efforts to contain the spread of COVID-19 in the United States (including in California where our corporate headquarters are located) have resulted in federal and state governments implementing measures such as quarantines, shelter-in-place orders, vaccination programs, and various other government restrictions.

52

COVID-19 has impacted, and may continue to impact, our business operations, employees, customers, their clients, the industries in which our customers operate, partners, suppliers, and communities. We have taken certain measures, and will continue to implement applicable steps, to manage the evolving risks and uncertainties. We temporarily suspended travel for employees, closed our offices, and virtually conducted our user forums until CDC guidelines allowed for these. Since mid-March 2020, we have requested that our employees work remotely. We are now allowing travel for our employees based on business need and some on-site meetings, and, in May 2022, we conducted our first in-person user forum since the COVID-19 pandemic began. We plan for in-person events in 2023 as well. While we have been operating effectively under our remote work model, and we do not foresee it changing, we cannot be certain that a prolonged remote work model will continue to be effective or will not introduce new operational difficulties that could result in harm to our business. Our shift to remote work has caused us to assess our IT security measures, identify any vulnerabilities, and enhance protections against unauthorized access to our network and systems. While we have not yet experienced a network breach or intrusion as a result of moving to a remote work model, we are unable to unequivocally affirm that the protective measures we have taken will remain sufficient given the ever-changing threat landscape, and any such related security compromise that may occur could materially and adversely impact our business, results of operations, or reputation.
We continue to evaluate, and adjust, our hiring plans and investment spending accordingly. We are monitoring the potential effects of changed rate of spending on software solutions, purchasing decisions, delayed payments, and supply chain shortages on our business.
The pace and shape of the COVID-19 recovery as well as the impact and extent of potential resurgences is not presently known. We continue to monitor and evaluate the nature and extent of changes to the market and economic conditions related to the COVID-19 pandemic and current and potential impact on our business and financial position. However, given the dynamic nature of this situation, we cannot reasonably estimate the impacts of COVID-19 on our future results of operations or cash flows at this time.
To the extent economic volatility, including as a result of the COVID-19 pandemic, adversely affects our business, results of operations, financial condition, or liquidity, many of the other risks described in this “Risk Factors” section may also be heightened.
A breach or compromise of our security measures or those we rely on could result in unauthorized access to or other compromise of customers’ data or customers’ clients’ data, which may materially and adversely impact our reputation, business, and results of operations.
Certain elements of our business and software solutions, particularly our origination and analytics solutions, involves the processing and storage of personally identifiable information, or PII, such as banking information and PII of our customers’ clients. We may also have access to PII during various stages of the implementation process of our solutions or during the course of providing customer support. Furthermore, as we develop additional functionality, we may gain greater access to PII and process additional PII. We maintain policies, procedures, and technological safeguards designed to protect the confidentiality, integrity, and availability of this information and our information technology systems. However, we cannot entirely eliminate the risk of improper, unlawful, or unauthorized access to, or disclosure, alteration, corruption, unavailability, or loss of PII or other data that we process or maintain, other security events that impact the integrity or availability of PII or our systems and operations (including ransomware and other security attacks), or the related costs we may incur to mitigate the consequences from such events. Additionally, we may be exposed to increased risk of security breaches or other security compromises with our employees working remotely, as they have since the beginning of the COVID-19 pandemic.

53

Further, our solutions are a combination of flexible and complex software, and there is a risk that configurations of, or defects in, one or more of the solutions or errors in implementation could create vulnerabilities to, or result in, security breaches or other security compromises. We may face difficulties or delays in identifying or responding to security compromises or breaches. In addition, because we leverage third-party providers, including cloud, software, data center, and other critical technology vendors to deliver our software solutions to our customers and their clients, we rely heavily on the data security procedures, measures, and policies adopted by these third-party providers. A vulnerability in a third-party provider’s software or systems, a failure of our third-party providers’ safeguards, policies, measures, or procedures, or a breach of a third-party provider’s software or systems could result in the compromise of the confidentiality, integrity, or availability of our systems or of data housed in our platform or that is maintained or processed by such third-party provider. When engaging third-party providers, we assess their policies and procedures relating to cybersecurity and privacy, however, we have no formal policy regarding subsequent audits of these providers to confirm their ongoing compliance efforts, and our failure to detect issues with these third-party providers could result in vulnerabilities that would materially and adversely impact our business, customers, and results of operations.
Cyberattacks and other malicious internet-based activity continue to increase and evolve, and cloud-based providers of products and services have been and are expected to continue to be targeted. In addition to traditional computer “hackers,” malicious code (such as viruses and worms), phishing attempts, theft or misuse and other intentional or negligent acts of our employees and contractors, ransomware attacks, denial-of-service attacks, sophisticated criminal networks, as well as nation-state and nation-state supported actors now engage in intrusions and attacks, including advanced persistent threat intrusions. Current or future criminal capabilities, discovery of existing or new vulnerabilities, and attempts to exploit those vulnerabilities or other developments, may compromise or breach our systems or software solutions. In the event our or our third-party providers’ protection efforts are unsuccessful and our systems or software solutions are breached or compromised, we could suffer substantial harm. A security breach or compromise could result in operational disruptions, loss, compromise, unauthorized use of, or access to, alteration, or corruption of customer data or customers’ client data or data we rely on to provide our software solutions, including our analytics initiatives and offerings, that impair our ability to provide our software solutions and meet our customers’ requirements. Such impairment would result in decreased revenues and otherwise materially negatively impact our financial results. Also, in the event that any of these events occurs or is perceived to have occurred, our reputation could suffer irreparable harm, causing our current and prospective customers to decline to use our software solutions in the future. Further, we could be forced to expend significant financial and operational resources in response to any actual or perceived security breach or compromise, including repairing system damage, increasing security protection costs by deploying additional personnel and protection technologies, and defending against and resolving legal and regulatory claims and proceedings, all of which could be costly and divert resources and the attention of our management and key personnel away from our business operations. While maintaining and enhancing an incident response and disaster recovery program in the event of any of the foregoing attacks or system unavailability are internal priorities, we cannot be certain that our incident response and disaster recovery efforts will be adequate if they are needed, and any gaps in our ability to respond to incidents and move our customers to back-up systems would result in additional adverse impacts on our business, results of operations, and reputation. We anticipate expending increasing expenses and other resources in an effort to identify, prevent, and respond to actual or potential security breaches.
Federal and state regulations may require us or our customers to notify individuals or other persons or entities, including regulatory authorities of data security breaches or compromises involving certain types of personal data or information technology systems, and we otherwise may find it necessary or appropriate to notify customers, individuals, or other parties of certain data security incidents. Security breaches or compromises experienced by others in our industry, our customers, or us may lead to public disclosures and widespread negative publicity. Any security breach or compromise in our industry, whether actual or perceived, could erode customer confidence in the effectiveness of our security measures, negatively impact our ability to attract new customers, cause existing customers to elect not to renew or expand their use of our software solutions, or subject us to third-party claims and lawsuits, indemnification, or other claims from customers and other third parties, regulatory investigations or proceedings, fines or other actions or liabilities, which could materially and adversely affect our business and results of operations.

54

In addition, some of our customers contractually require notification of data security breaches or compromises and include representations and warranties in their contracts with us that our software solutions comply with certain legal and technical standards related to data security and privacy and meets certain service levels. In certain of our contracts, a data security breach or compromise or operational disruption impacting us or one of our vendors, or system unavailability or damage due to other circumstances, may constitute a material breach and give rise to a customer’s right to terminate their contract with us or may cause us to be liable for certain monetary penalties, including as a result of a failure to meet service level agreements. While we have not, as of the date of this Quarterly Report on Form 10-Q, incurred any material monetary penalties as a result of these provisions, we cannot be certain that we will not in the future be liable for such payments, which could materially and adversely impact our business, results of operations, and reputation with our customers. In these circumstances, it may be difficult or impossible to cure such a breach or compromise in order to prevent customers from potentially terminating their contracts with us. Furthermore, although our customer contracts typically include limitations on our potential liability, there can be no assurance that such limitations of liability would be adequate. We also cannot be sure that our existing general liability insurance coverage and coverage for errors or omissions will be available on acceptable terms or in sufficient amounts to cover one or more claims or that our insurers will not deny or attempt to deny coverage as to any future claim. The successful assertion of one or more claims against us, the inadequacy or denial of coverage under our insurance policies, litigation to pursue claims under our policies, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or coinsurance requirements, could materially and adversely affect our business and results of operations.
We depend on data centers operated by third parties and third-party Internet hosting providers, and any disruption in the operation of these facilities or access to the Internet could adversely affect our business.
We currently serve our customers from two third-party data center hosting facilities located in Lone Mountain, Nevada and Atlanta, Georgia. The third-party owners and operators of these current and future facilities do not guarantee that our customers’ access to our software solutions will be uninterrupted, error-free, or secure. We may experience website disruptions, outages, and other performance problems at third-party data centers. These problems may be caused by a variety of factors, including infrastructure changes, human or software errors, viruses, security attacks (including ransomware attacks), fraud, spikes in customer usage, and denial of service issues. In some instances, we may not be able to identify the cause or causes of these performance problems within an acceptable period of time. Data center facilities are vulnerable to damage or interruption from human error, intentional bad acts, power loss, hardware failures, telecommunications failures, fires, wars, terrorist attacks, floods, earthquakes, hurricanes, tornadoes, or similar catastrophic events. They also could be subject to break-ins, computer viruses, sabotage, intentional acts of vandalism, and other misconduct. The occurrence of a natural disaster or an act of terrorism, a decision to close the facilities without adequate notice or terminate our hosting arrangement or other unanticipated problems could result in lengthy interruptions in the delivery of our software solutions, cause system interruptions, prevent our customers’ account holders from accessing their accounts online, cause reputational harm and loss, corruption, or unavailability of critical data, prevent us from supporting our software solutions, or cause us to incur additional expense in arranging for new facilities and support.
We also depend on third-party Internet-hosting providers and continuous and uninterrupted access to the Internet through third-party bandwidth providers to operate our business. As we continue to expand the number of our customers and available solutions, we may not be able to scale our technology to accommodate the increased capacity requirements, which may result in interruptions or delays in service. In addition, the failure of data centers, Internet service providers, or other third-party service providers to meet our capacity requirements could result in interruptions or delays in access to our solutions or impede our ability to grow our business and scale our operations. If our third-party infrastructure service agreements are terminated, if there is a service lapse, interruption of Internet service provider connectivity, or damage to data centers, or if we experience a service loss or disruption of one or more of our Internet-hosting or bandwidth providers for any reason, such as viruses, denial of service, ransomware, cybersecurity attacks or other attacks on their systems, human error, intentional bad acts, power loss, hardware failures, telecommunications failures, fires, wars, terrorist attacks, floods, earthquakes, hurricanes, tornadoes, or other catastrophic events, we could experience disruption in our ability to offer our software solutions and adverse perception of our software solutions’ reliability. We could also be required to retain the services of replacement providers, which could cause interruptions in access to our solutions as well as delays and additional expense in arranging new facilities and services and could also increase our operating costs and harm our business and reputation. Additionally, any need to change Internet-hosting service providers would require a significant amount of time and effort by our information technology department.

55

The recent transition of our software solutions to the public cloud could present significant risks and uncertainties unique to such a migration, which could adversely affect our business and operations.
We recently completed the transition of all our software solutions to the public cloud. This migration could introduce future risks associated with data and services migration that could affect our business continuity, result in loss, corruption, or compromise of data, and impact the provision of our software solutions. Further, the success in transitioning to the public cloud is dependent on our ability to effectively align, prioritize, and allocate our information technology, information security, product, and other resources to balance the needs of maintaining our existing infrastructure, while also innovating in future products and features and ensuring security and resiliency.
While we expect the transition to allow for greater scalability and integration, if this planned transition impacts the reliability and availability of our software solutions, we may not realize our financial and strategic objectives. In addition, any unanticipated interruption, delay, or degradation in the performance and delivery of our solutions could negatively impact our customer relationships. Accordingly, any such delays, errors, or difficulties may result in operational challenges, security failures, increased costs, or reputational harm, any of which could materially adversely impact our profitability and operations.
Defects, errors, or other performance problems in our software solutions could harm our reputation, result in significant costs to us, impair our ability to sell our software solutions, and subject us to substantial liability.
Our software solutions are complex and may contain defects, viruses, or errors when implemented or when new functionality is released. Such defects or disruptions could be the result of undetected vulnerabilities in third-party supplied software and technologies, bug fixes or upgrades, whether in connection with day-to-day operations or otherwise, or employee, contractor, or other third-party acts or inaction. Despite extensive testing, from time to time we have discovered, and may in the future discover, defects or errors in our software solutions. We may experience temporary system interruptions, either to our solutions as a whole, individual software solutions or groups thereof, or to some or all of our software hosting locations, for a variety of reasons, including network failures, power failures, software errors, or an overwhelming number of users trying to access our software solutions during periods of strong demand. Defects, errors, or other performance problems or disruptions in our software solutions or service could be costly for us, damage our customers’ businesses, result in loss of credibility with current or potential customers or partners, and harm our reputation, any of which could result in a material adverse effect on our business, operating results, and financial condition. In addition, our customers could seek to terminate their contracts, elect not to renew their subscriptions, delay or withhold payment, or make claims against us.
Because we are dependent on third parties for the implementation and maintenance of certain aspects of our systems and because some of the causes of system interruptions may be outside of our control, we may not be able to remedy such interruptions in a timely manner, if at all. As we rely heavily on our servers, computer, and communications systems and the Internet to conduct our business, any of these actions could result in liability, lost business, increased insurance costs, difficulty in collecting accounts receivable, costly litigation, or adverse publicity. Errors, defects, or other problems could also result in reduced sales or a loss of, or delay in, the market acceptance of our software solutions.
If we are unable to effectively integrate our software solutions with other systems, products, or other technologies used by our customers and prospective customers, or if there are performance issues with such third-party systems, products, or other technologies, our software solutions will not operate effectively and our operations will be adversely affected.
The functionality of our software solutions depends on our ability to integrate with other third-party systems, products, and other technologies used by our customers. Certain providers of these third-party systems, products, or other technologies also offer products that are competitive with our software solutions. These products may have an advantage over ours if customers using their software are better able to integrate with their own software. In addition, these third-party providers may be able to bundle their competitive products with other applications used by our customers and prospective customers at favorable pricing.

56

In addition, some of our competitors may be able to disrupt the operations or compatibility of our solutions with their products or services or exert strong business influence on our ability to, and terms on which we, provide our solutions. For example, core banking system companies provide critical back-end services to financial institutions. If these core banking system companies seek to compete with us in the markets we target or make it more difficult for us to integrate our solutions with their offerings, our business and results of operations could be materially and adversely affected. We do not have formal arrangements with many of these third-party providers regarding our access to their application programming interfaces, or APIs, to enable these customer integrations.
Our business may be harmed if any of our third-party providers:
change the features or functionality of their applications and platforms in a manner adverse to us;
discontinue or limit our software solutions’ access to their systems or other technologies;
terminate or do not allow us to renew or replace our existing contractual relationships on the same or better terms;
modify their terms of service or other legal terms or policies, including fees charged to, or other restrictions on, us or our customers;
establish exclusive or more favorable relationships with one or more of our competitors, or acquire one or more of our competitors and offer competing services; or
otherwise have or develop their own competitive offerings.
Third-party services and products are constantly evolving. We may not be able to modify our solutions to assure compatibility with that of other third parties as they continue to develop or emerge in the future or make such modifications in a timely and cost-effective manner. Such changes could limit or prevent us from integrating our software solutions with these third-party systems, which could impair the functionality of, prohibit the use of, or limit our ability to sell our software solutions to customers. If we are not permitted or able to integrate with such third-party technologies as a result of changes to, or third parties restricting our access to, the technologies during the terms of existing customer agreements, we may not be able to meet our contractual obligations to customers who use such third-party software. Should any of our competitors modify their products or standards in a manner that degrades the functionality of our solutions or gives preferential treatment to our competitors or competitive products, whether to enhance their competitive position or for any other reason, the interoperability of our products with these products could decrease, and our business, results of operations, and financial condition would be harmed. In addition, if any third-party technology providers experience an outage, our software solutions integrated with such technology will not function properly or at all, and our customers may be dissatisfied with our software solutions. If the technology of such third-party providers has performance or other problems, such issues may reflect poorly on us, and the adoption and renewal of our software solutions and our business may be harmed. Although our customers may be able to switch to alternative technologies if a provider’s services were unreliable or if a provider were to limit such customer’s access and utilization of its data or the provider’s functionality, our business could nevertheless be harmed due to the risk that our customers could reduce their use of our software solutions.
As the number of customers that we serve increases, we may encounter implementation challenges, and we may have to delay revenue recognition for some complex engagements, which would harm our business and operating results.
We may face unexpected implementation challenges related to the complexity of our customers’ implementation and integration requirements. Our implementation expenses increase when customers have unexpected data, hardware, or software technology challenges or complex or unanticipated business requirements. In addition, certain of our customers require complex acceptance testing related to the implementation of our software solutions. Further, because we do not fully control our customers’ implementation schedules, implementation issues may occur if our customers do not allocate the internal resources necessary to meet implementation timelines or if there are unanticipated implementation delays. Any difficulties or delays in implementation processes could cause customers to delay or forego future purchases of our software solutions or require us to delay revenue recognition under the related customer agreement longer than expected, either of which would adversely affect our business, operating results, and financial condition.

57

If we fail to meet our service level commitments, we could be obligated to provide credits or refunds or face contract terminations, which could adversely affect our business, operating results, and financial condition.
Certain of our agreements with our customers contain service level commitments. If we are unable to meet the stated service level commitments or suffer extended periods of unavailability for our solutions, we may be contractually obligated to provide these parties with service credits or refunds. In addition, we could face contract terminations, in which case we would be subject to a loss of future revenues. Our revenues could be significantly affected if we suffer unexcused downtime under our agreements with our customers and partners. Further, any extended service outages could adversely affect our reputation, revenues, and operating results.
Certain of our key operating metrics are subject to inherent challenges in measurement, and real or perceived inaccuracies in such metrics may harm our reputation and negatively affect our business.
We track certain key operating metrics using internal tools, which have certain limitations. In addition, we rely on data received from third parties, including industry forecast reports, to track certain performance indicators. We have only a limited ability to verify data from both of these sources. Our methodologies for tracking metrics may also change over time, which could result in changes to the metrics we report. If we under count or over count performance due to the internal tools we use or issues with the data received from third parties, or if our internal tools contain errors, the data we report may not be accurate or comparable with prior periods. In addition, limitations, changes or errors with respect to how we measure data may affect our understanding of certain details of our business, which could affect our longer-term strategies.
If our performance metrics are not, or are not perceived to be, accurate representations of our financial or operational performance, if we discover material inaccuracies in our metrics, or if we can no longer calculate any of our key performance metrics with a sufficient degree of accuracy and cannot find an adequate replacement for the metric, our business, operating results, and financial condition could be adversely affected.
Our usage and volume-based pricing can cause revenue fluctuation and may adversely affect our business and operating results.
Our customer relationships are generally conducted in accordance with the terms of multi-year contracts that, among other things, may provide for minimum purchases and specified levels of pricing based on the volume of loans, applications, or searches conducted or processed during the applicable billing period. These contractual features are key determinants of profitability. Certain of our contracts provide for contractually scheduled price changes. From time to time, we also negotiate pricing or other changes with our existing customers that include, but are not limited to, extending or renewing a contract or adjusting minimum volumes. Our usage and volume-based pricing, which is seasonal and cyclical, can cause our revenues to fluctuate which could affect our business. Additionally, our usage and volume-based pricing can be negatively impacted by macroeconomic trends, which may disproportionately impact our revenues.
We depend on satisfied customers to succeed and, in certain instances, have aligned our financial goals with those of our customers. Our historical contracts are subject to de minimis minimum commitments with certain of our customers, who may be less willing or able to accommodate modifications to our contracts given their own business constraints. Such minimum commitment obligations may not be cost-effective or provide positive returns.
Our sales cycle can be unpredictable, time-consuming, and costly, which could harm our business and operating results.
Our sales process involves educating prospective customers and existing customers about the use, technical capabilities, and benefits of our software solutions. Prospective customers often undertake a prolonged evaluation process, which typically involves not only our software solutions but also those of our competitors, and typically lasts from six to nine months or longer. We may spend substantial time, effort, and money on our sales and marketing efforts without any assurance that our efforts will produce any sales. It is also difficult to predict the level and timing of sales opportunities that come from our referral partners. Events affecting our customers’ businesses may occur during the sales cycle that could affect the size or timing of a purchase, contributing to more unpredictability in our business and operating results. As a result of these factors, we may face greater costs, longer sales cycles, and less predictability in the future.

58

If we fail to effectively expand our sales and marketing capabilities and teams, including through partner relationships, we may not be able to increase our customer base and achieve broader market acceptance of our software solutions.
Increasing our customer base and achieving broader market acceptance of our software solutions will depend on our ability to expand our sales and marketing organizations and their abilities to obtain new customers and sell additional solutions and services to existing customers. We believe there is significant competition for direct sales professionals with the skills and knowledge that we require, and we may be unable to hire or retain sufficient numbers of qualified individuals in the future. Our ability to achieve significant future revenue growth will depend on our success in recruiting, training, and retaining a sufficient number of direct sales professionals. New hires require significant training and time before they become fully productive and may not become as productive as quickly as we anticipate. As a result, the cost of hiring and carrying new representatives cannot be offset by the revenues they produce for a significant period of time. Our growth prospects will be harmed if our efforts to expand, train, and retain our direct sales team do not generate a corresponding significant increase in revenues. Additionally, if we fail to sufficiently invest in our marketing programs or they are unsuccessful in creating market awareness of our company and software solutions, our business may be harmed, and our sales opportunities may be limited.
In addition to our direct sales team, we also extend our sales distribution through formal and informal relationships with referral and reseller partners. While we are not substantially dependent upon referrals from any partner, our ability to achieve significant revenue growth in the future will depend upon continued referrals from our partners and growth of the network of our referral partners. These partners are under no contractual obligation to continue to refer business to us, nor do these partners have exclusive relationships with us and may choose to instead refer potential customers to our competitors. We cannot be certain that these partners will prioritize or provide adequate resources for promoting our software solutions or that we will be successful in maintaining, expanding, or developing our relationships with referral partners. Our competitors may be effective in providing incentives to third parties, including our partners, to favor their software products or prevent or reduce subscriptions to our software solutions, either by disrupting our relationship with existing customers or limiting our ability to win new customers. Establishing and retaining qualified partners and training them with respect to our software solutions requires significant time and resources. If we are unable to devote sufficient time and resources to establish and train these partners or if we are unable to maintain successful relationships with them, we may lose sales opportunities and our revenues could suffer.
Our product partners may change their dependence on our system for providing service to their customers, which could harm our business and operating results.
Our continued success will depend in part on our ability to retain a number of key product partners. In addition, we believe that our future success will depend in large part on our ability to attract product partners who utilize our system to service their customers, driving further volumes through our platform. Value associated with our platform is derived from the ability of our customers to access these product partners through our solutions. There can be no assurance that we will be successful in attracting and retaining such partners. The loss of certain key product partners or our inability to attract or retain other product partners could have a material adverse effect on our business, operating results, and financial condition.
If we fail to offer high-quality customer support, or if our support is more expensive than anticipated, our business and reputation could suffer.
Our customers rely on our customer support services to resolve issues and realize the full benefits provided by our solutions. High-quality support is also important to maintain and drive further adoption by our existing customers. We primarily provide customer support over the phone, chat, and via web portal. If we do not help our customers quickly resolve issues and provide effective ongoing support or if our support personnel or methods of providing support are insufficient to meet the needs of our customers, our ability to retain customers, increase adoption by our existing customers, and acquire new customers could suffer, and our reputation with existing or potential customers could be harmed. If we are not able to meet the customer support needs of our customers during the hours that we currently provide support, we may need to increase our support coverage and provide additional support, which may reduce our profitability.

59

We depend on key and highly skilled personnel to operate our business, and if we are unable to retain our current personnel or hire additional personnel, our ability to develop and successfully market our business could be harmed.
We believe our future success will depend in large part upon our ability to attract and retain highly skilled managerial, technical, finance, creative, and sales and marketing personnel. Moreover, we believe that our future success is highly dependent on the contributions of our executive officers. All of our officers and other employees are at-will employees, which means they may terminate their employment relationship with us at any time, and their knowledge of our business and industry would be extremely difficult to replace. In addition, the loss of any key employees or the inability to attract or retain qualified personnel could delay the development and introduction of, and harm our ability to sell, our software solutions and harm the market’s perception of us. Qualified individuals are in high demand, and we may incur significant costs to attract them. We may be unable to attract and retain suitably qualified individuals who are capable of meeting our growing sales, operational, and managerial requirements, or may be required to pay increased compensation in order to do so. If we are unable to attract and retain the qualified personnel we need to succeed, our business will suffer.
Volatility or lack of performance in our stock price may also affect our ability to attract and retain our key employees. Certain of our employees have become, or will soon become, vested in a substantial amount of stock options. Employees may be more likely to leave us if the shares they own or the shares underlying their vested options have significantly appreciated in value relative to the original purchase prices of the shares or the exercise prices of the vested options, or if the exercise prices of the options that they hold are significantly above the market price of our common stock. If we are unable to retain or find a suitable replacement for our named executive officers or other key employees, our business will be harmed.
Growth may place significant demands on our management and our infrastructure.
Our growth has placed, and may continue to place, significant demands on our management and our operational and financial infrastructure. As our operations grow in size, scope, and complexity, we will need to improve and upgrade our systems and infrastructure to offer an increasing number of customers enhanced software solutions, features, and functionality. The expansion of our systems and infrastructure will require us to commit substantial financial, operational, and technical resources in advance of an increase in the volume of business, with no assurance that the volume of business will increase. To support our growth, we must also continue to improve our management resources and our operational and financial controls and systems, and these improvements may increase our expenses more than anticipated and result in a more complex business. Continued growth could also strain our ability to maintain reliable service levels for our customers and recruit, train, and retain highly skilled personnel.
Managing our growth will require significant expenditures and allocation of valuable management resources. If we fail to achieve the necessary level of efficiency in our organization as it grows, our business would be harmed.
We have shifted a significant portion of our product development operations to India, which poses risks.
We have used, and intend to continue to use, unrelated third parties to provide us with technology development services, through individuals based in India. We have increased the amount of our product development work performed by contractors in India to expand our access to additional resources so we can meet the needs of our increased development efforts. However, we may not achieve the cost savings and other benefits we anticipate from these programs, and we may not be able to find sufficient numbers of developers with the necessary skill sets in India to meet our needs. While our experience to date with our India-based contractors has been positive, there is no assurance that this will continue. Specifically, there are a number of risks associated with this activity, including but not limited to the following:
communications and information flow may be less efficient and accurate as a consequence of the time and distance differences between our primary development organization and the foreign-based activities, resulting in delays in development or errors in the software developed;
in addition to the risk of misappropriation of intellectual property from departing personnel, there is a general risk of the potential for misappropriation of our intellectual property that might not be readily discoverable;
the ability to obtain fulsome rights to intellectual property arising from the work performed by India-based individuals may be more difficult than it is with respect to intellectual property arising from work performed for us by our U.S.-based employees;
the quality of the development efforts undertaken offshore may not meet our requirements, including due to experiential differences, resulting in potential product errors and/or delays;

60

currency exchange rates could fluctuate and adversely impact the cost advantages intended from maintaining these relationships; and
as would be the case with any of our third-party developers, if those based in India were to leave their employment or if the third-party development services agreement with us were terminated, we would lose some short-term development capacity, and while we believe we would still be able to continue maintaining and improving all of our service offerings, we would need to expend resources and management time to on-board additional development resources.
In addition, as a result of the foregoing arrangements, we have a heightened risk exposure to changes in the economic, security, and political conditions of India. India has also been affected by the pandemic and taken measures to try to contain it, at times resulting in disruptions to their work force and slowdowns in certain deliverables. Economic and political instability, military actions, and other unforeseen occurrences in India could impair our ability to develop and introduce new software applications and functionality in a timely manner, which could put our products at a competitive disadvantage whereby we lose existing customers and/or fail to attract new customers.
Our business is subject to the risks of earthquakes, fires, floods, and other natural catastrophic events and to interruption by man-made problems such as terrorism.
Our systems and operations are vulnerable to damage or interruption from earthquakes, fires, floods, power losses, telecommunications failures, terrorist attacks, acts of war, and similar events beyond our control, many of which are becoming more acute and frequent as a result of climate change. Any such event could have a material adverse impact on our business, operating results, and financial condition. Significant recovery time could be required to resume operations and any negative effects of a catastrophic event could be compounded if concurrently occurring with another unexpected and adverse event. Our corporate offices and one of the facilities we lease to house our computer and telecommunications equipment are located in Southern California, a region known for seismic activity. In addition, acts of terrorism, which may be targeted at metropolitan areas which have higher population density than rural areas, could cause disruptions in our or our customers’ businesses or the economy as a whole. We may not have sufficient protection or recovery plans in certain circumstances, such as natural disasters affecting Southern California, and our business interruption insurance may be insufficient to compensate us for losses that may occur.
Risks Related to Legal and Regulatory Matters
Any future litigation against us could damage our reputation and be costly and time-consuming to defend.
We have in the past and may become in the future subject to legal proceedings and claims that arise in the ordinary course of business, such as claims brought by our customers in connection with commercial disputes or employment claims made by current or former employees. In other instances, our customers become involved in litigation where we are required to provide information pursuant to a court order. From time to time, we also may initiate litigation to enforce our rights, including with respect to payments that we are owed. Litigation could result in reputational damage and substantial costs and may divert management’s attention and resources, any of which may adversely impact our business, overall financial condition, and results of operations and affect the value of our common stock. While we maintain insurance coverage for certain types of claims, such insurance coverage may be insufficient to cover all losses or all types of claims that may arise. We are not currently aware of any material pending or threatened litigation against us but can make no assurances the same will continue to be true in the future.
If we are unable to protect our intellectual property, our business could be adversely affected.
We rely on a combination of copyrights, trademarks, service marks, patents and trade secret laws, confidentiality obligations, and other contractual restrictions to establish and protect our intellectual property and other proprietary rights. Despite our efforts, these protections may be limited and may not adequately permit us to gain or keep any competitive advantage. Unauthorized third parties may try to copy or reverse engineer our solutions, technology, systems, methods, processes, or proprietary information. A third party may develop software solutions, adopt trade names or domain names, or acquire other intellectual property and proprietary rights similar to ours, thus diluting or diminishing the value of our intellectual property, proprietary rights, and overall brand. Our ability to assert our intellectual property rights against potential competitors or to settle current or future disputes could be limited by our agreements with third parties. Our patents may be invalidated or circumvented. A patent application may not be issued with the claim scope we seek, if at all. In addition, the laws of some countries do not provide the same level of intellectual property protection as U.S. laws and courts.

61

We may be required to spend significant resources to monitor and protect our intellectual property rights. We may initiate claims or litigation against third parties for infringement of our proprietary rights or to establish the validity of our proprietary rights. We may also allow certain of our registered intellectual property rights, or our pending applications or registrations for intellectual property rights, to lapse or to become abandoned if we determine that obtaining or maintaining the applicable registered intellectual property rights is not worthwhile. Our inability to protect our intellectual property against unauthorized copying or use, as well as any costly litigation or diversion of our management’s attention and resources, could delay sales or the implementation of our software solutions, impair the functionality of our software solutions, delay introductions of new software solutions, result in our substituting less-advanced or more-costly technologies into our software solutions, or harm our reputation. In addition, should any of our protections fail, we may be required to license additional intellectual property from third parties to develop and market new software solutions, and we cannot ensure that we could license that intellectual property on commercially reasonable terms or at all.
We use open source software in our solutions, which could subject us to litigation or other actions, or otherwise negatively affect our ability to sell our solutions.
Our solutions incorporate software modules licensed to us by third-party authors under “open source” licenses. Use and distribution of open source software may entail greater risks than use of third-party commercial software, as open source licensors generally do not provide support, warranties, indemnification, or other contractual protections regarding infringement claims or the quality of the code. In addition, the public availability and unknown vulnerabilities of such software may make our solutions more susceptible to compromise. The terms of many open source licenses have not been interpreted by U.S. or foreign courts, and there is a risk that these licenses could be construed in a way that imposes unanticipated conditions or restrictions on our ability to provide or distribute our solutions.
We could become subject to lawsuits by parties claiming ownership of what we believe to be open source software. If we are held to have breached or failed to fully comply with all the terms and conditions of an open source software license, we could face infringement or other liability, or be required to seek costly licenses from third parties, to re-engineer our solutions, to discontinue or delay the provision of our offerings if re-engineering could not be accomplished on a timely basis, or to make generally available, in source code form, our proprietary code, any of which could adversely affect our business, financial condition, and results of operations. In addition, some open source licenses may require us to release source code for modifications or derivative works or to license our intellectual property. A release of our proprietary code could also allow our competitors to create similar offerings with lower development effort and time and ultimately could result in a loss of our competitive advantages. Although we monitor our use of open source software to avoid subjecting our solutions to unintended conditions, such use may require us to take remedial action that may divert resources away from our development efforts and could materially adversely affect our business.
Lawsuits by third parties against us or our customers for alleged infringement of the third parties’ proprietary rights or for other intellectual property-related claims relating to our solutions or business could result in significant expenses and harm our operating results.
Our industry is characterized by the existence of a large number of patents, copyrights, trademarks, trade secrets, and other intellectual property and proprietary rights, along with frequent litigation based on allegations of infringement or other violations of intellectual property rights. We have been, are currently, and, from time to time, expect to be involved in disputes related to patent and other intellectual property rights of third parties. To date, none of these disputes have resulted in material liabilities. Our business could be adversely affected by any significant disputes between us and our customers as to the applicability or scope of our indemnification obligations to them. There can be no assurances that any existing limitations of liability provisions in our contracts would be enforceable or adequate or would otherwise protect us from any such liabilities or damages with respect to any particular claim. If such claims are successful, or if we are required to indemnify or defend our customers from these or other claims, these matters could be disruptive to our business and management, result in material liabilities, and have an adverse effect on our business, operating results, and financial condition.

62

From time to time, we have received, and may continue to receive, threatening letters or notices or, in the future, may be the subject of claims that our software solutions and underlying technology infringe or otherwise violate the intellectual property rights of others, and we may be found to be infringing upon or otherwise violating such rights. We also face, from time to time, trade name or trademark or service mark infringement claims brought by owners of other registered or unregistered trademarks or service marks, including trademarks or service marks that may incorporate variations of our brand names. In addition, the risk of patent litigation has been amplified by the increase in the number of patent holding companies or other adverse patent owners that have no relevant product revenues, and therefore, our existing patent and any patents we may obtain in the future may provide little or no deterrence as we would not be able to assert them against such entities or individuals. Any claims or litigation could cause us to incur significant expenses and, if successfully asserted against us or our customers whom we indemnify, could subject our technologies to injunction preventing us from accessing such third-party intellectual property rights, require that we pay substantial damages or ongoing royalty payments, prevent us from offering our software solutions, or require that we comply with other unfavorable terms. Even if the claims do not result in litigation or are resolved in our favor, these claims and the time and resources necessary to resolve them could divert the resources of our management and harm our business and operating results. Any claims related to our intellectual property or customer confusion related to our solutions could damage our reputation and adversely affect our growth prospects.
Any use of our solutions by our customers in violation of legal or regulatory requirements could damage our reputation and subject us to additional liability.
If our customers or their clients use our solutions in violation of regulatory requirements and applicable laws, we could suffer damage to our reputation and could become subject to claims in connection with their use of our solutions. We rely on our customers’ contractual obligations that their use and their clients’ use of our solutions will comply with applicable laws. However, we do not audit our customers or their clients to confirm compliance. Even if claims asserted against us do not result in liability, we may incur costs in investigating and defending against such claims. If we are found liable in connection with our customers’ or their clients’ activities, we could incur liabilities and be required to redesign our solutions or otherwise expend resources to remedy any damages caused by such actions and to avoid future liability.
Privacy, information security, and data protection concerns, data collection and transfer restrictions, and related domestic regulations may limit the use and adoption of our software solutions and adversely affect our business and results of operations.
The regulatory framework governing privacy, information security, data protection, and the collection, processing, storage, and use of certain information, particularly financial and other personally identifiable information, is rapidly evolving. We expect that there will continue to be new proposed and adopted laws, regulations, and industry standards concerning privacy, data protection, and information security in the United States. For example, California enacted the California Consumer Privacy Act, or CCPA, which went into effect in January 2020 and, among other things, requires companies covered by the legislation to provide new disclosures to California consumers and afford such consumers new rights of access and deletion for personal information, as well as the right to opt-out of certain sales of personal information. Additionally, on November 3, 2020, the California Privacy Rights Act, or CPRA, was approved by California voters. The CPRA amends and expands the CCPA. The CCPA and the CPRA will require us to modify and augment our practices and policies and incur substantial costs and expenses in an effort to comply or respond to further changes to laws or regulations.
We cannot yet fully determine the impact these or future laws, rules, and regulations may have on our business or operations. Any such laws, rules, and regulations may be inconsistent among different jurisdictions, subject to new or differing interpretations, or conflict with our current or future practices. Additionally, we may be bound by contractual requirements applicable to our collection, use, processing, and disclosure of various types of information, including financial and PII, and may be bound by, or voluntarily comply with, self-regulatory or other industry standards relating to these matters that may further change as laws, rules, and regulations evolve. Any failure or perceived failure by us, our third-party service providers, or any other third parties with which we do business, to comply with these laws, rules, and regulations, or with other obligations to which we or such third parties are or may become subject, may materially and adversely affect our business and results of operations, and result in reputational harm, governmental investigations and enforcement actions, litigation, claims, fines and penalties, or adverse publicity.
Additionally, if in the future we seek to sell our solutions outside of the United States, we would face similar or potentially more stringent laws and regulations relating to personal privacy, information security, and data protection and we cannot be certain we would be able to adequately address these laws and regulations as part of any international expansion.

63

Our customers are highly regulated and subject to a number of challenges and risks. Our failure to comply with laws and regulations applicable to us as a technology provider to financial institutions could adversely affect our business and results of operations, increase costs, and impose constraints on the way we conduct our business.
Our customers and prospective customers are highly regulated and are generally required to comply with stringent regulations in connection with performing business functions that our software solutions address. As a provider of technology to financial institutions, and as a result of obligations under some of our customer contracts, we are required to comply with certain provisions of the Gramm-Leach-Bliley Act, or GLBA, related to the privacy and security of certain consumer information, in addition to other contractual obligations that relate to our customers’ obligations under the GLBA and other laws and regulations to which they are subject. We also may be subject to other laws and regulations, including those relating to privacy and data security, due to the software solutions we provide to financial institutions.
Matters subject to review and examination by federal and state financial institution regulatory agencies and external auditors include our internal information technology controls in connection with our performance of data processing services, the agreements giving rise to those processing activities, and the design of our software solutions. Any inability to satisfy these examinations and maintain compliance with applicable regulations could adversely affect our ability to conduct our business, including attracting and maintaining customers. If we have to make changes to our internal processes and software solutions as result of these regulations, we could be required to invest substantial additional time and funds and divert time and resources from other corporate purposes to remedy any identified deficiency.
Our indirect, wholly-owned subsidiary, Professional Credit Reporting, Inc., functions as a consumer reporting agency and, as a result, is subject to rules and regulations applicable to consumer reporting agencies, such as the Fair Credit Reporting Act, or FCRA. In addition, with our acquisition of the assets of TazWorks, we may have additional exposure to FCRA. Other than these exposures to FCRA, we have adopted the position that we are not otherwise subject directly to the FCRA in our position as a provider of technology to financial institutions. It is possible that this position may be challenged by regulatory authorities or others, however, which could result in regulatory investigations and other proceedings, claims, and other liability, and which could require us to redesign our solutions and otherwise substantially modify our operations, processes, and solutions. This could require dedication of substantial funds and other resources, and time of management and technical personnel, and could be highly disruptive to our operations. This could adversely affect our business and results of operations.
The evolving, complex, and often unpredictable regulatory environment in which our customers operate could result in our failure to provide compliant software solutions, which could result in customers not purchasing our software solutions or terminating their contracts with us or the imposition of fines or other liabilities for which we may be responsible. In addition, as a service provider to financial institutions, we may be subject to direct regulation and examination by federal and/or state agencies, and such agencies may attempt to further regulate our activities in the future which could adversely affect our business and results of operations.
The financial services industry is heavily regulated and changes in current legislation or new legislation could adversely affect our business.
The financial services industry in the United States, and, in particular, the consumer lending and mortgage industries, are heavily regulated. Our software solutions are designed to assist our customers with their compliance of consumer protection laws and institutionally mandated compliance policies and, therefore, must continually be updated to incorporate changes to such laws and policies. For example, we made the decision to make certain changes to our software solutions to assist our customers with compliance with modifications to the Truth in Lending Act, or TILA. Federal and state governments and agencies could enact legislation or other policies that could negatively impact the business of our customers and our product partners. Any changes to existing laws or regulations or adoption of new laws or regulations that increase restrictions on the consumer lending and mortgage industries may decrease usage and volumes transacted with our solutions or otherwise limit the ability of our customers and our product partners to operate their businesses, resulting in decreased usage of our software solutions. Updates that we have undertaken in the past have caused us to incur significant expense, and future updates to address such legal and regulatory developments will likely similarly cause us to incur significant expense.

64

While our customers are ultimately responsible for compliance with the laws and regulations that apply to the consumer lending and mortgage industries, a failure to design or to appropriately update our software solutions to reflect and comply with changes to existing laws or regulations or with new laws or regulations may contribute to violations by our customers of such laws and regulations. Any such violations could encourage our customers to discontinue using our software solutions and cause us reputational harm, which would negatively impact our financial position and results of operations.
Failure to comply with anti-bribery, anti-corruption, and anti-money laundering laws, foreign export controls and trade sanctions, and similar laws, could subject us to penalties and other adverse consequences.
Failure to comply with anti-bribery, anti-corruption, anti-money laundering, and similar laws could subject us to penalties and other adverse consequences. We are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended, or the FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. § 201, the U.S. Travel Act, the USA PATRIOT Act, and other federal, state, and local laws that address anti-bribery, anti-corruption, and anti-money laundering. If we expand internationally, we may become subject to the anti-corruption, anti-bribery, and anti-money laundering laws of other countries. Anti-corruption and anti-bribery laws have been enforced aggressively in recent years and are interpreted broadly to generally prohibit companies, their employees, agents, representatives, business partners, and third-party intermediaries from authorizing, offering, or providing, directly or indirectly, improper payments or benefits to recipients in the public or private sector.
If we pursue international expansion, our risks under these laws may increase as we, our employees, agents, representatives, business partners, and our third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities, and we may be held liable for the corrupt or other illegal activities of these employees, agents, representatives, business partners, or third-party intermediaries even if we do not explicitly authorize such activities. These laws also require that we keep accurate books and records and maintain internal controls and compliance procedures designed to prevent any such actions.
While we have policies and procedures to address compliance with such laws, we cannot ensure that none of our employees, agents, representatives, business partners, or third-party intermediaries will take actions in violation of our policies and applicable law, for which we may be ultimately held responsible.
In some cases, our solutions may be subject to U.S. and foreign export controls, trade sanctions, and import laws and regulations. Governmental regulation of the import or export of our solutions, or our failure to obtain any required import or export authorization for our solutions, when applicable, could harm future international sales and adversely affect our revenue. Compliance with applicable regulatory requirements regarding the export of our solutions may create delays in the introduction of our solutions in international markets or, in some cases, prevent the export of our solutions to some countries altogether. Furthermore, U.S. export control laws and economic sanctions prohibit the shipment of certain products and services to countries, governments, and persons targeted by U.S. sanctions. If we fail to comply with export and import regulations and such economic sanctions, penalties could be imposed, including fines and/or denial of certain export privileges. Moreover, any new export or import restrictions, new legislation, or shifting approaches in the enforcement or scope of existing regulations, or in the countries, persons, or products targeted by such regulations, could result in decreased use of our solutions by, or in our decreased ability to export our solutions to, existing or potential customers with international operations. Any decreased use of our solutions or limitation on our ability to export or sell our solutions would likely adversely affect our business.
Any allegations or violation of the FCPA or other applicable anti-bribery or anti-corruption laws, anti-money laundering laws, or foreign export controls and trade sanctions could result in whistleblower complaints, sanctions, settlements, prosecution, enforcement actions, fines, damages, adverse media coverage, investigations, loss of export privileges, severe criminal or civil sanctions, or suspension or debarment from U.S. government contracts, all of which may have an adverse effect on our reputation, business, results of operations, and prospects. Responding to any investigation or action will likely result in a materially significant diversion of management’s attention and resources and significant defense costs and other professional fees. In addition, the U.S. government may seek to hold us liable for successor liability for FCPA violations committed by companies in which we invest or that we acquire. As a general matter, investigations, enforcement actions, and sanctions could harm our reputation, business, results of operations, and financial condition.
If one or more U.S. states or local jurisdictions successfully assert that we should have collected, or in the future should collect, additional sales or use taxes on our fees, we could be subject to additional liability with respect to past or future sales, and the results of our operations could be adversely affected.

65

An increasing number of states have considered or adopted laws that attempt to impose sales tax collection obligations on out-of-state sellers. We do not collect state and local sales and use taxes in all jurisdictions in which our customers are located, based on our belief that such taxes are not applicable. Jurisdictions in which we do not collect sales and use taxes may assert that such taxes are applicable and require us to calculate, collect, and remit taxes, interest, and penalties, as well as collect such taxes in the future. In addition, one or more states, the federal government, or other countries may seek to impose additional reporting, record-keeping, or indirect tax collection obligations on businesses like ours that offer subscription services. For example, on June 21, 2018, the Supreme Court held in South Dakota v. Wayfair, Inc. that states could impose sales tax collection obligations on out-of-state sellers even if those sellers lack any physical presence within the states imposing the sales taxes. In response to Wayfair, states may require us to collect and remit sales and use taxes where we have not collected and remitted sales and use taxes that occurred in prior tax years. The imposition by state governments or local governments of sales tax collection obligations on out-of-state sellers could also create additional administrative burdens for us, subject us to additional costs, put us at a competitive disadvantage if similar obligations are not imposed on our competitors, and decrease our future sales, which could have an adverse effect on our business, financial condition, and results of operations.
Risks Related to Finance and Accounting
Our quarterly results may fluctuate significantly and may not fully reflect the underlying performance of our business.
Our quarterly results of operations, including the levels of our revenues, gross margin, profitability, and cash flow may vary significantly in the future and, accordingly, period-to-period comparisons of our results of operations may not be meaningful. Thus, the results of any one quarter should not be relied upon as an indication of future performance. Our quarterly financial results may fluctuate as a result of a variety of factors, many of which are outside of our control, and may not fully or accurately reflect the underlying performance of our business. For example, while subscriptions with our customers often include multi-year terms that typically range from three to five years, a majority of our revenues from these subscriptions comes from usage or volume-based fees, such as application fees and per inquiry fees, as opposed to annual or monthly base fees. As such, if our customers terminate their agreements with us prior to their scheduled term, we may only recover all or a portion of our contractual base fees, and not any usage or volume-based fees. Fluctuation in quarterly results may negatively impact the value of our common stock. Factors that may cause fluctuations in our quarterly financial results include, without limitation, those listed below:
our ability to retain current customers or attract new customers;
the overall usage, volume, and type of transactions handled or processed using our software solutions, which may vary based on external factors such as macroeconomic conditions, including the impact of the COVID-19 pandemic, and seasonality;
the activation, delay in activation, or cancellation by customers;
the timing of recognition of professional services revenues;
the amount and timing of operating expenses related to the maintenance and expansion of our business, operations, and infrastructure;
consolidations between or mergers or acquisitions of our customers, to the extent the combined entity or acquirer elects not to continue using our solutions or reduces subscriptions to it;
customer renewal, expansion, and retention rates;
increases or decreases in usage or pricing changes upon renewals of customer contracts;
network outages or security breaches;
general economic, industry, and market conditions (particularly those affecting financial institutions);
changes in our pricing policies or those of our competitors;
seasonal variations in sales of our software solutions, which have historically been highest in the third quarter of our fiscal year;
the timing and success of introductions of new solutions or features and functionality by us or our competitors or any other change in the competitive dynamics of our industry, including consolidation among competitors, customers, or strategic partners;
unexpected expenses such as those related to litigation and other disputes; and

66

the timing of expenses related to the development or acquisition of technologies or businesses and potential future charges for impairment of goodwill from acquired companies.
Our forecasts are subject to significant risks, assumptions, estimates, and uncertainties, which may cause our revenues, market share, expenses, and profitability to differ materially from our expectations.
Our forecasts, as well as our internal estimates and research, are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. We operate in rapidly evolving, fragmented, and competitive industries, which make our results of operations difficult to predict. Additionally, we have a limited operating history at the current scale of our business, which makes it difficult to forecast our future results.
Forecasts are inherently imperfect predictors of actual results due to their basis on historical data and assumptions regarding factors, such as the competition our business faces, our ability to attract and retain customers and partners, our ability to successfully implement our business strategy, future demand, subscription renewals, and industry and market trends. In addition, any issues with the quality or effectiveness of our data aggregation and validation procedures, as well as the quality and integrity of data inputs, could result in ineffective or inaccurate forecast outputs and reports. Forecasts based on historical data sets might not be accurate predictors of future outcomes, and their ability to appropriately predict future outcomes may degrade over time.
Given the challenges of predicting future behavior, management judgment is used at every stage of the forecasting process, from forecast design decisions regarding core underlying assumptions, to interpreting and applying final output. Further, when market conditions change quickly and unpredictably, there is an increased risk that the assumptions and data inputs for our forecasts are not representative of the most recent market conditions, which requires management judgment to make adjustments or overrides to our forecasts. In a rapidly changing environment, we may be unable to update existing forecasts expeditiously to properly account for the most recently available data and events.
If the forecasts of market growth, anticipated spending, or predictions regarding market size prove to be inaccurate, our business and growth prospects could be adversely affected. Even if all or some of the forecasted growth occurs, our business may not grow at a similar rate, or at all. If actual results differ from our estimates, analysts may negatively react and our stock price could be materially impacted.
Because we recognize certain subscription fee revenues over the term of the contract, downturns or upturns in our business may not be fully reflected in our results of operations until future periods.
We generally recognize revenues from subscription fees ratably over the terms of our customer contracts, which typically have an initial term of three years. As such, a portion of the subscription fee revenues we report each quarter are derived from the recognition of deferred revenues relating to subscriptions activated in previous quarters. Consequently, a reduction in customer subscriptions in any single quarter may only have a small impact on our revenues for that quarter. However, such a decline will negatively affect our revenues in future quarters. Accordingly, the effect of significant downturns in sales or market acceptance of our software solutions may not be fully reflected in our results of operations until future periods.
If our goodwill and other intangibles become impaired, we may be required to record a significant charge to earnings.
We have a significant amount of goodwill and other intangibles. Our goodwill and other intangible asset balances as of September 30, 2022 were approximately $571.6 million and $279.5 million, respectively. We test goodwill at least annually, on October 1, or more frequently if circumstances indicate that goodwill may not be recoverable. Testing involves estimates and judgments by management. Such assets are considered to be impaired when the carrying value of an intangible asset exceeds its estimated fair value. We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible assets is determined. While no impairment has been recorded in the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q, any future impairment of a significant portion of our goodwill could materially adversely affect our financial condition and results of operations.

67

Our debt agreements contain restrictions that limit our flexibility.
Our debt agreements contain, and any future indebtedness of ours would likely contain, a number of covenants that impose significant operating and financial restrictions on us, including restrictions on our and our subsidiaries’ ability, among other things, to:
incur additional indebtedness;
incur liens;
engage in mergers, consolidations, liquidations, or dissolutions;
pay dividends and distributions on, or redeem, repurchase, or retire our capital stock;
make investments, acquisitions, loans, or advances;
create negative pledge or restrictions on the payment of dividends or payment of other amounts owed from subsidiaries;
sell, transfer, or otherwise dispose of assets, including capital stock of subsidiaries;
make prepayments of material debt that is subordinated with respect to right of payment or liens, or is unsecured;
engage in certain transactions with affiliates;
modify certain documents governing material debt that is subordinated with respect to right of payment; and
change our lines of business.
As a result of these covenants, we will be limited in the manner in which we conduct our business, and we may be unable to engage in favorable business activities or finance future operations or capital needs.
We are highly leveraged and have substantial indebtedness, which reduces our capability to withstand adverse developments or business conditions.
We have incurred substantial amounts of indebtedness to finance our business operations, including our growth initiatives. Our level of indebtedness increases the possibility that we may be unable to generate cash sufficient to pay, when due, the principal of, interest on, or other amounts due in respect of our indebtedness.
Our overall leverage and the terms of our financing arrangements could also:
make it more difficult for us to satisfy obligations under our outstanding indebtedness, and any failure to comply with the obligations under any of our debt instruments, including restrictive covenants, could result in an event of default under any of the agreements governing our indebtedness;
limit our ability to obtain additional financing in the future for working capital, capital expenditures, or acquisitions;
limit our ability to refinance our indebtedness on terms acceptable to us or at all;
delay investments, restrict us from making strategic acquisitions, or cause us to make non-strategic divestitures;
require us to dedicate a significant portion of our cash flow from operations to paying the principal of and interest on our indebtedness, thereby limiting the availability of our cash flow to fund future capital expenditures, working capital, and other corporate purposes;
increase our vulnerability to adverse economic and industry conditions, which could place us at a competitive disadvantage or require us to dispose of assets to raise funds if needed for working capital;
limit our flexibility in planning for, or reacting to, changes in our business and our industry;
place us at a competitive disadvantage compared with competitors that have a less significant debt burden; and
expose us to increased market interest rates resulting in our variable-rate debt having higher debt service requirements.

68

We may not be able to secure sufficient additional financing on favorable terms, or at all, to meet our future capital needs.
We may require additional capital in the future to pursue business opportunities or acquisitions or respond to challenges and unforeseen circumstances. We may also decide to engage in equity or debt financings or enter into additional credit facilities for other reasons. We may not be able to secure additional debt or equity financing in a timely manner, on favorable terms, or at all.
The phase-out, replacement, or unavailability of the London Inter-Bank Offered Rate, or LIBOR, could affect interest rates under our revolving credit facility, as well as our ability to obtain future debt financing on favorable terms.
We are subject to interest rate risk on floating interest rate borrowings under our credit facilities. Borrowings under our credit facilities use LIBOR as a benchmark for establishing the interest rate. In July 2017, the Financial Conduct Authority (the regulatory authority over LIBOR) stated that it would phase out LIBOR as a benchmark after 2021 to allow for an orderly transition to an alternative reference rate, and have since initiated the phase-out of LIBOR. Our term loan and revolving credit facilities provide for alternative methods of calculating the interest rate payable on such facilities by moving through a waterfall of defined successor SOFR-based benchmark interest rates (or, if a SOFR-based benchmark rate is not available, such rate as agreed between us and the administrative agent of the credit facility), along with technical changes to reflect the adoption of any such new benchmark rate upon the occurrence of certain triggering events. It is not presently known whether SOFR or any other alternative reference rates that have been proposed will attain market acceptance as replacements of LIBOR. In addition, the overall financial markets may be disrupted as a result of the phase-out or replacement of LIBOR. Furthermore, the consequences of the transition from LIBOR could result in an increase in the cost of our borrowings on our variable rate debt, which could adversely impact our interest expense, results of operations and cash flows. Uncertainty as to the nature of such phase out and selection of an alternative reference rate, together with disruption in the financial markets, could have a material adverse effect on our financial condition, results of operations and cash flows, and may adversely affect our ability to obtain future debt financing on favorable terms.
Amendments to existing, or enactment of new unfavorable, tax laws, rules, or regulations could adversely affect our financial position.
Changes in applicable U.S. federal, state, and local income taxation laws, rules, or regulations, or their interpretation and application, including possible retroactive effect, could adversely affect our tax expense and profitability. In recent years, many such changes have been made, and changes are likely to continue to occur in the future. For example, many provisions of the Tax Cuts and Jobs Act of 2017 and the CARES Act, enacted in March 2020, still require guidance through the issuance or finalization of regulations by the U.S. Treasury Department in order to fully assess their effects. There may be substantial delays before such regulations are promulgated or finalized as well as proposed technical corrections or other legislation, resulting in uncertainty as to their ultimate effects. The CARES Act included certain changes in tax law intended to stimulate the U.S. economy in light of the COVID-19 pandemic, including temporary beneficial changes to the treatment of net operating losses, interest deductibility limitations, and payroll tax matters. Changes in our tax provisions or an increase in our tax liabilities, whether due to changes in applicable laws and regulations, the interpretation or application thereof, or a final determination of tax audits or litigation or agreements, could have an adverse effect on our financial position.

69

Risks Related to Potential Conflicts of Interests and Related Parties
We are a controlled company within the meaning of the NYSE rules and, as a result, qualify for and rely on exemptions from certain corporate governance requirements.
Thoma Bravo, as the ultimate general partner of the Thoma Bravo Funds, and its related entities own a majority of the voting power of our outstanding common stock. As a result, we are, and expect we will continue to be, a controlled company within the meaning of the NYSE corporate governance standards. Under the NYSE rules, a company of which more than 50% of the voting power is held by another person or group of persons acting together is a controlled company and may elect not to comply with certain NYSE corporate governance requirements, including the requirements that:
a majority of the board of directors consist of independent directors as defined under the rules of the NYSE;
the nominating and governance committee be composed entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and
the compensation committee be composed entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities.
We have and, for so long as we remain a controlled company, expect to continue to use some or all of these exemptions. Additionally, our current executive officers, directors, and the Thoma Bravo Funds beneficially own approximately 68.85% of our issued and outstanding shares of common stock as of November 4, 2022. These stockholders may be able to determine all matters requiring stockholder approval including, but not limited to, elections of directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may feel are in your best interest as one of our stockholders. Accordingly, you may not have the same protections afforded to stockholders of companies that are subject to all of the NYSE corporate governance requirements.
Thoma Bravo has a controlling influence over matters requiring stockholder approval, which may have the effect of delaying or preventing changes of control, or limiting the ability of other stockholders to approve transactions they deem to be in their best interest.
As of November 4, 2022, Thoma Bravo, as the ultimate general partner of the Thoma Bravo Funds, and its related entities beneficially own, in the aggregate, approximately 50.01% of our issued and outstanding shares of common stock. As a result, Thoma Bravo could exert significant influence over our operations and business strategy and would have sufficient voting power to determine the outcome of all matters requiring stockholder approval. These matters may include:
the composition of our board of directors, which has the authority to direct our business and to appoint and remove our officers;
approving or rejecting a merger, consolidation, or other business combination;
raising future capital; and
amending our charter and bylaws, which govern the rights attached to our common stock.
Pursuant to our certificate of incorporate and bylaws, for so long as Thoma Bravo beneficially owns 30% or more of our outstanding shares of common stock, Thoma Bravo will have the right to designate a majority of our board of directors. Accordingly, we expect the directors designated by Thoma Bravo to constitute a majority of each committee of our board of directors, other than the audit committee, and to chair each of the committees, other than the audit committee. At such time as we are not a “controlled company” under the NYSE corporate governance standards, however, our board of directors and committee membership will comply with all applicable requirements of those standards.
This concentration of ownership of our common stock could delay or prevent proxy contests, mergers, tender offers, open-market purchase programs, or other purchases of our common stock that might otherwise give you the opportunity to realize a premium over the then-prevailing market price of our common stock, and could, in turn, adversely affect our share price.

70

Thoma Bravo may pursue corporate opportunities independent of us that could present conflicts with our and our stockholders’ interests.
Thoma Bravo is in the business of making or advising on investments in companies and holds (and may from time to time in the future acquire) interests in or provides advice to businesses that may directly or indirectly compete with our business or be suppliers or customers of ours. Thoma Bravo may also pursue acquisitions that may be complementary to our business and, as a result, those acquisition opportunities may not be available to us.
Our charter provides that none of our officers or directors who are also an officer, director, employee, partner, managing director, principal, independent contractor, or other affiliate of Thoma Bravo will be liable to us or our stockholders for breach of any fiduciary duty by reason of the fact that any such individual pursues or acquires a corporate opportunity for its own account or the account of an affiliate, as applicable, instead of us, directs a corporate opportunity to any other person, instead of us, or does not communicate information regarding a corporate opportunity to us. Such provision will apply for so long as Thoma Bravo holds any of our securities.
Risks Related to Our Common Stock and Governance Structure
The trading price of our common stock could be volatile, and you could lose all or part of your investment.
Our IPO occurred in July 2021. As such, there has only been a public market for our common stock for a short period of time. An active trading market for our common stock may not develop or be sustained. In addition, the trading prices of technology stocks have historically experienced high levels of volatility. The trading price of our common stock may fluctuate substantially.
Some of the factors that may cause the market price of our common stock to fluctuate, many of which may be beyond our control and may not be related to our operating performance, include:
announcements of new products or technologies, commercial relationships, acquisitions, or other events by us or our competitors;
changes in how customers perceive the benefits of software solutions;
shifts in the mix of billings and revenues attributable to subscription fees, service fees, and product partner fees, from quarter to quarter;
departures of key personnel;
price and volume fluctuations in the overall stock market from time to time;
fluctuations in the trading volume of our shares or the size of our public float;
sales of large blocks of our common stock, including by the Thoma Bravo Discover Fund, L.P., Thoma Bravo Discover Fund A, L.P., Thoma Bravo Discover Fund II, L.P., Thoma Bravo Discover Fund II-A, L.P., and Thoma Bravo Discover Executive Fund II, L.P. (collectively, the “Thoma Bravo Funds”);
actual or anticipated changes or fluctuations in our operating results;
unfavorable securities analysts’ research and reports published about us, our business, our market, or our competitors;
whether our operating results meet the expectations of securities analysts or investors, or changes in actual or future expectations of investors or securities analysts;
fluctuations in our quarterly or annual earnings results or those of other companies in our industry;
litigation involving us, our industry, or both;
changes in monetary policy by the Federal Reserve;
regulatory developments;
actual or perceived security compromises or breaches;
general economic conditions and trends, including changes in interest rates and consumer borrowing habits;
major catastrophic events in domestic and foreign markets; and
the other factors described in these “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q.

71

These fluctuations may limit or prevent investors from readily selling their shares of common stock, could cause investors to lose all or part of their investment in our common stock, and may otherwise negatively affect the liquidity of our common stock.
In addition, if the market for technology stocks or the stock market in general experiences a loss of investor confidence, the trading price of our common stock could decline for reasons unrelated to our business, operating results, or financial condition. The trading price of our common stock might also decline in reaction to events that affect other companies in our industry even if these events do not directly affect us. In the past, following periods of volatility in the trading price of a company’s securities, securities class action litigation has often been brought against that company.
For as long as we are an emerging growth company, we will not be required to comply with certain requirements that apply to other public companies.
We are an emerging growth company, as defined in the JOBS Act. For as long as we are an emerging growth company, unlike other public companies, we will not be required to, among other things: (i) provide an auditor’s attestation report on management’s assessment of the effectiveness of our system of internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002, or Sarbanes-Oxley Act; (ii) comply with any new requirements adopted by the Public Company Accounting Oversight Board requiring mandatory audit firm rotation or a supplement to the auditor’s report in which the auditor would be required to provide additional information about the audit and the financial statements of the issuer; (iii) provide certain disclosures regarding executive compensation required of larger public companies; or (iv) hold nonbinding advisory votes on executive compensation and any golden parachute payments not previously approved. In addition, the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for adopting new or revised financial accounting standards. We intend to take advantage of the longer phase-in periods for the adoption of new or revised financial accounting standards permitted under the JOBS Act until we are no longer an emerging growth company. If we were to subsequently elect instead to comply with these public company effective dates, such election would be irrevocable pursuant to the JOBS Act.
We will remain an emerging growth company up until December 31, 2026, although we will lose that status sooner if we have more than $1.235 billion of revenues in a fiscal year, have more than $700 million in market value of our common stock held by non-affiliates (and have been a public company for at least 12 months and have filed one annual report on Form 10-K), or issue more than $1.0 billion of non-convertible debt over a three-year period.
To the extent that we rely on any of the exemptions available to emerging growth companies, you will receive less information about our executive compensation and internal control over financial reporting than issuers that are not emerging growth companies. We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions. If some investors find our common stock to be less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.
Our issuance of additional capital stock in connection with financings, acquisitions, investments, our stock incentive plans, or otherwise will dilute all other stockholders.
We may issue additional capital stock in the future that will result in dilution to all other stockholders. We may also raise capital through equity financings in the future. As part of our business strategy, we may acquire or make investments in complementary companies, products, or technologies and issue equity securities to pay for any such acquisition or investment. We have issued and currently plan to issue common stock pursuant to our 2021 Stock Option and Incentive Plan, 2021 Employee Stock Purchase Plan, or other equity incentive plans that we may adopt in the future. Any such issuances of additional capital stock may cause stockholders to experience significant dilution of their ownership interests and the per share value of our common stock to decline.
We do not intend to pay dividends on our common stock and, consequently, our stockholders’ return on investment will depend on appreciation in the price of our common stock.
We have never declared or paid any dividends on our common stock. We intend to retain any earnings to finance the operation and expansion of our business, and we do not anticipate paying any cash dividends in the foreseeable future. As a result, you may only receive a return on your investment in our common stock if the market price of our common stock increases.

72

We cannot guarantee that our stock repurchase program will be fully consummated or will enhance long-term stockholder value, and stock repurchases could increase the volatility of our stock prices and could diminish our cash reserves.
In May 2022, our board of directors approved a stock repurchase program under which we are authorized to purchase up to $75.0 million of our common stock from time to time. Our repurchase program does not have an expiration date and does not obligate us to repurchase any specific dollar amount or to acquire any specific number of shares, on any particular timetable or at all. There can be no assurance that we will repurchase stock at favorable prices. Further, our stock repurchases could affect our stock trading prices, increase their volatility, reduce our cash reserves, and may be suspended or terminated at any time, which may result in a lower market valuation of our common stock.
We may issue preferred stock the terms of which could adversely affect the voting power or value of our common stock.
Our charter authorizes us to issue, without the approval of our stockholders, one or more classes or series of preferred stock having such designations, preferences, limitations, and relative rights, including preferences over our common stock respecting dividends and distributions, as our board of directors may determine. The terms of one or more classes or series of preferred stock could adversely impact the voting power or value of our common stock. For example, we might grant holders of preferred stock the right to elect some number of our directors in all events or on the happening of specified events or the right to veto specified transactions. Similarly, the repurchase or redemption rights or liquidation preferences we might assign to holders of preferred stock could affect the residual value of our common stock.
Delaware law and certain provisions in our charter and bylaws could delay, discourage, or prevent a change in control of our company.
Our status as a Delaware corporation and the existence of certain provisions of our charter and bylaws contain provisions that could delay, discourage, or prevent a change in control of our company that a stockholder may consider favorable. These provisions include:
a classified board of directors with three-year staggered terms;
after Thoma Bravo ceases to beneficially own at least 30% of the outstanding shares of our common stock, the removal of directors only for cause and subject to the affirmative vote of holders of at least 66 2/3% of our voting power;
the ability of our board of directors to both issue shares of preferred stock and determine the price and other terms of those shares without stockholder approval;
allowing Thoma Bravo to fill any vacancy on our board of directors for so long as affiliates of Thoma Bravo own 30% or more of our outstanding shares of common stock and, thereafter, allowing only our board of directors to fill vacancies on our board of directors;
after Thoma Bravo ceases to beneficially own at least a majority of the outstanding shares of our common stock, a prohibition on stockholder action by written consent;
after we cease to be a controlled company, the requirement that a special meeting of stockholders may be called only by our board of directors, the chairperson of our board of directors, our chief executive officer, or our president (in the absence of a chief executive officer);
after we cease to be a controlled company, the requirement for the affirmative vote of holders of at least 66 2/3% of our outstanding voting stock, voting together as a single class, to amend the provisions of our charter relating to the management of our business or the requirement for the affirmative vote of holders of at least 75% of our outstanding voting stock, voting together as a single class, to amend certain provisions of our bylaws;
the ability of our board of directors to amend our bylaws;
advance notice procedures for stockholders to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders’ meeting; and
prohibition of cumulative voting in the election of our board of directors.

73

Our charter also provides us with protections similar to Section 203 of the Delaware General Corporation Law and prevents certain business combinations with a stockholder owning at least 15% of our outstanding voting stock, unless approved in a prescribed manner. Our charter also provides, however, that transactions with Thoma Bravo, including the Thoma Bravo Funds and any persons to whom any Thoma Bravo Fund sells its common stock, will be deemed to have been approved by our board of directors.
While these provisions may protect our stockholders from coercive or otherwise unfair takeover tactics, these provisions could also delay, discourage, or prevent a change in control transaction or changes in our board of directors that some stockholders may consider beneficial or prevent our stockholders from receiving a premium over the market price of our common stock that they might otherwise receive.
Our bylaws designate the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us.
Our bylaws provide that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for state law claims for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a breach of fiduciary duty by one or more of our directors, officers or employees, (iii) any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, or (iv) any action asserting a claim against us that is governed by the internal affairs doctrine. The choice of forum selection clause may impose additional litigation costs on stockholders, discourage claims, or limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us. Although this provision may be beneficial in its consistency in the application of Delaware law, the Court of Chancery of the State of Delaware may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders. Alternatively, if the enforceability of the choice of forum provision contained in our bylaws is challenged and a court finds such provision to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions. Our bylaws further provide that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. This provision would not apply to any action brought to enforce a duty or liability created by the Exchange Act and the rules and regulations thereunder. Our stockholders will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder as a result of our exclusive forum provisions.

74

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Use of IPO Proceeds
On July 27, 2021, the Registration Statement on Form S-1 (File No. 333-255680) relating to our IPO was declared effective by the SEC. There has been no material change in the use of proceeds from our IPO as described in our final prospectus dated July 27, 2021 and as filed with the SEC on July 28, 2021 pursuant to Rule 424(b) of the Securities Act and other periodic reports previously filed with the SEC.
Purchases of Equity Securities by the Issuer
The following table summarizes the stock repurchase activity for the three months ended September 30, 2022:
PeriodTotal Number of Shares PurchasedAverage Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced Programs
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
(in thousands) (1)
July 1 to July 31, 2022— $— 12,300 $74,807 
August 1 to August 31, 2022— $— 12,300 $74,807 
September 1 to September 30, 20224,403 $15.86 16,703 $74,737 
Total4,403 $— 16,703 $74,737 
______________
(1)In May 2022, our board of directors authorized a stock repurchase program to acquire up to $75.0 million of the Company’s common stock, with no fixed expiration date. Shares may be repurchased through privately negotiated transactions, or open market purchases, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934.
Item 3. Defaults upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.

75

Item 6. Exhibit Index

Exhibit No.Exhibit TitleFormExhibitFiling Date
3.110-Q3.1September 7, 2021
3.2S-13.3April 30, 2021
4.1S-14.1April 30, 2021
4.2S-14.2April 30, 2021
31.1Filed herewith
31.2Filed herewith
32.1#Filed herewith
32.2#Filed herewith
101.INSInline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).Filed herewith
101.SCHInline XBRL Taxonomy Extension Schema Document.Filed herewith
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.Filed herewith
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.Filed herewith
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.Filed herewith
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.Filed herewith
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).Filed herewith
_____________________
#    The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed “furnished” and not “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange Act, except to the extent that the Registrant specifically incorporates them by reference.

76

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
MERIDIANLINK, INC.
Dated: November 7, 2022
By:/s/ Nicolaas Vlok
Name:Nicolaas Vlok
Title:Chief Executive Officer (Principal Executive Officer)
Dated: November 7, 2022
By:/s/ Sean Blitchok
Name:Sean Blitchok
Title:Chief Financial Officer (Principal Financial and Accounting Officer)


77
EX-31.1 2 exhibit311toq32022form10-q.htm EX-31.1 Document

Exhibit 31.1
Certification of Principal Executive Officer
Pursuant to SEC Rule 13a-14(a)/15d-14(a)

I, Nicolaas Vlok, certify that:
1.    I have reviewed this report on Form 10-Q of MeridianLink, Inc. for the period ended September 30, 2022;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)    (Paragraph omitted in accordance with Exchange Act Rule 13a-14(a));
(c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
November 7, 2022
/s/ Nicolaas Vlok                
Name: Nicolaas Vlok
Title: President and Chief Executive Officer
(Principal Executive Officer)


EX-31.2 3 exhibit312toq32022form10-q.htm EX-31.2 Document

Exhibit 31.2
Certification of Principal Financial Officer
Pursuant to SEC Rule 13a-14(a)/15d-14(a)

I, Sean Blitchok, certify that:
1.    I have reviewed this report on Form 10-Q of MeridianLink, Inc. for the period ended September 30, 2022;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)    (Paragraph omitted in accordance with Exchange Act Rule 13a-14(a));
(c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
November 7, 2022

/s/ Sean Blitchok                
Name: Sean Blitchok
Title: Chief Financial Officer and Treasurer
(Principal Financial and Accounting Officer)


EX-32.1 4 exhibit321toq32022form10-q.htm EX-32.1 Document

Exhibit 32.1

Certification of Principal Executive Officer
Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report on Form 10-Q of MeridianLink, Inc. (the “Company”) for the period ended September 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Nicolaas Vlok, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
1.    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934.

2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Nicolaas Vlok                    
Name: Nicolaas Vlok
Title: President and Chief Executive Officer
(Principal Executive Officer)
November 7, 2022

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
This certification is being furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.


EX-32.2 5 exhibit322toq32022form10-q.htm EX-32.2 Document

Exhibit 32.2

Certification of Principal Financial Officer
Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report on Form 10-Q of MeridianLink, Inc. (the “Company”) for the period ended September 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Sean Blitchok, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
1.    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934.
2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Sean Blitchok                    
Name: Sean Blitchok
Title: Chief Financial Officer and Treasurer
(Principal Financial and Accounting Officer)
November 7, 2022

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
This certification is being furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.


EX-101.SCH 6 mlnk-20220930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Condensed Consolidated Statements of Preferred Units and Stockholders' Equity / Members' Deficit link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000007 - Disclosure - Organization and Description of Business link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Balance Sheet Components link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Net Income (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Business Combinations link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Balance Sheet Components (Tables) link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Net Income (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Business Combinations (Tables) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Organization and Description of Business (Details) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Revenue Recognition - Disaggregation of Revenue by Solution Type (Details) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Revenue Recognition - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Revenue Recognition - Disaggregation of Revenue by Major Source (Details) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Revenue Recognition - Schedule of Changes in Deferred Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Revenue Recognition - Schedule of Changes in Contract Cost Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Balance Sheet Components - Summary of Prepaid Expenses and Other Current Assets (Detail) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Balance Sheet Components - Summary of Property and Equipment, Net (Detail) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Balance Sheet Components - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Balance Sheet Components - Summary of Intangible Assets, Net (Detail) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Balance Sheet Components - Summary of Estimated Useful Lives and Weighted Average Amortization Periods for Intangible Assets (Detail) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Balance Sheet Components - Summary of amortization expense related to intangible assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Balance Sheet Components - Summary of Estimated Future Amortization of Intangible Assets (Detail) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Balance Sheet Components - Summary of Accrued Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - Commitments and Contingencies - Future Minimum Payments Under Non-Cancelable Purchase Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Leases - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - Leases - Summary of Rent Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - Leases - Supplemental Cash Flow Information About the Company's Leases (Details) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - Leases - Supplemental Balance Sheet Information About The Company's Leases (Details) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Leases - Summary of Future Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Leases - Summary of Future Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - Long-Term Debt - Summary of Long-term Debt (Detail) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - Long-Term Debt - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - Long-Term Debt - Summary of Future Principal Payments of Long-term Debt (Detail) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - Share-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - Share-Based Compensation - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - Share-Based Compensation - Schedule of RSU Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - Share-Based Compensation - Summary of Stock-based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 0000059 - Disclosure - Income Taxes - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000060 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000061 - Disclosure - Net Income (Loss) Per Share - Summary of calculation of basic and diluted net income (loss) per share (Detail) link:presentationLink link:calculationLink link:definitionLink 0000062 - Disclosure - Net Income (Loss) Per Share - Summary of outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per common unit attributable to common unitholders (Detail) link:presentationLink link:calculationLink link:definitionLink 0000063 - Disclosure - Business Combinations - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000064 - Disclosure - Business Combinations - Summary of the Allocation of the Purchase Price (Details) link:presentationLink link:calculationLink link:definitionLink 0000065 - Disclosure - Business Combinations - Summary of Fair Value of the Separately Identifiable Finite-Lived Intangible Assets Acquired and Estimated Useful Lives (Details) link:presentationLink link:calculationLink link:definitionLink 0000066 - Disclosure - Business Combinations - Summary of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 0000067 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 mlnk-20220930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 mlnk-20220930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 mlnk-20220930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Business Acquisition [Axis] Business Acquisition [Axis] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Total operating lease payments Lessee, Operating Lease, Liability, to be Paid Net income (loss) Net income (loss) Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Related Party Transactions [Abstract] Lending Software Solutions Lending Software Solutions [Member] Lending Software Solutions [Member] Deferred tax assets, net Deferred Income Tax Assets, Net 2021 Term loan Total Long-Term Debt, Gross Entity Address, Postal Zip Code Entity Address, Postal Zip Code Data Verification Software Solutions Data Verification Software Solutions [Member] Data Verification Software Solutions [Member] Effect of Corporate Conversion Effect of Corporate Conversion Stockholders' Equity, Effect Of Reorganization Stockholders' Equity, Effect Of Reorganization Effect of corporate conversion (Note 1) Noncash, Effect Of Corporate Conversion Noncash, Effect Of Corporate Conversion Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding 2024 Long-Term Debt, Maturity, Year Two Revenue recognized Contract With Customer, Liability, Revenue Recognized, Including Opening Balance Contract With Customer, Liability, Revenue Recognized, Including Opening Balance Prepaid expenses, related party Prepaid Expenses, Related Party Prepaid Expenses, Related Party Debt Instrument [Axis] Debt Instrument [Axis] Stock shares tendered for sale by the existing stockholders (in shares) Stock Shares Tendered For Sale By The Existing Stockholders Stock shares tendered for sale by the existing stockholders. Property plant and equipment gross Property, Plant and Equipment, Gross Related party transaction, cost of sales Related Party Transaction, Expenses from Transactions with Related Party Revolving credit facility, principal amount Line of Credit Facility, Maximum Borrowing Capacity Income Tax Disclosure [Abstract] Deferred revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Prepaid expenses and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Additions Capitalized Contract Cost Additions Capitalized contract cost additions. Depreciation and amortization Other Depreciation and Amortization Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Depreciation Depreciation Summary of future minimum lease payments (pre ASC 842 adoption) Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Issuance of common stock due to exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Interest expense Interest Expense, Debt, Excluding Amortization Concentration risk Concentration Risk Percentage Concentration risk percentage. Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent RSAs cancelled or forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations Share-Based Payment Arrangement [Abstract] Organization, Consolidation and Presentation of Financial Statements [Table] Organization Consolidation And Presentation Of Financial Statements [Table] Organization Consolidation And Presentation Of Financial Statements [Table]. Effect of Corporate Conversion (in shares) Effect of Corporate Conversion (in shares) Stockholders' Equity, Effect Of Reorganization, Shares Stockholders' Equity, Effect Of Reorganization, Shares Additional paid-in capital Additional Paid in Capital, Common Stock Working capital adjustments, intangibles Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles Preferred units outstanding (in shares) Preferred Units, Outstanding Summary of prepaid expenses and other current assets Schedule Of Prepaid Expenses And Other Current Assets [Table Text Block] Schedule of prepaid expenses and other current assets Other adjustments Other Noncash Income (Expense) Schedule Of Rent Expense [Line Items] Schedule Of Rent Expense [Line Items] Schedule of rent expense line items. Shares that remained subject to future vesting (in shares) Conversion Of Stock, Shares Converted, Nonvested Conversion Of Stock, Shares Converted, Nonvested Beginning balance (in shares) Ending balance (in shares) Temporary Equity, Shares Outstanding Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Carried Equity Units Carried Equity Units [Member] Carried equity units [Member]. Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Weighted average common stock outstanding: Weighted Average Number of Shares Outstanding, Basic And Diluted [Abstract] Weighted Average Number of Shares Outstanding, Basic And Diluted Summary of future principal payments of long-term debt Schedule of Maturities of Long-Term Debt [Table Text Block] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Secured Debt Secured Debt [Member] Scenario [Axis] Scenario [Axis] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Related party receivable net against holdback payment to prior shareholders Related Party Receivable Net Against Holdback Payment To Prior Shareholders Related party receivable net against holdback payment to prior shareholders. Leases Lessee, Operating Leases [Text Block] Related Party [Domain] Related Party [Domain] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Plan Name [Axis] Plan Name [Axis] Accrued liabilities, related parties Accrued Liabilities, Related Parties Accrued Liabilities, Related Parties Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Adjusted Eurocurrency Rate Adjusted Eurocurrency Rate [Member] Adjusted Eurocurrency Rate Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Unrecognized stock-based compensation expense, awards other than options Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Plan Name [Domain] Plan Name [Domain] Beginning balance Ending balance Total deferred contract cost assets Capitalized Contract Cost, Net 2022 (remaining three months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Goodwill [Line Items] Goodwill [Line Items] Statement of Cash Flows [Abstract] Entity Address, State or Province Entity Address, State or Province Purchase rights committed under the ESPP Employee Stock [Member] 2023 Operating Leases, Future Minimum Payments, Due in Two Years Weighted average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Share price (in dollars per share) Shares Issued, Price Per Share Award Type [Axis] Award Type [Axis] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Thereafter Long-Term Debt, Maturity, After Year Four Long-Term Debt, Maturity, After Year Four Lease liability – current Operating Lease, Liability, Current Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Class A Units Capital Unit, Class A Capital Unit, Class A [Member] Related Party Transaction [Domain] Related Party Transaction [Domain] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Lease Contractual Asset Type [Axis] Lease Contractual Asset Type [Axis] Lease contractual asset type. Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Accounts receivable, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Property and equipment, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Capitalized computer software, gross Capitalized Computer Software, Gross Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Four Finite-Lived Intangible Asset, Expected Amortization, after Year Four Payment due to effect of corporate conversion Payment Due To Effect Of Corporate Conversion Payment Due To Effect Of Corporate Conversion Long-term debt, net of debt issuance costs Total non-current portion of long-term debt, net Long-Term Debt, Excluding Current Maturities Total liabilities Liabilities Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Purchase accounting adjustments, goodwill Goodwill, Purchase Accounting Adjustments Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Issuance of common stock in connection with initial public offering, net of underwriters’ discounts and commissions and issuance costs Stock Issued During Period, Value, New Issues StreetShares StreetShares [Member] StreetShares Capitalized software Capitalized Software [Member] Capitalized software [Member]. Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Temporary equity stock shares converted into permanent equity (in shares) Conversion of Stock, Shares Converted Revolving Credit Facility Revolving Credit Facility [Member] Summary of property and equipment, net Property, Plant and Equipment [Table Text Block] Preferred sock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Beanstalk Networks, L.L.C. Beanstalk Networks, L.L.C. [Member] Beanstalk Networks, L.L.C. Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Number of RSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Acquisition, net of cash and restricted cash acquired – Saylent Technologies, Inc. Payments to Acquire Business Two, Net of Cash Acquired Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Non-vested beginning balance (in dollars per share) Non-vested ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Segments [Axis] Segments [Axis] Long-Term Debt Debt Disclosure [Text Block] Cost of revenues: Cost of Revenue [Abstract] Product and Service [Domain] Product and Service [Domain] Class B Common Units Common Class B [Member] Entity Shell Company Entity Shell Company Accrued liabilities Increase (Decrease) in Accrued Liabilities Temporary equity compound interest rate Temporary Equity Compound Interest Rate Temporary equity compound interest rate. 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Developed technology Developed technology Developed Technology Rights [Member] 2025 Long-Term Debt, Maturity, Year Three Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Leased Property From Related Party Leased Property From Related Party [Member] Leased property from related party. Affiliated Entity Affiliated Entity [Member] Subsequent Event Subsequent Event [Member] Schedule of changes in the deferred revenue Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Document Period End Date Document Period End Date Deferred rent Increase (Decrease) in Other Deferred Liability Total assets Assets Debt Disclosure [Abstract] Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Sales tax liability from acquisitions Sales and Excise Tax Payable, Current Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Current portion of long-term debt, net of debt issuance costs Current portion of long term debt Long-Term Debt, Current Maturities Estimated Fair Values Finite-Lived Intangible Assets Acquired Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Stock repurchase program authorized amount Stock Repurchase Program, Authorized Amount Accrued payroll and payroll-related expenses Employee-related Liabilities, Current Line of Credit Line of Credit [Member] Beginning balance Ending balance Temporary Equity, Carrying Amount, Attributable to Parent Income (loss) before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Prepaid expenses and other current assets Total prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Segments [Domain] Segments [Domain] Deferred income taxes Deferred Income Taxes and Tax Credits Schedule of Goodwill [Table] Schedule of Goodwill [Table] Net Income (Loss) Per Share Earnings Per Share [Text Block] Stock shares offered but not yet tendered by the existing stockholders (in shares) Stock Shares Partially Tendered For Sale By The Existing Stockholders Stock shares partially tendered for sale by the existing stockholders. Liabilities assumed: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Initial recognition of operating lease liability Increase (Decrease) in Operating Lease Liability Related Party Transaction [Line Items] Related Party Transaction [Line Items] Fair value of options vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Award Type [Domain] Award Type [Domain] Unrecognized stock-based compensation expense, weighted -average period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Loss on debt repayment and extinguishment Loss on debt repayment and extinguishment Gain (Loss) on Extinguishment of Debt Accounts payable, related parties Accounts Payable, Related Parties Weighted average remaining contractual term, exercisable at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Basic and diluted net income (loss) per share Reconciliation Of Earnings Per Share, Basic And Diluted [Abstract] Reconciliation Of Earnings Per Share, Basic And Diluted Summary of intangible assets, net and estimated useful lives and weighted average amortization periods Schedule of Finite-Lived Intangible Assets [Table Text Block] Proceeds from employee stock purchase plan Proceeds from Stock Plans Vesting of restricted stock Stock Issued During Period, Value, Restricted Stock Award, Gross Income tax receivable Income Taxes Receivable, Current Cash consideration, gross Payments to Acquire Businesses, Gross Computer equipment and software Computer Equipment [Member] Gross profit Gross Profit Entity Registrant Name Entity Registrant Name Issuance of common stock in connection with initial public offering, net of underwriters' discounts and commissions and issuance costs (in shares) Stock Issued During Period, Shares, New Issues Variable Rate Component [Domain] Variable Rate Component [Domain] Variable Rate Component Subsequent Events Subsequent Events [Text Block] Related Party Related Party [Member] Related party Customer relationships Customer Relationships [Member] Entity Address, City or Town Entity Address, City or Town Leases [Abstract] Operating expenses: Operating Expenses [Abstract] Deferred rent Deferred Rent Credit, Noncurrent Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Capitalized computer software, accumulated amortization Capitalized Computer Software, Accumulated Amortization Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Debt issuance costs Debt Issuance Costs, Net Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Variable Rate Component Two Variable Rate Component Two [Member] Variable Rate Component Two Payment to sellers of Teledata Communications, Inc Repayment Of Paycheck Protection Program Loan To Sellers On Acquisition Repayment Of Paycheck Protection Program Loan To Sellers On Acquisition Trading Symbol Trading Symbol Entity File Number Entity File Number 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Long-term deferred revenue Contract with Customer, Liability, Noncurrent Research and development Research and Development Expense Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted stock units Restricted stock units (RSUs) Restricted Stock Units (RSUs) [Member] Effective income tax rate reconciliation, percent Effective Income Tax Rate Reconciliation, Percent 2021 Plan Two Thousand Twenty One Stock Option and Incentive Plan [Member] 2021 stock option and incentive plan. Vested and expected to vest in the future (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Use of Estimates Use of Estimates, Policy [Policy Text Block] Business Combinations Business Combination Disclosure [Text Block] Operating leases, termination liability Operating Leases, Termination Liability Operating Leases, Termination Liability Fair value of assets acquired and liabilities assumed Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Subsequent Events [Abstract] Stockholders’ Equity Limited Liability Company (LLC) Members' Equity [Abstract] Income Taxes Income Tax Disclosure [Text Block] Credit Facility [Domain] Credit Facility [Domain] Amortization of intangible assets Amortization of Intangible Assets Summary of Company's Goodwill Schedule of Goodwill [Table Text Block] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Other Service, Other [Member] Basic (in dollars per share) Earnings Per Share, Basic 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Billing of transaction consideration Contract With Customer, Liability, Additions Contract With Customer, Liability, Additions Right of use assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Assets Counterparty Name [Domain] Counterparty Name [Domain] Organization, Consolidation and Presentation of Financial Statements [Line Items] Organization Consolidation And Presentation Of Financial Statements [Line Items] Organization Consolidation And Presentation Of Financial Statements [Line Items] Sales and marketing Selling and Marketing Expense Total stockholders’ equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Prepaid expenses Prepaid Expense, Current Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Accrued costs of revenues Accrued Costs Of Revenues Accrued costs of revenues. Entity Interactive Data Current Entity Interactive Data Current Amortization Capitalized Contract Cost, Amortization Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Restricted stock units, unvested Restricted Stock Units, Unvested [Member] Restricted Stock Units, Unvested Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities, net of acquisitions: Increase (Decrease) in Operating Capital [Abstract] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Accelerated stock-based compensation expense Share-Based Payment Arrangement, Accelerated Cost Accumulated deficit Retained Earnings [Member] Unrecognized stock-based compensation expense related to stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Rent expense Lease, Cost Initial recognition of operating lease right-of-use asset Increase (Decrease) in Operating Lease Right-Of-Use Asset Increase (Decrease) in Operating Lease Right-Of-Use Asset Common Stock Common Stock [Member] Summary of stock-based compensation Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Payments of Class A cumulative preferred return Payment Of Preferred Dividend Payment of preferred dividend. Summary of rent expense (post ASC 842 adoption) Lease, Cost [Table Text Block] Repurchases of common stock Payments for Repurchase of Common Stock Contingent earnout Business Combination, Contingent Consideration, Liability Class of Stock [Axis] Class of Stock [Axis] Schedule of RSU activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Statement [Table] Statement [Table] Principal payments of long-term debt Repayments of Other Long-Term Debt Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Interest rate, effective Debt Instrument, Interest Rate, Effective Percentage Document Quarterly Report Document Quarterly Report Letter of Credit Letter of Credit [Member] Current assets: Assets, Current [Abstract] Noncurrent operating lease liabilities Operating Lease, Liability, Noncurrent Holdback payment to sellers of MeridianLink Payment for Contingent Consideration Liability, Financing Activities Related Party Transaction [Axis] Related Party Transaction [Axis] Leasehold improvements Leasehold Improvements [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Accounts receivable, net of allowance for doubtful accounts Accounts Receivable, after Allowance for Credit Loss, Current Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Equity Components [Axis] Equity Components [Axis] Scenario [Domain] Scenario [Domain] Trademarks Trademarks [Member] Working capital adjustments, DTA Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Exercisable at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Related Party Transactions Related Party Transactions Disclosure [Text Block] 2026 Operating Leases, Future Minimum Payments, Due in Five Years Document Fiscal Year Focus Document Fiscal Year Focus Summary of amortization expense related to intangible assets Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Subscription and services Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization Annual increase in shares authorized, percentage Share-Based Compensation Arrangement By Share-Based Payment Award, Annual Increase In Shares Reserved For Issuance, Percentage Share-Based Compensation Arrangement By Share-Based Payment Award, Annual Increase In Shares Reserved For Issuance, Percentage Total future minimum lease payments Operating Leases, Future Minimum Payments Due Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Proceeds from long-term debt Proceeds from Issuance of Other Long-Term Debt Unvested (in shares) Non-vested beginning balance (in shares) Non-vested ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Total other expense, net Nonoperating Income (Expense) Variable Rate [Domain] Variable Rate [Domain] 2022 Operating Leases, Future Minimum Payments Due, Next 12 Months Intangible assets, gross amount Finite-Lived Intangible Assets, Gross Percent of original principal Debt Instrument, Periodic Payment, Percent Of Principal Percentage of principal payments on Term loan. Gain on change in fair value of earnout Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Right of use assets Operating lease ROU assets Operating Lease, Right-of-Use Asset Repurchase of stock Stock repurchased Stock Repurchased During Period, Value Sublease Receipts Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals Capitalized Contract Cost [Roll Forward] Capitalized Contract Cost [Roll Forward] Capitalized Contract Cost Variable Rate Component One Variable Rate Component One [Member] Variable Rate Component One Operating lease, expense Operating Lease, Expense Vested and expected to vest in the future (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Document Transition Report Document Transition Report Local Phone Number Local Phone Number Summary of stock option activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Operating income (loss) Operating Income (Loss) Recent Accounting Pronouncements Adopted And Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Escrow deposit Increase (Decrease) in Deposit Assets Repurchases of Units Payments for Repurchase of Other Equity Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Weighted average common stock outstanding: Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Goodwill Beginning balance Ending balance Goodwill Professional services Professional Services [Member] Professional Services [Member] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Repurchase of stock (in shares) Stock repurchased (in shares) Stock Repurchased During Period, Shares Debt issuance costs Debt Issuance Costs, Current, Net Related party transaction, general and administrative expenses from transactions with related party Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party Accelerated vesting (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number Adjustments to reconcile net income (loss) to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Provision for income taxes Income Tax Expense (Benefit) Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Variable Rate Component [Axis] Variable Rate Component [Axis] Variable Rate Component 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Loss on sublease liability Gain Loss On Sublease Liability Gain loss on sublease liability. Income Statement [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Additional paid-in capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Net income (loss) per share: Earnings Per Share, Basic [Abstract] Intrinsic value of options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Less: Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accrued compensation and benefits Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Compensation And Benefits Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued compensation and benefits. Lease Contractual Asset Type [Domain] Lease Contractual Asset Type [Domain] Lease contractual asset type. Supplemental balance sheet information about the Company's leases Assets and Liabilities, Lessee [Table Text Block] Assets and Liabilities, Lessee Debt issuance costs, gross Debt Issuance Costs, Gross Base Rate Base Rate [Member] Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Common stock, $0.001 par value; 600,000,000 shares authorized, 80,732,286 and 79,734,984 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Temporary equity future value Temporary Equity Future Value Temporary equity future value. Class A Preferred Units Series A Redeemable Convertible Preferred Stock [Member] Series A Redeemable Convertible Preferred Stock [Member] Third Party Third Party [Member] Third party. Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Conversion price of stock (in dollars per share) Conversion Of Stock, Conversion Price Conversion Of Stock, Conversion Price Vesting of restricted stock (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Summary of Outstanding Potentially Dilutive Securities were Excluded from the Calculation of Diluted Net Loss Per Common Unit Attributable to Common Unitholders Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Assets acquired: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract] Deferred tax asset Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Aggregate intrinsic value, exercisable at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Accrued bonuses Accrued Bonuses, Current Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Current liabilities: Liabilities, Current [Abstract] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Net income (loss) attributable to common stockholders, basic Net income (loss) attributable to common stockholders, basic Net Income (Loss) Available to Common Stockholders, Basic Common stock, shares issued (in shares) Common Stock, Shares, Issued Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill Weighted average remaining contractual term, vested and expected to vest in the future Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Deferred revenue Deferred revenue, beginning balance Deferred revenue, current Contract with Customer, Liability, Current First Lien First Lien [Member] First Lien [Member] 2023 Purchase Obligation, to be Paid, Year One Purchases of property and equipment included in accounts payable and accrued expenses Capital Expenditures Incurred but Not yet Paid Schedule of changes in contract cost assets Capitalized Contract Cost [Table Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Acquisition related costs Business Combination, Acquisition Related Costs Notes payable to Regulation A+ investors Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt Amendment Flag Amendment Flag Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Term loan Debt Instrument, Face Amount Issuance of common stock through employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Goodwill additions during period Goodwill, Acquired During Period Contract cost assets – current Capitalized Contract Cost, Net, Current Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Vesting of Class B carried equity units Share Based Compensation By Share Based Award Vesting Of Equity Units Value Share based compensation by share based award vesting of equity units value. Entity Current Reporting Status Entity Current Reporting Status Class A preferred return Preferred Stock Dividends, Income Statement Impact Other assets Other Assets, Noncurrent Weighted Average Remaining Contract Term and Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Exercisable at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Payment of Regulation A+ investor note Repayments of Notes Payable Impairment of right of use assets Operating Lease, Impairment Loss Contract cost assets, noncurrent Capitalized Contract Cost, Net, Noncurrent 2024 Purchase Obligation, to be Paid, Year Two Issuance of common stock through employee purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Counterparty Name [Axis] Counterparty Name [Axis] Summary of the Allocation of the Purchase Price Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number IPO IPO [Member] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Contingent earnout Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability Basis of Presentation/Unaudited Interim Condensed Consolidated Financial Information Basis of Accounting, Policy [Policy Text Block] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Summary of Fair Value of the Separately Identifiable Finite-Lived Intangible Assets Acquired and Estimated Useful Lives Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Schedule of estimated future amortization of intangible assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Office equipment and furniture Office Equipment [Member] Stock options Share-Based Payment Arrangement, Option [Member] Sales and marketing Selling and Marketing Expense [Member] Issuance of common stock due to exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Total debt, net Long-Term Debt Other income Other Nonoperating Income (Expense) Sale of stock issue price per share (in dollars per share) Sale of Stock, Price Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Total operating expenses Operating Expenses Options to purchase common stock outstanding, unexercised Options To Purchase Common Stock Outstanding, Unexercised [Member] Options To Purchase Common Stock Outstanding, Unexercised Accounts payable Increase (Decrease) in Accounts Payable, Trade Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Rent expense Operating leases, rent expense Operating Leases, Rent Expense Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Deferred revenue Increase (Decrease) in Contract with Customer, Liability Total current assets Assets, Current Cash paid for income taxes Income Taxes Paid, Net Business Acquisition [Line Items] Business Acquisition [Line Items] Entity Small Business Entity Small Business Other Commitments [Table] Other Commitments [Table] Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Intangible assets, net Total amortization expense Finite-Lived Intangible Assets, Net Line of Credit Facility [Table] Line of Credit Facility [Table] Deferred offering costs included in accounts payable and accrued expenses Deferred Offering Costs Incurred But Not Paid Included In Accounts Payable And Accrued Liabilities Deferred offering costs incurred but not paid included in accounts payable and accrued liabilities. Significant Accounting Policies Significant Accounting Policies [Text Block] 2025 Operating Leases, Future Minimum Payments, Due in Four Years Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Future minimum payments under non-cancelable purchase commitments Contractual Obligation, Fiscal Year Maturity [Table Text Block] Sublease income Sublease Income Aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Vesting of restricted stock awards and RSUs Share Based Payment Arrangement, Vested Share Based Payment Arrangement, Vested Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Subscription fees Subscription Fees [Member] Subscription Fees [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Debt Instrument [Line Items] Debt Instrument [Line Items] Business Combination and Asset Acquisition [Abstract] Payments of debt issuance costs Payments of Debt Issuance Costs Total operating lease liabilities Total operating lease liabilities Operating Lease, Liability 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 2022 (remaining three months) Long-Term Debt, Maturity, Remainder of Fiscal Year Payment of Class A units cumulative preferred return Adjustment to Accumulated Deficit Adjustment to accumulated deficit. Business combination, adjustment consideration transferred Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred Accounts payable Accounts Payable, Current Aggregate intrinsic value, vested and expected to vest in the future Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Contract With Customer, Liability [Roll Forward] Contract With Customer, Liability [Roll Forward] Contract With Customer, Liability 2026 Long-Term Debt, Maturity, Year Four Weighted Average Remaining Useful Life Finite-Lived Intangible Asset, Weighted Average Period before Next Renewal or Extension Organization and Description of Business Nature of Operations [Text Block] Entity Filer Category Entity Filer Category Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Class B Units Capital Unit, Class B Capital Unit, Class B [Member] Total share-based compensation expense Share-Based Payment Arrangement, Expense Accrued operating costs Accrued Operating Costs Accrued operating costs. Non-cash investing and financing activities: Noncash Investing and Financing Items [Abstract] Commitments and contingencies (Note 5) Commitments and Contingencies Security Exchange Name Security Exchange Name Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Loss on disposal of assets Gain (Loss) on Disposition of Assets Weighted Average Amortization Life (years) Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Preferred stock, $0.001 par value; 50,000,000 shares authorized; zero shares issued and outstanding at September 30, 2022 and December 31, 2021 Preferred Stock, Value, Issued Restricted cash Restricted Cash, Current Restricted stock awards Restricted Stock [Member] Other long-term liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] General and administrative expense General and Administrative Expense [Member] Revenues, net Revenue from Contract with Customer, Excluding Assessed Tax Restricted Stock Units, Formerly Class B Units Restricted Stock Units, Formerly Class B Units [Member] Restricted Stock Units, Formerly Class B Units Common stock, capital shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Cover [Abstract] Leases Lessee, Leases [Policy Text Block] Share-Based Compensation Share-Based Payment Arrangement [Text Block] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss Advisory Services Agreement Advisory Services Agreement [Member] Advisory Services Agreement Numerator: Net Income (Loss) Available To Common Stockholders, Basic And Diluted [Abstract] Net Income (Loss) Available To Common Stockholders, Basic And Diluted Revenue Recognition Revenue from Contract with Customer [Text Block] Common units, units outstanding (in shares) Common Unit, Outstanding Forecast Forecast [Member] Taxes paid related to net share settlement of RSUs Shares withheld with respect to net settlement of RSUs Payment, Tax Withholding, Share-Based Payment Arrangement Total liabilities and stockholders’ equity Liabilities and Equity Amortization of debt issuance costs Amortization of financing costs Amortization of Debt Issuance Costs Goodwill [Roll Forward] Goodwill [Roll Forward] Related Party [Axis] Related Party [Axis] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Stock remaining for repurchase under repurchase program Stock Repurchase Program, Remaining Authorized Repurchase Amount Organization, Consolidation and Presentation of Financial Statements [Abstract] Acquisition, net of cash acquired – TazWorks, LLC Payments to Acquire Businesses, Net of Cash Acquired Goodwill considered deductible for income tax purposes Business Acquisition, Goodwill, Expected Tax Deductible Amount Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date Penalties and interest on unrecognized tax benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Conversion ratio Conversion Of Stock, Conversion Ratio Conversion Of Stock, Conversion Ratio Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Diluted (in dollars per share) Earnings Per Share, Diluted Net income (loss) attributable to common stockholders, diluted Net income (loss) attributable to common stockholders, diluted Net Income (Loss) Available to Common Stockholders, Diluted Liability balance related to unvested RSAs Conversion Of Stock, Shares Converted, Nonvested, Value Conversion Of Stock, Shares Converted, Nonvested, Value Sale of Stock [Domain] Sale of Stock [Domain] Stock split ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Payments of deferred offering costs Payment of stock issuance costs Payments of Stock Issuance Costs Loss on disposal of fixed assets Gain (Loss) on Disposition of Property Plant Equipment Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Total current liabilities Liabilities, Current Amortization of developed technology Cost, Amortization 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Others Other Assets, Current 2021 Term Loan 2021 Term Loan [Member] 2021 Term Loan Uncertain tax positions Unrecognized Tax Benefits Capitalized software costs Capitalized Computer Software, Additions Entity Ex Transition Period Entity Ex Transition Period Commitment fee rate Line of Credit Facility, Commitment Fee Percentage Other (income) expense, net: Nonoperating Income (Expense) [Abstract] Summary of future minimum lease payments (post ASC 842 adoption) Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Total cost of revenues Cost of Revenue Deferred revenue, ending balance Total deferred revenue Contract with Customer, Liability Share-based compensation expense capitalized to software additions Share-Based Payment Arrangement, Amount Capitalized Product and Service [Axis] Product and Service [Axis] Class of Stock [Domain] Class of Stock [Domain] Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Sublease rental income Operating Leases, Rent Expense, Sublease Rentals Unused revolving credit facility balance Line of Credit Facility, Remaining Borrowing Capacity Interest expense, net Interest Expense Acquisition, net of cash and restricted cash acquired – StreetShares, Inc. Payments to Acquire Business Three, Net of Cash Acquired Credit Facility [Axis] Credit Facility [Axis] Contingent earnout, measurement period Business Combination, Contingent Consideration, Liability, Measurement Period Business Combination, Contingent Consideration, Liability, Measurement Period Accrued expenses Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses. Summary of rent expense (pre ASC 842 adoption) Schedule of Rent Expense [Table Text Block] Summary of accrued liabilities Schedule of Accrued Liabilities [Table Text Block] Reconciliation of cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Schedule of long-term debt Schedule of Long-Term Debt Instruments [Table Text Block] Equity [Abstract] Subsequent Event [Table] Subsequent Event [Table] Vested (in shares) Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Entity Tax Identification Number Entity Tax Identification Number Unamortized debt issuance costs Unamortized Debt Issuance Expense 2025 Purchase Obligation, to be Paid, Year Three Number of days granted to underwriters to purchase additional shares of common stock Number Of Days Granted To Underwriters To Purchase Additional Shares Of Common Stock Number of days granted to underwriters to purchase additional shares of common stock. 2021 Revolving Credit Facility 2021 Revolving Credit Facility [Member] 2021 Revolving Credit Facility 2022 (remaining three months) Purchase Obligation, to be Paid, Remainder of Fiscal Year Summary of disaggregation of revenue Disaggregation of Revenue [Table Text Block] Monthly payments Lessee Operating Lease Monthly Payments Lessee Operating Lease Monthly Payments Revenue from Contract with Customer [Abstract] 2022 (remaining three months) Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Non-competition agreements Noncompete Agreements [Member] Shares withheld related to net share settlement of RSUs (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Restricted cash Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Restricted Cash Business combination recognized identifiable assets acquired and liabilities assumed restricted cash. Net increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Property from a related party Number Of Related Party Properties Leased Number Of Related Party Properties Leased Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Shares withheld related to net share settlement of RSUs Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Other accrued expenses Other Accrued Liabilities, Current Capitalized computer software, net carrying amount Capitalized Computer Software, Net City Area Code City Area Code General and administrative General and Administrative Expense Assets Assets [Abstract] Regulation A+ investor note assumed in business combination Noncash or Part Noncash Acquisition, Debt Assumed Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Other Commitments [Line Items] Other Commitments [Line Items] Total future minimum payments under non-cancelable purchase commitments Purchase Obligation Capitalized software additions Payments for Software Statement of Stockholders' Equity [Abstract] Sale of Stock [Axis] Sale of Stock [Axis] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Vesting of Class B carried equity units (in shares) Share Based Compensation By Share Based Award Vesting Of Equity Units Share based compensation by share based award vesting of equity units. Proceeds from initial public offering, net of underwriters’ discounts and commissions Proceeds from issuance initial public offering Proceeds from Issuance Initial Public Offering 2023 Long-Term Debt, Maturity, Year One Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Capital Units by Class [Axis] Capital Units by Class [Axis] Variable Rate [Axis] Variable Rate [Axis] Restricted stock awards, unvested Restricted Stock Awards, Unvested [Member] Restricted Stock Awards, Unvested Other long-term liabilities Other Liabilities, Noncurrent Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Research and development Research and Development Expense [Member] Schedule Of Rent Expense [Table] Schedule Of Rent Expense [Table] Schedule of rent expense table. Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Escrow deposit Escrow Deposit 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Summary of Calculation of Basic and Diluted Net Income (Loss) Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Operating lease assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Cost of revenues Cost of Sales [Member] Capital Unit, Class [Domain] Capital Unit, Class [Domain] 2024 Operating Leases, Future Minimum Payments, Due in Three Years EX-101.PRE 10 mlnk-20220930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover Page - shares
9 Months Ended
Sep. 30, 2022
Nov. 04, 2022
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2022  
Document Transition Report false  
Entity File Number 001-40680  
Entity Registrant Name MeridianLink, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 82-4844620  
Entity Address, Address Line One 3560 Hyland Avenue  
Entity Address, Address Line Two Suite 200  
Entity Address, City or Town Costa Mesa  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92626  
City Area Code 714  
Local Phone Number 708-6950  
Title of 12(b) Security Common stock, par value $0.001 per share  
Trading Symbol MLNK  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   80,917,710
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Entity Central Index Key 0001834494  
Current Fiscal Year End Date --12-31  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 115,752 $ 113,645
Accounts receivable, net of allowance for doubtful accounts 32,034 24,913
Prepaid expenses and other current assets 12,542 9,398
Escrow deposit 30,000 0
Total current assets 190,328 147,956
Property and equipment, net 5,044 5,989
Right of use assets 2,638 0
Intangible assets, net 279,548 298,597
Deferred tax assets, net 10,717 4,286
Goodwill 571,554 564,799
Other assets 4,170 4,266
Total assets 1,063,999 1,025,893
Current liabilities:    
Accounts payable 2,173 2,335
Accrued liabilities 29,807 24,667
Deferred revenue 22,655 14,707
Current portion of long-term debt, net of debt issuance costs 3,367 2,139
Total current liabilities 58,002 43,848
Long-term debt, net of debt issuance costs 423,599 425,371
Long-term deferred revenue 378 0
Deferred rent 0 396
Other long-term liabilities 1,527 0
Total liabilities 483,506 469,615
Commitments and contingencies (Note 5)
Stockholders’ Equity    
Preferred stock, $0.001 par value; 50,000,000 shares authorized; zero shares issued and outstanding at September 30, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value; 600,000,000 shares authorized, 80,732,286 and 79,734,984 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 128 88
Additional paid-in capital 614,222 596,542
Accumulated deficit (33,857) (40,352)
Total stockholders’ equity 580,493 556,278
Total liabilities and stockholders’ equity $ 1,063,999 $ 1,025,893
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 50,000,000 50,000,000
Preferred sock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 600,000,000 600,000,000
Common stock, shares issued (in shares) 80,732,286 79,734,984
Common stock, shares outstanding (in shares) 80,732,286 79,734,984
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenues, net $ 71,754 $ 67,367 $ 217,495 $ 203,652
Cost of revenues:        
Subscription and services 23,812 23,467 68,292 58,078
Amortization of developed technology 4,003 3,219 11,287 9,190
Total cost of revenues 27,815 26,686 79,579 67,268
Gross profit 43,939 40,681 137,916 136,384
Operating expenses:        
General and administrative 21,423 29,917 60,416 64,103
Research and development 11,518 13,533 30,414 27,807
Sales and marketing 6,311 5,994 16,519 13,817
Acquisition related costs 163 0 2,549 781
Total operating expenses 39,415 49,444 109,898 106,508
Operating income (loss) 4,524 (8,763) 28,018 29,876
Other (income) expense, net:        
Other income (327) (9) (706) (39)
Interest expense, net 6,855 7,165 16,649 27,073
Loss on debt repayment and extinguishment 0 (4,351) 0 (4,351)
Total other expense, net 6,528 11,507 15,943 31,385
Income (loss) before provision for income taxes (2,004) (20,270) 12,075 (1,509)
Provision for income taxes 890 1,176 5,318 5,274
Net income (loss) (2,894) (21,446) 6,757 (6,783)
Class A preferred return 0 (2,780) 0 (20,944)
Net income (loss) attributable to common stockholders, basic (2,894) (24,226) 6,757 (27,727)
Net income (loss) attributable to common stockholders, diluted $ (2,894) $ (24,226) $ 6,757 $ (27,727)
Net income (loss) per share:        
Basic (in dollars per share) $ (0.04) $ (0.34) $ 0.08 $ (0.47)
Diluted (in dollars per share) $ (0.04) $ (0.34) $ 0.08 $ (0.47)
Weighted average common stock outstanding:        
Basic (in shares) 80,659,320 71,697,083 80,353,399 58,495,073
Diluted (in shares) 80,659,320 71,697,083 82,364,835 58,495,073
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Preferred Units and Stockholders' Equity / Members' Deficit - USD ($)
$ in Thousands
Total
Restricted stock awards
Restricted Stock Units, Formerly Class B Units
Common Stock
Common Stock
Restricted stock awards
Common Stock
Restricted stock units
Common Stock
Restricted Stock Units, Formerly Class B Units
Additional paid-in capital
Additional paid-in capital
Restricted Stock Units, Formerly Class B Units
Accumulated deficit
Class A Preferred Units
Class B Common Units
Common Stock
Beginning balance (in shares) at Dec. 31, 2020                     319,913  
Beginning balance at Dec. 31, 2020                     $ 319,913  
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Repurchase of stock (in shares)                     (54) (103,421)
Repurchase of stock $ (1,887)             $ (1,849)     $ (54) $ (38)
Ending balance (in shares) at Mar. 31, 2021                     319,859  
Ending balance at Mar. 31, 2021                     $ 319,859  
Beginning balance (in shares) at Dec. 31, 2020       0               51,492,805
Beginning balance at Dec. 31, 2020 (26,429)     $ 0       3,909   $ (30,338)   $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Payment of Class A units cumulative preferred return (12)                 (12)    
Vesting of Class B carried equity units (in shares)                       575,004
Vesting of Class B carried equity units 38                     $ 38
Repurchase of stock (in shares)                     (54) (103,421)
Repurchase of stock (1,887)             (1,849)     $ (54) $ (38)
Share-based compensation expense 643             643        
Net income (loss) 7,231                 7,231    
Ending balance (in shares) at Mar. 31, 2021       0               51,964,388
Ending balance at Mar. 31, 2021 (20,416)     $ 0       2,703   (23,119)   $ 0
Beginning balance (in shares) at Dec. 31, 2020                     319,913  
Beginning balance at Dec. 31, 2020                     $ 319,913  
Ending balance (in shares) at Sep. 30, 2021                     0  
Ending balance at Sep. 30, 2021                     $ 0  
Beginning balance (in shares) at Dec. 31, 2020       0               51,492,805
Beginning balance at Dec. 31, 2020 (26,429)     $ 0       3,909   (30,338)   $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) (6,783)                      
Ending balance (in shares) at Sep. 30, 2021       79,528,555               0
Ending balance at Sep. 30, 2021 555,388     $ 79       592,448   (37,139)   $ 0
Beginning balance (in shares) at Mar. 31, 2021                     319,859  
Beginning balance at Mar. 31, 2021                     $ 319,859  
Ending balance (in shares) at Jun. 30, 2021                     319,859  
Ending balance at Jun. 30, 2021                     $ 319,859  
Beginning balance (in shares) at Mar. 31, 2021       0               51,964,388
Beginning balance at Mar. 31, 2021 (20,416)     $ 0       2,703   (23,119)   $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Vesting of Class B carried equity units (in shares)                       148,516
Vesting of Class B carried equity units 9                     $ 9
Share-based compensation expense 665             665        
Net income (loss) 7,432                 7,432    
Ending balance (in shares) at Jun. 30, 2021       0               52,112,904
Ending balance at Jun. 30, 2021 (12,310)     $ 0       3,368   (15,687)   $ 9
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Effect of Corporate Conversion (in shares)       68,720,140             (319,859) (52,112,904)
Effect of Corporate Conversion 319,853     $ 69       319,799   (6) $ (319,859) $ (9)
Ending balance (in shares) at Sep. 30, 2021                     0  
Ending balance at Sep. 30, 2021                     $ 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Vesting of restricted stock (in shares)           21,691 573,316          
Vesting of restricted stock     $ 38           $ 38      
Issuance of common stock due to exercise of stock options (in shares)       213,408                
Issuance of common stock due to exercise of stock options 1,317             1,317        
Effect of Corporate Conversion (in shares)       68,720,140             (319,859) (52,112,904)
Effect of Corporate Conversion 319,853     $ 69       319,799   (6) $ (319,859) $ (9)
Issuance of common stock in connection with initial public offering, net of underwriters' discounts and commissions and issuance costs (in shares)       10,000,000                
Issuance of common stock in connection with initial public offering, net of underwriters’ discounts and commissions and issuance costs 242,364     $ 10       242,354        
Share-based compensation expense 25,572             25,572        
Net income (loss) (21,446)                 (21,446)    
Ending balance (in shares) at Sep. 30, 2021       79,528,555               0
Ending balance at Sep. 30, 2021 555,388     $ 79       592,448   (37,139)   $ 0
Beginning balance (in shares) at Dec. 31, 2021       79,734,984                
Beginning balance at Dec. 31, 2021 556,278     $ 88       596,542   (40,352)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Vesting of restricted stock (in shares)         484,401 76,937            
Vesting of restricted stock   $ 32     $ 32              
Issuance of common stock due to exercise of stock options (in shares)       28,909                
Issuance of common stock due to exercise of stock options 179             179        
Share-based compensation expense 3,887             3,887        
Net income (loss) 7,479                 7,479    
Ending balance (in shares) at Mar. 31, 2022       80,325,231                
Ending balance at Mar. 31, 2022 $ 567,855     $ 120       600,608   (32,873)    
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Repurchase of stock (in shares) (16,703)                      
Repurchase of stock $ (300)                      
Beginning balance (in shares) at Dec. 31, 2021       79,734,984                
Beginning balance at Dec. 31, 2021 $ 556,278     $ 88       596,542   (40,352)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock due to exercise of stock options (in shares) 29,909                      
Issuance of common stock through employee purchase plan (in shares) 64,985                      
Repurchase of stock (in shares) (16,703)                      
Repurchase of stock $ (300)                      
Net income (loss) 6,757                      
Ending balance (in shares) at Sep. 30, 2022       80,732,286                
Ending balance at Sep. 30, 2022 580,493     $ 128       614,222   (33,857)    
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Repurchase of stock (in shares)       (12,300)                
Repurchase of stock (193)                 (193)    
Beginning balance (in shares) at Mar. 31, 2022       80,325,231                
Beginning balance at Mar. 31, 2022 567,855     $ 120       600,608   (32,873)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Vesting of restricted stock (in shares)         92,209 4,656            
Vesting of restricted stock   6     $ 6              
Issuance of common stock due to exercise of stock options (in shares)       1,000                
Issuance of common stock due to exercise of stock options 7             7        
Issuance of common stock through employee purchase plan (in shares)       64,985                
Issuance of common stock through employee stock purchase plan 922             922        
Repurchase of stock (in shares)       (12,300)                
Repurchase of stock (193)                 (193)    
Share-based compensation expense 5,548             5,548        
Net income (loss) 2,172                 2,172    
Ending balance (in shares) at Jun. 30, 2022       80,475,781                
Ending balance at Jun. 30, 2022 $ 576,317     $ 126       607,085   (30,894)    
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Repurchase of stock (in shares) (4,403)     (4,403)                
Repurchase of stock $ (69)                 (69)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Vesting of restricted stock (in shares)         11,496 259,868            
Vesting of restricted stock   $ 2     $ 2              
Shares withheld related to net share settlement of RSUs (in shares)       (10,456)                
Shares withheld related to net share settlement of RSUs $ (184)             (184)        
Repurchase of stock (in shares) (4,403)     (4,403)                
Repurchase of stock $ (69)                 (69)    
Share-based compensation expense 7,321             7,321        
Net income (loss) (2,894)                 (2,894)    
Ending balance (in shares) at Sep. 30, 2022       80,732,286                
Ending balance at Sep. 30, 2022 $ 580,493     $ 128       $ 614,222   $ (33,857)    
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ 6,757 $ (6,783)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 39,746 37,654
Amortization of debt issuance costs 1,705 2,551
Share-based compensation expense 16,501 26,835
Loss on disposal of fixed assets 164 524
Loss on sublease liability 0 405
Loss on debt repayment and extinguishment 0 4,351
Gain on change in fair value of earnout (162) 0
Other adjustments 0 (18)
Deferred income taxes 5,193 4,992
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (6,964) (2,033)
Prepaid expenses and other assets (2,480) (6,179)
Accounts payable (450) (961)
Accrued liabilities (247) (2,271)
Deferred revenue 7,472 10,016
Deferred rent 0 (71)
Net cash provided by operating activities 67,235 69,012
Cash flows from investing activities:    
Acquisition, net of cash acquired – TazWorks, LLC 0 (85,420)
Acquisition, net of cash and restricted cash acquired – Saylent Technologies, Inc. 0 (35,945)
Acquisition, net of cash and restricted cash acquired – StreetShares, Inc. (23,138) 0
Escrow deposit (30,000) 0
Capitalized software additions (6,323) (3,590)
Purchases of property and equipment (889) (692)
Net cash used in investing activities (60,350) (125,647)
Cash flows from financing activities:    
Repurchases of common stock (262) 0
Proceeds from initial public offering, net of underwriters’ discounts and commissions 0 247,227
Proceeds from exercise of stock options 186 1,317
Payment due to effect of corporate conversion 0 (6)
Proceeds from employee stock purchase plan 922 0
Taxes paid related to net share settlement of RSUs (184) 0
Proceeds from long-term debt 0 100,000
Principal payments of long-term debt (2,175) (202,590)
Payment of Regulation A+ investor note (3,265) 0
Payments of debt issuance costs 0 (1,970)
Payments of Class A cumulative preferred return 0 (12)
Payments of deferred offering costs 0 (4,435)
Payment to sellers of Teledata Communications, Inc 0 (2,142)
Holdback payment to sellers of MeridianLink 0 (25,665)
Net cash (used in) provided by financing activities (4,778) 109,783
Net increase in cash, cash equivalents and restricted cash 2,107 53,148
Cash, cash equivalents and restricted cash, beginning of period 113,645 39,881
Cash, cash equivalents and restricted cash, end of period 115,752 93,029
Reconciliation of cash, cash equivalents, and restricted cash    
Cash and cash equivalents 115,752 93,029
Restricted cash 0 0
Cash, cash equivalents, and restricted cash 115,752 93,029
Supplemental disclosures of cash flow information:    
Cash paid for interest 14,852 24,549
Cash paid for income taxes 1,179 239
Non-cash investing and financing activities:    
Regulation A+ investor note assumed in business combination 3,265 0
Initial recognition of operating lease liability 3,786 0
Initial recognition of operating lease right-of-use asset 3,096 0
Share-based compensation expense capitalized to software additions 255 45
Shares withheld with respect to net settlement of RSUs 184 0
Purchases of property and equipment included in accounts payable and accrued expenses 2 0
Vesting of restricted stock awards and RSUs 40 85
Deferred offering costs included in accounts payable and accrued expenses 0 423
Effect of corporate conversion (Note 1) 0 320
Related party receivable net against holdback payment to prior shareholders 0 4,335
Class A Units    
Cash flows from financing activities:    
Repurchases of Units 0 (54)
Class B Units    
Cash flows from financing activities:    
Repurchases of Units $ 0 $ (1,887)
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization and Description of Business
9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Description of Business Organization and Description of Business
MeridianLink, Inc., and its wholly-owned subsidiaries, (collectively the “Company”) provides secure, cloud-based digital solutions that transform the ways in which traditional and emerging financial services providers engage with account holders and end users. The Company sells its solutions to financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies. The Company delivers its solutions to the substantial majority of its customers using a software-as-a-service (“SaaS”) model under which its customers pay subscription fees for the use of the Company’s solutions. The Company is controlled by its majority stockholder, which is represented by various investment funds of Thoma Bravo UBP, LLC and its affiliates (“Thoma Bravo”). The Company is headquartered in Costa Mesa, California.
Corporate Conversion
Prior to July 27, 2021, the Company operated as a Delaware limited liability company under the name Project Angel Parent, LLC (“Parent”), which directly and indirectly held all the equity interests in its operating subsidiaries. On May 31, 2018, a subsidiary of Parent acquired all the outstanding common stock of MeridianLink, Inc. (“MeridianLink”). Under the terms of the Amended and Restated Limited Liability Company Operating Agreement (“Agreement”), dated as of May 31, 2018, of Parent, the members were not obligated for debt, liabilities, contracts or other obligations of Parent. Profits and losses were allocated to members as defined in the Agreement.
On July 27, 2021, prior to the effectiveness of the registration statement for the Company’s initial public offering, MeridianLink, the then operating company and the indirect wholly owned subsidiary of Project Angel Parent, LLC, changed its name to ML California Sub, Inc, and Project Angel Parent, LLC converted into a Delaware corporation pursuant to a statutory conversion and changed its name to MeridianLink, Inc. As a result of the corporate conversion, MeridianLink, Inc. succeeded to all property and assets and debts and obligations of Project Angel Parent, LLC. Effective July 27, 2021, MeridianLink, Inc. is governed by its certificate of incorporation filed with the Delaware Secretary of State and its bylaws.
Upon its conversion into a corporation, the Company converted each of its outstanding Class A preferred units (“Class A Units”) into a number of shares of common stock equal to the result of the accrued preferred return price per Class A Unit divided by the per share of common stock conversion price determined by the board of directors to be $25.50. The preferred return price for each Class A Unit was equal to the future value of $1,000 at a 9% interest rate compounded quarterly over the time passed since the issuance of such unit. Upon the Company’s conversion into a corporation, the outstanding Class A Units converted into an aggregate of 16,607,235 shares of common stock and were reclassified into permanent equity. Additionally, all the outstanding Class B common units (“Class B Units”) converted into an aggregate of 53,646,668 shares of common stock on a one-for-one basis. At the time of the corporate conversion there were 1,533,763 of such shares that remained subject to future vesting and were not included in the outstanding shares. Following the Corporate Conversion, there were no units of Class A Units outstanding.
The effects of the events described in the preceding two paragraphs are collectively referred to as the “Corporate Conversion.”
Initial Public Offering and Reverse Stock Split
On July 30, 2021, the Company completed its initial public offering (“IPO”) through an underwritten sale of 13.2 million shares of its common stock, of which 10.0 million newly issued shares were sold by the Company at a price to the public of $26.00 per share. The Company received net proceeds of approximately $242.1 million after deducting approximately $17.9 million in underwriting discounts, commissions, and offering-related expenses.
The IPO also included the sale of 3.2 million shares of our common stock by the selling stockholders. The Company did not receive any proceeds from the sale of common stock by the selling stockholders. Additionally, the selling stockholders granted the underwriters an option, exercisable for 30 days after the effective date of the Prospectus, to purchase up to 2.0 million additional shares of common stock. The option was exercised for 1.2 million additional shares on August 26, 2021.
In connection with the listing of the Company’s common stock on the New York Stock Exchange (the “NYSE”), the Company entered into indemnification agreements with its directors and certain officers and employees that require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or services as directors, officers, or employees.
In advance of the IPO, on July 16, 2021, the Company effected a 1-for-2 reverse unit split of the Company’s Class B Units, whereby every two Class B Units converted into one Class B Unit. All Class B Unit and per unit information included in the accompanying condensed consolidated financial statements have been adjusted to reflect this reverse unit split for all periods presented. Following the Corporate Conversion, there were no units of Class B Units outstanding.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Significant Accounting Policies
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Significant Accounting Policies Significant Accounting Policies
Basis of Presentation
The unaudited condensed consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany balances and transactions have been eliminated in consolidation.
Unaudited Condensed Consolidated Financial Information
In the Company's opinion, the unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and include all adjustments, consisting of normal, recurring adjustments, necessary for a fair presentation. Certain information and disclosures normally included in the notes to the annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted from these unaudited condensed consolidated financial statements pursuant to the rules and regulations of the SEC. Accordingly, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (“Annual Report”). The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any other period.
Use of Estimates
The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the reported amounts of revenues and expenses. Significant items subject to such estimates include revenue recognition including determining the nature and timing of satisfaction of performance obligations and variable consideration; share-based compensation; the fair value of acquired intangibles; the capitalization of software development costs; the useful lives of long-lived intangible assets; impairment of goodwill and long-lived assets; and income taxes. In accordance with GAAP, management bases its estimates on historical experience and on various other assumptions that management believes are reasonable under the circumstances. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from those estimates.
Significant Accounting Policies
The Company’s significant accounting policies are discussed in Note 2, “Significant Accounting Policies” in the Company’s Annual Report. There have been no changes to the Company’s significant accounting policies described in the Company’s Annual Report that have had a material impact on its condensed consolidated financial statements and related notes, except for updates resulting from the adoption of ASU 2016-02, “Leases (Topic 842)” as discussed below.
Leases
Leases arise from contractual obligations that convey the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. At the inception of the contract, the Company determines if an arrangement contains a lease based on whether there is an identified asset and whether the Company controls the use of the identified asset. The Company also determines the classification of that lease, between financing and operating, at the lease commencement date. The Company accounts for and allocates consideration to the lease and non-lease components as a single lease component.
A right-of-use (“ROU”) asset represents the Company’s right to use an underlying asset, and a lease liability represents the Company’s obligation to make payments during the lease term. ROU assets are recorded and recognized at commencement for the lease liability amount, adjusted for initial direct costs incurred and lease incentives received, and adjusted for prepaid or accrued lease payments. Lease liabilities are recorded at the present value of the future lease payments over the lease term at commencement. The discount rate used to determine the present value is the incremental borrowing rate, unless the interest rate implicit in the lease is readily determinable. As the implicit rate for the operating leases is generally not determinable, the Company uses an incremental borrowing rate as the discount rate at the lease commencement date to determine the present value of lease payments. The Company determines the discount rate of the leases by considering various factors, such as the credit rating, interest rates of similar debt instruments of entities with comparable credit ratings, jurisdictions, and the lease term.
The Company’s operating leases typically include non-lease components such as common-area maintenance costs, utilities, and other maintenance costs. For real estate leases, the Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.
The Company’s lease terms may include options to extend or terminate the lease. The Company generally uses the base, non-cancelable, lease term when recognizing the lease assets and liabilities, unless it is reasonably certain that the Company will exercise those options. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
The Company’s ROU assets are included in right of use assets and the current and non-current portions of the lease liabilities are included in accrued liabilities and other long-term liabilities, respectively, on the condensed consolidated balance sheets. The Company does not record leases with terms of 12 months or less on the condensed consolidated balance sheets. Lease expense is recognized on a straight-line basis over the expected lease term.
The Company has entered into subleases, or has made decisions and taken actions to exit and sublease certain unoccupied leased office space. Sublease income is recorded as a reduction of rent expense straight-line over the term of the sublease. The Company tests ROU assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. For leased assets, such circumstances would include the decision to leave a leased facility prior to the end of the minimum lease term or subleases for which estimated cash flows do not fully cover the costs of the associated lease. No impairment of ROU assets was recorded during the nine months ended September 30, 2022.
Accounting Pronouncements Recently Adopted
The Company is an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and has elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies.
ASU 2016-02, “Leases (Topic 842)”
The new standard establishes a right-of-use model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the condensed consolidated statements of operations. The new standard provides for a modified retrospective approach which requires recognition at the beginning of the earliest comparative period presented of leases that exist at that date, as well as adjusting equity at the beginning of the earliest comparative period presented as if the new standard had always been applied. In July 2018, the FASB issued ASU 2018-11, which provides an additional transition method. Under the additional transition method, an entity initially applies the new lease guidance at the adoption date (rather than at the beginning of the earliest period presented). Therefore, an entity which elects the additional transition method would apply Topic 840 in the comparative periods and recognize the effects of applying Topic 842 as a cumulative adjustment to retained earnings as of the adoption date. If an entity elects the new transition method, it is required to provide the Topic 840 disclosures for all prior periods presented that remain under the legacy lease guidance.
The Company adopted the new standard on January 1, 2022, utilizing the optional transition approach to not apply Topic 842 in the comparative periods presented. Additionally, the Company elected the package of practical expedients to not (1) reassess whether any expired or existing contracts are considered or contain leases; (2) reassess the lease classification for any expired or existing leases; and (3) reassess the initial direct costs for any existing leases. The most significant impact upon adoption was related to its long-term office space leases that resulted in the recognition of right of use assets and related liabilities of approximately $2.6 million and $3.4 million, respectively, on the Company’s condensed consolidated balance sheets.
ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”
The amendments in this ASU require that an acquirer recognizes and measures contract assets and contract liabilities acquired in a business combination in accordance with Topic 606 rather than at fair value. The ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted.
The Company adopted the new standard on January 1, 2022, prospectively, for business combinations that occur subsequent to the adoption date. The adoption did not have a material impact on the Company’s condensed consolidated financial statements.
Recent Accounting Pronouncements Not Yet Adopted
ASU 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.”
Rather than generally recognizing credit losses when it is probable that the loss has been incurred, the revised guidance requires companies to recognize an allowance for credit losses for the difference between the amortized cost basis of a financial instrument and the amount of amortized cost that the company expects to collect over the instrument’s contractual life.
ASU 2016-13 is effective for the Company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years; early adoption is permitted. The Company intends to adopt the new standard as of January 1, 2023 as a cumulative effect adjustment to retained earnings. The Company does not expect the adoption of this guidance to have a material impact on its condensed consolidated financial statements and disclosures.
ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”
The standard simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 related to the approach for intraperiod tax allocation and the recognition of deferred tax liabilities for outside basis differences and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard also improves consistent application of and simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance.
For the Company, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted. The Company intends to adopt the new standard as of January 1, 2023 and does not expect the adoption of this guidance to have a material impact on its condensed consolidated financial statements and disclosures.
ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”
ASU 2020-04 provides optional guidance for a limited time to ease the potential accounting burden associated with transitioning away from reference rates, such as the London Inter-Bank Offered Rate (LIBOR), which regulators in the United Kingdom are currently phasing out. The expedients and exceptions provided by ASU 2020-04 are for the application of U.S. GAAP to contracts, hedging relationships, and other transactions affected by the rate reform, and will not be available after December 31, 2022, other than for certain hedging relationships entered into before December 31, 2022. Companies can apply the ASU immediately. However, the guidance will only be available for a limited time. The Company is currently evaluating the impact of this guidance on its condensed consolidated financial statements and related disclosures.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue Recognition
9 Months Ended
Sep. 30, 2022
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
Disaggregation of Revenue
The following table disaggregates the Company’s net revenues by solution type (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Lending Software Solutions
$52,414 $44,657 $153,249 $133,034 
Data Verification Software Solutions
19,340 22,710 64,246 70,618 
Total$71,754 $67,367 $217,495 $203,652 
Lending Software Solutions accounted for 73% and 66% of total revenues for the three months ended September 30, 2022, and 2021, respectively. Data Verification Software Solutions accounted for 27% and 34% of total revenues for the three months ended September 30, 2022 and 2021, respectively.
Lending Software Solutions accounted for 70% and 65% of total revenues for the nine months ended September 30, 2022, and 2021, respectively. Data Verification Software Solutions accounted for 30% and 35% of total revenues for the nine months ended September 30, 2022 and 2021, respectively.
The following table disaggregates the Company’s net revenues by major source (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Subscription fees$61,861 $58,988 $188,860 $179,732 
Professional services7,293 5,706 21,070 16,812 
Other2,600 2,673 7,565 7,108 
Total revenues$71,754 $67,367 $217,495 $203,652 
Deferred Revenue
The deferred revenue balance consists of subscription and implementation fees which have been invoiced up front and are recognized as revenue only when the revenue recognition criteria are met. The Company’s subscription contracts are typically invoiced to its customers annually, and revenue is recognized ratably over the service term. Any fees invoiced up front for contracts that have a service term that extend multiple years, the portion of deferred revenue that will be recognized beyond 12 months from the date of the financial statements, are classified as long-term deferred revenue.

The changes in the Company’s deferred revenue as of September 30, 2022 and 2021 were as follows (in thousands):
Nine Months Ended September 30,
20222021
Deferred revenue, beginning balance$14,707 $10,873 
Billing of transaction consideration225,821 213,668 
Revenue recognized(217,495)(203,652)
Deferred revenue, ending balance$23,033 $20,889 
Deferred revenue, current$22,655 $20,889 
Long-term deferred revenue378 — 
Total deferred revenue$23,033 $20,889 
Assets Recognized from Costs to Obtain a Contract with a Customer
Sales commissions related to the Company’s customer agreements are capitalized and charged to expense over the expected period of customer benefit. Current costs are included in prepaid expenses and other current assets, and non-current costs are included in other assets on the accompanying condensed consolidated balance sheets. The following table represents the changes in contract cost assets (in thousands):
Nine Months Ended September 30,
20222021
Beginning balance$5,835 $3,207 
Additions2,114 2,832 
Amortization(1,856)(1,014)
Ending balance$6,093 $5,025 
Contract cost assets, current$2,835 $2,004 
Contract cost assets, noncurrent3,258 3,021 
Total deferred contract cost assets$6,093 $5,025 

Allowance for Doubtful Accounts
Allowance for doubtful accounts as of September 30, 2022 and December 31, 2021 was $0.2 million and $0.2 million, respectively.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components
9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following (in thousands):
As of
September 30, 2022
As of
December 31, 2021
Prepaid expenses$8,309 $6,752 
Contract cost assets – current2,835 2,402 
Income tax receivable989 — 
Others409 244 
Total prepaid expenses and other current assets$12,542 $9,398 
Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
As of
September 30, 2022
As of
December 31, 2021
Computer equipment and software $8,795 $7,995 
Leasehold improvements3,015 2,994 
Office equipment and furniture1,250 1,378 
Total13,060 12,367 
Less: Accumulated depreciation(8,016)(6,378)
Property and equipment, net$5,044 $5,989 
Depreciation expense amounted to $0.6 million for both the three months ended September 30, 2022 and 2021, and $1.7 million for both the nine months ended September 30, 2022 and 2021. The Company disposed of office furniture that resulted in a loss of $0.0 million and $0.3 million during the three months ended September 30, 2022 and 2021, respectively, and $0.2 million and $0.5 million during the nine months ended September 30, 2022 and 2021, respectively. The losses are included in general and administrative expenses in the accompanying condensed consolidated statements of operations.
Intangible Assets, Net
Intangible assets, net consisted of the following (in thousands):
As of September 30, 2022
Gross AmountAccumulated AmortizationNet Carrying Amount
Customer relationships$329,100 $(123,870)$205,230 
Developed technology86,600 (37,375)49,225 
Trademarks24,275 (9,502)14,773 
Non-competition agreements600 (450)150 
Capitalized software17,481 (7,311)10,170 
Total intangible assets, net$458,056 $(178,508)$279,548 
As of December 31, 2021
Gross AmountAccumulated AmortizationNet Carrying Amount
Customer relationships$328,600 $(99,320)$229,280 
Developed technology74,800 (29,207)45,593 
Trademarks24,175 (7,474)16,701 
Non-competition agreements600 (225)375 
Capitalized software10,902 (4,254)6,648 
Total intangible assets, net$439,077 $(140,480)$298,597 
The weighted average remaining useful lives for intangible assets at September 30, 2022 were as follows:
Weighted Average Remaining Useful Life
Customer relationships6 years
Developed technology5 years
Trademarks6 years
Non-competition agreements1 year
Capitalized software3 years
Amortization expense related to intangible assets was as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Cost of revenues$4,003 $3,219 $11,287 $9,190 
General and administrative expense8,790 8,906 26,741 26,721 
Total amortization expense$12,793 $12,125 $38,028 $35,911 
The estimated future amortization of intangible assets as of September 30, 2022 was as follows (in thousands):
Years ending December 31,
2022 (remaining three months)
$13,003 
202350,531 
202448,584 
202542,750 
202638,794 
Thereafter85,886 
Total amortization expense$279,548 
Accrued Liabilities
Accrued liabilities consisted of the following (in thousands):
As of
September 30, 2022
As of
December 31, 2021
Accrued payroll and payroll-related expenses$9,056 $8,522 
Accrued costs of revenues6,135 2,217 
Accrued operating costs3,789 2,099 
Accrued bonuses4,174 6,708 
Sales tax liability from acquisitions2,939 2,939 
Lease liability – current1,401 233 
Other accrued expenses2,313 1,949 
Total accrued liabilities$29,807 $24,667 
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Legal Matters
The Company is, and from time to time may be, involved in legal proceedings and claims arising out of the Company’s operations in the ordinary course of business. Management is not currently aware of any legal proceedings or claims against it that could have a material adverse effect on the financial position, results of operations, or cash flows of the Company.
Other Contractual Commitments
The Company’s contractual commitments primarily consist of third-party cloud infrastructure agreements and service subscription arrangements used to support operations at the enterprise level. Future minimum payments under the Company’s non-cancelable purchase commitments as of September 30, 2022 are as follows (in thousands):
Contractual Commitments
Years ending December 31,
2022 (remaining three months)$— 
2023375 
2024395 
20257,911 
Total$8,681 
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases
9 Months Ended
Sep. 30, 2022
Leases [Abstract]  
Leases Leases
The Company leases office space and server equipment under various operating lease agreements that expire through December 2026. The Company recognizes the related rent expense on a straight-line basis over the term of each lease. Free rent and rental increases are recognized on a straight-line basis over the term of each lease.
As of September 30, 2022, the weighted average remaining lease term was three years and the weighted average discount rate was 5.7%. The Company does not have any finance leases as of September 30, 2022.
One lease is with a related party with a termination date of December 2022. The monthly payments during each of the nine months ended September 30, 2022 and 2021 were $0.1 million. The monthly payments are subject to annual increases.
The Company also has subleases of former office spaces which expire at various dates from 2022 to 2026. Sublease income from operating leases, which is recorded as a reduction of rental expense, was $0.1 million for both the three months ended September 30, 2022 and 2021, and $0.3 million and $0.2 million for the nine months ended September 30, 2022 and 2021, respectively. One of the subleases was entered into during March 2022 resulting in a total loss of $0.1 million from the disposal of related assets. The loss is included in general and administrative expense on the condensed consolidated statements of operations for the nine months ended September 30, 2022.
Rent expense, gross of sublease income, has been recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 (in thousands):
Three Months Ended
September 30, 2022
Nine Months Ended
September 30, 2022
Cost of revenues$201 $507 
General and administrative23 187 
Research and development170 387 
Sales and marketing66 163 
Total rent expense$460 $1,244 
The following table presents supplemental cash flow information about the Company’s leases (in thousands):
Nine Months Ended
September 30, 2022
Cash paid for amounts included in the measurement of lease liabilities$1,563 
Operating lease assets obtained in exchange for new operating lease liabilities1,082 
The following table presents supplemental balance sheet information about the Company’s leases (in thousands):
As of
September 30, 2022
Operating lease ROU assets$2,638 
Operating lease liabilities, current$1,401 
Noncurrent operating lease liabilities1,511 
Total operating lease liabilities$2,912 
As of September 30, 2022, remaining maturities of lease liabilities were as follows (in thousands):
Related PartyThird PartyTotal
Years Ending December 31,
2022 (remaining three months)$219 $226 $445 
2023— 1,259 1,259 
2024— 843 843 
2025— 321 321 
2026— 244 244 
Total operating lease payments (1)
219 2,893 3,112 
Less: imputed interest(1)(199)(200)
Total operating lease liabilities$218 $2,694 $2,912 
______________
(1)Presented gross of sublease income. The Company expects to receive sublease income of approximately $0.1 million in the remainder of the year ended December 31, 2022, $0.3 million in 2023, and $0.2 million thereafter.
As of December 31, 2021, prior to the adoption of Topic 842, the aggregate future non-cancelable minimum rental payments and expected sublease receipts were as follows (in thousands):
Related PartyThird PartySublease ReceiptsTotal
Years Ending December 31,
2022$875 $736 $(293)$1,318 
2023— 753 — 753 
2024— 722 — 722 
2025— 319 — 319 
2026 244 — 244 
Thereafter— — — — 
Total future minimum lease payments$875 $2,774 $(293)$3,356 
Rent expense for the three and nine months ended September 30, 2021 was as follows (in thousands):
Three Months Ended September 30, 2021Nine Months Ended September 30, 2021
Cost of revenues$156 $608 
General and administrative41 153 
Research and development100 393 
Sales and marketing44 174 
Total rent expense$341 $1,328 
As of December 31, 2021, the Company had an accrued lease termination liability related to leased office space it ceased using during February 2021. The termination liability as of December 31, 2021 was $0.2 million. Upon adoption of Topic 842 on January 1, 2022, the termination liability was removed as an adjustment to the related right of use asset.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Long-Term Debt
9 Months Ended
Sep. 30, 2022
Debt Disclosure [Abstract]  
Long-Term Debt Long-Term Debt
Long-term debt consisted of the following (in thousands):
As of
September 30, 2022
As of
December 31, 2021
2021 Term loan
$432,825 $435,000 
Debt issuance costs
(5,859)(7,490)
Total debt, net
426,966 427,510 
Less: Current portion of long-term debt
2021 Term loan4,350 3,263 
Debt issuance costs
(983)(1,124)
Total current portion of long-term debt, net
3,367 2,139 
Total non-current portion of long-term debt, net
$423,599 $425,371 
Amortization of deferred financing fees was $0.3 million and $0.7 million for the three months ended September 30, 2022 and 2021, respectively. Total interest expense, excluding amortization of deferred financing fees, was $6.6 million and $6.4 million for the three months ended September 30, 2022 and 2021, respectively.

Amortization of deferred financing fees was $1.7 million and $2.6 million for the nine months ended September 30, 2022 and 2021, respectively. Total interest expense, excluding amortization of deferred financing fees, was $14.9 million and $24.5 million for the nine months ended September 30, 2022 and 2021, respectively.
2021 Credit Agreement
On November 10, 2021, the Company entered into a credit agreement (the “2021 Credit Agreement”), which provides for a term loan facility (the “2021 Term Loan”) in an aggregate principal amount of $435.0 million, and a revolving credit facility (the “2021 Revolving Credit Facility”) in an aggregate principal amount of $50.0 million, inclusive of a $10.0 million letter of credit sub-facility. The Company used the proceeds from the 2021 Term Loan to pay all outstanding amounts due under the Company’s previous 2018 First Lien plus certain fees and expenses. The 2021 Term Loan and 2021 Revolving Credit Facility mature on November 10, 2028 and November 10, 2026, respectively. The Company has not drawn on the 2021 Revolving Credit Facility as of September 30, 2022.
The obligations under the 2021 Credit Agreement are secured by a lien on substantially all tangible and intangible property of the Company, subject to customary exceptions, limitations, and exclusions from the collateral.
The 2021 Credit Agreement contains customary affirmative covenants, negative covenants and events of default, including covenants and restrictions that, among other things, require the Company to satisfy a financial covenant, and restricts or limits the ability of the Company to grant or incur liens, incur additional indebtedness, enter into joint ventures or partnerships, engage in mergers and acquisitions, engage in asset sales, and declare dividends on its capital stock, subject in each case to certain customary exceptions. A failure to comply with certain covenants could permit the lenders to declare the 2021 Term Loan, and any then outstanding borrowings on the 2021 Revolving Credit Facility, together with accrued interest and fees thereon, to be immediately due and payable. The Company was in compliance with all financial covenants of the 2021 Credit Agreement at September 30, 2022.
2021 Term Loan
Borrowings under the 2021 Term Loan bear interest at a variable rate, elected by the Company, equal to the Base Rate (as defined in the 2021 Credit Agreement) or the Adjusted Eurocurrency Rate (as defined in the 2021 Credit Agreement), plus, an initial margin based on the Company’s Consolidated First Lien Net Leverage Ratio (as defined by the 2021 Credit Agreement), which was 3.00% at September 30, 2022. Beginning in June 2022, the Company is required to make quarterly principal payments equal to 0.25% of the original principal, with the remainder due at maturity.
Debt issuance costs of $7.6 million were included as a reduction of the debt balance on the condensed consolidated balance sheets and are amortized into interest expense over the contractual life of the loans using the effective interest method. Included in the debt issuance costs were $4.8 million incurred in connection with the 2021 Term Loan, and $2.8 million carried forward from the Company’s previous 2018 First Lien. The Company recognized $0.3 million and $1.6 million of amortization of debt issuance costs for the 2021 Term Loan during the three and nine months ended September 30, 2022, respectively. The effective interest rate on the 2021 Term Loan was 6.2% as of September 30, 2022.
2021 Revolving Credit Facility
Borrowings under the 2021 Revolving Credit Facility bear interest, at the election of the Company, at a rate equal to the Base Rate (as defined in the 2021 Credit Agreement) or the Adjusted Eurocurrency Rate (as defined in the 2021 Credit Agreement), plus, in each case, the Applicable Rate (as defined in the 2021 Credit Agreement), which shall vary based on the Company’s Consolidated First Lien Net Leverage Ratio.
In connection with the 2021 Revolving Credit Facility, the Company incurred $0.5 million in debt issuance costs. Expenses associated with the issuance of the revolving credit facility are presented in the accompanying condensed consolidated balance sheets in prepaid expenses and other current assets and other assets, and are amortized to interest expense over the life of the 2021 Revolving Credit Facility using the straight-line method. The remaining unamortized debt issuance costs were $0.4 million and $0.5 million as of September 30, 2022 and December 31, 2022, respectively.
The 2021 Revolving Credit Facility also requires a quarterly commitment fee based on the Company’s consolidated first lien net leverage ratio. As of September 30, 2022, the applicable rate was 0.5%, which was applied against the $50.0 million unused revolving credit facility balance.
Future Principal Payments
Future principal payments of long-term debt as of September 30, 2022 were as follows (in thousands):
Years ending December 31,
2022 (remaining three months)$1,087 
20234,350 
20244,350 
20254,350 
20264,350 
Thereafter414,338 
Total$432,825 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity
9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
Stock Repurchase Program
In May 2022, the Company’s board of directors authorized a new stock repurchase program to acquire up to $75.0 million of the Company’s common stock, with no requirement to purchase any minimum number of shares. The manner, timing, and actual number of shares repurchased under the program will depend on a variety of factors, including price, working capital needs, general business and market conditions, regulatory requirements, and other investment opportunities. Shares may be repurchased through privately negotiated transactions, or open market purchases, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934. The repurchase program may be commenced, suspended, or terminated at any time by the Company at its discretion without prior notice.
The Company retires the repurchased shares, which shall automatically return to the status of authorized but unissued shares of common stock. During the three months ended September 30, 2022, the Company repurchased 4,403 shares of its common stock for approximately $0.1 million, including commissions and fees. During the nine months ended September 30, 2022, the Company repurchased 16,703 shares of its common stock for approximately $0.3 million, including commissions and fees. As of September 30, 2022, there was a total of $74.7 million remaining for repurchase under the stock repurchase program.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-based Compensation
2021 Stock Option and Incentive Plan
The 2021 Stock Option and Incentive Plan (the “2021 Plan”) was adopted by the board of directors and approved by the Company’s stockholders following the Corporate Conversion and became effective as of July 26, 2021. The 2021 Plan replaced both the Company’s 2019 Equity Option Plan (the “2019 Plan”) and the Project Angel Parent, LLC Equity Plan (the “2018 Plan”). Outstanding options to purchase Class B Units granted under the 2019 Plan were converted into options to purchase shares of common stock, and all outstanding Carried Equity Units granted under the 2018 Plan were converted into restricted stock awards (“RSAs”), both of which have been granted under the 2021 Plan.
The Company had initially reserved 13,171,588 shares of its common stock for the issuance of awards under the 2021 Plan. The 2021 Plan provides that the number of shares reserved and available for issuance under the 2021 Plan will automatically increase on January 1, 2022 and each January 1 thereafter, by 5% of the outstanding number of shares of common stock on the immediately preceding December 31, or such lesser number of shares as determined by the Company’s compensation committee. The number of shares reserved under the 2021 Plan is subject to adjustment in the event of a stock split, stock dividend, or other change in the Company’s capitalization.
The 2021 Plan provides flexibility to the Company’s compensation committee to use various equity-based incentive awards as compensation tools to motivate the Company’s workforce. The incentive awards that may be granted under the 2021 Plan include, but are not limited to, options to purchase common stock, stock appreciation rights, restricted shares of common stock, restricted stock units, and cash bonuses.
Stock Options
A summary of stock option activity during the nine months ended September 30, 2022 is as follows (in thousands, except options, price per option, and term amounts):
Number of OptionsWeighted Average Exercise PriceWeighted Average Remaining Contract TermAggregate Intrinsic Value
Outstanding – January 1, 2022
4,256,812 $13.05 
8.44
$42,429 
Granted
927,364 17.09 
Exercised(29,909)6.22 
Forfeited(331,781)21.04 
Outstanding – September 30, 2022
4,822,486 $13.32 
7.90
$26,811,786 
Vested and expected to vest in the future at September 30, 2022
4,822,486 13.32 
7.90
26,811,786 
Exercisable at September 30, 2022
2,833,199 $8.56 
7.15
$25,074,833 
The total fair value of options that vested during the three months ended September 30, 2022 and 2021 was $4.9 million and $10.6 million, respectively, and for the nine months ended September 30, 2022 and 2021 was $6.6 million and $12.1 million, respectively.

The total intrinsic value of options exercised during the three months ended September 30, 2022 and 2021 was $0.0 million and $4.2 million, respectively, and for the nine months ended September 30, 2022 and 2021 was $0.4 million and $4.2 million, respectively.
The Company recognized approximately $2.1 million and $11.8 million in share-based compensation expense related to time-based and performance-based stock options for the three months ended September 30, 2022 and 2021, respectively, and $5.1 million and $12.8 million for the nine months ended September 30, 2022 and 2021, respectively. Included in the amounts of share-based compensation for the three and nine months ended September 30, 2021, is the acceleration of stock-based compensation expense in the amount of $10.3 million related to 500,000 options to purchase common stock, which became fully vested upon the completion of the Company’s IPO.
During the three and nine months ended September 30, 2022 and 2021, performance-based options were probable of vesting and, therefore, were included as part of share-based compensation expense.
As of September 30, 2022, there was approximately $19.1 million of unrecognized share-based compensation expense related to stock options, which is expected to be recognized over a weighted-average period of approximately 2.86 years.
Restricted Stock Awards
The number of restricted stock awards that vested during the three and nine months ended September 30, 2022 was 11,496 and 588,106, respectively. The liability balance as of September 30, 2022, related to the unvested RSAs was $0.0 million. As of September 30, 2022, the number of unvested RSAs amounted to 75,102. There were a total of 0 and 27,146 RSAs cancelled or forfeited during the three and nine months ended September 30, 2022, respectively.
The Company recognized approximately $0.1 million and $0.2 million in share-based compensation expense related to the vesting of RSAs for the three and nine months ended September 30, 2022. The Company recognized $11.2 million and $11.5 million in share-based compensation expense related to the vesting of RSAs during the three and nine months ended September 30, 2021. Included in the amounts of share-based compensation for the three and nine months ended September 30, 2021, is the acceleration of stock-based compensation expense in the amount of $11.1 million related to 426,657 Carried Equity Units, which became fully vested upon the completion of the Company’s IPO.

Share-based compensation expense related to the excess of fair value per unit on date of issuance over the $0.06 per share purchase price paid by the participants, has been recognized as additional compensation expense attributable to the participants.
Restricted Stock Units
A summary of restricted stock unit (“RSU”) activity during the nine months ended September 30, 2022, is as follows:
Number of RSUsWeighted Average Grant Date Fair Value
Non-vested – January 1, 2022
1,073,529 $25.76 
Granted
2,708,097 17.94 
Vested(341,461)25.89 
Forfeited(266,138)21.42 
Non-vested – September 30, 2022
3,174,027 $19.44 
As of September 30, 2022, 3,174,027 RSUs are expected to vest. The Company recognized approximately $4.9 million and $11.0 million in share-based compensation expense related to RSUs for the three and nine months ended September 30, 2022, respectively. The Company recognized $2.3 million in share-based compensation expense related to RSUs for both the three and nine months ended September 30, 2021.
As of September 30, 2022, there was approximately $54.5 million of unrecognized share-based compensation expense related to RSUs, which is expected to be recognized over a weighted-average period of approximately 3.26 years.
Employee Stock Purchase Program
As of September 30, 2022, the Company has issued 64,985 shares of common stock pursuant to the 2021 Employee Stock Purchase Plan under its employee stock purchase program (“ESPP”). As of September 30, 2022, there was approximately $0.1 million of unrecognized share-based compensation related to the ESPP that is expected to be recognized over the remaining term of the current offering period. The Company recognized $0.2 million and $0.5 million of share-based compensation expense related to the ESPP for the three and nine months ended September 30, 2022, respectively.
Share-Based Compensation
Share-based compensation for share-based awards granted to participants has been recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021 as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Cost of revenues$1,352 $5,296 $3,567 $5,461 
General and administrative3,170 12,158 6,947 12,864 
Research and development (1)
2,092 6,194 4,457 6,358 
Sales and marketing639 1,879 1,530 2,152 
Total share-based compensation expense $7,253 $25,527 $16,501 $26,835 
______________
(1)Net of $0.1 million and $0.3 million additions to capitalized software on the Company’s condensed consolidated balance sheets during the three and nine months ended September 30, 2022, respectively, and $0.1 million during both the three and nine months ended September 30, 2021.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes
9 Months Ended
Sep. 30, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
In accordance with applicable accounting guidance, the Company is required to use an estimated annual effective tax rate to compute its tax provision during an interim period. The Company’s provision for income taxes reflected an effective tax rate of approximately (44)% and (6)% for the three months ended September 30, 2022 and 2021, respectively, and 44% and (350)% for the nine months ended September 30, 2022 and 2021, respectively. During the three and nine months ended September 30, 2022, the Company’s effective tax rate differs from the U.S. federal statutory rate primarily due to R&D credits, state taxes, permanent unfavorable differences related to share-based compensation expense, transaction expenses, certain employee remuneration under section 162(m) of the Internal Revenue Code and other expected permanent differences. During the three and nine months ended September 30, 2021, the Company’s effective tax rate differs from the U.S. federal statutory rate as ASC 740 generally requires providing for income taxes during interim periods based on the estimated annual effective tax rate (“AETR”) for the full fiscal year. For the three and nine months ended September 30, 2021, the Company calculated its income tax provision as though the interim year to date period was an annual period, referred to herein as the discrete method. The Company believes that the application of the AETR method was impractical at the time, given that normal deviations in the projected pre-tax net income (loss) for the Company due to certain employee remuneration limited under section 162(m) of the Internal Revenue Code and certain employee share-based remuneration that the Company recognized due to the Company becoming a public issuer of its securities in the three months ended September 30, 2021.
The Company has gross unrecognized tax benefits with respect to R&D credits of $2.3 million as of September 30, 2022 and $1.9 million as of December 31, 2021. There are no penalties or interest recorded on these liabilities as the credits have not yet been utilized.
The Company assesses whether a valuation allowance should be recorded against its deferred tax assets based on the consideration of all available evidence, using a “more likely than not” realization standard. The four sources of taxable income that must be considered in determining whether deferred tax assets will be realized are: (l) future reversals of existing taxable temporary differences (i.e., offset of gross deferred tax assets against gross deferred tax liabilities); (2) taxable income in prior carryback years, if carryback is permitted under the applicable tax law; (3) tax planning strategies; and (4) future taxable income exclusive of reversing temporary differences and carryforwards. Based on the evaluation of the evidence and sources of taxable income, the Company has determined that no valuation allowance is necessary as of September 30, 2022.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Related Party Transactions
9 Months Ended
Sep. 30, 2022
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
The Company has leased one property from a related party. Rental expense for this property totaled $0.2 million for both the three months ended September 30, 2022 and 2021, and $0.5 million for both the nine months ended September 30, 2022 and 2021.
On May 31, 2018, the Company entered into an Advisory Services Agreement with Thoma Bravo, a private equity firm, that owns the majority of the Company through private equity funds managed by the firm. During the three and nine months ended September 30, 2021, the Company recorded $0.2 million and $1.2 million, respectively, in general and administrative expenses on the accompanying condensed consolidated statements of operations for management and advisory fees. The Advisory Services Agreement was terminated upon completion of the IPO.
During the three and nine months ended September 30, 2022, the Company recorded $0.4 million and $1.3 million, respectively, in cost of revenues for third party expenses with a Thoma Bravo affiliated company, and $0.4 million and $1.2 million, respectively, for the three and nine months ended September 30, 2021. As of September 30, 2022, the Company had prepaid expenses of $0.2 million, accounts payable of $0.1 million, and accrued liabilities of $0.3 million with a Thoma Bravo affiliated company. As of December 31, 2021, the Company had prepaid expenses of $0.1 million, accounts payable of $0.2 million, and accrued liabilities of $0.2 million with a Thoma Bravo affiliated company.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Income (Loss) Per Share
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Net Income (Loss) Per Share Net Income (Loss) Per Share
The following table presents the calculation of basic and diluted net income (loss) per share (in thousands, except share and per share data):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Basic and diluted net income (loss) per share
Numerator:
Net income (loss) attributable to common stockholders
$(2,894)$(24,226)$6,757 $(27,727)
Denominator:
Weighted average common stock outstanding:
Basic80,659,32071,697,08380,353,39958,495,073
Diluted80,659,32071,697,08382,364,83558,495,073
Net income (loss) per share:
Basic$(0.04)$(0.34)$0.08 $(0.47)
Diluted(0.04)(0.34)0.08 (0.47)
The following outstanding potentially dilutive securities were excluded from the calculation of diluted net income (loss) per share attributable to common stockholders because their impact would have been anti-dilutive for the periods presented:
As of September 30,
20222021
Options to purchase common stock outstanding, unexercised1,833,279 4,448,454 
Restricted stock awards, unvested— 947,540 
Restricted stock units, unvested757,859 1,088,230 
Purchase rights committed under the ESPP— — 
Total2,591,138 6,484,224 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business Combinations
9 Months Ended
Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
Business Combinations Business Combinations
Acquisition of StreetShares
On April 1, 2022, the Company acquired all of the outstanding stock of StreetShares, Inc. (“StreetShares”) for cash consideration of $28.0 million, $30.0 million in escrow for a contingent earnout that expires April 1, 2023, subject to adjustment as defined in the purchase agreement, and $1.6 million in acquisition costs. The $30.0 million is considered contingent consideration and accounted for separate from the business combination accounting. The acquisition was funded by the Company’s available cash. StreetShares is based out of Reston, VA, and is a financial technology company that provides digital small business lending technology to banks and credit unions. The acquisition is accounted for using the acquisition method of accounting whereby the acquired assets and liabilities are recorded at their respective fair values and added to those of the Company, including an amount for goodwill representing the difference between the acquisition consideration and the fair value of the identifiable net assets. Results of operations of StreetShares have been included in the operations of the Company beginning with the closing date of the acquisition. The acquisition was deemed immaterial to the Company’s operating results as a whole.
The table below summarizes the allocation of the purchase price of StreetShares based on the estimated fair value of the assets acquired and the liabilities assumed (in thousands):
Assets acquired:
Cash and cash equivalents$1,580 
Restricted cash (1)
3,265 
Accounts receivable157 
Prepaid expenses and other current assets561 
Property and equipment142 
Right of use assets613 
Deferred tax asset11,624 
Goodwill6,755 
Intangible assets12,400 
Other assets83 
Total assets acquired37,180 
Liabilities assumed:
Accounts payable368 
Accrued compensation and benefits3,585 
Accrued expenses738 
Contingent earnout162 
Notes payable to Regulation A+ investors (1)
3,265 
Deferred revenue854 
Other long-term liabilities225 
Total liabilities assumed9,197 
Fair value of assets acquired and liabilities assumed$27,983 
______________
(1)Prior to the acquisition, StreetShares was subject to Regulation A+ of the Securities and Exchange Commission and had offered StreetShares notes to investors. The notes were scheduled to mature during various dates through 2023. Subsequent to the acquisition, during April 2022, the Company used the $3.3 million restricted cash balance to repay the Regulation A+ payable in full.
During the three months ended September 30, 2022, the Company completed measurement period adjustments related to the fair value of identifiable intangible assets and final working capital adjustment, resulting in a reduction to the fair values of customer relationships and developed technology by $1.9 million and $1.5 million, respectively, an increase in deferred tax assets of $1.1 million, and an increase in goodwill of $2.3 million. The final working capital adjustment amounted to approximately $0.1 million being paid by the Company to the sellers of StreetShares. The working capital adjustment was settled in September 2022 and resulted in a corresponding adjustment to prepaid expenses and other current assets.

As of September 30, 2022, the Company is still finalizing the provisional purchase price allocation related to income tax effects. The goodwill recognized is attributable to the Company’s expected acceleration of its small business lending service capabilities. The StreetShares acquisition is treated as a stock purchase for income tax purposes; therefore, of the goodwill recorded, none is considered deductible for income tax purposes.
The fair value of the separately identifiable finite-lived intangible assets acquired and estimated useful lives are as follows (in thousands, except years):
Estimated Fair ValuesWeighted Average Amortization Life (years)
Customer relationships$500 5
Developed technology11,800 10
Trademarks100 2
Total acquisition-related intangible assets$12,400 9
The fair value estimates for intangible assets include significant assumptions in the prospective financial information, such as revenue growth and discount rates. The fair value of the intangible assets was primarily based on the income approach using various methods such as the relief from royalty, with-or-without, and excess earnings methods.
Goodwill Rollforward
A rollforward of the Company’s goodwill balance from January 1, 2022 to September 30, 2022 is as follows:
Nine Months Ended September 30,
2022
Beginning balance$564,799 
StreetShares acquisition6,755 
Ending balance$571,554 
Contingent Earnout Liability
The purchase price for StreetShares includes a potential earnout that will be measured over 12 months from April 2, 2022, through April 1, 2023, based on performance factors outlined in the acquisition agreement.
The contingent earnout liability is recorded at estimated fair value each reporting period using a Monte Carlo simulation based on the forecasted operating results over the earnout period, estimates for market volatility, discount rates, and the earnout formula specified in the acquisition agreement. As the fair value uses significant unobservable inputs, it is considered a Level 3 fair value measurement.
The contingent earnout liability is recorded in accrued liabilities on the Company’s condensed consolidated balance sheets. Changes to the fair value are recorded as an adjustment to general and administrative expenses on the condensed consolidated statements of operations. The fair value of the contingent earnout liability was $0.0 million as of September 30, 2022 and $0.2 million as of April 1, 2022.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events
9 Months Ended
Sep. 30, 2022
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
Acquisition of OpenClose
On November 4, 2022, the Company acquired all of the outstanding stock of Beanstalk Networks, L.L.C. doing business as OpenClose (“OpenClose”) for cash consideration of $65.0 million, which includes approximately $1.4 million in acquisition costs. The acquisition was funded by the Company’s available cash. OpenClose is based out of West Palm Beach, Florida, and provides mortgage lending technology, with a particular focus on supporting depository institutions. The acquisition will be accounted for using the acquisition method of accounting whereby the acquired assets and liabilities will be recorded at their respective fair values and added to those of the Company, including an amount for goodwill representing the difference between the acquisition consideration and the fair value of the identifiable net assets.
Results of operations of OpenClose will be included in the operations of the Company beginning with the closing date of the acquisition. As of the date of issuance of these condensed consolidated financial statements, the initial acquisition and disclosures under ASC 805, Business Combinations, have not been prepared as the Company has not obtained all of the information necessary, nor has there been sufficient time, to complete the related activities.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Basis of Presentation/Unaudited Interim Condensed Consolidated Financial Information
Basis of Presentation
The unaudited condensed consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany balances and transactions have been eliminated in consolidation.
Unaudited Condensed Consolidated Financial Information
In the Company's opinion, the unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and include all adjustments, consisting of normal, recurring adjustments, necessary for a fair presentation. Certain information and disclosures normally included in the notes to the annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted from these unaudited condensed consolidated financial statements pursuant to the rules and regulations of the SEC. Accordingly, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (“Annual Report”). The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any other period.
Use of Estimates
Use of Estimates
The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the reported amounts of revenues and expenses. Significant items subject to such estimates include revenue recognition including determining the nature and timing of satisfaction of performance obligations and variable consideration; share-based compensation; the fair value of acquired intangibles; the capitalization of software development costs; the useful lives of long-lived intangible assets; impairment of goodwill and long-lived assets; and income taxes. In accordance with GAAP, management bases its estimates on historical experience and on various other assumptions that management believes are reasonable under the circumstances. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from those estimates.
Leases
Leases
Leases arise from contractual obligations that convey the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. At the inception of the contract, the Company determines if an arrangement contains a lease based on whether there is an identified asset and whether the Company controls the use of the identified asset. The Company also determines the classification of that lease, between financing and operating, at the lease commencement date. The Company accounts for and allocates consideration to the lease and non-lease components as a single lease component.
A right-of-use (“ROU”) asset represents the Company’s right to use an underlying asset, and a lease liability represents the Company’s obligation to make payments during the lease term. ROU assets are recorded and recognized at commencement for the lease liability amount, adjusted for initial direct costs incurred and lease incentives received, and adjusted for prepaid or accrued lease payments. Lease liabilities are recorded at the present value of the future lease payments over the lease term at commencement. The discount rate used to determine the present value is the incremental borrowing rate, unless the interest rate implicit in the lease is readily determinable. As the implicit rate for the operating leases is generally not determinable, the Company uses an incremental borrowing rate as the discount rate at the lease commencement date to determine the present value of lease payments. The Company determines the discount rate of the leases by considering various factors, such as the credit rating, interest rates of similar debt instruments of entities with comparable credit ratings, jurisdictions, and the lease term.
The Company’s operating leases typically include non-lease components such as common-area maintenance costs, utilities, and other maintenance costs. For real estate leases, the Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.
The Company’s lease terms may include options to extend or terminate the lease. The Company generally uses the base, non-cancelable, lease term when recognizing the lease assets and liabilities, unless it is reasonably certain that the Company will exercise those options. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
The Company’s ROU assets are included in right of use assets and the current and non-current portions of the lease liabilities are included in accrued liabilities and other long-term liabilities, respectively, on the condensed consolidated balance sheets. The Company does not record leases with terms of 12 months or less on the condensed consolidated balance sheets. Lease expense is recognized on a straight-line basis over the expected lease term.
The Company has entered into subleases, or has made decisions and taken actions to exit and sublease certain unoccupied leased office space. Sublease income is recorded as a reduction of rent expense straight-line over the term of the sublease. The Company tests ROU assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. For leased assets, such circumstances would include the decision to leave a leased facility prior to the end of the minimum lease term or subleases for which estimated cash flows do not fully cover the costs of the associated lease. No impairment of ROU assets was recorded during the nine months ended September 30, 2022.
Recent Accounting Pronouncements Adopted And Not Yet Adopted
Accounting Pronouncements Recently Adopted
The Company is an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and has elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies.
ASU 2016-02, “Leases (Topic 842)”
The new standard establishes a right-of-use model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the condensed consolidated statements of operations. The new standard provides for a modified retrospective approach which requires recognition at the beginning of the earliest comparative period presented of leases that exist at that date, as well as adjusting equity at the beginning of the earliest comparative period presented as if the new standard had always been applied. In July 2018, the FASB issued ASU 2018-11, which provides an additional transition method. Under the additional transition method, an entity initially applies the new lease guidance at the adoption date (rather than at the beginning of the earliest period presented). Therefore, an entity which elects the additional transition method would apply Topic 840 in the comparative periods and recognize the effects of applying Topic 842 as a cumulative adjustment to retained earnings as of the adoption date. If an entity elects the new transition method, it is required to provide the Topic 840 disclosures for all prior periods presented that remain under the legacy lease guidance.
The Company adopted the new standard on January 1, 2022, utilizing the optional transition approach to not apply Topic 842 in the comparative periods presented. Additionally, the Company elected the package of practical expedients to not (1) reassess whether any expired or existing contracts are considered or contain leases; (2) reassess the lease classification for any expired or existing leases; and (3) reassess the initial direct costs for any existing leases. The most significant impact upon adoption was related to its long-term office space leases that resulted in the recognition of right of use assets and related liabilities of approximately $2.6 million and $3.4 million, respectively, on the Company’s condensed consolidated balance sheets.
ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”
The amendments in this ASU require that an acquirer recognizes and measures contract assets and contract liabilities acquired in a business combination in accordance with Topic 606 rather than at fair value. The ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted.
The Company adopted the new standard on January 1, 2022, prospectively, for business combinations that occur subsequent to the adoption date. The adoption did not have a material impact on the Company’s condensed consolidated financial statements.
Recent Accounting Pronouncements Not Yet Adopted
ASU 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.”
Rather than generally recognizing credit losses when it is probable that the loss has been incurred, the revised guidance requires companies to recognize an allowance for credit losses for the difference between the amortized cost basis of a financial instrument and the amount of amortized cost that the company expects to collect over the instrument’s contractual life.
ASU 2016-13 is effective for the Company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years; early adoption is permitted. The Company intends to adopt the new standard as of January 1, 2023 as a cumulative effect adjustment to retained earnings. The Company does not expect the adoption of this guidance to have a material impact on its condensed consolidated financial statements and disclosures.
ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”
The standard simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 related to the approach for intraperiod tax allocation and the recognition of deferred tax liabilities for outside basis differences and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard also improves consistent application of and simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance.
For the Company, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted. The Company intends to adopt the new standard as of January 1, 2023 and does not expect the adoption of this guidance to have a material impact on its condensed consolidated financial statements and disclosures.
ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”
ASU 2020-04 provides optional guidance for a limited time to ease the potential accounting burden associated with transitioning away from reference rates, such as the London Inter-Bank Offered Rate (LIBOR), which regulators in the United Kingdom are currently phasing out. The expedients and exceptions provided by ASU 2020-04 are for the application of U.S. GAAP to contracts, hedging relationships, and other transactions affected by the rate reform, and will not be available after December 31, 2022, other than for certain hedging relationships entered into before December 31, 2022. Companies can apply the ASU immediately. However, the guidance will only be available for a limited time. The Company is currently evaluating the impact of this guidance on its condensed consolidated financial statements and related disclosures.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue Recognition (Tables)
9 Months Ended
Sep. 30, 2022
Revenue from Contract with Customer [Abstract]  
Summary of disaggregation of revenue
The following table disaggregates the Company’s net revenues by solution type (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Lending Software Solutions
$52,414 $44,657 $153,249 $133,034 
Data Verification Software Solutions
19,340 22,710 64,246 70,618 
Total$71,754 $67,367 $217,495 $203,652 
The following table disaggregates the Company’s net revenues by major source (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Subscription fees$61,861 $58,988 $188,860 $179,732 
Professional services7,293 5,706 21,070 16,812 
Other2,600 2,673 7,565 7,108 
Total revenues$71,754 $67,367 $217,495 $203,652 
Schedule of changes in the deferred revenue
The changes in the Company’s deferred revenue as of September 30, 2022 and 2021 were as follows (in thousands):
Nine Months Ended September 30,
20222021
Deferred revenue, beginning balance$14,707 $10,873 
Billing of transaction consideration225,821 213,668 
Revenue recognized(217,495)(203,652)
Deferred revenue, ending balance$23,033 $20,889 
Deferred revenue, current$22,655 $20,889 
Long-term deferred revenue378 — 
Total deferred revenue$23,033 $20,889 
Schedule of changes in contract cost assets The following table represents the changes in contract cost assets (in thousands):
Nine Months Ended September 30,
20222021
Beginning balance$5,835 $3,207 
Additions2,114 2,832 
Amortization(1,856)(1,014)
Ending balance$6,093 $5,025 
Contract cost assets, current$2,835 $2,004 
Contract cost assets, noncurrent3,258 3,021 
Total deferred contract cost assets$6,093 $5,025 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components (Tables)
9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of prepaid expenses and other current assets
Prepaid expenses and other current assets consisted of the following (in thousands):
As of
September 30, 2022
As of
December 31, 2021
Prepaid expenses$8,309 $6,752 
Contract cost assets – current2,835 2,402 
Income tax receivable989 — 
Others409 244 
Total prepaid expenses and other current assets$12,542 $9,398 
Summary of property and equipment, net
Property and equipment, net consisted of the following (in thousands):
As of
September 30, 2022
As of
December 31, 2021
Computer equipment and software $8,795 $7,995 
Leasehold improvements3,015 2,994 
Office equipment and furniture1,250 1,378 
Total13,060 12,367 
Less: Accumulated depreciation(8,016)(6,378)
Property and equipment, net$5,044 $5,989 
Summary of intangible assets, net and estimated useful lives and weighted average amortization periods
Intangible assets, net consisted of the following (in thousands):
As of September 30, 2022
Gross AmountAccumulated AmortizationNet Carrying Amount
Customer relationships$329,100 $(123,870)$205,230 
Developed technology86,600 (37,375)49,225 
Trademarks24,275 (9,502)14,773 
Non-competition agreements600 (450)150 
Capitalized software17,481 (7,311)10,170 
Total intangible assets, net$458,056 $(178,508)$279,548 
As of December 31, 2021
Gross AmountAccumulated AmortizationNet Carrying Amount
Customer relationships$328,600 $(99,320)$229,280 
Developed technology74,800 (29,207)45,593 
Trademarks24,175 (7,474)16,701 
Non-competition agreements600 (225)375 
Capitalized software10,902 (4,254)6,648 
Total intangible assets, net$439,077 $(140,480)$298,597 
The weighted average remaining useful lives for intangible assets at September 30, 2022 were as follows:
Weighted Average Remaining Useful Life
Customer relationships6 years
Developed technology5 years
Trademarks6 years
Non-competition agreements1 year
Capitalized software3 years
Summary of amortization expense related to intangible assets
Amortization expense related to intangible assets was as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Cost of revenues$4,003 $3,219 $11,287 $9,190 
General and administrative expense8,790 8,906 26,741 26,721 
Total amortization expense$12,793 $12,125 $38,028 $35,911 
Schedule of estimated future amortization of intangible assets
The estimated future amortization of intangible assets as of September 30, 2022 was as follows (in thousands):
Years ending December 31,
2022 (remaining three months)
$13,003 
202350,531 
202448,584 
202542,750 
202638,794 
Thereafter85,886 
Total amortization expense$279,548 
Summary of accrued liabilities
Accrued liabilities consisted of the following (in thousands):
As of
September 30, 2022
As of
December 31, 2021
Accrued payroll and payroll-related expenses$9,056 $8,522 
Accrued costs of revenues6,135 2,217 
Accrued operating costs3,789 2,099 
Accrued bonuses4,174 6,708 
Sales tax liability from acquisitions2,939 2,939 
Lease liability – current1,401 233 
Other accrued expenses2,313 1,949 
Total accrued liabilities$29,807 $24,667 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Future minimum payments under non-cancelable purchase commitments Future minimum payments under the Company’s non-cancelable purchase commitments as of September 30, 2022 are as follows (in thousands):
Contractual Commitments
Years ending December 31,
2022 (remaining three months)$— 
2023375 
2024395 
20257,911 
Total$8,681 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases (Tables)
9 Months Ended
Sep. 30, 2022
Leases [Abstract]  
Summary of rent expense (post ASC 842 adoption)
Rent expense, gross of sublease income, has been recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 (in thousands):
Three Months Ended
September 30, 2022
Nine Months Ended
September 30, 2022
Cost of revenues$201 $507 
General and administrative23 187 
Research and development170 387 
Sales and marketing66 163 
Total rent expense$460 $1,244 
The following table presents supplemental cash flow information about the Company’s leases (in thousands):
Nine Months Ended
September 30, 2022
Cash paid for amounts included in the measurement of lease liabilities$1,563 
Operating lease assets obtained in exchange for new operating lease liabilities1,082 
Supplemental balance sheet information about the Company's leases The following table presents supplemental balance sheet information about the Company’s leases (in thousands):
As of
September 30, 2022
Operating lease ROU assets$2,638 
Operating lease liabilities, current$1,401 
Noncurrent operating lease liabilities1,511 
Total operating lease liabilities$2,912 
Summary of future minimum lease payments (post ASC 842 adoption) As of September 30, 2022, remaining maturities of lease liabilities were as follows (in thousands):
Related PartyThird PartyTotal
Years Ending December 31,
2022 (remaining three months)$219 $226 $445 
2023— 1,259 1,259 
2024— 843 843 
2025— 321 321 
2026— 244 244 
Total operating lease payments (1)
219 2,893 3,112 
Less: imputed interest(1)(199)(200)
Total operating lease liabilities$218 $2,694 $2,912 
______________
(1)Presented gross of sublease income. The Company expects to receive sublease income of approximately $0.1 million in the remainder of the year ended December 31, 2022, $0.3 million in 2023, and $0.2 million thereafter.
Summary of future minimum lease payments (pre ASC 842 adoption)
As of December 31, 2021, prior to the adoption of Topic 842, the aggregate future non-cancelable minimum rental payments and expected sublease receipts were as follows (in thousands):
Related PartyThird PartySublease ReceiptsTotal
Years Ending December 31,
2022$875 $736 $(293)$1,318 
2023— 753 — 753 
2024— 722 — 722 
2025— 319 — 319 
2026 244 — 244 
Thereafter— — — — 
Total future minimum lease payments$875 $2,774 $(293)$3,356 
Summary of rent expense (pre ASC 842 adoption)
Rent expense for the three and nine months ended September 30, 2021 was as follows (in thousands):
Three Months Ended September 30, 2021Nine Months Ended September 30, 2021
Cost of revenues$156 $608 
General and administrative41 153 
Research and development100 393 
Sales and marketing44 174 
Total rent expense$341 $1,328 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Long-Term Debt (Tables)
9 Months Ended
Sep. 30, 2022
Debt Disclosure [Abstract]  
Schedule of long-term debt
Long-term debt consisted of the following (in thousands):
As of
September 30, 2022
As of
December 31, 2021
2021 Term loan
$432,825 $435,000 
Debt issuance costs
(5,859)(7,490)
Total debt, net
426,966 427,510 
Less: Current portion of long-term debt
2021 Term loan4,350 3,263 
Debt issuance costs
(983)(1,124)
Total current portion of long-term debt, net
3,367 2,139 
Total non-current portion of long-term debt, net
$423,599 $425,371 
Summary of future principal payments of long-term debt
Future principal payments of long-term debt as of September 30, 2022 were as follows (in thousands):
Years ending December 31,
2022 (remaining three months)$1,087 
20234,350 
20244,350 
20254,350 
20264,350 
Thereafter414,338 
Total$432,825 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of stock option activity
A summary of stock option activity during the nine months ended September 30, 2022 is as follows (in thousands, except options, price per option, and term amounts):
Number of OptionsWeighted Average Exercise PriceWeighted Average Remaining Contract TermAggregate Intrinsic Value
Outstanding – January 1, 2022
4,256,812 $13.05 
8.44
$42,429 
Granted
927,364 17.09 
Exercised(29,909)6.22 
Forfeited(331,781)21.04 
Outstanding – September 30, 2022
4,822,486 $13.32 
7.90
$26,811,786 
Vested and expected to vest in the future at September 30, 2022
4,822,486 13.32 
7.90
26,811,786 
Exercisable at September 30, 2022
2,833,199 $8.56 
7.15
$25,074,833 
Schedule of RSU activity
A summary of restricted stock unit (“RSU”) activity during the nine months ended September 30, 2022, is as follows:
Number of RSUsWeighted Average Grant Date Fair Value
Non-vested – January 1, 2022
1,073,529 $25.76 
Granted
2,708,097 17.94 
Vested(341,461)25.89 
Forfeited(266,138)21.42 
Non-vested – September 30, 2022
3,174,027 $19.44 
Summary of stock-based compensation
Share-based compensation for share-based awards granted to participants has been recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021 as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Cost of revenues$1,352 $5,296 $3,567 $5,461 
General and administrative3,170 12,158 6,947 12,864 
Research and development (1)
2,092 6,194 4,457 6,358 
Sales and marketing639 1,879 1,530 2,152 
Total share-based compensation expense $7,253 $25,527 $16,501 $26,835 
______________
(1)Net of $0.1 million and $0.3 million additions to capitalized software on the Company’s condensed consolidated balance sheets during the three and nine months ended September 30, 2022, respectively, and $0.1 million during both the three and nine months ended September 30, 2021.
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Income (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Summary of Calculation of Basic and Diluted Net Income (Loss) Per Share
The following table presents the calculation of basic and diluted net income (loss) per share (in thousands, except share and per share data):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Basic and diluted net income (loss) per share
Numerator:
Net income (loss) attributable to common stockholders
$(2,894)$(24,226)$6,757 $(27,727)
Denominator:
Weighted average common stock outstanding:
Basic80,659,32071,697,08380,353,39958,495,073
Diluted80,659,32071,697,08382,364,83558,495,073
Net income (loss) per share:
Basic$(0.04)$(0.34)$0.08 $(0.47)
Diluted(0.04)(0.34)0.08 (0.47)
Summary of Outstanding Potentially Dilutive Securities were Excluded from the Calculation of Diluted Net Loss Per Common Unit Attributable to Common Unitholders
The following outstanding potentially dilutive securities were excluded from the calculation of diluted net income (loss) per share attributable to common stockholders because their impact would have been anti-dilutive for the periods presented:
As of September 30,
20222021
Options to purchase common stock outstanding, unexercised1,833,279 4,448,454 
Restricted stock awards, unvested— 947,540 
Restricted stock units, unvested757,859 1,088,230 
Purchase rights committed under the ESPP— — 
Total2,591,138 6,484,224 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business Combinations (Tables)
9 Months Ended
Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
Summary of the Allocation of the Purchase Price
The table below summarizes the allocation of the purchase price of StreetShares based on the estimated fair value of the assets acquired and the liabilities assumed (in thousands):
Assets acquired:
Cash and cash equivalents$1,580 
Restricted cash (1)
3,265 
Accounts receivable157 
Prepaid expenses and other current assets561 
Property and equipment142 
Right of use assets613 
Deferred tax asset11,624 
Goodwill6,755 
Intangible assets12,400 
Other assets83 
Total assets acquired37,180 
Liabilities assumed:
Accounts payable368 
Accrued compensation and benefits3,585 
Accrued expenses738 
Contingent earnout162 
Notes payable to Regulation A+ investors (1)
3,265 
Deferred revenue854 
Other long-term liabilities225 
Total liabilities assumed9,197 
Fair value of assets acquired and liabilities assumed$27,983 
______________
(1)Prior to the acquisition, StreetShares was subject to Regulation A+ of the Securities and Exchange Commission and had offered StreetShares notes to investors. The notes were scheduled to mature during various dates through 2023. Subsequent to the acquisition, during April 2022, the Company used the $3.3 million restricted cash balance to repay the Regulation A+ payable in full.
Summary of Fair Value of the Separately Identifiable Finite-Lived Intangible Assets Acquired and Estimated Useful Lives The fair value of the separately identifiable finite-lived intangible assets acquired and estimated useful lives are as follows (in thousands, except years):
Estimated Fair ValuesWeighted Average Amortization Life (years)
Customer relationships$500 5
Developed technology11,800 10
Trademarks100 2
Total acquisition-related intangible assets$12,400 9
Summary of Company's Goodwill
A rollforward of the Company’s goodwill balance from January 1, 2022 to September 30, 2022 is as follows:
Nine Months Ended September 30,
2022
Beginning balance$564,799 
StreetShares acquisition6,755 
Ending balance$571,554 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization and Description of Business (Details)
9 Months Ended
Aug. 26, 2021
shares
Jul. 30, 2021
USD ($)
$ / shares
shares
Jul. 27, 2021
USD ($)
$ / shares
shares
Jul. 16, 2021
Sep. 30, 2022
USD ($)
shares
Sep. 30, 2021
USD ($)
Jul. 28, 2021
shares
Organization, Consolidation and Presentation of Financial Statements [Line Items]              
Conversion price of stock (in dollars per share) | $ / shares     $ 25.50        
Temporary equity future value | $     $ 1,000        
Temporary equity compound interest rate     9.00%        
Shares that remained subject to future vesting (in shares)     1,533,763        
Conversion ratio     1        
Sale of stock, number of shares issued in transaction (in shares)   13,200,000          
Proceeds from issuance initial public offering | $         $ 0 $ 247,227,000  
Payment of stock issuance costs | $         $ 0 $ 4,435,000  
Stock shares tendered for sale by the existing stockholders (in shares) 1,200,000 3,200,000          
Number of days granted to underwriters to purchase additional shares of common stock   30 days          
Stock shares offered but not yet tendered by the existing stockholders (in shares)   2,000,000          
Stock split ratio       0.5      
Common units, units outstanding (in shares)             0
IPO              
Organization, Consolidation and Presentation of Financial Statements [Line Items]              
Sale of stock, number of shares issued in transaction (in shares)   10,000,000          
Sale of stock issue price per share (in dollars per share) | $ / shares   $ 26.00          
Proceeds from issuance initial public offering | $   $ 242,100,000          
Payment of stock issuance costs | $   $ 17,900,000          
Capital Unit, Class A              
Organization, Consolidation and Presentation of Financial Statements [Line Items]              
Temporary equity stock shares converted into permanent equity (in shares)     16,607,235        
Preferred units outstanding (in shares)             0
Capital Unit, Class B              
Organization, Consolidation and Presentation of Financial Statements [Line Items]              
Temporary equity stock shares converted into permanent equity (in shares)     53,646,668        
Shares that remained subject to future vesting (in shares)         75,102    
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Significant Accounting Policies - Additional Information (Details) - USD ($)
9 Months Ended
Sep. 30, 2022
Jan. 01, 2022
Dec. 31, 2021
Accounting Policies [Abstract]      
Right of use assets $ 2,638,000 $ 2,600,000 $ 0
Total operating lease liabilities 2,912,000 $ 3,400,000  
Impairment of right of use assets $ 0    
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue Recognition - Disaggregation of Revenue by Solution Type (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Disaggregation of Revenue [Line Items]        
Revenues, net $ 71,754 $ 67,367 $ 217,495 $ 203,652
Lending Software Solutions        
Disaggregation of Revenue [Line Items]        
Revenues, net 52,414 44,657 153,249 133,034
Data Verification Software Solutions        
Disaggregation of Revenue [Line Items]        
Revenues, net $ 19,340 $ 22,710 $ 64,246 $ 70,618
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue Recognition - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Segment Reporting Information [Line Items]          
Allowance for doubtful accounts $ 0.2   $ 0.2   $ 0.2
Lending Software Solutions          
Segment Reporting Information [Line Items]          
Concentration risk 73.00% 66.00% 70.00% 65.00%  
Data Verification Software Solutions          
Segment Reporting Information [Line Items]          
Concentration risk 27.00% 34.00% 30.00% 35.00%  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue Recognition - Disaggregation of Revenue by Major Source (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Disaggregation of Revenue [Line Items]        
Revenues, net $ 71,754 $ 67,367 $ 217,495 $ 203,652
Subscription fees        
Disaggregation of Revenue [Line Items]        
Revenues, net 61,861 58,988 188,860 179,732
Professional services        
Disaggregation of Revenue [Line Items]        
Revenues, net 7,293 5,706 21,070 16,812
Other        
Disaggregation of Revenue [Line Items]        
Revenues, net $ 2,600 $ 2,673 $ 7,565 $ 7,108
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue Recognition - Schedule of Changes in Deferred Revenue (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Contract With Customer, Liability [Roll Forward]      
Deferred revenue, beginning balance $ 14,707 $ 10,873  
Billing of transaction consideration 225,821 213,668  
Revenue recognized (217,495) (203,652)  
Deferred revenue, ending balance 23,033 20,889  
Deferred revenue, current 22,655 20,889  
Long-term deferred revenue 378 0 $ 0
Total deferred revenue $ 23,033 $ 20,889  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue Recognition - Schedule of Changes in Contract Cost Assets (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Capitalized Contract Cost [Roll Forward]      
Beginning balance $ 5,835 $ 3,207  
Additions 2,114 2,832  
Amortization (1,856) (1,014)  
Ending balance 6,093 5,025  
Contract cost assets – current 2,835 2,004 $ 2,402
Contract cost assets, noncurrent 3,258 3,021  
Total deferred contract cost assets $ 6,093 $ 5,025 $ 5,835
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Summary of Prepaid Expenses and Other Current Assets (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Prepaid expenses $ 8,309 $ 6,752  
Contract cost assets – current 2,835 2,402 $ 2,004
Income tax receivable 989 0  
Others 409 244  
Total prepaid expenses and other current assets $ 12,542 $ 9,398  
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Summary of Property and Equipment, Net (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property plant and equipment gross $ 13,060 $ 12,367
Less: Accumulated depreciation (8,016) (6,378)
Property and equipment, net 5,044 5,989
Computer equipment and software    
Property, Plant and Equipment [Line Items]    
Property plant and equipment gross 8,795 7,995
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property plant and equipment gross 3,015 2,994
Office equipment and furniture    
Property, Plant and Equipment [Line Items]    
Property plant and equipment gross $ 1,250 $ 1,378
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Depreciation $ 600 $ 600 $ 1,700 $ 1,700
Loss on disposal of fixed assets     164 524
Office equipment and furniture        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Loss on disposal of fixed assets $ 0 $ 300 $ 200 $ 500
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Summary of Intangible Assets, Net (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross amount $ 458,056 $ 439,077
Intangible assets, accumulated amortization (178,508) (140,480)
Total amortization expense 279,548 298,597
Capitalized computer software, gross 17,481 10,902
Capitalized computer software, accumulated amortization (7,311) (4,254)
Capitalized computer software, net carrying amount 10,170 6,648
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross amount 329,100 328,600
Intangible assets, accumulated amortization (123,870) (99,320)
Total amortization expense 205,230 229,280
Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross amount 86,600 74,800
Intangible assets, accumulated amortization (37,375) (29,207)
Total amortization expense 49,225 45,593
Trademarks    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross amount 24,275 24,175
Intangible assets, accumulated amortization (9,502) (7,474)
Total amortization expense 14,773 16,701
Non-competition agreements    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross amount 600 600
Intangible assets, accumulated amortization (450) (225)
Total amortization expense $ 150 $ 375
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Summary of Estimated Useful Lives and Weighted Average Amortization Periods for Intangible Assets (Detail)
9 Months Ended
Sep. 30, 2022
Customer relationships  
Finite-Lived Intangible Assets [Line Items]  
Weighted Average Remaining Useful Life 6 years
Developed technology  
Finite-Lived Intangible Assets [Line Items]  
Weighted Average Remaining Useful Life 5 years
Trademarks  
Finite-Lived Intangible Assets [Line Items]  
Weighted Average Remaining Useful Life 6 years
Non-competition agreements  
Finite-Lived Intangible Assets [Line Items]  
Weighted Average Remaining Useful Life 1 year
Capitalized software  
Finite-Lived Intangible Assets [Line Items]  
Weighted Average Remaining Useful Life 3 years
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Summary of amortization expense related to intangible assets (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Finite-Lived Intangible Assets [Line Items]        
Amortization of intangible assets $ 12,793 $ 12,125 $ 38,028 $ 35,911
Cost of revenues        
Finite-Lived Intangible Assets [Line Items]        
Amortization of intangible assets 4,003 3,219 11,287 9,190
General and administrative expense        
Finite-Lived Intangible Assets [Line Items]        
Amortization of intangible assets $ 8,790 $ 8,906 $ 26,741 $ 26,721
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Summary of Estimated Future Amortization of Intangible Assets (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
2022 (remaining three months) $ 13,003  
2023 50,531  
2024 48,584  
2025 42,750  
2026 38,794  
Thereafter 85,886  
Total amortization expense $ 279,548 $ 298,597
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Summary of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued payroll and payroll-related expenses $ 9,056 $ 8,522
Accrued costs of revenues 6,135 2,217
Accrued operating costs 3,789 2,099
Accrued bonuses 4,174 6,708
Sales tax liability from acquisitions 2,939 2,939
Lease liability – current 1,401 233
Other accrued expenses 2,313 1,949
Total accrued liabilities $ 29,807 $ 24,667
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies - Future Minimum Payments Under Non-Cancelable Purchase Commitments (Details)
$ in Thousands
Sep. 30, 2022
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2022 (remaining three months) $ 0
2023 375
2024 395
2025 7,911
Total future minimum payments under non-cancelable purchase commitments $ 8,681
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2021
Other Commitments [Line Items]                
Weighted average remaining lease term   3 years   3 years        
Weighted average discount rate   5.70%   5.70%        
Monthly payments       $ 0.1 $ 0.1      
Sublease income   $ 0.1   0.3        
Sublease rental income     $ 0.1   $ 0.2      
Loss on disposal of assets       $ 0.1        
Operating leases, termination liability               $ 0.2
Forecast                
Other Commitments [Line Items]                
Sublease income $ 0.1         $ 0.2 $ 0.3  
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Summary of Rent Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Schedule Of Rent Expense [Line Items]        
Rent expense $ 460   $ 1,244  
Rent expense   $ 341   $ 1,328
Cost of revenues        
Schedule Of Rent Expense [Line Items]        
Rent expense 201   507  
Rent expense   156   608
General and administrative expense        
Schedule Of Rent Expense [Line Items]        
Rent expense 23   187  
Rent expense   41   153
Research and development        
Schedule Of Rent Expense [Line Items]        
Rent expense 170   387  
Rent expense   100   393
Sales and marketing        
Schedule Of Rent Expense [Line Items]        
Rent expense $ 66   $ 163  
Rent expense   $ 44   $ 174
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Supplemental Cash Flow Information About the Company's Leases (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2022
USD ($)
Leases [Abstract]  
Cash paid for amounts included in the measurement of lease liabilities $ 1,563
Operating lease assets obtained in exchange for new operating lease liabilities $ 1,082
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Supplemental Balance Sheet Information About The Company's Leases (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Jan. 01, 2022
Dec. 31, 2021
Leases [Abstract]      
Operating lease ROU assets $ 2,638 $ 2,600 $ 0
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Accrued liabilities    
Lease liability – current $ 1,401   $ 233
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other long-term liabilities    
Noncurrent operating lease liabilities $ 1,511    
Total operating lease liabilities $ 2,912 $ 3,400  
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
Leases - Summary of Future Minimum Lease Payments (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Jan. 01, 2022
Dec. 31, 2021
Lessee, Lease, Description [Line Items]      
2022 (remaining three months) $ 445    
2023 1,259    
2024 843    
2025 321    
2026 244    
Total operating lease payments 3,112    
Less: imputed interest (200)    
Total operating lease liabilities 2,912 $ 3,400  
2022     $ 1,318
2023     753
2024     722
2025     319
2026     244
Thereafter     0
Total future minimum lease payments     3,356
Sublease Receipts     (293)
Related Party      
Lessee, Lease, Description [Line Items]      
2022 (remaining three months) 219    
2023 0    
2024 0    
2025 0    
2026 0    
Total operating lease payments 219    
Less: imputed interest (1)    
Total operating lease liabilities 218    
2022     875
2023     0
2024     0
2025     0
2026     0
Thereafter     0
Total future minimum lease payments     875
Third Party      
Lessee, Lease, Description [Line Items]      
2022 (remaining three months) 226    
2023 1,259    
2024 843    
2025 321    
2026 244    
Total operating lease payments 2,893    
Less: imputed interest (199)    
Total operating lease liabilities $ 2,694    
2022     736
2023     753
2024     722
2025     319
2026     244
Thereafter     0
Total future minimum lease payments     $ 2,774
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
Long-Term Debt - Summary of Long-term Debt (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
2021 Term loan $ 432,825 $ 435,000
Debt issuance costs (5,859) (7,490)
Total debt, net 426,966 427,510
Current portion of long term debt 3,367 2,139
Debt issuance costs (983) (1,124)
Total non-current portion of long-term debt, net 423,599 425,371
Secured Debt | 2021 Term Loan    
Debt Instrument [Line Items]    
Current portion of long term debt $ 4,350 $ 3,263
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
Long-Term Debt - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Nov. 10, 2021
Debt Instrument [Line Items]            
Amortization of financing costs $ 300 $ 700 $ 1,705 $ 2,551    
Interest expense 6,600 $ 6,400 14,900 $ 24,500    
Debt issuance costs, gross 7,600   7,600      
Unamortized debt issuance costs 400   400   $ 500  
2021 Term Loan            
Debt Instrument [Line Items]            
Amortization of financing costs $ 300   $ 1,600      
Percent of original principal 0.25%   0.25%      
Debt issuance costs, gross           $ 4,800
Interest rate, effective 6.20%   6.20%      
2021 Term Loan | Base Rate | Variable Rate Component One            
Debt Instrument [Line Items]            
Basis spread on variable rate     3.00%      
2021 Term Loan | Adjusted Eurocurrency Rate | Variable Rate Component Two            
Debt Instrument [Line Items]            
Basis spread on variable rate     3.00%      
2021 Term Loan | Secured Debt            
Debt Instrument [Line Items]            
Term loan           435,000
2021 Revolving Credit Facility | Revolving Credit Facility            
Debt Instrument [Line Items]            
Debt issuance costs, gross           500
Commitment fee rate     0.50%      
2021 Revolving Credit Facility | Letter of Credit            
Debt Instrument [Line Items]            
Revolving credit facility, principal amount           10,000
2021 Revolving Credit Facility | Line of Credit | Revolving Credit Facility            
Debt Instrument [Line Items]            
Revolving credit facility, principal amount           50,000
Unused revolving credit facility balance $ 50,000   $ 50,000      
First Lien            
Debt Instrument [Line Items]            
Debt issuance costs, gross           $ 2,800
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
Long-Term Debt - Summary of Future Principal Payments of Long-term Debt (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Debt Disclosure [Abstract]    
2022 (remaining three months) $ 1,087  
2023 4,350  
2024 4,350  
2025 4,350  
2026 4,350  
Thereafter 414,338  
Total $ 432,825 $ 435,000
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2021
Sep. 30, 2022
May 31, 2022
Equity [Abstract]          
Stock repurchase program authorized amount         $ 75,000,000
Stock repurchased (in shares) 4,403     16,703  
Stock repurchased $ 69,000 $ 193,000 $ 1,887,000 $ 300,000  
Stock remaining for repurchase under repurchase program $ 74,700,000     $ 74,700,000  
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Jul. 26, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Jul. 27, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Fair value of options vested   $ 4,900 $ 10,600 $ 6,600 $ 12,100    
Intrinsic value of options exercised   0 4,200 400 4,200    
Total share-based compensation expense   7,253 25,527 16,501 26,835    
Unrecognized stock-based compensation expense related to stock options   $ 19,100   $ 19,100      
Shares that remained subject to future vesting (in shares)             1,533,763
Unvested (in shares)   3,174,027   3,174,027      
Issuance of common stock through employee purchase plan (in shares)       64,985      
Capitalized software costs   $ 100 100 $ 300 100    
Class B Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Liability balance related to unvested RSAs   $ 0   $ 0      
Shares that remained subject to future vesting (in shares)   75,102   75,102      
RSAs cancelled or forfeited (in shares)   0   27,146      
Stock options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total share-based compensation expense   $ 2,100 11,800 $ 5,100 12,800    
Accelerated stock-based compensation expense     $ 10,300   $ 10,300    
Accelerated vesting (in shares)     500,000   500,000    
Unrecognized stock-based compensation expense, weighted -average period for recognition       2 years 10 months 9 days      
Restricted stock awards              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total share-based compensation expense   $ 100 $ 11,200 $ 200 $ 11,500    
Accelerated stock-based compensation expense     $ 11,100   $ 11,100    
Accelerated vesting (in shares)     426,657   426,657    
Vested (in shares)   11,496   588,106      
Carried Equity Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Share price (in dollars per share)   $ 0.06   $ 0.06      
Restricted stock units (RSUs)              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total share-based compensation expense   $ 4,900 $ 2,300 $ 11,000 $ 2,300    
Unrecognized stock-based compensation expense, weighted -average period for recognition       3 years 3 months 3 days      
Vested (in shares)       341,461      
Unvested (in shares)   3,174,027   3,174,027   1,073,529  
Unrecognized stock-based compensation expense, awards other than options   $ 54,500   $ 54,500      
Purchase rights committed under the ESPP              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total share-based compensation expense   200   500      
Unrecognized stock-based compensation expense, awards other than options   $ 100   $ 100      
2021 Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Common stock, capital shares reserved for future issuance (in shares) 13,171,588            
Annual increase in shares authorized, percentage 5.00%            
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation - Summary of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Number of Options    
Beginning balance (in shares) 4,256,812  
Granted (in shares) 927,364  
Exercised (in shares) (29,909)  
Forfeited (in shares) (331,781)  
Ending balance (in shares) 4,822,486 4,256,812
Vested and expected to vest in the future (in shares) 4,822,486  
Exercisable at end of period (in shares) 2,833,199  
Weighted Average Exercise Price    
Beginning balance (in dollars per share) $ 13.05  
Granted (in dollars per share) 17.09  
Exercised (in dollars per share) 6.22  
Forfeited (in dollars per share) 21.04  
Ending balance (in dollars per share) 13.32 $ 13.05
Vested and expected to vest in the future (in dollars per share) 13.32  
Exercisable at end of period (in dollars per share) $ 8.56  
Weighted Average Remaining Contract Term and Aggregate Intrinsic Value    
Weighted average remaining contractual term 7 years 10 months 24 days 8 years 5 months 8 days
Weighted average remaining contractual term, vested and expected to vest in the future 7 years 10 months 24 days  
Weighted average remaining contractual term, exercisable at end of period 7 years 1 month 24 days  
Aggregate intrinsic value $ 26,811,786 $ 42,429
Aggregate intrinsic value, vested and expected to vest in the future 26,811,786  
Aggregate intrinsic value, exercisable at end of period $ 25,074,833  
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation - Schedule of RSU Activity (Details)
9 Months Ended
Sep. 30, 2022
$ / shares
shares
Number of RSUs  
Non-vested ending balance (in shares) 3,174,027
Restricted stock units (RSUs)  
Number of RSUs  
Non-vested beginning balance (in shares) 1,073,529
Granted (in shares) 2,708,097
Vested (in shares) (341,461)
Forfeited (in shares) (266,138)
Non-vested ending balance (in shares) 3,174,027
Weighted Average Grant Date Fair Value  
Non-vested beginning balance (in dollars per share) | $ / shares $ 25.76
Granted (in dollars per share) | $ / shares 17.94
Vested (in dollars per share) | $ / shares 25.89
Forfeited (in dollars per share) | $ / shares 21.42
Non-vested ending balance (in dollars per share) | $ / shares $ 19.44
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation - Summary of Stock-based Compensation (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense $ 7,253 $ 25,527 $ 16,501 $ 26,835
Cost of revenues        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense 1,352 5,296 3,567 5,461
General and administrative expense        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense 3,170 12,158 6,947 12,864
Research and development        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense 2,092 6,194 4,457 6,358
Sales and marketing        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share-based compensation expense $ 639 $ 1,879 $ 1,530 $ 2,152
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Income Tax Disclosure [Abstract]          
Effective income tax rate reconciliation, percent (44.00%) (6.00%) 44.00% (350.00%)  
Uncertain tax positions $ 2,300,000   $ 2,300,000   $ 1,900,000
Penalties and interest on unrecognized tax benefits $ 0   $ 0   $ 0
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.22.2.2
Related Party Transactions - Additional Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
Property
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
Property
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Related Party Transaction [Line Items]          
Property from a related party | Property 1   1    
Operating leases, rent expense   $ 341   $ 1,328  
Advisory Services Agreement          
Related Party Transaction [Line Items]          
Related party transaction, general and administrative expenses from transactions with related party   200 $ 1,200    
Leased Property From Related Party          
Related Party Transaction [Line Items]          
Operating lease, expense $ 200   500    
Operating leases, rent expense   200   500  
Affiliated Entity          
Related Party Transaction [Line Items]          
Related party transaction, cost of sales 400 $ 400 1,300 $ 1,200  
Prepaid expenses, related party 200   200   $ 100
Accounts payable, related parties 100   100   200
Accrued liabilities, related parties $ 300   $ 300   $ 200
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Income (Loss) Per Share - Summary of calculation of basic and diluted net income (loss) per share (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Numerator:        
Net income (loss) attributable to common stockholders, basic $ (2,894) $ (24,226) $ 6,757 $ (27,727)
Net income (loss) attributable to common stockholders, diluted $ (2,894) $ (24,226) $ 6,757 $ (27,727)
Weighted average common stock outstanding:        
Basic (in shares) 80,659,320 71,697,083 80,353,399 58,495,073
Diluted (in shares) 80,659,320 71,697,083 82,364,835 58,495,073
Net income (loss) per share:        
Basic (in dollars per share) $ (0.04) $ (0.34) $ 0.08 $ (0.47)
Diluted (in dollars per share) $ (0.04) $ (0.34) $ 0.08 $ (0.47)
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Income (Loss) Per Share - Summary of outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per common unit attributable to common unitholders (Detail) - shares
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 2,591,138 6,484,224
Options to purchase common stock outstanding, unexercised    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 1,833,279 4,448,454
Restricted stock awards, unvested    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 0 947,540
Restricted stock units, unvested    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 757,859 1,088,230
Purchase rights committed under the ESPP    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 0 0
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business Combinations - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Apr. 01, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]              
Escrow deposit   $ 30,000,000   $ 30,000,000     $ 0
Acquisition related costs   163,000 $ 0 2,549,000 $ 781,000    
Contingent earnout   0   $ 0   $ 200,000  
StreetShares              
Business Acquisition [Line Items]              
Cash consideration, gross $ 28,000,000            
Escrow deposit 30,000,000            
Acquisition related costs 1,600,000            
Goodwill considered deductible for income tax purposes $ 0            
Contingent earnout, measurement period 12 months            
Purchase accounting adjustments, goodwill   2,300,000          
Working capital adjustments, DTA   1,100,000          
Business combination, adjustment consideration transferred   100,000          
StreetShares | Customer relationships              
Business Acquisition [Line Items]              
Working capital adjustments, intangibles   1,900,000          
StreetShares | Developed technology              
Business Acquisition [Line Items]              
Working capital adjustments, intangibles   $ 1,500,000          
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business Combinations - Summary of the Allocation of the Purchase Price (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Apr. 01, 2022
Dec. 31, 2021
Assets acquired:      
Goodwill $ 571,554   $ 564,799
StreetShares      
Assets acquired:      
Cash and cash equivalents   $ 1,580  
Restricted cash   3,265  
Accounts receivable, net   157  
Prepaid expenses and other current assets   561  
Property and equipment, net   142  
Right of use assets   613  
Deferred tax asset   11,624  
Goodwill   6,755  
Intangible assets   12,400  
Other assets   83  
Total assets acquired   37,180  
Liabilities assumed:      
Accounts payable   368  
Accrued compensation and benefits   3,585  
Accrued expenses   738  
Contingent earnout   162  
Notes payable to Regulation A+ investors   3,265  
Deferred revenue   854  
Other long-term liabilities   225  
Total liabilities assumed   9,197  
Fair value of assets acquired and liabilities assumed   $ 27,983  
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business Combinations - Summary of Fair Value of the Separately Identifiable Finite-Lived Intangible Assets Acquired and Estimated Useful Lives (Details) - StreetShares
$ in Thousands
Apr. 01, 2022
USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]  
Estimated Fair Values $ 12,400
Weighted Average Amortization Life (years) 9 years
Customer relationships  
Acquired Finite-Lived Intangible Assets [Line Items]  
Estimated Fair Values $ 500
Weighted Average Amortization Life (years) 5 years
Developed technology  
Acquired Finite-Lived Intangible Assets [Line Items]  
Estimated Fair Values $ 11,800
Weighted Average Amortization Life (years) 10 years
Trademarks  
Acquired Finite-Lived Intangible Assets [Line Items]  
Estimated Fair Values $ 100
Weighted Average Amortization Life (years) 2 years
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business Combinations - Summary of Goodwill (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2022
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 564,799
Goodwill additions during period 6,755
Ending balance $ 571,554
XML 77 R67.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Nov. 04, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Subsequent Event [Line Items]          
Acquisition related costs   $ 163 $ 0 $ 2,549 $ 781
Subsequent Event | Beanstalk Networks, L.L.C.          
Subsequent Event [Line Items]          
Cash consideration, gross $ 65,000        
Acquisition related costs $ 1,400        
XML 78 mlnk-20220930_htm.xml IDEA: XBRL DOCUMENT 0001834494 2022-01-01 2022-09-30 0001834494 2022-11-04 0001834494 2022-09-30 0001834494 2021-12-31 0001834494 2022-07-01 2022-09-30 0001834494 2021-07-01 2021-09-30 0001834494 2021-01-01 2021-09-30 0001834494 us-gaap:CommonStockMember 2021-12-31 0001834494 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001834494 us-gaap:RetainedEarningsMember 2021-12-31 0001834494 us-gaap:RestrictedStockMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001834494 us-gaap:RestrictedStockMember 2022-01-01 2022-03-31 0001834494 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001834494 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001834494 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001834494 2022-01-01 2022-03-31 0001834494 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001834494 us-gaap:CommonStockMember 2022-03-31 0001834494 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001834494 us-gaap:RetainedEarningsMember 2022-03-31 0001834494 2022-03-31 0001834494 us-gaap:RestrictedStockMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001834494 us-gaap:RestrictedStockMember 2022-04-01 2022-06-30 0001834494 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001834494 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001834494 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001834494 2022-04-01 2022-06-30 0001834494 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001834494 us-gaap:CommonStockMember 2022-06-30 0001834494 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001834494 us-gaap:RetainedEarningsMember 2022-06-30 0001834494 2022-06-30 0001834494 us-gaap:RestrictedStockMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001834494 us-gaap:RestrictedStockMember 2022-07-01 2022-09-30 0001834494 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001834494 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001834494 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001834494 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001834494 us-gaap:CommonStockMember 2022-09-30 0001834494 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001834494 us-gaap:RetainedEarningsMember 2022-09-30 0001834494 mlnk:SeriesARedeemableConvertiblePreferredStockMember 2020-12-31 0001834494 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0001834494 us-gaap:CommonStockMember 2020-12-31 0001834494 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001834494 us-gaap:RetainedEarningsMember 2020-12-31 0001834494 2020-12-31 0001834494 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001834494 2021-01-01 2021-03-31 0001834494 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001834494 mlnk:SeriesARedeemableConvertiblePreferredStockMember 2021-01-01 2021-03-31 0001834494 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001834494 mlnk:SeriesARedeemableConvertiblePreferredStockMember 2021-03-31 0001834494 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001834494 us-gaap:CommonStockMember 2021-03-31 0001834494 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001834494 us-gaap:RetainedEarningsMember 2021-03-31 0001834494 2021-03-31 0001834494 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001834494 2021-04-01 2021-06-30 0001834494 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001834494 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001834494 mlnk:SeriesARedeemableConvertiblePreferredStockMember 2021-06-30 0001834494 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001834494 us-gaap:CommonStockMember 2021-06-30 0001834494 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001834494 us-gaap:RetainedEarningsMember 2021-06-30 0001834494 2021-06-30 0001834494 mlnk:SeriesARedeemableConvertiblePreferredStockMember 2021-07-01 2021-09-30 0001834494 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001834494 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001834494 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001834494 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001834494 mlnk:RestrictedStockUnitsFormerlyClassBUnitsMember us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001834494 mlnk:RestrictedStockUnitsFormerlyClassBUnitsMember us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001834494 mlnk:RestrictedStockUnitsFormerlyClassBUnitsMember 2021-07-01 2021-09-30 0001834494 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001834494 mlnk:SeriesARedeemableConvertiblePreferredStockMember 2021-09-30 0001834494 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-09-30 0001834494 us-gaap:CommonStockMember 2021-09-30 0001834494 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001834494 us-gaap:RetainedEarningsMember 2021-09-30 0001834494 2021-09-30 0001834494 us-gaap:CapitalUnitClassAMember 2022-01-01 2022-09-30 0001834494 us-gaap:CapitalUnitClassAMember 2021-01-01 2021-09-30 0001834494 us-gaap:CapitalUnitClassBMember 2022-01-01 2022-09-30 0001834494 us-gaap:CapitalUnitClassBMember 2021-01-01 2021-09-30 0001834494 2021-07-27 0001834494 us-gaap:CapitalUnitClassAMember 2021-07-27 2021-07-27 0001834494 us-gaap:CapitalUnitClassBMember 2021-07-27 2021-07-27 0001834494 us-gaap:CapitalUnitClassAMember 2021-07-28 0001834494 2021-07-30 2021-07-30 0001834494 us-gaap:IPOMember 2021-07-30 2021-07-30 0001834494 us-gaap:IPOMember 2021-07-30 0001834494 2021-08-26 2021-08-26 0001834494 2021-07-28 0001834494 2021-07-16 2021-07-16 0001834494 2022-01-01 0001834494 mlnk:LendingSoftwareSolutionsMember 2022-07-01 2022-09-30 0001834494 mlnk:LendingSoftwareSolutionsMember 2021-07-01 2021-09-30 0001834494 mlnk:LendingSoftwareSolutionsMember 2022-01-01 2022-09-30 0001834494 mlnk:LendingSoftwareSolutionsMember 2021-01-01 2021-09-30 0001834494 mlnk:DataVerificationSoftwareSolutionsMember 2022-07-01 2022-09-30 0001834494 mlnk:DataVerificationSoftwareSolutionsMember 2021-07-01 2021-09-30 0001834494 mlnk:DataVerificationSoftwareSolutionsMember 2022-01-01 2022-09-30 0001834494 mlnk:DataVerificationSoftwareSolutionsMember 2021-01-01 2021-09-30 0001834494 mlnk:LendingSoftwareSolutionsMember 2022-07-01 2022-09-30 0001834494 mlnk:LendingSoftwareSolutionsMember 2021-07-01 2021-09-30 0001834494 mlnk:DataVerificationSoftwareSolutionsMember 2022-07-01 2022-09-30 0001834494 mlnk:DataVerificationSoftwareSolutionsMember 2021-07-01 2021-09-30 0001834494 mlnk:LendingSoftwareSolutionsMember 2022-01-01 2022-09-30 0001834494 mlnk:LendingSoftwareSolutionsMember 2021-01-01 2021-09-30 0001834494 mlnk:DataVerificationSoftwareSolutionsMember 2022-01-01 2022-09-30 0001834494 mlnk:DataVerificationSoftwareSolutionsMember 2021-01-01 2021-09-30 0001834494 mlnk:SubscriptionFeesMember 2022-07-01 2022-09-30 0001834494 mlnk:SubscriptionFeesMember 2021-07-01 2021-09-30 0001834494 mlnk:SubscriptionFeesMember 2022-01-01 2022-09-30 0001834494 mlnk:SubscriptionFeesMember 2021-01-01 2021-09-30 0001834494 mlnk:ProfessionalServicesMember 2022-07-01 2022-09-30 0001834494 mlnk:ProfessionalServicesMember 2021-07-01 2021-09-30 0001834494 mlnk:ProfessionalServicesMember 2022-01-01 2022-09-30 0001834494 mlnk:ProfessionalServicesMember 2021-01-01 2021-09-30 0001834494 us-gaap:ServiceOtherMember 2022-07-01 2022-09-30 0001834494 us-gaap:ServiceOtherMember 2021-07-01 2021-09-30 0001834494 us-gaap:ServiceOtherMember 2022-01-01 2022-09-30 0001834494 us-gaap:ServiceOtherMember 2021-01-01 2021-09-30 0001834494 us-gaap:ComputerEquipmentMember 2022-09-30 0001834494 us-gaap:ComputerEquipmentMember 2021-12-31 0001834494 us-gaap:LeaseholdImprovementsMember 2022-09-30 0001834494 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001834494 us-gaap:OfficeEquipmentMember 2022-09-30 0001834494 us-gaap:OfficeEquipmentMember 2021-12-31 0001834494 us-gaap:OfficeEquipmentMember 2022-07-01 2022-09-30 0001834494 us-gaap:OfficeEquipmentMember 2021-07-01 2021-09-30 0001834494 us-gaap:OfficeEquipmentMember 2022-01-01 2022-09-30 0001834494 us-gaap:OfficeEquipmentMember 2021-01-01 2021-09-30 0001834494 us-gaap:CustomerRelationshipsMember 2022-09-30 0001834494 us-gaap:DevelopedTechnologyRightsMember 2022-09-30 0001834494 us-gaap:TrademarksMember 2022-09-30 0001834494 us-gaap:NoncompeteAgreementsMember 2022-09-30 0001834494 us-gaap:CustomerRelationshipsMember 2021-12-31 0001834494 us-gaap:DevelopedTechnologyRightsMember 2021-12-31 0001834494 us-gaap:TrademarksMember 2021-12-31 0001834494 us-gaap:NoncompeteAgreementsMember 2021-12-31 0001834494 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-09-30 0001834494 us-gaap:DevelopedTechnologyRightsMember 2022-01-01 2022-09-30 0001834494 us-gaap:TrademarksMember 2022-01-01 2022-09-30 0001834494 us-gaap:NoncompeteAgreementsMember 2022-01-01 2022-09-30 0001834494 mlnk:CapitalizedSoftwareMember 2022-01-01 2022-09-30 0001834494 us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0001834494 us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0001834494 us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0001834494 us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0001834494 us-gaap:GeneralAndAdministrativeExpenseMember 2022-07-01 2022-09-30 0001834494 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001834494 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-09-30 0001834494 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001834494 us-gaap:ResearchAndDevelopmentExpenseMember 2022-07-01 2022-09-30 0001834494 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-09-30 0001834494 us-gaap:SellingAndMarketingExpenseMember 2022-07-01 2022-09-30 0001834494 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-09-30 0001834494 mlnk:RelatedPartyMember 2022-09-30 0001834494 mlnk:ThirdPartyMember 2022-09-30 0001834494 srt:ScenarioForecastMember 2022-10-01 2022-12-31 0001834494 srt:ScenarioForecastMember 2023-01-01 2023-12-31 0001834494 srt:ScenarioForecastMember 2024-01-01 2024-12-31 0001834494 mlnk:RelatedPartyMember 2021-12-31 0001834494 mlnk:ThirdPartyMember 2021-12-31 0001834494 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2021-09-30 0001834494 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-09-30 0001834494 us-gaap:SellingAndMarketingExpenseMember 2021-07-01 2021-09-30 0001834494 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-09-30 0001834494 mlnk:A2021TermLoanMember us-gaap:SecuredDebtMember 2022-09-30 0001834494 mlnk:A2021TermLoanMember us-gaap:SecuredDebtMember 2021-12-31 0001834494 mlnk:A2021TermLoanMember us-gaap:SecuredDebtMember 2021-11-10 0001834494 us-gaap:RevolvingCreditFacilityMember mlnk:A2021RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2021-11-10 0001834494 us-gaap:LetterOfCreditMember mlnk:A2021RevolvingCreditFacilityMember 2021-11-10 0001834494 mlnk:A2021TermLoanMember us-gaap:BaseRateMember mlnk:VariableRateComponentOneMember 2022-01-01 2022-09-30 0001834494 mlnk:A2021TermLoanMember mlnk:AdjustedEurocurrencyRateMember mlnk:VariableRateComponentTwoMember 2022-01-01 2022-09-30 0001834494 mlnk:A2021TermLoanMember 2022-09-30 0001834494 mlnk:A2021TermLoanMember 2021-11-10 0001834494 mlnk:FirstLienMember 2021-11-10 0001834494 mlnk:A2021TermLoanMember 2022-07-01 2022-09-30 0001834494 mlnk:A2021TermLoanMember 2022-01-01 2022-09-30 0001834494 us-gaap:RevolvingCreditFacilityMember mlnk:A2021RevolvingCreditFacilityMember 2021-11-10 0001834494 us-gaap:RevolvingCreditFacilityMember mlnk:A2021RevolvingCreditFacilityMember 2022-01-01 2022-09-30 0001834494 us-gaap:RevolvingCreditFacilityMember mlnk:A2021RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-09-30 0001834494 2022-05-31 0001834494 mlnk:TwoThousandTwentyOneStockOptionAndIncentivePlanMember 2021-07-26 0001834494 mlnk:TwoThousandTwentyOneStockOptionAndIncentivePlanMember 2021-07-26 2021-07-26 0001834494 2021-01-01 2021-12-31 0001834494 us-gaap:EmployeeStockOptionMember 2022-07-01 2022-09-30 0001834494 us-gaap:EmployeeStockOptionMember 2021-07-01 2021-09-30 0001834494 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001834494 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0001834494 us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0001834494 us-gaap:CapitalUnitClassBMember 2022-09-30 0001834494 us-gaap:CapitalUnitClassBMember 2022-07-01 2022-09-30 0001834494 us-gaap:RestrictedStockMember 2021-07-01 2021-09-30 0001834494 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0001834494 mlnk:CarriedEquityUnitsMember 2022-09-30 0001834494 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001834494 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001834494 us-gaap:RestrictedStockUnitsRSUMember 2022-09-30 0001834494 us-gaap:RestrictedStockUnitsRSUMember 2022-07-01 2022-09-30 0001834494 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001834494 us-gaap:RestrictedStockUnitsRSUMember 2021-07-01 2021-09-30 0001834494 us-gaap:EmployeeStockMember 2022-09-30 0001834494 us-gaap:EmployeeStockMember 2022-07-01 2022-09-30 0001834494 us-gaap:EmployeeStockMember 2022-01-01 2022-09-30 0001834494 mlnk:LeasedPropertyFromRelatedPartyMember 2022-07-01 2022-09-30 0001834494 mlnk:LeasedPropertyFromRelatedPartyMember 2021-07-01 2021-09-30 0001834494 mlnk:LeasedPropertyFromRelatedPartyMember 2022-01-01 2022-09-30 0001834494 mlnk:LeasedPropertyFromRelatedPartyMember 2021-01-01 2021-09-30 0001834494 mlnk:AdvisoryServicesAgreementMember 2021-07-01 2021-09-30 0001834494 mlnk:AdvisoryServicesAgreementMember 2022-01-01 2022-09-30 0001834494 srt:AffiliatedEntityMember 2022-07-01 2022-09-30 0001834494 srt:AffiliatedEntityMember 2022-01-01 2022-09-30 0001834494 srt:AffiliatedEntityMember 2021-07-01 2021-09-30 0001834494 srt:AffiliatedEntityMember 2021-01-01 2021-09-30 0001834494 srt:AffiliatedEntityMember 2022-09-30 0001834494 srt:AffiliatedEntityMember 2021-12-31 0001834494 mlnk:OptionsToPurchaseCommonStockOutstandingUnexercisedMember 2022-01-01 2022-09-30 0001834494 mlnk:OptionsToPurchaseCommonStockOutstandingUnexercisedMember 2021-01-01 2021-09-30 0001834494 mlnk:RestrictedStockAwardsUnvestedMember 2022-01-01 2022-09-30 0001834494 mlnk:RestrictedStockAwardsUnvestedMember 2021-01-01 2021-09-30 0001834494 mlnk:RestrictedStockUnitsUnvestedMember 2022-01-01 2022-09-30 0001834494 mlnk:RestrictedStockUnitsUnvestedMember 2021-01-01 2021-09-30 0001834494 us-gaap:EmployeeStockMember 2022-01-01 2022-09-30 0001834494 us-gaap:EmployeeStockMember 2021-01-01 2021-09-30 0001834494 mlnk:StreetSharesMember 2022-04-01 2022-04-01 0001834494 mlnk:StreetSharesMember 2022-04-01 0001834494 mlnk:StreetSharesMember us-gaap:CustomerRelationshipsMember 2022-07-01 2022-09-30 0001834494 mlnk:StreetSharesMember us-gaap:DevelopedTechnologyRightsMember 2022-07-01 2022-09-30 0001834494 mlnk:StreetSharesMember 2022-07-01 2022-09-30 0001834494 mlnk:StreetSharesMember us-gaap:CustomerRelationshipsMember 2022-04-01 2022-04-01 0001834494 mlnk:StreetSharesMember us-gaap:DevelopedTechnologyRightsMember 2022-04-01 2022-04-01 0001834494 mlnk:StreetSharesMember us-gaap:TrademarksMember 2022-04-01 2022-04-01 0001834494 mlnk:BeanstalkNetworksLLCMember us-gaap:SubsequentEventMember 2022-11-04 2022-11-04 shares iso4217:USD iso4217:USD shares pure mlnk:Property 2022 Q3 false 0001834494 --12-31 0.5 http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent 10-Q true 2022-09-30 false 001-40680 MeridianLink, Inc. DE 82-4844620 3560 Hyland Avenue Suite 200 Costa Mesa CA 92626 714 708-6950 Common stock, par value $0.001 per share MLNK NYSE Yes Yes Non-accelerated Filer false true false false 80917710 115752000 113645000 32034000 24913000 12542000 9398000 30000000 0 190328000 147956000 5044000 5989000 2638000 0 279548000 298597000 10717000 4286000 571554000 564799000 4170000 4266000 1063999000 1025893000 2173000 2335000 29807000 24667000 22655000 14707000 3367000 2139000 58002000 43848000 423599000 425371000 378000 0 0 396000 1527000 0 483506000 469615000 0.001 0.001 50000000 50000000 0 0 0 0 0 0 0.001 0.001 600000000 600000000 80732286 80732286 79734984 79734984 128000 88000 614222000 596542000 -33857000 -40352000 580493000 556278000 1063999000 1025893000 71754000 67367000 217495000 203652000 23812000 23467000 68292000 58078000 4003000 3219000 11287000 9190000 27815000 26686000 79579000 67268000 43939000 40681000 137916000 136384000 21423000 29917000 60416000 64103000 11518000 13533000 30414000 27807000 6311000 5994000 16519000 13817000 163000 0 2549000 781000 39415000 49444000 109898000 106508000 4524000 -8763000 28018000 29876000 327000 9000 706000 39000 6855000 7165000 16649000 27073000 0 -4351000 0 -4351000 -6528000 -11507000 -15943000 -31385000 -2004000 -20270000 12075000 -1509000 890000 1176000 5318000 5274000 -2894000 -21446000 6757000 -6783000 0 2780000 0 20944000 -2894000 -2894000 -24226000 -24226000 6757000 6757000 -27727000 -27727000 -0.04 -0.04 -0.34 -0.34 0.08 -0.47 -0.04 -0.34 0.08 -0.47 80659320 71697083 80353399 58495073 80659320 71697083 82364835 58495073 79734984 88000 596542000 -40352000 556278000 484401 32000 32000 76937 28909 179000 179000 3887000 3887000 7479000 7479000 80325231 120000 600608000 -32873000 567855000 92209 6000 6000 4656 1000 7000 7000 64985 922000 922000 12300 193000 193000 5548000 5548000 2172000 2172000 80475781 126000 607085000 -30894000 576317000 11496 2000 2000 259868 10456 184000 184000 4403 69000 69000 7321000 7321000 -2894000 -2894000 80732286 128000 614222000 -33857000 580493000 319913 319913000 51492805 0 0 0 3909000 -30338000 -26429000 12000 12000 575004 38000 38000 54 54000 103421 38000 1849000 1887000 643000 643000 7231000 7231000 319859 319859000 51964388 0 0 0 2703000 -23119000 -20416000 148516 9000 9000 665000 665000 7432000 7432000 319859 319859000 52112904 9000 0 0 3368000 -15687000 -12310000 -319859 -319859000 -52112904 -9000 68720140 69000 319799000 -6000 319853000 10000000 10000 242354000 242364000 213408 1317000 1317000 573316 38000 38000 21691 25572000 25572000 -21446000 -21446000 0 0 0 0 79528555 79000 592448000 -37139000 555388000 6757000 -6783000 39746000 37654000 1705000 2551000 16501000 26835000 -164000 -524000 0 -405000 0 -4351000 -162000 0 0 18000 5193000 4992000 6964000 2033000 2480000 6179000 -450000 -961000 -247000 -2271000 7472000 10016000 0 -71000 67235000 69012000 0 85420000 0 35945000 23138000 0 30000000 0 6323000 3590000 889000 692000 -60350000 -125647000 262000 0 0 54000 0 1887000 0 247227000 186000 1317000 0 6000 922000 0 184000 0 0 100000000 2175000 202590000 3265000 0 0 1970000 0 12000 0 4435000 0 2142000 0 25665000 -4778000 109783000 2107000 53148000 113645000 39881000 115752000 93029000 115752000 93029000 0 0 115752000 93029000 14852000 24549000 1179000 239000 3265000 0 3786000 0 3096000 0 255000 45000 184000 0 2000 0 40000 85000 0 423000 0 320000 0 4335000 Organization and Description of Business<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MeridianLink, Inc., and its wholly-owned subsidiaries, (collectively the “Company”) provides secure, cloud-based digital solutions that transform the ways in which traditional and emerging financial services providers engage with account holders and end users. The Company sells its solutions to financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies. The Company delivers its solutions to the substantial majority of its customers using a software-as-a-service (“SaaS”) model under which its customers pay subscription fees for the use of the Company’s solutions. The Company is controlled by its majority stockholder, which is represented by various investment funds of Thoma Bravo UBP, LLC and its affiliates (“Thoma Bravo”). The Company is headquartered in Costa Mesa, California.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Conversion</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to July 27, 2021, the Company operated as a Delaware limited liability company under the name Project Angel Parent, LLC (“Parent”), which directly and indirectly held all the equity interests in its operating subsidiaries. On May 31, 2018, a subsidiary of Parent acquired all the outstanding common stock of MeridianLink, Inc. (“MeridianLink”). Under the terms of the Amended and Restated Limited Liability Company Operating Agreement (“Agreement”), dated as of May 31, 2018, of Parent, the members were not obligated for debt, liabilities, contracts or other obligations of Parent. Profits and losses were allocated to members as defined in the Agreement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2021, prior to the effectiveness of the registration statement for the Company’s initial public offering, MeridianLink, the then operating company and the indirect wholly owned subsidiary of Project Angel Parent, LLC, changed its name to ML California Sub, Inc, and Project Angel Parent, LLC converted into a Delaware corporation pursuant to a statutory conversion and changed its name to MeridianLink, Inc. As a result of the corporate conversion, MeridianLink, Inc. succeeded to all property and assets and debts and obligations of Project Angel Parent, LLC. Effective July 27, 2021, MeridianLink, Inc. is governed by its certificate of incorporation filed with the Delaware Secretary of State and its bylaws.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon its conversion into a corporation, the Company converted each of its outstanding Class A preferred units (“Class A Units”) into a number of shares of common stock equal to the result of the accrued preferred return price per Class A Unit divided by the per share of common stock conversion price determined by the board of directors to be $25.50. The preferred return price for each Class A Unit was equal to the future value of $1,000 at a 9% interest rate compounded quarterly over the time passed since the issuance of such unit. Upon the Company’s conversion into a corporation, the outstanding Class A Units converted into an aggregate of 16,607,235 shares of common stock and were reclassified into permanent equity. Additionally, all the outstanding Class B common units (“Class B Units”) converted into an aggregate of 53,646,668 shares of common stock on a one-for-one basis. At the time of the corporate conversion there were 1,533,763 of such shares that remained subject to future vesting and were not included in the outstanding shares. Following the Corporate Conversion, there were no units of Class A Units outstanding.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of the events described in the preceding two paragraphs are collectively referred to as the “Corporate Conversion.”</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Initial Public Offering and Reverse Stock Split</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2021, the Company completed its initial public offering (“IPO”) through an underwritten sale of 13.2 million shares of its common stock, of which 10.0 million newly issued shares were sold by the Company at a price to the public of $26.00 per share. The Company received net proceeds of approximately $242.1 million after deducting approximately $17.9 million in underwriting discounts, commissions, and offering-related expenses. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPO also included the sale of 3.2 million shares of our common stock by the selling stockholders. The Company did not receive any proceeds from the sale of common stock by the selling stockholders. Additionally, the selling stockholders granted the underwriters an option, exercisable for 30 days after the effective date of the Prospectus, to purchase up to 2.0 million additional shares of common stock. The option was exercised for 1.2 million additional shares on August 26, 2021. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the listing of the Company’s common stock on the New York Stock Exchange (the “NYSE”), the Company entered into indemnification agreements with its directors and certain officers and employees that require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or services as directors, officers, or employees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In advance of the IPO, on July 16, 2021, the Company effected a 1-for-2 reverse unit split of the Company’s Class B Units, whereby every two Class B Units converted into one Class B Unit. All Class B Unit and per unit information included in the accompanying condensed consolidated financial statements have been adjusted to reflect this reverse unit split for all periods presented. Following the Corporate Conversion, there were no units of Class B Units outstanding.</span></div> 25.50 1000 0.09 16607235 53646668 1 1533763 0 13200000 10000000 26.00 242100000 17900000 3200000 P30D 2000000 1200000 0 Significant Accounting Policies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany balances and transactions have been eliminated in consolidation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Condensed Consolidated Financial Information</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Company's opinion, the unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and include all adjustments, consisting of normal, recurring adjustments, necessary for a fair presentation. Certain information and disclosures normally included in the notes to the annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted from these unaudited condensed consolidated financial statements pursuant to the rules and regulations of the SEC. Accordingly, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (“Annual Report”). The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any other period.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the reported amounts of revenues and expenses. Significant items subject to such estimates include revenue recognition including determining the nature and timing of satisfaction of performance obligations and variable consideration; share-based compensation; the fair value of acquired intangibles; the capitalization of software development costs; the useful lives of long-lived intangible assets; impairment of goodwill and long-lived assets; and income taxes. In accordance with GAAP, management bases its estimates on historical experience and on</span><span style="color:#332f2f;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">various other assumptions that management believes are reasonable under the circumstances. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from those estimates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s significant accounting policies are discussed in Note 2, “Significant Accounting Policies” in the Company’s Annual Report. There have been no changes to the Company’s significant accounting policies described in the Company’s Annual Report that have had a material impact on its condensed consolidated financial statements and related notes, except for updates resulting from the adoption of ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“Leases (Topic 842)”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as discussed below. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases arise from contractual obligations that convey the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. At the inception of the contract, the Company determines if an arrangement contains a lease based on whether there is an identified asset and whether the Company controls the use of the identified asset. The Company also determines the classification of that lease, between financing and operating, at the lease commencement date. The Company accounts for and allocates consideration to the lease and non-lease components as a single lease component.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A right-of-use (“ROU”) asset represents the Company’s right to use an underlying asset, and a lease liability represents the Company’s obligation to make payments during the lease term. ROU assets are recorded and recognized at commencement for the lease liability amount, adjusted for initial direct costs incurred and lease incentives received, and adjusted for prepaid or accrued lease payments. Lease liabilities are recorded at the present value of the future lease payments over the lease term at commencement. The discount rate used to determine the present value is the incremental borrowing rate, unless the interest rate implicit in the lease is readily determinable. As the implicit rate for the operating leases is generally not determinable, the Company uses an incremental borrowing rate as the discount rate at the lease commencement date to determine the present value of lease payments. The Company determines the discount rate of the leases by considering various factors, such as the credit rating, interest rates of similar debt instruments of entities with comparable credit ratings, jurisdictions, and the lease term.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s operating leases typically include non-lease components such as common-area maintenance costs, utilities, and other maintenance costs. For real estate leases, the Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s lease terms may include options to extend or terminate the lease. The Company generally uses the base, non-cancelable, lease term when recognizing the lease assets and liabilities, unless it is reasonably certain that the Company will exercise those options. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s ROU assets are included in right of use assets and the current and non-current portions of the lease liabilities are included in accrued liabilities and other long-term liabilities, respectively, on the condensed consolidated balance sheets. The Company does not record leases with terms of 12 months or less on the condensed consolidated balance sheets. Lease expense is recognized on a straight-line basis over the expected lease term.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into subleases, or has made decisions and taken actions to exit and sublease certain unoccupied leased office space. Sublease income is recorded as a reduction of rent expense straight-line over the term of the sublease. The Company tests ROU assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. For leased assets, such circumstances would include the decision to leave a leased facility prior to the end of the minimum lease term or subleases for which estimated cash flows do not fully cover the costs of the associated lease. No impairment of ROU assets was recorded during the nine months ended September 30, 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and has elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU 2016-02, “Leases (Topic 842)”</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new standard establishes a right-of-use model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the condensed consolidated statements of operations. The new standard provides for a modified retrospective approach which requires recognition at the beginning of the earliest comparative period presented of leases that exist at that date, as well as adjusting equity at the beginning of the earliest comparative period presented as if the new standard had always been applied. In July 2018, the FASB issued ASU 2018-11, which provides an additional transition method. Under the additional transition method, an entity initially applies the new lease guidance at the adoption date (rather than at the beginning of the earliest period presented). Therefore, an entity which elects the additional transition method would apply Topic 840 in the comparative periods and recognize the effects of applying Topic 842 as a cumulative adjustment to retained earnings as of the adoption date. If an entity elects the new transition method, it is required to provide the Topic 840 disclosures for all prior periods presented that remain under the legacy lease guidance. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted the new standard on January 1, 2022, utilizing the optional transition approach to not apply Topic 842 in the comparative periods presented. Additionally, the Company elected the package of practical expedients to not (1) reassess whether any expired or existing contracts are considered or contain leases; (2) reassess the lease classification for any expired or existing leases; and (3) reassess the initial direct costs for any existing leases. The most significant impact upon adoption was related to its long-term office space leases that resulted in the recognition of right of use assets and related liabilities of approximately $2.6 million and $3.4 million, respectively, on the Company’s condensed consolidated balance sheets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this ASU require that an acquirer recognizes and measures contract assets and contract liabilities acquired in a business combination in accordance with Topic 606 rather than at fair value. The ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted the new standard on January 1, 2022, prospectively, for business combinations that occur subsequent to the adoption date. The adoption did not have a material impact on the Company’s condensed consolidated financial statements. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rather than generally recognizing credit losses when it is probable that the loss has been incurred, the revised guidance requires companies to recognize an allowance for credit losses for the difference between the amortized cost basis of a financial instrument and the amount of amortized cost that the company expects to collect over the instrument’s contractual life. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2016-13 is effective for the Company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years; early adoption is permitted. The Company intends to adopt the new standard as of January 1, 2023 as a cumulative effect adjustment to retained earnings. The Company does not expect the adoption of this guidance to have a material impact on its condensed consolidated financial statements and disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The standard simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 related to the approach for intraperiod tax allocation and the recognition of deferred tax liabilities for outside basis differences and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard also improves consistent application of and simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted. The Company intends to adopt the new standard as of January 1, 2023 and does not expect the adoption of this guidance to have a material impact on its condensed consolidated financial statements and disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2020-04 provides optional guidance for a limited time to ease the potential accounting burden associated with transitioning away from reference rates, such as the London Inter-Bank Offered Rate (LIBOR), which regulators in the United Kingdom are currently phasing out. The expedients and exceptions provided by ASU 2020-04 are for the application of U.S. GAAP to contracts, hedging relationships, and other transactions affected by the rate reform, and will not be available after December 31, 2022, other than for certain hedging relationships entered into before December 31, 2022. Companies can apply the ASU immediately. However, the guidance will only be available for a limited time. The Company is currently evaluating the impact of this guidance on its condensed consolidated financial statements and related disclosures.</span></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany balances and transactions have been eliminated in consolidation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Condensed Consolidated Financial Information</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Company's opinion, the unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and include all adjustments, consisting of normal, recurring adjustments, necessary for a fair presentation. Certain information and disclosures normally included in the notes to the annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted from these unaudited condensed consolidated financial statements pursuant to the rules and regulations of the SEC. Accordingly, these unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (“Annual Report”). The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any other period.</span></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the reported amounts of revenues and expenses. Significant items subject to such estimates include revenue recognition including determining the nature and timing of satisfaction of performance obligations and variable consideration; share-based compensation; the fair value of acquired intangibles; the capitalization of software development costs; the useful lives of long-lived intangible assets; impairment of goodwill and long-lived assets; and income taxes. In accordance with GAAP, management bases its estimates on historical experience and on</span><span style="color:#332f2f;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">various other assumptions that management believes are reasonable under the circumstances. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from those estimates.</span></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases arise from contractual obligations that convey the right to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. At the inception of the contract, the Company determines if an arrangement contains a lease based on whether there is an identified asset and whether the Company controls the use of the identified asset. The Company also determines the classification of that lease, between financing and operating, at the lease commencement date. The Company accounts for and allocates consideration to the lease and non-lease components as a single lease component.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A right-of-use (“ROU”) asset represents the Company’s right to use an underlying asset, and a lease liability represents the Company’s obligation to make payments during the lease term. ROU assets are recorded and recognized at commencement for the lease liability amount, adjusted for initial direct costs incurred and lease incentives received, and adjusted for prepaid or accrued lease payments. Lease liabilities are recorded at the present value of the future lease payments over the lease term at commencement. The discount rate used to determine the present value is the incremental borrowing rate, unless the interest rate implicit in the lease is readily determinable. As the implicit rate for the operating leases is generally not determinable, the Company uses an incremental borrowing rate as the discount rate at the lease commencement date to determine the present value of lease payments. The Company determines the discount rate of the leases by considering various factors, such as the credit rating, interest rates of similar debt instruments of entities with comparable credit ratings, jurisdictions, and the lease term.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s operating leases typically include non-lease components such as common-area maintenance costs, utilities, and other maintenance costs. For real estate leases, the Company has elected to include non-lease components with lease payments for the purpose of calculating lease right-of-use assets and liabilities to the extent that they are fixed. Non-lease components that are not fixed are expensed as incurred as variable lease payments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s lease terms may include options to extend or terminate the lease. The Company generally uses the base, non-cancelable, lease term when recognizing the lease assets and liabilities, unless it is reasonably certain that the Company will exercise those options. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s ROU assets are included in right of use assets and the current and non-current portions of the lease liabilities are included in accrued liabilities and other long-term liabilities, respectively, on the condensed consolidated balance sheets. The Company does not record leases with terms of 12 months or less on the condensed consolidated balance sheets. Lease expense is recognized on a straight-line basis over the expected lease term.</span></div>The Company has entered into subleases, or has made decisions and taken actions to exit and sublease certain unoccupied leased office space. Sublease income is recorded as a reduction of rent expense straight-line over the term of the sublease. The Company tests ROU assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. For leased assets, such circumstances would include the decision to leave a leased facility prior to the end of the minimum lease term or subleases for which estimated cash flows do not fully cover the costs of the associated lease. No impairment of ROU assets was recorded during the nine months ended September 30, 2022. 0 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and has elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU 2016-02, “Leases (Topic 842)”</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new standard establishes a right-of-use model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the condensed consolidated statements of operations. The new standard provides for a modified retrospective approach which requires recognition at the beginning of the earliest comparative period presented of leases that exist at that date, as well as adjusting equity at the beginning of the earliest comparative period presented as if the new standard had always been applied. In July 2018, the FASB issued ASU 2018-11, which provides an additional transition method. Under the additional transition method, an entity initially applies the new lease guidance at the adoption date (rather than at the beginning of the earliest period presented). Therefore, an entity which elects the additional transition method would apply Topic 840 in the comparative periods and recognize the effects of applying Topic 842 as a cumulative adjustment to retained earnings as of the adoption date. If an entity elects the new transition method, it is required to provide the Topic 840 disclosures for all prior periods presented that remain under the legacy lease guidance. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted the new standard on January 1, 2022, utilizing the optional transition approach to not apply Topic 842 in the comparative periods presented. Additionally, the Company elected the package of practical expedients to not (1) reassess whether any expired or existing contracts are considered or contain leases; (2) reassess the lease classification for any expired or existing leases; and (3) reassess the initial direct costs for any existing leases. The most significant impact upon adoption was related to its long-term office space leases that resulted in the recognition of right of use assets and related liabilities of approximately $2.6 million and $3.4 million, respectively, on the Company’s condensed consolidated balance sheets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this ASU require that an acquirer recognizes and measures contract assets and contract liabilities acquired in a business combination in accordance with Topic 606 rather than at fair value. The ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted the new standard on January 1, 2022, prospectively, for business combinations that occur subsequent to the adoption date. The adoption did not have a material impact on the Company’s condensed consolidated financial statements. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rather than generally recognizing credit losses when it is probable that the loss has been incurred, the revised guidance requires companies to recognize an allowance for credit losses for the difference between the amortized cost basis of a financial instrument and the amount of amortized cost that the company expects to collect over the instrument’s contractual life. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2016-13 is effective for the Company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years; early adoption is permitted. The Company intends to adopt the new standard as of January 1, 2023 as a cumulative effect adjustment to retained earnings. The Company does not expect the adoption of this guidance to have a material impact on its condensed consolidated financial statements and disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The standard simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 related to the approach for intraperiod tax allocation and the recognition of deferred tax liabilities for outside basis differences and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard also improves consistent application of and simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted. The Company intends to adopt the new standard as of January 1, 2023 and does not expect the adoption of this guidance to have a material impact on its condensed consolidated financial statements and disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2020-04 provides optional guidance for a limited time to ease the potential accounting burden associated with transitioning away from reference rates, such as the London Inter-Bank Offered Rate (LIBOR), which regulators in the United Kingdom are currently phasing out. The expedients and exceptions provided by ASU 2020-04 are for the application of U.S. GAAP to contracts, hedging relationships, and other transactions affected by the rate reform, and will not be available after December 31, 2022, other than for certain hedging relationships entered into before December 31, 2022. Companies can apply the ASU immediately. However, the guidance will only be available for a limited time. The Company is currently evaluating the impact of this guidance on its condensed consolidated financial statements and related disclosures.</span></div> 2600000 3400000 Revenue Recognition<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company’s net revenues by solution type (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lending Software Solutions </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,414 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,657 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,249 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,034 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Data Verification Software Solutions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,340 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,710 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,246 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,754 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,367 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,495 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,652 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lending Software Solutions accounted for 73% and 66% of total revenues for the three months ended September 30, 2022, and 2021, respectively. Data Verification Software Solutions accounted for 27% and 34% of total revenues for the three months ended September 30, 2022 and 2021, respectively.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lending Software Solutions accounted for 70% and 65% of total revenues for the nine months ended September 30, 2022, and 2021, respectively. Data Verification Software Solutions accounted for 30% and 35% of total revenues for the nine months ended September 30, 2022 and 2021, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company’s net revenues by major source (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,861 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,860 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,732 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,293 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,706 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,070 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,812 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,565 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,754 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,367 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,495 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,652 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deferred revenue balance consists of subscription and implementation fees which have been invoiced up front and are recognized as revenue only when the revenue recognition criteria are met. The Company’s subscription contracts are typically invoiced to its customers annually, and revenue is recognized ratably over the service term. Any fees invoiced up front for contracts that have a service term that extend multiple years, the portion of deferred revenue that will be recognized beyond 12 months from the date of the financial statements, are classified as long-term deferred revenue. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the Company’s deferred revenue as of September 30, 2022 and 2021 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,707 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,873 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Billing of transaction consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,821 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217,495)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203,652)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,033 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,889 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, current</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,655 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,889 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,033 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,889 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets Recognized from Costs to Obtain a Contract with a Customer</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions related to the Company’s customer agreements are capitalized and charged to expense over the expected period of customer benefit. Current costs are included in prepaid expenses and other current assets, and non-current costs are included in other assets on the accompanying condensed consolidated balance sheets. The following table represents the changes in contract cost assets (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,835 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,207 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,832 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,856)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,014)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,093 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,025 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract cost assets, current</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,004 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract cost assets, noncurrent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,021 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred contract cost assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,093 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,025 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div>Allowance for doubtful accounts as of September 30, 2022 and December 31, 2021 was $0.2 million and $0.2 million, respectively. <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company’s net revenues by solution type (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lending Software Solutions </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,414 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,657 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,249 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,034 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Data Verification Software Solutions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,340 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,710 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,246 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,754 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,367 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,495 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,652 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company’s net revenues by major source (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,861 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,988 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,860 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,732 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,293 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,706 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,070 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,812 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,565 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,754 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,367 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,495 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,652 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 52414000 44657000 153249000 133034000 19340000 22710000 64246000 70618000 71754000 67367000 217495000 203652000 0.73 0.66 0.27 0.34 0.70 0.65 0.30 0.35 61861000 58988000 188860000 179732000 7293000 5706000 21070000 16812000 2600000 2673000 7565000 7108000 71754000 67367000 217495000 203652000 <div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the Company’s deferred revenue as of September 30, 2022 and 2021 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,707 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,873 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Billing of transaction consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,821 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217,495)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203,652)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,033 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,889 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, current</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,655 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,889 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,033 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,889 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 14707000 10873000 225821000 213668000 217495000 203652000 23033000 20889000 22655000 20889000 378000 0 23033000 20889000 The following table represents the changes in contract cost assets (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,835 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,207 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,832 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,856)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,014)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,093 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,025 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract cost assets, current</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,004 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract cost assets, noncurrent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,021 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred contract cost assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,093 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,025 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 5835000 3207000 2114000 2832000 1856000 1014000 6093000 5025000 2835000 2004000 3258000 3021000 6093000 5025000 200000 200000 Balance Sheet Components<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prepaid Expenses and Other Current Assets</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,309 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,752 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract cost assets – current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,542 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,398 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,795 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,995 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,060 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,367 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,016)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,378)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,044 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,989 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense amounted to $0.6 million for both the three months ended September 30, 2022 and 2021, and $1.7 million for both the nine months ended September 30, 2022 and 2021. The Company disposed of office furniture that resulted in a loss of $0.0 million and $0.3 million during the three months ended September 30, 2022 and 2021, respectively, and $0.2 million and $0.5 million during the nine months ended September 30, 2022 and 2021, respectively. The losses are included in general and administrative expenses in the accompanying condensed consolidated statements of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,100 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,870)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,230 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,375)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,275 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,502)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,773 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,311)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458,056 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178,508)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,548 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328,600 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,320)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,280 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,593 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,701 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,902 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,077 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140,480)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,597 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining useful lives for intangible assets at September 30, 2022 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.749%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets was as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,003 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,219 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,287 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,190 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,906 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,741 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,793 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,125 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,028 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,911 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization of intangible assets as of September 30, 2022 was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years ending December 31,</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,003 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,531 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,584 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,794 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,886 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortization expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,548 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and payroll-related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,056 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,522 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued costs of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued bonuses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,708 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales tax liability from acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability – current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,313 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,807 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,667 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,309 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,752 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract cost assets – current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,542 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,398 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 8309000 6752000 2835000 2402000 989000 0 409000 244000 12542000 9398000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,795 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,995 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,060 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,367 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,016)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,378)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,044 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,989 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 8795000 7995000 3015000 2994000 1250000 1378000 13060000 12367000 8016000 6378000 5044000 5989000 600000 600000 1700000 1700000 -0 -300000 -200000 -500000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,100 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,870)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,230 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,375)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,275 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,502)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,773 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,311)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458,056 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178,508)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,548 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328,600 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,320)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,280 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,593 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,701 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,902 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,077 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140,480)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,597 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining useful lives for intangible assets at September 30, 2022 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.749%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr></table></div> 329100000 123870000 205230000 86600000 37375000 49225000 24275000 9502000 14773000 600000 450000 150000 17481000 7311000 10170000 458056000 178508000 279548000 328600000 99320000 229280000 74800000 29207000 45593000 24175000 7474000 16701000 600000 225000 375000 10902000 4254000 6648000 439077000 140480000 298597000 P6Y P5Y P6Y P1Y P3Y <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets was as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,003 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,219 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,287 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,190 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,906 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,741 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,793 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,125 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,028 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,911 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 4003000 3219000 11287000 9190000 8790000 8906000 26741000 26721000 12793000 12125000 38028000 35911000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization of intangible assets as of September 30, 2022 was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years ending December 31,</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,003 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,531 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,584 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,794 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,886 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortization expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,548 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 13003000 50531000 48584000 42750000 38794000 85886000 279548000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and payroll-related expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,056 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,522 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued costs of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued bonuses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,708 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales tax liability from acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability – current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,313 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,807 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,667 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 9056000 8522000 6135000 2217000 3789000 2099000 4174000 6708000 2939000 2939000 1401000 233000 2313000 1949000 29807000 24667000 Commitments and Contingencies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is, and from time to time may be, involved in legal proceedings and claims arising out of the Company’s operations in the ordinary course of business. Management is not currently aware of any legal proceedings or claims against it that could have a material adverse effect on the financial position, results of operations, or cash flows of the Company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Contractual Commitments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s contractual commitments primarily consist of third-party cloud infrastructure agreements and service subscription arrangements used to support operations at the enterprise level. Future minimum payments under the Company’s non-cancelable purchase commitments as of September 30, 2022 are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractual Commitments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years ending December 31, </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,911 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,681 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> Future minimum payments under the Company’s non-cancelable purchase commitments as of September 30, 2022 are as follows (in thousands): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractual Commitments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years ending December 31, </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,911 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,681 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 0 375000 395000 7911000 8681000 Leases<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases office space and server equipment under various operating lease agreements that expire through December 2026. The Company recognizes the related rent expense on a straight-line basis over the term of each lease. Free rent and rental increases are recognized on a straight-line basis over the term of each lease.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the weighted average remaining lease term was three years and the weighted average discount rate was 5.7%. The Company does not have any finance leases as of September 30, 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One lease is with a related party with a termination date of December 2022. The monthly payments during each of the nine months ended September 30, 2022 and 2021 were $0.1 million. The monthly payments are subject to annual increases.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has subleases of former office spaces which expire at various dates from 2022 to 2026. Sublease income from operating leases, which is recorded as a reduction of rental expense, was $0.1 million for both the three months ended September 30, 2022 and 2021, and $0.3 million and $0.2 million for the nine months ended September 30, 2022 and 2021, respectively. One of the subleases was entered into during March 2022 resulting in a total loss of $0.1 million from the disposal of related assets. The loss is included in general and administrative expense on the condensed consolidated statements of operations for the nine months ended September 30, 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense, gross of sublease income, has been recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total rent expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information about the Company’s leases (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.687%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental balance sheet information about the Company’s leases (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>September 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease ROU assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,638 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQzOGIwODlhYWU1MzQ2ZTg4Y2FmOTIwZTFlNTM5OTdmL3NlYzpkMzhiMDg5YWFlNTM0NmU4OGNhZjkyMGUxZTUzOTk3Zl82MS9mcmFnOmUyN2M1MWFlNmFhYTQ2YmZiNjAzOGM3MzhjYzU0MDcxL3RhYmxlOjhhNWJkZTkwY2NmNjRlYThhZWJmNmI4NDZkY2JlYTUzL3RhYmxlcmFuZ2U6OGE1YmRlOTBjY2Y2NGVhOGFlYmY2Yjg0NmRjYmVhNTNfMy0wLTEtMS0xMTIxNDg_1d8201b6-df15-4c75-a6aa-fd159f8fbd7d">Operating lease liabilities, current</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQzOGIwODlhYWU1MzQ2ZTg4Y2FmOTIwZTFlNTM5OTdmL3NlYzpkMzhiMDg5YWFlNTM0NmU4OGNhZjkyMGUxZTUzOTk3Zl82MS9mcmFnOmUyN2M1MWFlNmFhYTQ2YmZiNjAzOGM3MzhjYzU0MDcxL3RhYmxlOjhhNWJkZTkwY2NmNjRlYThhZWJmNmI4NDZkY2JlYTUzL3RhYmxlcmFuZ2U6OGE1YmRlOTBjY2Y2NGVhOGFlYmY2Yjg0NmRjYmVhNTNfNC0wLTEtMS0xMTIxNDg_b07ee06b-eeaf-4c6a-957a-1f6169196b5b">Noncurrent operating lease liabilities</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, remaining maturities of lease liabilities were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"/><td style="width:57.893%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.162%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.162%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.165%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Party</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Party</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ending December 31, </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,893 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,112 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,694 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Presented gross of sublease income. The Company expects to receive sublease income of approximately $0.1 million in the remainder of the year ended December 31, 2022, $0.3 million in 2023, and $0.2 million thereafter.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, prior to the adoption of Topic 842, the aggregate future non-cancelable minimum rental payments and expected sublease receipts were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Party</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Party</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sublease Receipts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ending December 31,</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,356 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense for the three and nine months ended September 30, 2021 was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total rent expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company had an accrued lease termination liability related to leased office space it ceased using during February 2021. The termination liability as of December 31, 2021 was $0.2 million. Upon adoption of Topic 842 on January 1, 2022, the termination liability was removed as an adjustment to the related right of use asset.</span></div> P3Y 0.057 100000 100000 100000 100000 300000 200000 -100000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense, gross of sublease income, has been recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total rent expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information about the Company’s leases (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.687%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 201000 507000 23000 187000 170000 387000 66000 163000 460000 1244000 1563000 1082000 The following table presents supplemental balance sheet information about the Company’s leases (in thousands): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.113%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of <br/>September 30, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease ROU assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,638 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQzOGIwODlhYWU1MzQ2ZTg4Y2FmOTIwZTFlNTM5OTdmL3NlYzpkMzhiMDg5YWFlNTM0NmU4OGNhZjkyMGUxZTUzOTk3Zl82MS9mcmFnOmUyN2M1MWFlNmFhYTQ2YmZiNjAzOGM3MzhjYzU0MDcxL3RhYmxlOjhhNWJkZTkwY2NmNjRlYThhZWJmNmI4NDZkY2JlYTUzL3RhYmxlcmFuZ2U6OGE1YmRlOTBjY2Y2NGVhOGFlYmY2Yjg0NmRjYmVhNTNfMy0wLTEtMS0xMTIxNDg_1d8201b6-df15-4c75-a6aa-fd159f8fbd7d">Operating lease liabilities, current</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmQzOGIwODlhYWU1MzQ2ZTg4Y2FmOTIwZTFlNTM5OTdmL3NlYzpkMzhiMDg5YWFlNTM0NmU4OGNhZjkyMGUxZTUzOTk3Zl82MS9mcmFnOmUyN2M1MWFlNmFhYTQ2YmZiNjAzOGM3MzhjYzU0MDcxL3RhYmxlOjhhNWJkZTkwY2NmNjRlYThhZWJmNmI4NDZkY2JlYTUzL3RhYmxlcmFuZ2U6OGE1YmRlOTBjY2Y2NGVhOGFlYmY2Yjg0NmRjYmVhNTNfNC0wLTEtMS0xMTIxNDg_b07ee06b-eeaf-4c6a-957a-1f6169196b5b">Noncurrent operating lease liabilities</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 2638000 1401000 1511000 2912000 As of September 30, 2022, remaining maturities of lease liabilities were as follows (in thousands): <div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"/><td style="width:57.893%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.162%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.162%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.165%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Party</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Party</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ending December 31, </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,893 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,112 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,694 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Presented gross of sublease income. The Company expects to receive sublease income of approximately $0.1 million in the remainder of the year ended December 31, 2022, $0.3 million in 2023, and $0.2 million thereafter.</span></div> 219000 226000 445000 0 1259000 1259000 0 843000 843000 0 321000 321000 0 244000 244000 219000 2893000 3112000 1000 199000 200000 218000 2694000 2912000 100000 300000 200000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, prior to the adoption of Topic 842, the aggregate future non-cancelable minimum rental payments and expected sublease receipts were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Party</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third Party</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sublease Receipts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ending December 31,</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,356 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 875000 736000 293000 1318000 0 753000 753000 0 722000 722000 0 319000 319000 0 244000 244000 0 0 0 875000 2774000 293000 3356000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense for the three and nine months ended September 30, 2021 was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total rent expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 156000 608000 41000 153000 100000 393000 44000 174000 341000 1328000 200000 Long-Term Debt<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Term loan</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,825 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,859)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, net </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426,966 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427,510 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,263 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current portion of long-term debt, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,139 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current portion of long-term debt, net </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423,599 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425,371 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of deferred financing fees was $0.3 million and $0.7 million for the three months ended September 30, 2022 and 2021, respectively. Total interest expense, excluding amortization of deferred financing fees, was $6.6 million and $6.4 million for the three months ended September 30, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of deferred financing fees was $1.7 million and $2.6 million for the nine months ended September 30, 2022 and 2021, respectively. Total interest expense, excluding amortization of deferred financing fees, was $14.9 million and $24.5 million for the nine months ended September 30, 2022 and 2021, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021 Credit Agreement</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2021, the Company entered into a credit agreement (the “2021 Credit Agreement”), which provides for a term loan facility (the “2021 Term Loan”) in an aggregate principal amount of $435.0 million, and a revolving credit facility (the “2021 Revolving Credit Facility”) in an aggregate principal amount of $50.0 million, inclusive of a $10.0 million letter of credit sub-facility. The Company used the proceeds from the 2021 Term Loan to pay all outstanding amounts due under the Company’s previous 2018 First Lien plus certain fees and expenses. The 2021 Term Loan and 2021 Revolving Credit Facility mature on November 10, 2028 and November 10, 2026, respectively. The Company has not drawn on the 2021 Revolving Credit Facility as of September 30, 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations under the 2021 Credit Agreement are secured by a lien on substantially all tangible and intangible property of the Company, subject to customary exceptions, limitations, and exclusions from the collateral.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains customary affirmative covenants, negative covenants and events of default, including covenants and restrictions that, among other things, require the Company to satisfy a financial covenant, and restricts or limits the ability of the Company to grant or incur liens, incur additional indebtedness, enter into joint ventures or partnerships, engage in mergers and acquisitions, engage in asset sales, and declare dividends on its capital stock, subject in each case to certain customary exceptions. A failure to comply with certain covenants could permit the lenders to declare the 2021 Term Loan, and any then outstanding borrowings on the 2021 Revolving Credit Facility, together with accrued interest and fees thereon, to be immediately due and payable. The Company was in compliance with all financial covenants of the 2021 Credit Agreement at September 30, 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Term Loan</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2021 Term Loan bear interest at a variable rate, elected by the Company, equal to the Base Rate (as defined in the 2021 Credit Agreement) or the Adjusted Eurocurrency Rate (as defined in the 2021 Credit Agreement), plus, an initial margin based on the Company’s Consolidated First Lien Net Leverage Ratio (as defined by the 2021 Credit Agreement), which was 3.00% at September 30, 2022. Beginning in June 2022, the Company is required to make quarterly principal payments equal to 0.25% of the original principal, with the remainder due at maturity. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt issuance costs of $7.6 million were included as a reduction of the debt balance on the condensed consolidated balance sheets and are amortized into interest expense over the contractual life of the loans using the effective interest method. Included in the debt issuance costs were $4.8 million incurred in connection with the 2021 Term Loan, and $2.8 million carried forward from the Company’s previous 2018 First Lien. The Company recognized $0.3 million and $1.6 million of amortization of debt issuance costs for the 2021 Term Loan during the three and nine months ended September 30, 2022, respectively. The effective interest rate on the 2021 Term Loan was 6.2% as of September 30, 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Revolving Credit Facility</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2021 Revolving Credit Facility bear interest, at the election of the Company, at a rate equal to the Base Rate (as defined in the 2021 Credit Agreement) or the Adjusted Eurocurrency Rate (as defined in the 2021 Credit Agreement), plus, in each case, the Applicable Rate (as defined in the 2021 Credit Agreement), which shall vary based on the Company’s Consolidated First Lien Net Leverage Ratio.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2021 Revolving Credit Facility, the Company incurred $0.5 million in debt issuance costs. Expenses associated with the issuance of the revolving credit facility are presented in the accompanying condensed consolidated balance sheets in prepaid expenses and other current assets and other assets, and are amortized to interest expense over the life of the 2021 Revolving Credit Facility using the straight-line method. The remaining unamortized debt issuance costs were $0.4 million and $0.5 million as of September 30, 2022 and December 31, 2022, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Revolving Credit Facility also requires a quarterly commitment fee based on the Company’s consolidated first lien net leverage ratio. As of September 30, 2022, the applicable rate was 0.5%, which was applied against the $50.0 million unused revolving credit facility balance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Principal Payments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future principal payments of long-term debt as of September 30, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years ending December 31,</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414,338 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,825 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Term loan</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,825 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,859)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, net </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426,966 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427,510 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,263 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current portion of long-term debt, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,139 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current portion of long-term debt, net </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423,599 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425,371 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 432825000 435000000 5859000 7490000 426966000 427510000 4350000 3263000 983000 1124000 3367000 2139000 423599000 425371000 300000 700000 6600000 6400000 1700000 2600000 14900000 24500000 435000000 50000000 10000000 0.0300 0.0300 0.0025 7600000 4800000 2800000 300000 1600000 0.062 500000 400000 500000 0.005 50000000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future principal payments of long-term debt as of September 30, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years ending December 31,</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,087 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414,338 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,825 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1087000 4350000 4350000 4350000 4350000 414338000 432825000 Stockholders’ Equity<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company’s board of directors authorized a new stock repurchase program to acquire up to $75.0 million of the Company’s common stock, with no requirement to purchase any minimum number of shares. The manner, timing, and actual number of shares repurchased under the program will depend on a variety of factors, including price, working capital needs, general business and market conditions, regulatory requirements, and other investment opportunities. Shares may be repurchased through privately negotiated transactions, or open market purchases, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934. The repurchase program may be commenced, suspended, or terminated at any time by the Company at its discretion without prior notice.</span></div>The Company retires the repurchased shares, which shall automatically return to the status of authorized but unissued shares of common stock. During the three months ended September 30, 2022, the Company repurchased 4,403 shares of its common stock for approximately $0.1 million, including commissions and fees. During the nine months ended September 30, 2022, the Company repurchased 16,703 shares of its common stock for approximately $0.3 million, including commissions and fees. As of September 30, 2022, there was a total of $74.7 million remaining for repurchase under the stock repurchase program. 75000000 4403 100000 16703 300000 74700000 Share-based Compensation<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021 Stock Option and Incentive Plan</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Stock Option and Incentive Plan (the “2021 Plan”) was adopted by the board of directors and approved by the Company’s stockholders following the Corporate Conversion and became effective as of July 26, 2021. The 2021 Plan replaced both the Company’s 2019 Equity Option Plan (the “2019 Plan”) and the Project Angel Parent, LLC Equity Plan (the “2018 Plan”). Outstanding options to purchase Class B Units granted under the 2019 Plan were converted into options to purchase shares of common stock, and all outstanding Carried Equity Units granted under the 2018 Plan were converted into restricted stock awards (“RSAs”), both of which have been granted under the 2021 Plan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had initially reserved 13,171,588 shares of its common stock for the issuance of awards under the 2021 Plan. The 2021 Plan provides that the number of shares reserved and available for issuance under the 2021 Plan will automatically increase on January 1, 2022 and each January 1 thereafter, by 5% of the outstanding number of shares of common stock on the immediately preceding December 31, or such lesser number of shares as determined by the Company’s compensation committee. The number of shares reserved under the 2021 Plan is subject to adjustment in the event of a stock split, stock dividend, or other change in the Company’s capitalization.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Plan provides flexibility to the Company’s compensation committee to use various equity-based incentive awards as compensation tools to motivate the Company’s workforce. The incentive awards that may be granted under the 2021 Plan include, but are not limited to, options to purchase common stock, stock appreciation rights, restricted shares of common stock, restricted stock units, and cash bonuses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity during the nine months ended September 30, 2022 is as follows (in thousands, except options, price per option, and term amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contract Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding – January 1, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,256,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.05 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.44</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927,364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.09 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,909)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331,781)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.04 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding – September 30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,822,486 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.32 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.90</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,811,786 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest in the future at September 30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,822,486 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.32 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.90</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,811,786 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,833,199 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.56 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.15</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,074,833 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of options that vested during the three months ended September 30, 2022 and 2021 was $4.9 million and $10.6 million, respectively, and for the nine months ended September 30, 2022 and 2021 was $6.6 million and $12.1 million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of options exercised during the three months ended September 30, 2022 and 2021 was $0.0 million and $4.2 million, respectively, and for the nine months ended September 30, 2022 and 2021 was $0.4 million and $4.2 million, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized approximately $2.1 million and $11.8 million in share-based compensation expense related to time-based and performance-based stock options for the three months ended September 30, 2022 and 2021, respectively, and $5.1 million and $12.8 million for the nine months ended September 30, 2022 and 2021, respectively. Included in the amounts of share-based compensation for the three and nine months ended September 30, 2021, is the acceleration of stock-based compensation expense in the amount of $10.3 million related to 500,000 options to purchase common stock, which became fully vested upon the completion of the Company’s IPO. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September 30, 2022 and 2021, performance-based options were probable of vesting and, therefore, were included as part of share-based compensation expense. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, there was approximately $19.1 million of unrecognized share-based compensation expense related to stock options, which is expected to be recognized over a weighted-average period of approximately 2.86 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of restricted stock awards that vested during the three and nine months ended September 30, 2022 was 11,496 and 588,106, respectively. The liability balance as of September 30, 2022, related to the unvested RSAs was $0.0 million. As of September 30, 2022, the number of unvested RSAs amounted to 75,102. There were a total of 0 and 27,146 RSAs cancelled or forfeited during the three and nine months ended September 30, 2022, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized approximately $0.1 million and $0.2 million in share-based compensation expense related to the vesting of RSAs for the three and nine months ended September 30, 2022. The Company recognized $11.2 million and $11.5 million in share-based compensation expense related to the vesting of RSAs during the three and nine months ended September 30, 2021. Included in the amounts of share-based compensation for the three and nine months ended September 30, 2021, is the acceleration of stock-based compensation expense in the amount of $11.1 million related to 426,657 Carried Equity Units, which became fully vested upon the completion of the Company’s IPO.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to the excess of fair value per unit on date of issuance over the $0.06 per share purchase price paid by the participants, has been recognized as additional compensation expense attributable to the participants.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock unit (“RSU”) activity during the nine months ended September 30, 2022, is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested – January 1, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073,529 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.76 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,708,097 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.94 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266,138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested – September 30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,174,027 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.44 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, 3,174,027 RSUs are expected to vest. The Company recognized approximately $4.9 million and $11.0 million in share-based compensation expense related to RSUs for the three and nine months ended September 30, 2022, respectively. The Company recognized $2.3 million in share-based compensation expense related to RSUs for both the three and nine months ended September 30, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, there was approximately $54.5 million of unrecognized share-based compensation expense related to RSUs, which is expected to be recognized over a weighted-average period of approximately 3.26 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Program</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company has issued 64,985 shares of common stock pursuant to the 2021 Employee Stock Purchase Plan under its employee stock purchase program (“ESPP”). As of September 30, 2022, there was approximately $0.1 million of unrecognized share-based compensation related to the ESPP that is expected to be recognized over the remaining term of the current offering period. The Company recognized $0.2 million and $0.5 million of share-based compensation expense related to the ESPP for the three and nine months ended September 30, 2022, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation for share-based awards granted to participants has been recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021 as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,567 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,461 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,158 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,947 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,864 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,879 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,527 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,501 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,835 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">______________</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net of $0.1 million and $0.3 million additions to capitalized software on the Company’s condensed consolidated balance sheets during the three and nine months ended September 30, 2022, respectively, and $0.1 million during both the three and nine months ended September 30, 2021.</span></div> 13171588 0.05 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity during the nine months ended September 30, 2022 is as follows (in thousands, except options, price per option, and term amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contract Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding – January 1, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,256,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.05 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.44</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927,364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.09 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,909)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331,781)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.04 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding – September 30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,822,486 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.32 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.90</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,811,786 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest in the future at September 30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,822,486 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.32 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.90</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,811,786 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,833,199 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.56 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.15</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,074,833 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4256812 13.05 P8Y5M8D 42429000 927364 17.09 29909 6.22 331781 21.04 4822486 13.32 P7Y10M24D 26811786000 4822486 13.32 P7Y10M24D 26811786000 2833199 8.56 P7Y1M24D 25074833000 4900000 10600000 6600000 12100000 0 4200000 400000 4200000 2100000 11800000 5100000 12800000 10300000 10300000 500000 500000 19100000 P2Y10M9D 11496 588106 0 75102 0 27146 100000 200000 11200000 11500000 11100000 11100000 426657 426657 0.06 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock unit (“RSU”) activity during the nine months ended September 30, 2022, is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested – January 1, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,073,529 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.76 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,708,097 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.94 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266,138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested – September 30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,174,027 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.44 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1073529 25.76 2708097 17.94 341461 25.89 266138 21.42 3174027 19.44 3174027 4900000 11000000 2300000 2300000 54500000 P3Y3M3D 64985 100000 200000 500000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation for share-based awards granted to participants has been recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021 as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,567 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,461 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,170 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,158 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,947 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,864 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,879 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,527 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,501 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,835 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">______________</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Net of $0.1 million and $0.3 million additions to capitalized software on the Company’s condensed consolidated balance sheets during the three and nine months ended September 30, 2022, respectively, and $0.1 million during both the three and nine months ended September 30, 2021.</span></div> 1352000 5296000 3567000 5461000 3170000 12158000 6947000 12864000 2092000 6194000 4457000 6358000 639000 1879000 1530000 2152000 7253000 25527000 16501000 26835000 100000 300000 100000 100000 Income Taxes <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with applicable accounting guidance, the Company is required to use an estimated annual effective tax rate to compute its tax provision during an interim period. The Company’s provision for income taxes reflected an effective tax rate of approximately (44)% and (6)% for the three months ended September 30, 2022 and 2021, respectively, and 44% and (350)% for the nine months ended September 30, 2022 and 2021, respectively. During the three and nine months ended September 30, 2022, the Company’s effective tax rate differs from the U.S. federal statutory rate primarily due to R&amp;D credits, state taxes, permanent unfavorable differences related to share-based compensation expense, transaction expenses, certain employee remuneration under section 162(m) of the Internal Revenue Code and other expected permanent differences. During the three and nine months ended September 30, 2021, the Company’s effective tax rate differs from the U.S. federal statutory rate as ASC 740 generally requires providing for income taxes during interim periods based on the estimated annual effective tax rate (“AETR”) for the full fiscal year. For the three and nine months ended September 30, 2021, the Company calculated its income tax provision as though the interim year to date period was an annual period, referred to herein as the discrete method. The Company believes that the application of the AETR method was impractical at the time, given that normal deviations in the projected pre-tax net income (loss) for the Company due to certain employee remuneration limited under section 162(m) of the Internal Revenue Code and certain employee share-based remuneration that the Company recognized due to the Company becoming a public issuer of its securities in the three months ended September 30, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has gross unrecognized tax benefits with respect to R&amp;D credits of $2.3 million as of September 30, 2022 and $1.9 million as of December 31, 2021. There are no penalties or interest recorded on these liabilities as the credits have not yet been utilized.</span></div>The Company assesses whether a valuation allowance should be recorded against its deferred tax assets based on the consideration of all available evidence, using a “more likely than not” realization standard. The four sources of taxable income that must be considered in determining whether deferred tax assets will be realized are: (l) future reversals of existing taxable temporary differences (i.e., offset of gross deferred tax assets against gross deferred tax liabilities); (2) taxable income in prior carryback years, if carryback is permitted under the applicable tax law; (3) tax planning strategies; and (4) future taxable income exclusive of reversing temporary differences and carryforwards. Based on the evaluation of the evidence and sources of taxable income, the Company has determined that no valuation allowance is necessary as of September 30, 2022. -0.44 -0.06 0.44 -3.50 2300000 1900000 0 0 Related Party Transactions<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has leased one property from a related party. Rental expense for this property totaled $0.2 million for both the three months ended September 30, 2022 and 2021, and $0.5 million for both the nine months ended September 30, 2022 and 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 31, 2018, the Company entered into an Advisory Services Agreement with Thoma Bravo, a private equity firm, that owns the majority of the Company through private equity funds managed by the firm. During the three and nine months ended September 30, 2021, the Company recorded $0.2 million and $1.2 million, respectively, in general and administrative expenses on the accompanying condensed consolidated statements of operations for management and advisory fees. The Advisory Services Agreement was terminated upon completion of the IPO.</span></div>During the three and nine months ended September 30, 2022, the Company recorded $0.4 million and $1.3 million, respectively, in cost of revenues for third party expenses with a Thoma Bravo affiliated company, and $0.4 million and $1.2 million, respectively, for the three and nine months ended September 30, 2021. As of September 30, 2022, the Company had prepaid expenses of $0.2 million, accounts payable of $0.1 million, and accrued liabilities of $0.3 million with a Thoma Bravo affiliated company. As of December 31, 2021, the Company had prepaid expenses of $0.1 million, accounts payable of $0.2 million, and accrued liabilities of $0.2 million with a Thoma Bravo affiliated company. 1 200000 200000 500000 500000 200000 1200000 400000 1300000 400000 1200000 200000 100000 300000 100000 200000 200000 Net Income (Loss) Per Share<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net income (loss) per share (in thousands, except share and per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per share</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common stockholders</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,894)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,757 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock outstanding:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,659,320</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,697,083</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,353,399</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,495,073</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,659,320</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,697,083</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,364,835</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,495,073</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following outstanding potentially dilutive securities were excluded from the calculation of diluted net income (loss) per share attributable to common stockholders because their impact would have been anti-dilutive for the periods presented:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.022%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock outstanding, unexercised</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833,279 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,448,454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards, unvested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947,540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units, unvested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757,859 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase rights committed under the ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591,138 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,484,224 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net income (loss) per share (in thousands, except share and per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.023%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per share</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common stockholders</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,894)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,757 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock outstanding:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,659,320</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,697,083</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,353,399</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,495,073</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,659,320</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,697,083</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,364,835</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,495,073</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.47)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> -2894000 -2894000 -24226000 -24226000 6757000 6757000 -27727000 -27727000 80659320 71697083 80353399 58495073 80659320 71697083 82364835 58495073 -0.04 -0.04 -0.34 -0.34 0.08 -0.47 -0.04 -0.34 0.08 -0.47 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following outstanding potentially dilutive securities were excluded from the calculation of diluted net income (loss) per share attributable to common stockholders because their impact would have been anti-dilutive for the periods presented:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.022%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock outstanding, unexercised</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833,279 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,448,454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards, unvested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947,540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units, unvested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757,859 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase rights committed under the ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,591,138 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,484,224 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 1833279 4448454 0 947540 757859 1088230 0 0 2591138 6484224 Business Combinations<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of StreetShares</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, the Company acquired all of the outstanding stock of StreetShares, Inc. (“StreetShares”) for cash consideration of $28.0 million, $30.0 million in escrow for a contingent earnout that expires April 1, 2023, subject to adjustment as defined in the purchase agreement, and $1.6 million in acquisition costs. The $30.0 million is considered contingent consideration and accounted for separate from the business combination accounting. The acquisition was funded by the Company’s available cash. StreetShares is based out of Reston, VA, and is a financial technology company that provides digital small business lending technology to banks and credit unions. The acquisition is accounted for using the acquisition method of accounting whereby the acquired assets and liabilities are recorded at their respective fair values and added to those of the Company, including an amount for goodwill representing the difference between the acquisition consideration and the fair value of the identifiable net assets. Results of operations of StreetShares have been included in the operations of the Company beginning with the closing date of the acquisition. The acquisition was deemed immaterial to the Company’s operating results as a whole. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the allocation of the purchase price of StreetShares based on the estimated fair value of the assets acquired and the liabilities assumed (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.052%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,624 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,755 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,180 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earnout</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable to Regulation A+ investors </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,197 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired and liabilities assumed</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,983 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">______________</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Prior to the acquisition, StreetShares was subject to Regulation A+ of the Securities and Exchange Commission and had offered StreetShares notes to investors. The notes were scheduled to mature during various dates through 2023. Subsequent to the acquisition, during April 2022, the Company used the $3.3 million restricted cash balance to repay the Regulation A+ payable in full. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2022, the Company completed measurement period adjustments related to the fair value of identifiable intangible assets and final working capital adjustment, resulting in a reduction to the fair values of customer relationships and developed technology by $1.9 million and $1.5 million, respectively, an increase in deferred tax assets of $1.1 million, and an increase in goodwill of $2.3 million. The final working capital adjustment amounted to approximately $0.1 million being paid by the Company to the sellers of StreetShares. The working capital adjustment was settled in September 2022 and resulted in a corresponding adjustment to prepaid expenses and other current assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, the Company is still finalizing the provisional purchase price allocation related to income tax effects. The goodwill recognized is attributable to the Company’s expected acceleration of its small business lending service capabilities. The StreetShares acquisition is treated as a stock purchase for income tax purposes; therefore, of the goodwill recorded, none is considered deductible for income tax purposes. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the separately identifiable finite-lived intangible assets acquired and estimated useful lives are as follows (in thousands, except years):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Values</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Amortization Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,400 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value estimates for intangible assets include significant assumptions in the prospective financial information, such as revenue growth and discount rates. The fair value of the intangible assets was primarily based on the income approach using various methods such as the relief from royalty, with-or-without, and excess earnings methods.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill Rollforward </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the Company’s goodwill balance from January 1, 2022 to September 30, 2022 is as follows: </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.052%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564,799 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">StreetShares acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571,554 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Earnout Liability</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price for StreetShares includes a potential earnout that will be measured over 12 months from April 2, 2022, through April 1, 2023, based on performance factors outlined in the acquisition agreement. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent earnout liability is recorded at estimated fair value each reporting period using a Monte Carlo simulation based on the forecasted operating results over the earnout period, estimates for market volatility, discount rates, and the earnout formula specified in the acquisition agreement. As the fair value uses significant unobservable inputs, it is considered a Level 3 fair value measurement.</span></div>The contingent earnout liability is recorded in accrued liabilities on the Company’s condensed consolidated balance sheets. Changes to the fair value are recorded as an adjustment to general and administrative expenses on the condensed consolidated statements of operations. The fair value of the contingent earnout liability was $0.0 million as of September 30, 2022 and $0.2 million as of April 1, 2022. 28000000 30000000 1600000 30000000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the allocation of the purchase price of StreetShares based on the estimated fair value of the assets acquired and the liabilities assumed (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.052%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,624 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,755 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,180 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earnout</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable to Regulation A+ investors </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,197 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired and liabilities assumed</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,983 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">______________</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div>(1)Prior to the acquisition, StreetShares was subject to Regulation A+ of the Securities and Exchange Commission and had offered StreetShares notes to investors. The notes were scheduled to mature during various dates through 2023. Subsequent to the acquisition, during April 2022, the Company used the $3.3 million restricted cash balance to repay the Regulation A+ payable in full. 1580000 3265000 157000 561000 142000 613000 11624000 6755000 12400000 83000 37180000 368000 3585000 738000 162000 3265000 854000 225000 9197000 27983000 3300000 1900000 1500000 1100000 2300000 100000 0 The fair value of the separately identifiable finite-lived intangible assets acquired and estimated useful lives are as follows (in thousands, except years):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Values</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Amortization Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquisition-related intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,400 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td></tr></table> 500000 P5Y 11800000 P10Y 100000 P2Y 12400000 P9Y <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of the Company’s goodwill balance from January 1, 2022 to September 30, 2022 is as follows: </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.052%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564,799 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">StreetShares acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">571,554 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 564799000 6755000 571554000 P12M 0 200000 Subsequent Events<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of OpenClose</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 4, 2022, the Company acquired all of the outstanding stock of Beanstalk Networks, L.L.C. doing business as OpenClose (“OpenClose”) for cash consideration of $65.0 million, which includes approximately $1.4 million in acquisition costs. The acquisition was funded by the Company’s available cash. OpenClose is based out of West Palm Beach, Florida, and provides mortgage lending technology, with a particular focus on supporting depository institutions. The acquisition will be accounted for using the acquisition method of accounting whereby the acquired assets and liabilities will be recorded at their respective fair values and added to those of the Company, including an amount for goodwill representing the difference between the acquisition consideration and the fair value of the identifiable net assets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results of operations of OpenClose will be included in the operations of the Company beginning with the closing date of the acquisition. As of the date of issuance of these condensed consolidated financial statements, the initial acquisition and disclosures under ASC 805, Business Combinations, have not been prepared as the Company has not obtained all of the information necessary, nor has there been sufficient time, to complete the related activities.</span></div> 65000000 1400000 EXCEL 79 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 80 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 81 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 82 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 239 397 1 false 58 0 false 5 false false R1.htm 0000001 - Document - Cover Page Sheet http://med.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://med.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://med.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Statements of Operations Sheet http://med.com/role/CondensedConsolidatedStatementsofOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Statements of Preferred Units and Stockholders' Equity / Members' Deficit Sheet http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit Condensed Consolidated Statements of Preferred Units and Stockholders' Equity / Members' Deficit Statements 5 false false R6.htm 0000006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://med.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 0000007 - Disclosure - Organization and Description of Business Sheet http://med.com/role/OrganizationandDescriptionofBusiness Organization and Description of Business Notes 7 false false R8.htm 0000008 - Disclosure - Significant Accounting Policies Sheet http://med.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 0000009 - Disclosure - Revenue Recognition Sheet http://med.com/role/RevenueRecognition Revenue Recognition Notes 9 false false R10.htm 0000010 - Disclosure - Balance Sheet Components Sheet http://med.com/role/BalanceSheetComponents Balance Sheet Components Notes 10 false false R11.htm 0000011 - Disclosure - Commitments and Contingencies Sheet http://med.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 11 false false R12.htm 0000012 - Disclosure - Leases Sheet http://med.com/role/Leases Leases Notes 12 false false R13.htm 0000013 - Disclosure - Long-Term Debt Sheet http://med.com/role/LongTermDebt Long-Term Debt Notes 13 false false R14.htm 0000014 - Disclosure - Stockholders' Equity Sheet http://med.com/role/StockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 0000015 - Disclosure - Share-Based Compensation Sheet http://med.com/role/ShareBasedCompensation Share-Based Compensation Notes 15 false false R16.htm 0000016 - Disclosure - Income Taxes Sheet http://med.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 0000017 - Disclosure - Related Party Transactions Sheet http://med.com/role/RelatedPartyTransactions Related Party Transactions Notes 17 false false R18.htm 0000018 - Disclosure - Net Income (Loss) Per Share Sheet http://med.com/role/NetIncomeLossPerShare Net Income (Loss) Per Share Notes 18 false false R19.htm 0000019 - Disclosure - Business Combinations Sheet http://med.com/role/BusinessCombinations Business Combinations Notes 19 false false R20.htm 0000020 - Disclosure - Subsequent Events Sheet http://med.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 0000021 - Disclosure - Significant Accounting Policies (Policies) Sheet http://med.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://med.com/role/SignificantAccountingPolicies 21 false false R22.htm 0000022 - Disclosure - Revenue Recognition (Tables) Sheet http://med.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://med.com/role/RevenueRecognition 22 false false R23.htm 0000023 - Disclosure - Balance Sheet Components (Tables) Sheet http://med.com/role/BalanceSheetComponentsTables Balance Sheet Components (Tables) Tables http://med.com/role/BalanceSheetComponents 23 false false R24.htm 0000024 - Disclosure - Commitments and Contingencies (Tables) Sheet http://med.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://med.com/role/CommitmentsandContingencies 24 false false R25.htm 0000025 - Disclosure - Leases (Tables) Sheet http://med.com/role/LeasesTables Leases (Tables) Tables http://med.com/role/Leases 25 false false R26.htm 0000026 - Disclosure - Long-Term Debt (Tables) Sheet http://med.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://med.com/role/LongTermDebt 26 false false R27.htm 0000027 - Disclosure - Share-Based Compensation (Tables) Sheet http://med.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://med.com/role/ShareBasedCompensation 27 false false R28.htm 0000028 - Disclosure - Net Income (Loss) Per Share (Tables) Sheet http://med.com/role/NetIncomeLossPerShareTables Net Income (Loss) Per Share (Tables) Tables http://med.com/role/NetIncomeLossPerShare 28 false false R29.htm 0000029 - Disclosure - Business Combinations (Tables) Sheet http://med.com/role/BusinessCombinationsTables Business Combinations (Tables) Tables http://med.com/role/BusinessCombinations 29 false false R30.htm 0000030 - Disclosure - Organization and Description of Business (Details) Sheet http://med.com/role/OrganizationandDescriptionofBusinessDetails Organization and Description of Business (Details) Details http://med.com/role/OrganizationandDescriptionofBusiness 30 false false R31.htm 0000031 - Disclosure - Significant Accounting Policies - Additional Information (Details) Sheet http://med.com/role/SignificantAccountingPoliciesAdditionalInformationDetails Significant Accounting Policies - Additional Information (Details) Details 31 false false R32.htm 0000032 - Disclosure - Revenue Recognition - Disaggregation of Revenue by Solution Type (Details) Sheet http://med.com/role/RevenueRecognitionDisaggregationofRevenuebySolutionTypeDetails Revenue Recognition - Disaggregation of Revenue by Solution Type (Details) Details 32 false false R33.htm 0000033 - Disclosure - Revenue Recognition - Additional Information (Details) Sheet http://med.com/role/RevenueRecognitionAdditionalInformationDetails Revenue Recognition - Additional Information (Details) Details 33 false false R34.htm 0000034 - Disclosure - Revenue Recognition - Disaggregation of Revenue by Major Source (Details) Sheet http://med.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorSourceDetails Revenue Recognition - Disaggregation of Revenue by Major Source (Details) Details 34 false false R35.htm 0000035 - Disclosure - Revenue Recognition - Schedule of Changes in Deferred Revenue (Details) Sheet http://med.com/role/RevenueRecognitionScheduleofChangesinDeferredRevenueDetails Revenue Recognition - Schedule of Changes in Deferred Revenue (Details) Details 35 false false R36.htm 0000036 - Disclosure - Revenue Recognition - Schedule of Changes in Contract Cost Assets (Details) Sheet http://med.com/role/RevenueRecognitionScheduleofChangesinContractCostAssetsDetails Revenue Recognition - Schedule of Changes in Contract Cost Assets (Details) Details 36 false false R37.htm 0000037 - Disclosure - Balance Sheet Components - Summary of Prepaid Expenses and Other Current Assets (Detail) Sheet http://med.com/role/BalanceSheetComponentsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail Balance Sheet Components - Summary of Prepaid Expenses and Other Current Assets (Detail) Details 37 false false R38.htm 0000038 - Disclosure - Balance Sheet Components - Summary of Property and Equipment, Net (Detail) Sheet http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail Balance Sheet Components - Summary of Property and Equipment, Net (Detail) Details 38 false false R39.htm 0000039 - Disclosure - Balance Sheet Components - Additional Information (Detail) Sheet http://med.com/role/BalanceSheetComponentsAdditionalInformationDetail Balance Sheet Components - Additional Information (Detail) Details 39 false false R40.htm 0000040 - Disclosure - Balance Sheet Components - Summary of Intangible Assets, Net (Detail) Sheet http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail Balance Sheet Components - Summary of Intangible Assets, Net (Detail) Details 40 false false R41.htm 0000041 - Disclosure - Balance Sheet Components - Summary of Estimated Useful Lives and Weighted Average Amortization Periods for Intangible Assets (Detail) Sheet http://med.com/role/BalanceSheetComponentsSummaryofEstimatedUsefulLivesandWeightedAverageAmortizationPeriodsforIntangibleAssetsDetail Balance Sheet Components - Summary of Estimated Useful Lives and Weighted Average Amortization Periods for Intangible Assets (Detail) Details 41 false false R42.htm 0000042 - Disclosure - Balance Sheet Components - Summary of amortization expense related to intangible assets (Details) Sheet http://med.com/role/BalanceSheetComponentsSummaryofamortizationexpenserelatedtointangibleassetsDetails Balance Sheet Components - Summary of amortization expense related to intangible assets (Details) Details 42 false false R43.htm 0000043 - Disclosure - Balance Sheet Components - Summary of Estimated Future Amortization of Intangible Assets (Detail) Sheet http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail Balance Sheet Components - Summary of Estimated Future Amortization of Intangible Assets (Detail) Details 43 false false R44.htm 0000044 - Disclosure - Balance Sheet Components - Summary of Accrued Liabilities (Detail) Sheet http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail Balance Sheet Components - Summary of Accrued Liabilities (Detail) Details 44 false false R45.htm 0000045 - Disclosure - Commitments and Contingencies - Future Minimum Payments Under Non-Cancelable Purchase Commitments (Details) Sheet http://med.com/role/CommitmentsandContingenciesFutureMinimumPaymentsUnderNonCancelablePurchaseCommitmentsDetails Commitments and Contingencies - Future Minimum Payments Under Non-Cancelable Purchase Commitments (Details) Details 45 false false R46.htm 0000046 - Disclosure - Leases - Additional Information (Details) Sheet http://med.com/role/LeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 46 false false R47.htm 0000047 - Disclosure - Leases - Summary of Rent Expense (Details) Sheet http://med.com/role/LeasesSummaryofRentExpenseDetails Leases - Summary of Rent Expense (Details) Details 47 false false R48.htm 0000048 - Disclosure - Leases - Supplemental Cash Flow Information About the Company's Leases (Details) Sheet http://med.com/role/LeasesSupplementalCashFlowInformationAbouttheCompanysLeasesDetails Leases - Supplemental Cash Flow Information About the Company's Leases (Details) Details 48 false false R49.htm 0000049 - Disclosure - Leases - Supplemental Balance Sheet Information About The Company's Leases (Details) Sheet http://med.com/role/LeasesSupplementalBalanceSheetInformationAboutTheCompanysLeasesDetails Leases - Supplemental Balance Sheet Information About The Company's Leases (Details) Details 49 false false R50.htm 0000050 - Disclosure - Leases - Summary of Future Minimum Lease Payments (Details) Sheet http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails Leases - Summary of Future Minimum Lease Payments (Details) Details 50 false false R51.htm 0000051 - Disclosure - Long-Term Debt - Summary of Long-term Debt (Detail) Sheet http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail Long-Term Debt - Summary of Long-term Debt (Detail) Details 51 false false R52.htm 0000052 - Disclosure - Long-Term Debt - Additional Information (Detail) Sheet http://med.com/role/LongTermDebtAdditionalInformationDetail Long-Term Debt - Additional Information (Detail) Details 52 false false R53.htm 0000053 - Disclosure - Long-Term Debt - Summary of Future Principal Payments of Long-term Debt (Detail) Sheet http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail Long-Term Debt - Summary of Future Principal Payments of Long-term Debt (Detail) Details 53 false false R54.htm 0000054 - Disclosure - Stockholders' Equity (Details) Sheet http://med.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://med.com/role/StockholdersEquity 54 false false R55.htm 0000055 - Disclosure - Share-Based Compensation - Additional Information (Details) Sheet http://med.com/role/ShareBasedCompensationAdditionalInformationDetails Share-Based Compensation - Additional Information (Details) Details 55 false false R56.htm 0000056 - Disclosure - Share-Based Compensation - Summary of Stock Option Activity (Details) Sheet http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails Share-Based Compensation - Summary of Stock Option Activity (Details) Details 56 false false R57.htm 0000057 - Disclosure - Share-Based Compensation - Schedule of RSU Activity (Details) Sheet http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails Share-Based Compensation - Schedule of RSU Activity (Details) Details 57 false false R58.htm 0000058 - Disclosure - Share-Based Compensation - Summary of Stock-based Compensation (Details) Sheet http://med.com/role/ShareBasedCompensationSummaryofStockbasedCompensationDetails Share-Based Compensation - Summary of Stock-based Compensation (Details) Details 58 false false R59.htm 0000059 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://med.com/role/IncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 59 false false R60.htm 0000060 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 60 false false R61.htm 0000061 - Disclosure - Net Income (Loss) Per Share - Summary of calculation of basic and diluted net income (loss) per share (Detail) Sheet http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail Net Income (Loss) Per Share - Summary of calculation of basic and diluted net income (loss) per share (Detail) Details http://med.com/role/NetIncomeLossPerShareTables 61 false false R62.htm 0000062 - Disclosure - Net Income (Loss) Per Share - Summary of outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per common unit attributable to common unitholders (Detail) Sheet http://med.com/role/NetIncomeLossPerShareSummaryofoutstandingpotentiallydilutivesecuritieswereexcludedfromthecalculationofdilutednetlosspercommonunitattributabletocommonunitholdersDetail Net Income (Loss) Per Share - Summary of outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per common unit attributable to common unitholders (Detail) Details http://med.com/role/NetIncomeLossPerShareTables 62 false false R63.htm 0000063 - Disclosure - Business Combinations - Additional Information (Details) Sheet http://med.com/role/BusinessCombinationsAdditionalInformationDetails Business Combinations - Additional Information (Details) Details 63 false false R64.htm 0000064 - Disclosure - Business Combinations - Summary of the Allocation of the Purchase Price (Details) Sheet http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails Business Combinations - Summary of the Allocation of the Purchase Price (Details) Details 64 false false R65.htm 0000065 - Disclosure - Business Combinations - Summary of Fair Value of the Separately Identifiable Finite-Lived Intangible Assets Acquired and Estimated Useful Lives (Details) Sheet http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails Business Combinations - Summary of Fair Value of the Separately Identifiable Finite-Lived Intangible Assets Acquired and Estimated Useful Lives (Details) Details 65 false false R66.htm 0000066 - Disclosure - Business Combinations - Summary of Goodwill (Details) Sheet http://med.com/role/BusinessCombinationsSummaryofGoodwillDetails Business Combinations - Summary of Goodwill (Details) Details 66 false false R67.htm 0000067 - Disclosure - Subsequent Events (Details) Sheet http://med.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://med.com/role/SubsequentEvents 67 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 - mlnk-20220930.htm 4 mlnk-20220930.htm exhibit311toq32022form10-q.htm exhibit312toq32022form10-q.htm exhibit321toq32022form10-q.htm exhibit322toq32022form10-q.htm mlnk-20220930.xsd mlnk-20220930_cal.xml mlnk-20220930_def.xml mlnk-20220930_lab.xml mlnk-20220930_pre.xml http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 85 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mlnk-20220930.htm": { "axisCustom": 2, "axisStandard": 22, "contextCount": 239, "dts": { "calculationLink": { "local": [ "mlnk-20220930_cal.xml" ] }, "definitionLink": { "local": [ "mlnk-20220930_def.xml" ] }, "inline": { "local": [ "mlnk-20220930.htm" ] }, "labelLink": { "local": [ "mlnk-20220930_lab.xml" ] }, "presentationLink": { "local": [ "mlnk-20220930_pre.xml" ] }, "schema": { "local": [ "mlnk-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 586, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 3, "http://xbrl.sec.gov/dei/2022": 5, "total": 8 }, "keyCustom": 47, "keyStandard": 350, "memberCustom": 24, "memberStandard": 31, "nsprefix": "mlnk", "nsuri": "http://med.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "role": "http://med.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Balance Sheet Components", "role": "http://med.com/role/BalanceSheetComponents", "shortName": "Balance Sheet Components", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Commitments and Contingencies", "role": "http://med.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Leases", "role": "http://med.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Long-Term Debt", "role": "http://med.com/role/LongTermDebt", "shortName": "Long-Term Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Stockholders' Equity", "role": "http://med.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Share-Based Compensation", "role": "http://med.com/role/ShareBasedCompensation", "shortName": "Share-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Income Taxes", "role": "http://med.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Related Party Transactions", "role": "http://med.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Net Income (Loss) Per Share", "role": "http://med.com/role/NetIncomeLossPerShare", "shortName": "Net Income (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Business Combinations", "role": "http://med.com/role/BusinessCombinations", "shortName": "Business Combinations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://med.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Subsequent Events", "role": "http://med.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Significant Accounting Policies (Policies)", "role": "http://med.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Revenue Recognition (Tables)", "role": "http://med.com/role/RevenueRecognitionTables", "shortName": "Revenue Recognition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "mlnk:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Balance Sheet Components (Tables)", "role": "http://med.com/role/BalanceSheetComponentsTables", "shortName": "Balance Sheet Components (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "mlnk:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Commitments and Contingencies (Tables)", "role": "http://med.com/role/CommitmentsandContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Leases (Tables)", "role": "http://med.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Long-Term Debt (Tables)", "role": "http://med.com/role/LongTermDebtTables", "shortName": "Long-Term Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Share-Based Compensation (Tables)", "role": "http://med.com/role/ShareBasedCompensationTables", "shortName": "Share-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Net Income (Loss) Per Share (Tables)", "role": "http://med.com/role/NetIncomeLossPerShareTables", "shortName": "Net Income (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Business Combinations (Tables)", "role": "http://med.com/role/BusinessCombinationsTables", "shortName": "Business Combinations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://med.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i8d767520babb4b838433e0cc9785e4fc_I20210727", "decimals": "2", "first": true, "lang": "en-US", "name": "mlnk:ConversionOfStockConversionPrice", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Organization and Description of Business (Details)", "role": "http://med.com/role/OrganizationandDescriptionofBusinessDetails", "shortName": "Organization and Description of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i8d767520babb4b838433e0cc9785e4fc_I20210727", "decimals": "2", "first": true, "lang": "en-US", "name": "mlnk:ConversionOfStockConversionPrice", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Significant Accounting Policies - Additional Information (Details)", "role": "http://med.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "shortName": "Significant Accounting Policies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": "0", "lang": "en-US", "name": "us-gaap:OperatingLeaseImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - Revenue Recognition - Disaggregation of Revenue by Solution Type (Details)", "role": "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebySolutionTypeDetails", "shortName": "Revenue Recognition - Disaggregation of Revenue by Solution Type (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "if3ea5b5a004e4d9a9f777737ce2db17b_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Revenue Recognition - Additional Information (Details)", "role": "http://med.com/role/RevenueRecognitionAdditionalInformationDetails", "shortName": "Revenue Recognition - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "icf6c2c05246d40419f35550a0f7ff124_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Revenue Recognition - Disaggregation of Revenue by Major Source (Details)", "role": "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorSourceDetails", "shortName": "Revenue Recognition - Disaggregation of Revenue by Major Source (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i6cec820c03d44c0b9b4a570403221d78_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "icf6c2c05246d40419f35550a0f7ff124_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Revenue Recognition - Schedule of Changes in Deferred Revenue (Details)", "role": "http://med.com/role/RevenueRecognitionScheduleofChangesinDeferredRevenueDetails", "shortName": "Revenue Recognition - Schedule of Changes in Deferred Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i7218b0c8102f446d8207a0bcc129355e_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "icf6c2c05246d40419f35550a0f7ff124_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CapitalizedContractCostNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Revenue Recognition - Schedule of Changes in Contract Cost Assets (Details)", "role": "http://med.com/role/RevenueRecognitionScheduleofChangesinContractCostAssetsDetails", "shortName": "Revenue Recognition - Schedule of Changes in Contract Cost Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i7218b0c8102f446d8207a0bcc129355e_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CapitalizedContractCostNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "mlnk:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Balance Sheet Components - Summary of Prepaid Expenses and Other Current Assets (Detail)", "role": "http://med.com/role/BalanceSheetComponentsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail", "shortName": "Balance Sheet Components - Summary of Prepaid Expenses and Other Current Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "mlnk:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Balance Sheet Components - Summary of Property and Equipment, Net (Detail)", "role": "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail", "shortName": "Balance Sheet Components - Summary of Property and Equipment, Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Balance Sheet Components - Additional Information (Detail)", "role": "http://med.com/role/BalanceSheetComponentsAdditionalInformationDetail", "shortName": "Balance Sheet Components - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - Condensed Consolidated Statements of Operations", "role": "http://med.com/role/CondensedConsolidatedStatementsofOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Balance Sheet Components - Summary of Intangible Assets, Net (Detail)", "role": "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail", "shortName": "Balance Sheet Components - Summary of Intangible Assets, Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ic101e73b115d4f2db6cee2ea958097fd_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Balance Sheet Components - Summary of Estimated Useful Lives and Weighted Average Amortization Periods for Intangible Assets (Detail)", "role": "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedUsefulLivesandWeightedAverageAmortizationPeriodsforIntangibleAssetsDetail", "shortName": "Balance Sheet Components - Summary of Estimated Useful Lives and Weighted Average Amortization Periods for Intangible Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ic101e73b115d4f2db6cee2ea958097fd_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - Balance Sheet Components - Summary of amortization expense related to intangible assets (Details)", "role": "http://med.com/role/BalanceSheetComponentsSummaryofamortizationexpenserelatedtointangibleassetsDetails", "shortName": "Balance Sheet Components - Summary of amortization expense related to intangible assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - Balance Sheet Components - Summary of Estimated Future Amortization of Intangible Assets (Detail)", "role": "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail", "shortName": "Balance Sheet Components - Summary of Estimated Future Amortization of Intangible Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - Balance Sheet Components - Summary of Accrued Liabilities (Detail)", "role": "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail", "shortName": "Balance Sheet Components - Summary of Accrued Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - Commitments and Contingencies - Future Minimum Payments Under Non-Cancelable Purchase Commitments (Details)", "role": "http://med.com/role/CommitmentsandContingenciesFutureMinimumPaymentsUnderNonCancelablePurchaseCommitmentsDetails", "shortName": "Commitments and Contingencies - Future Minimum Payments Under Non-Cancelable Purchase Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - Leases - Additional Information (Details)", "role": "http://med.com/role/LeasesAdditionalInformationDetails", "shortName": "Leases - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "mlnk:LesseeOperatingLeaseMonthlyPayments", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": "-5", "lang": "en-US", "name": "mlnk:LesseeOperatingLeaseMonthlyPayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - Leases - Summary of Rent Expense (Details)", "role": "http://med.com/role/LeasesSummaryofRentExpenseDetails", "shortName": "Leases - Summary of Rent Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - Leases - Supplemental Cash Flow Information About the Company's Leases (Details)", "role": "http://med.com/role/LeasesSupplementalCashFlowInformationAbouttheCompanysLeasesDetails", "shortName": "Leases - Supplemental Cash Flow Information About the Company's Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - Leases - Supplemental Balance Sheet Information About The Company's Leases (Details)", "role": "http://med.com/role/LeasesSupplementalBalanceSheetInformationAboutTheCompanysLeasesDetails", "shortName": "Leases - Supplemental Balance Sheet Information About The Company's Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OperatingLeaseLiabilityNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ic22a1693ac504dd3b116b5f89b4921ce_I20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - Condensed Consolidated Statements of Preferred Units and Stockholders' Equity / Members' Deficit", "role": "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit", "shortName": "Condensed Consolidated Statements of Preferred Units and Stockholders' Equity / Members' Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iddfc6a256e62497c989a0fe312891228_D20210101-20210331", "decimals": "-3", "lang": "en-US", "name": "mlnk:AdjustmentToAccumulatedDeficit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - Leases - Summary of Future Minimum Lease Payments (Details)", "role": "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails", "shortName": "Leases - Summary of Future Minimum Lease Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - Long-Term Debt - Summary of Long-term Debt (Detail)", "role": "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail", "shortName": "Long-Term Debt - Summary of Long-term Debt (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - Long-Term Debt - Additional Information (Detail)", "role": "http://med.com/role/LongTermDebtAdditionalInformationDetail", "shortName": "Long-Term Debt - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - Long-Term Debt - Summary of Future Principal Payments of Long-term Debt (Detail)", "role": "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail", "shortName": "Long-Term Debt - Summary of Future Principal Payments of Long-term Debt (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i2bc63b8f9a604607b2fe8d989ed9b1ab_I20220531", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - Stockholders' Equity (Details)", "role": "http://med.com/role/StockholdersEquityDetails", "shortName": "Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i2bc63b8f9a604607b2fe8d989ed9b1ab_I20220531", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - Share-Based Compensation - Additional Information (Details)", "role": "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails", "shortName": "Share-Based Compensation - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "icf6c2c05246d40419f35550a0f7ff124_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - Share-Based Compensation - Summary of Stock Option Activity (Details)", "role": "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails", "shortName": "Share-Based Compensation - Summary of Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - Share-Based Compensation - Schedule of RSU Activity (Details)", "role": "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails", "shortName": "Share-Based Compensation - Schedule of RSU Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i1cb5a843fc6d448eb675d25e1260cbd5_D20220101-20220930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - Share-Based Compensation - Summary of Stock-based Compensation (Details)", "role": "http://med.com/role/ShareBasedCompensationSummaryofStockbasedCompensationDetails", "shortName": "Share-Based Compensation - Summary of Stock-based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i074d76ecfd8543e3bcb1de0828c9727d_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000059 - Disclosure - Income Taxes - Additional Information (Details)", "role": "http://med.com/role/IncomeTaxesAdditionalInformationDetails", "shortName": "Income Taxes - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://med.com/role/CondensedConsolidatedStatementsofCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherDepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "mlnk:NumberOfRelatedPartyPropertiesLeased", "reportCount": 1, "unitRef": "property", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000060 - Disclosure - Related Party Transactions - Additional Information (Details)", "role": "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails", "shortName": "Related Party Transactions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i5f3bddfafe8540e485c89c0b6e190514_D20210701-20210930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted", "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000061 - Disclosure - Net Income (Loss) Per Share - Summary of calculation of basic and diluted net income (loss) per share (Detail)", "role": "http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail", "shortName": "Net Income (Loss) Per Share - Summary of calculation of basic and diluted net income (loss) per share (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000062 - Disclosure - Net Income (Loss) Per Share - Summary of outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per common unit attributable to common unitholders (Detail)", "role": "http://med.com/role/NetIncomeLossPerShareSummaryofoutstandingpotentiallydilutivesecuritieswereexcludedfromthecalculationofdilutednetlosspercommonunitattributabletocommonunitholdersDetail", "shortName": "Net Income (Loss) Per Share - Summary of outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per common unit attributable to common unitholders (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EscrowDeposit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000063 - Disclosure - Business Combinations - Additional Information (Details)", "role": "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "shortName": "Business Combinations - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i6e301c9f41fb47598c65e85c67aac41b_I20220331", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ib5b96eef194c422ab572a513919d9e72_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000064 - Disclosure - Business Combinations - Summary of the Allocation of the Purchase Price (Details)", "role": "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails", "shortName": "Business Combinations - Summary of the Allocation of the Purchase Price (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i20f17e8109fc4af69cbf697a6dad7708_I20220401", "decimals": "-3", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "id7cbd94f8d764203a84165955fe5425c_D20220401-20220401", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000065 - Disclosure - Business Combinations - Summary of Fair Value of the Separately Identifiable Finite-Lived Intangible Assets Acquired and Estimated Useful Lives (Details)", "role": "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails", "shortName": "Business Combinations - Summary of Fair Value of the Separately Identifiable Finite-Lived Intangible Assets Acquired and Estimated Useful Lives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "id7cbd94f8d764203a84165955fe5425c_D20220401-20220401", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "icf6c2c05246d40419f35550a0f7ff124_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000066 - Disclosure - Business Combinations - Summary of Goodwill (Details)", "role": "http://med.com/role/BusinessCombinationsSummaryofGoodwillDetails", "shortName": "Business Combinations - Summary of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "iaad156a6810f428ba89ebe2f031abf2e_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000067 - Disclosure - Subsequent Events (Details)", "role": "http://med.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "ibc13e77363434eae8f1645acd6c0a266_D20221104-20221104", "decimals": "-5", "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000007 - Disclosure - Organization and Description of Business", "role": "http://med.com/role/OrganizationandDescriptionofBusiness", "shortName": "Organization and Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000008 - Disclosure - Significant Accounting Policies", "role": "http://med.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - Revenue Recognition", "role": "http://med.com/role/RevenueRecognition", "shortName": "Revenue Recognition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mlnk-20220930.htm", "contextRef": "i680b6fea8bb94fd5ba3083c65a5f3a20_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 58, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r552" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r553" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r560" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r549" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r551" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://med.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "mlnk_A2021RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Revolving Credit Facility", "label": "2021 Revolving Credit Facility [Member]", "terseLabel": "2021 Revolving Credit Facility" } } }, "localname": "A2021RevolvingCreditFacilityMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mlnk_A2021TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Term Loan", "label": "2021 Term Loan [Member]", "terseLabel": "2021 Term Loan" } } }, "localname": "A2021TermLoanMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail", "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "domainItemType" }, "mlnk_AccruedCostsOfRevenues": { "auth_ref": [], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued costs of revenues.", "label": "Accrued Costs Of Revenues", "terseLabel": "Accrued costs of revenues" } } }, "localname": "AccruedCostsOfRevenues", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "mlnk_AccruedLiabilitiesRelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Liabilities, Related Parties", "label": "Accrued Liabilities, Related Parties", "terseLabel": "Accrued liabilities, related parties" } } }, "localname": "AccruedLiabilitiesRelatedParties", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_AccruedOperatingCosts": { "auth_ref": [], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued operating costs.", "label": "Accrued Operating Costs", "terseLabel": "Accrued operating costs" } } }, "localname": "AccruedOperatingCosts", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "mlnk_AdjustedEurocurrencyRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adjusted Eurocurrency Rate", "label": "Adjusted Eurocurrency Rate [Member]", "terseLabel": "Adjusted Eurocurrency Rate" } } }, "localname": "AdjustedEurocurrencyRateMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mlnk_AdjustmentToAccumulatedDeficit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustment to accumulated deficit.", "label": "Adjustment to Accumulated Deficit", "negatedLabel": "Payment of Class A units cumulative preferred return" } } }, "localname": "AdjustmentToAccumulatedDeficit", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "monetaryItemType" }, "mlnk_AdvisoryServicesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisory Services Agreement", "label": "Advisory Services Agreement [Member]", "terseLabel": "Advisory Services Agreement" } } }, "localname": "AdvisoryServicesAgreementMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mlnk_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets and Liabilities, Lessee", "label": "Assets and Liabilities, Lessee [Table Text Block]", "terseLabel": "Supplemental balance sheet information about the Company's leases" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "mlnk_BeanstalkNetworksLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Beanstalk Networks, L.L.C.", "label": "Beanstalk Networks, L.L.C. [Member]", "terseLabel": "Beanstalk Networks, L.L.C." } } }, "localname": "BeanstalkNetworksLLCMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "mlnk_BusinessCombinationContingentConsiderationLiabilityMeasurementPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Contingent Consideration, Liability, Measurement Period", "label": "Business Combination, Contingent Consideration, Liability, Measurement Period", "terseLabel": "Contingent earnout, measurement period" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementPeriod", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "mlnk_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets", "terseLabel": "Working capital adjustments, DTA" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill": { "auth_ref": [], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedCompensationAndBenefits": { "auth_ref": [], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued compensation and benefits.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Compensation And Benefits", "terseLabel": "Accrued compensation and benefits" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedCompensationAndBenefits", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": { "auth_ref": [], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses", "terseLabel": "Accrued expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash": { "auth_ref": [], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 2.0, "parentTag": "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed restricted cash.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Restricted Cash", "terseLabel": "Restricted cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": { "auth_ref": [], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 4.0, "parentTag": "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Assets", "terseLabel": "Right of use assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_CapitalizedContractCostAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capitalized contract cost additions.", "label": "Capitalized Contract Cost Additions", "terseLabel": "Additions" } } }, "localname": "CapitalizedContractCostAdditions", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RevenueRecognitionScheduleofChangesinContractCostAssetsDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_CapitalizedContractCostRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capitalized Contract Cost", "label": "Capitalized Contract Cost [Roll Forward]", "terseLabel": "Capitalized Contract Cost [Roll Forward]" } } }, "localname": "CapitalizedContractCostRollForward", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RevenueRecognitionScheduleofChangesinContractCostAssetsDetails" ], "xbrltype": "stringItemType" }, "mlnk_CapitalizedSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capitalized software [Member].", "label": "Capitalized Software [Member]", "terseLabel": "Capitalized software" } } }, "localname": "CapitalizedSoftwareMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedUsefulLivesandWeightedAverageAmortizationPeriodsforIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "mlnk_CarriedEquityUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carried equity units [Member].", "label": "Carried Equity Units [Member]", "terseLabel": "Carried Equity Units" } } }, "localname": "CarriedEquityUnitsMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mlnk_ConcentrationRiskPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Concentration risk percentage.", "label": "Concentration Risk Percentage", "terseLabel": "Concentration risk" } } }, "localname": "ConcentrationRiskPercentage", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RevenueRecognitionAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "mlnk_ContractWithCustomerLiabilityAdditions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Liability, Additions", "label": "Contract With Customer, Liability, Additions", "terseLabel": "Billing of transaction consideration" } } }, "localname": "ContractWithCustomerLiabilityAdditions", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RevenueRecognitionScheduleofChangesinDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Liability, Revenue Recognized, Including Opening Balance", "label": "Contract With Customer, Liability, Revenue Recognized, Including Opening Balance", "negatedLabel": "Revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RevenueRecognitionScheduleofChangesinDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_ContractWithCustomerLiabilityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Liability", "label": "Contract With Customer, Liability [Roll Forward]", "terseLabel": "Contract With Customer, Liability [Roll Forward]" } } }, "localname": "ContractWithCustomerLiabilityRollForward", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RevenueRecognitionScheduleofChangesinDeferredRevenueDetails" ], "xbrltype": "stringItemType" }, "mlnk_ConversionOfStockConversionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion Of Stock, Conversion Price", "label": "Conversion Of Stock, Conversion Price", "terseLabel": "Conversion price of stock (in dollars per share)" } } }, "localname": "ConversionOfStockConversionPrice", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "perShareItemType" }, "mlnk_ConversionOfStockConversionRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion Of Stock, Conversion Ratio", "label": "Conversion Of Stock, Conversion Ratio", "terseLabel": "Conversion ratio" } } }, "localname": "ConversionOfStockConversionRatio", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "pureItemType" }, "mlnk_ConversionOfStockSharesConvertedNonvested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion Of Stock, Shares Converted, Nonvested", "label": "Conversion Of Stock, Shares Converted, Nonvested", "terseLabel": "Shares that remained subject to future vesting (in shares)" } } }, "localname": "ConversionOfStockSharesConvertedNonvested", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails", "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "mlnk_ConversionOfStockSharesConvertedNonvestedValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion Of Stock, Shares Converted, Nonvested, Value", "label": "Conversion Of Stock, Shares Converted, Nonvested, Value", "terseLabel": "Liability balance related to unvested RSAs" } } }, "localname": "ConversionOfStockSharesConvertedNonvestedValue", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_DataVerificationSoftwareSolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Data Verification Software Solutions [Member]", "label": "Data Verification Software Solutions [Member]", "terseLabel": "Data Verification Software Solutions" } } }, "localname": "DataVerificationSoftwareSolutionsMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RevenueRecognitionAdditionalInformationDetails", "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebySolutionTypeDetails" ], "xbrltype": "domainItemType" }, "mlnk_DebtInstrumentPeriodicPaymentPercentOfPrincipal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of principal payments on Term loan.", "label": "Debt Instrument, Periodic Payment, Percent Of Principal", "terseLabel": "Percent of original principal" } } }, "localname": "DebtInstrumentPeriodicPaymentPercentOfPrincipal", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mlnk_DeferredOfferingCostsIncurredButNotPaidIncludedInAccountsPayableAndAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs incurred but not paid included in accounts payable and accrued liabilities.", "label": "Deferred Offering Costs Incurred But Not Paid Included In Accounts Payable And Accrued Liabilities", "terseLabel": "Deferred offering costs included in accounts payable and accrued expenses" } } }, "localname": "DeferredOfferingCostsIncurredButNotPaidIncludedInAccountsPayableAndAccruedLiabilities", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "mlnk_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": { "auth_ref": [], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "mlnk_FirstLienMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien [Member]", "label": "First Lien [Member]", "terseLabel": "First Lien" } } }, "localname": "FirstLienMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mlnk_GainLossOnSubleaseLiability": { "auth_ref": [], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain loss on sublease liability.", "label": "Gain Loss On Sublease Liability", "negatedLabel": "Loss on sublease liability" } } }, "localname": "GainLossOnSubleaseLiability", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "mlnk_IncreaseDecreaseInOperatingLeaseRightOfUseAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) in Operating Lease Right-Of-Use Asset", "label": "Increase (Decrease) in Operating Lease Right-Of-Use Asset", "terseLabel": "Initial recognition of operating lease right-of-use asset" } } }, "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAsset", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "mlnk_LeaseContractualAssetTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease contractual asset type.", "label": "Lease Contractual Asset Type [Axis]", "terseLabel": "Lease Contractual Asset Type [Axis]" } } }, "localname": "LeaseContractualAssetTypeAxis", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "mlnk_LeaseContractualAssetTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease contractual asset type.", "label": "Lease Contractual Asset Type [Domain]", "terseLabel": "Lease Contractual Asset Type [Domain]" } } }, "localname": "LeaseContractualAssetTypeDomain", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mlnk_LeasedPropertyFromRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leased property from related party.", "label": "Leased Property From Related Party [Member]", "terseLabel": "Leased Property From Related Party" } } }, "localname": "LeasedPropertyFromRelatedPartyMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mlnk_LendingSoftwareSolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lending Software Solutions [Member]", "label": "Lending Software Solutions [Member]", "terseLabel": "Lending Software Solutions" } } }, "localname": "LendingSoftwareSolutionsMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RevenueRecognitionAdditionalInformationDetails", "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebySolutionTypeDetails" ], "xbrltype": "domainItemType" }, "mlnk_LesseeOperatingLeaseMonthlyPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lessee Operating Lease Monthly Payments", "label": "Lessee Operating Lease Monthly Payments", "terseLabel": "Monthly payments" } } }, "localname": "LesseeOperatingLeaseMonthlyPayments", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LeasesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_LongTermDebtMaturityAfterYearFour": { "auth_ref": [], "calculation": { "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail": { "order": 5.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-Term Debt, Maturity, After Year Four", "label": "Long-Term Debt, Maturity, After Year Four", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturityAfterYearFour", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail" ], "xbrltype": "monetaryItemType" }, "mlnk_NetIncomeLossAvailableToCommonStockholdersBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Income (Loss) Available To Common Stockholders, Basic And Diluted", "label": "Net Income (Loss) Available To Common Stockholders, Basic And Diluted [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAndDilutedAbstract", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail" ], "xbrltype": "stringItemType" }, "mlnk_NoncashEffectOfCorporateConversion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncash, Effect Of Corporate Conversion", "label": "Noncash, Effect Of Corporate Conversion", "terseLabel": "Effect of corporate conversion (Note 1)" } } }, "localname": "NoncashEffectOfCorporateConversion", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "mlnk_NumberOfDaysGrantedToUnderwritersToPurchaseAdditionalSharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of days granted to underwriters to purchase additional shares of common stock.", "label": "Number Of Days Granted To Underwriters To Purchase Additional Shares Of Common Stock", "terseLabel": "Number of days granted to underwriters to purchase additional shares of common stock" } } }, "localname": "NumberOfDaysGrantedToUnderwritersToPurchaseAdditionalSharesOfCommonStock", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "durationItemType" }, "mlnk_NumberOfRelatedPartyPropertiesLeased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Related Party Properties Leased", "label": "Number Of Related Party Properties Leased", "terseLabel": "Property from a related party" } } }, "localname": "NumberOfRelatedPartyPropertiesLeased", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "mlnk_OperatingLeasesTerminationLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Leases, Termination Liability", "label": "Operating Leases, Termination Liability", "terseLabel": "Operating leases, termination liability" } } }, "localname": "OperatingLeasesTerminationLiability", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LeasesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_OptionsToPurchaseCommonStockOutstandingUnexercisedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options To Purchase Common Stock Outstanding, Unexercised", "label": "Options To Purchase Common Stock Outstanding, Unexercised [Member]", "terseLabel": "Options to purchase common stock outstanding, unexercised" } } }, "localname": "OptionsToPurchaseCommonStockOutstandingUnexercisedMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/NetIncomeLossPerShareSummaryofoutstandingpotentiallydilutivesecuritieswereexcludedfromthecalculationofdilutednetlosspercommonunitattributabletocommonunitholdersDetail" ], "xbrltype": "domainItemType" }, "mlnk_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization Consolidation And Presentation Of Financial Statements [Line Items]", "label": "Organization Consolidation And Presentation Of Financial Statements [Line Items]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Line Items]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BalanceSheetComponentsAdditionalInformationDetail", "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "stringItemType" }, "mlnk_OrganizationConsolidationAndPresentationOfFinancialStatementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization Consolidation And Presentation Of Financial Statements [Table].", "label": "Organization Consolidation And Presentation Of Financial Statements [Table]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Table]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BalanceSheetComponentsAdditionalInformationDetail", "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "stringItemType" }, "mlnk_PaymentDueToEffectOfCorporateConversion": { "auth_ref": [], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment Due To Effect Of Corporate Conversion", "label": "Payment Due To Effect Of Corporate Conversion", "negatedTerseLabel": "Payment due to effect of corporate conversion" } } }, "localname": "PaymentDueToEffectOfCorporateConversion", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "mlnk_PaymentOfPreferredDividend": { "auth_ref": [], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of preferred dividend.", "label": "Payment Of Preferred Dividend", "negatedTerseLabel": "Payments of Class A cumulative preferred return" } } }, "localname": "PaymentOfPreferredDividend", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "mlnk_PrepaidExpensesRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid Expenses, Related Party", "label": "Prepaid Expenses, Related Party", "terseLabel": "Prepaid expenses, related party" } } }, "localname": "PrepaidExpensesRelatedParty", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_ProfessionalServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Professional Services [Member]", "label": "Professional Services [Member]", "terseLabel": "Professional services" } } }, "localname": "ProfessionalServicesMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorSourceDetails" ], "xbrltype": "domainItemType" }, "mlnk_ReconciliationOfEarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reconciliation Of Earnings Per Share, Basic And Diluted", "label": "Reconciliation Of Earnings Per Share, Basic And Diluted [Abstract]", "verboseLabel": "Basic and diluted net income (loss) per share" } } }, "localname": "ReconciliationOfEarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail" ], "xbrltype": "stringItemType" }, "mlnk_RelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related party", "label": "Related Party [Member]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "domainItemType" }, "mlnk_RelatedPartyReceivableNetAgainstHoldbackPaymentToPriorShareholders": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Related party receivable net against holdback payment to prior shareholders.", "label": "Related Party Receivable Net Against Holdback Payment To Prior Shareholders", "terseLabel": "Related party receivable net against holdback payment to prior shareholders" } } }, "localname": "RelatedPartyReceivableNetAgainstHoldbackPaymentToPriorShareholders", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "mlnk_RepaymentOfPaycheckProtectionProgramLoanToSellersOnAcquisition": { "auth_ref": [], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repayment Of Paycheck Protection Program Loan To Sellers On Acquisition", "label": "Repayment Of Paycheck Protection Program Loan To Sellers On Acquisition", "negatedTerseLabel": "Payment to sellers of Teledata Communications, Inc" } } }, "localname": "RepaymentOfPaycheckProtectionProgramLoanToSellersOnAcquisition", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "mlnk_RestrictedStockAwardsUnvestedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Awards, Unvested", "label": "Restricted Stock Awards, Unvested [Member]", "terseLabel": "Restricted stock awards, unvested" } } }, "localname": "RestrictedStockAwardsUnvestedMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/NetIncomeLossPerShareSummaryofoutstandingpotentiallydilutivesecuritieswereexcludedfromthecalculationofdilutednetlosspercommonunitattributabletocommonunitholdersDetail" ], "xbrltype": "domainItemType" }, "mlnk_RestrictedStockUnitsFormerlyClassBUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Units, Formerly Class B Units", "label": "Restricted Stock Units, Formerly Class B Units [Member]", "terseLabel": "Restricted Stock Units, Formerly Class B Units" } } }, "localname": "RestrictedStockUnitsFormerlyClassBUnitsMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "domainItemType" }, "mlnk_RestrictedStockUnitsUnvestedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Units, Unvested", "label": "Restricted Stock Units, Unvested [Member]", "terseLabel": "Restricted stock units, unvested" } } }, "localname": "RestrictedStockUnitsUnvestedMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/NetIncomeLossPerShareSummaryofoutstandingpotentiallydilutivesecuritieswereexcludedfromthecalculationofdilutednetlosspercommonunitattributabletocommonunitholdersDetail" ], "xbrltype": "domainItemType" }, "mlnk_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of prepaid expenses and other current assets", "label": "Schedule Of Prepaid Expenses And Other Current Assets [Table Text Block]", "terseLabel": "Summary of prepaid expenses and other current assets" } } }, "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "mlnk_ScheduleOfRentExpenseLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of rent expense line items.", "label": "Schedule Of Rent Expense [Line Items]", "terseLabel": "Schedule Of Rent Expense [Line Items]" } } }, "localname": "ScheduleOfRentExpenseLineItems", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LeasesSummaryofRentExpenseDetails" ], "xbrltype": "stringItemType" }, "mlnk_ScheduleOfRentExpenseTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of rent expense table.", "label": "Schedule Of Rent Expense [Table]", "terseLabel": "Schedule Of Rent Expense [Table]" } } }, "localname": "ScheduleOfRentExpenseTable", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LeasesSummaryofRentExpenseDetails" ], "xbrltype": "stringItemType" }, "mlnk_SeriesARedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A Redeemable Convertible Preferred Stock [Member]", "label": "Series A Redeemable Convertible Preferred Stock [Member]", "terseLabel": "Class A Preferred Units" } } }, "localname": "SeriesARedeemableConvertiblePreferredStockMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "domainItemType" }, "mlnk_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInSharesReservedForIssuancePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Annual Increase In Shares Reserved For Issuance, Percentage", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Annual Increase In Shares Reserved For Issuance, Percentage", "terseLabel": "Annual increase in shares authorized, percentage" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseInSharesReservedForIssuancePercentage", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "mlnk_ShareBasedCompensationByShareBasedAwardVestingOfEquityUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation by share based award vesting of equity units.", "label": "Share Based Compensation By Share Based Award Vesting Of Equity Units", "terseLabel": "Vesting of Class\u00a0B carried equity units (in shares)" } } }, "localname": "ShareBasedCompensationByShareBasedAwardVestingOfEquityUnits", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "sharesItemType" }, "mlnk_ShareBasedCompensationByShareBasedAwardVestingOfEquityUnitsValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share based compensation by share based award vesting of equity units value.", "label": "Share Based Compensation By Share Based Award Vesting Of Equity Units Value", "terseLabel": "Vesting of Class B carried equity units" } } }, "localname": "ShareBasedCompensationByShareBasedAwardVestingOfEquityUnitsValue", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "monetaryItemType" }, "mlnk_ShareBasedPaymentArrangementVested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share Based Payment Arrangement, Vested", "label": "Share Based Payment Arrangement, Vested", "terseLabel": "Vesting of restricted stock awards and RSUs" } } }, "localname": "ShareBasedPaymentArrangementVested", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "mlnk_StockSharesPartiallyTenderedForSaleByTheExistingStockholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock shares partially tendered for sale by the existing stockholders.", "label": "Stock Shares Partially Tendered For Sale By The Existing Stockholders", "terseLabel": "Stock shares offered but not yet tendered by the existing stockholders (in shares)" } } }, "localname": "StockSharesPartiallyTenderedForSaleByTheExistingStockholders", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "sharesItemType" }, "mlnk_StockSharesTenderedForSaleByTheExistingStockholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock shares tendered for sale by the existing stockholders.", "label": "Stock Shares Tendered For Sale By The Existing Stockholders", "terseLabel": "Stock shares tendered for sale by the existing stockholders (in shares)" } } }, "localname": "StockSharesTenderedForSaleByTheExistingStockholders", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "sharesItemType" }, "mlnk_StockholdersEquityEffectOfReorganization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stockholders' Equity, Effect Of Reorganization", "label": "Stockholders' Equity, Effect Of Reorganization", "terseLabel": "Effect of Corporate Conversion", "verboseLabel": "Effect of Corporate Conversion" } } }, "localname": "StockholdersEquityEffectOfReorganization", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "monetaryItemType" }, "mlnk_StockholdersEquityEffectOfReorganizationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stockholders' Equity, Effect Of Reorganization, Shares", "label": "Stockholders' Equity, Effect Of Reorganization, Shares", "terseLabel": "Effect of Corporate Conversion (in shares)", "verboseLabel": "Effect of Corporate Conversion (in shares)" } } }, "localname": "StockholdersEquityEffectOfReorganizationShares", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "sharesItemType" }, "mlnk_StreetSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "StreetShares", "label": "StreetShares [Member]", "terseLabel": "StreetShares" } } }, "localname": "StreetSharesMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails", "http://med.com/role/BusinessCombinationsSummaryofGoodwillDetails", "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "domainItemType" }, "mlnk_SubscriptionFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subscription Fees [Member]", "label": "Subscription Fees [Member]", "terseLabel": "Subscription fees" } } }, "localname": "SubscriptionFeesMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorSourceDetails" ], "xbrltype": "domainItemType" }, "mlnk_TemporaryEquityCompoundInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity compound interest rate.", "label": "Temporary Equity Compound Interest Rate", "terseLabel": "Temporary equity compound interest rate" } } }, "localname": "TemporaryEquityCompoundInterestRate", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "percentItemType" }, "mlnk_TemporaryEquityFutureValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Temporary equity future value.", "label": "Temporary Equity Future Value", "terseLabel": "Temporary equity future value" } } }, "localname": "TemporaryEquityFutureValue", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "monetaryItemType" }, "mlnk_ThirdPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third party.", "label": "Third Party [Member]", "terseLabel": "Third Party" } } }, "localname": "ThirdPartyMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "domainItemType" }, "mlnk_TwoThousandTwentyOneStockOptionAndIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 stock option and incentive plan.", "label": "Two Thousand Twenty One Stock Option and Incentive Plan [Member]", "terseLabel": "2021 Plan" } } }, "localname": "TwoThousandTwentyOneStockOptionAndIncentivePlanMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "mlnk_VariableRateComponentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Rate Component", "label": "Variable Rate Component [Axis]", "terseLabel": "Variable Rate Component [Axis]" } } }, "localname": "VariableRateComponentAxis", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mlnk_VariableRateComponentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Rate Component", "label": "Variable Rate Component [Domain]", "terseLabel": "Variable Rate Component [Domain]" } } }, "localname": "VariableRateComponentDomain", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mlnk_VariableRateComponentOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Rate Component One", "label": "Variable Rate Component One [Member]", "terseLabel": "Variable Rate Component One" } } }, "localname": "VariableRateComponentOneMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mlnk_VariableRateComponentTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Rate Component Two", "label": "Variable Rate Component Two [Member]", "terseLabel": "Variable Rate Component Two" } } }, "localname": "VariableRateComponentTwoMember", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mlnk_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Number of Shares Outstanding, Basic And Diluted", "label": "Weighted Average Number of Shares Outstanding, Basic And Diluted [Abstract]", "verboseLabel": "Weighted average common stock outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAbstract", "nsuri": "http://med.com/20220930", "presentation": [ "http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail" ], "xbrltype": "stringItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r328", "r477", "r478", "r480", "r546", "r558" ], "lang": { "en-us": { "role": { "documentation": "An affiliate is a party that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with the entity.", "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Future minimum payments under non-cancelable purchase commitments" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://med.com/role/CommitmentsandContingenciesTables" ], "xbrltype": "textBlockItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r43", "r45", "r100", "r101", "r250", "r285", "r559" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "stringItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r176", "r230", "r231", "r317", "r320", "r492", "r534", "r535" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorSourceDetails", "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebySolutionTypeDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r176", "r230", "r231", "r317", "r320", "r492", "r534", "r535" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorSourceDetails", "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebySolutionTypeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r44", "r45", "r100", "r101", "r250", "r285" ], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r112", "r330", "r557" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.", "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://med.com/role/LeasesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r112", "r117", "r229", "r330" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://med.com/role/LeasesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r112", "r117", "r229", "r330", "r488" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://med.com/role/LeasesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r31", "r485" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r99", "r478", "r514", "r529" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties.", "label": "Accounts Payable, Related Parties", "terseLabel": "Accounts payable, related parties" } } }, "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r179", "r180" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowance for doubtful accounts" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedBonusesCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Bonuses, Current", "terseLabel": "Accrued bonuses" } } }, "localname": "AccruedBonusesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities", "totalLabel": "Total accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail", "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r9", "r219" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r209" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted Average Amortization Life (years)" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r22" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r104", "r105", "r106", "r374", "r375", "r376", "r432" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "negatedTerseLabel": "Shares withheld related to net share settlement of RSUs" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r332", "r378", "r379" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r366" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Total share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://med.com/role/ShareBasedCompensationSummaryofStockbasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r27", "r181", "r185", "r186", "r187" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r58", "r83", "r269", "r447" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt issuance costs", "verboseLabel": "Amortization of financing costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows", "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r83", "r206", "r213" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofamortizationexpenserelatedtointangibleassetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/NetIncomeLossPerShareSummaryofoutstandingpotentiallydilutivesecuritieswereexcludedfromthecalculationofdilutednetlosspercommonunitattributabletocommonunitholdersDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/NetIncomeLossPerShareSummaryofoutstandingpotentiallydilutivesecuritieswereexcludedfromthecalculationofdilutednetlosspercommonunitattributabletocommonunitholdersDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/NetIncomeLossPerShareSummaryofoutstandingpotentiallydilutivesecuritieswereexcludedfromthecalculationofdilutednetlosspercommonunitattributabletocommonunitholdersDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/NetIncomeLossPerShareSummaryofoutstandingpotentiallydilutivesecuritieswereexcludedfromthecalculationofdilutednetlosspercommonunitattributabletocommonunitholdersDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r13", "r96", "r161", "r167", "r174", "r183", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r423", "r427", "r435", "r483", "r485", "r509", "r523" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r30", "r96", "r183", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r423", "r427", "r435", "r483", "r485" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r334", "r335", "r336", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r348", "r349", "r350", "r351", "r352", "r353", "r355", "r356", "r358", "r359", "r360", "r361", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit", "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation/Unaudited Interim Condensed Consolidated Financial Information" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r329", "r331", "r409" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails", "http://med.com/role/BusinessCombinationsSummaryofGoodwillDetails", "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails", "http://med.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r329", "r331", "r403", "r404", "r409" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails", "http://med.com/role/BusinessCombinationsSummaryofGoodwillDetails", "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails", "http://med.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": { "auth_ref": [ "r419" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.", "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount", "terseLabel": "Goodwill considered deductible for income tax purposes" } } }, "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r402" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "http://med.com/role/CondensedConsolidatedStatementsofOperations", "http://med.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r82", "r420" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "terseLabel": "Gain on change in fair value of earnout" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r415", "r416", "r418" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Contingent earnout" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r410", "r421" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinations" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": { "auth_ref": [ "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred", "terseLabel": "Business combination, adjustment consideration transferred" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": { "auth_ref": [ "r408" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles", "terseLabel": "Working capital adjustments, intangibles" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]", "terseLabel": "Assets acquired:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 5.0, "parentTag": "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": { "auth_ref": [ "r405", "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability", "terseLabel": "Contingent earnout" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 1.0, "parentTag": "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 8.0, "parentTag": "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts receivable, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "auth_ref": [ "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": { "auth_ref": [ "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 9.0, "parentTag": "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets", "terseLabel": "Deferred tax asset" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 3.0, "parentTag": "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "totalLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]", "terseLabel": "Liabilities assumed:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": { "auth_ref": [ "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt", "terseLabel": "Notes payable to Regulation A+ investors" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "terseLabel": "Other long-term liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 10.0, "parentTag": "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r405", "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 7.0, "parentTag": "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property and equipment, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r406" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Fair value of assets acquired and liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r87", "r88", "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Purchases of property and equipment included in accounts payable and accrued expenses" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalUnitClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class A of capital units, which are a type of ownership interest in a corporation.", "label": "Capital Unit, Class A [Member]", "terseLabel": "Class A Units", "verboseLabel": "Capital Unit, Class A" } } }, "localname": "CapitalUnitClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows", "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalUnitClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class B of capital units, which are a type of ownership interest in a corporation.", "label": "Capital Unit, Class B [Member]", "terseLabel": "Class B Units", "verboseLabel": "Capital Unit, Class B" } } }, "localname": "CapitalUnitClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows", "http://med.com/role/OrganizationandDescriptionofBusinessDetails", "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalUnitClassDomain": { "auth_ref": [ "r542" ], "lang": { "en-us": { "role": { "documentation": "Description of the type or class of capital units or capital shares.", "label": "Capital Unit, Class [Domain]", "terseLabel": "Capital Unit, Class [Domain]" } } }, "localname": "CapitalUnitClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows", "http://med.com/role/OrganizationandDescriptionofBusinessDetails", "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalUnitsByClassAxis": { "auth_ref": [ "r541", "r543" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of the entity's capital units.", "label": "Capital Units by Class [Axis]", "terseLabel": "Capital Units by Class [Axis]" } } }, "localname": "CapitalUnitsByClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows", "http://med.com/role/OrganizationandDescriptionofBusinessDetails", "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization": { "auth_ref": [ "r548" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail": { "order": 1.0, "parentTag": "us-gaap_CapitalizedComputerSoftwareNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.", "label": "Capitalized Computer Software, Accumulated Amortization", "negatedLabel": "Capitalized computer software, accumulated amortization" } } }, "localname": "CapitalizedComputerSoftwareAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareAdditions": { "auth_ref": [ "r207" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additions made to capitalized computer software costs during the period.", "label": "Capitalized Computer Software, Additions", "terseLabel": "Capitalized software costs" } } }, "localname": "CapitalizedComputerSoftwareAdditions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareGross": { "auth_ref": [ "r548" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail": { "order": 2.0, "parentTag": "us-gaap_CapitalizedComputerSoftwareNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.", "label": "Capitalized Computer Software, Gross", "terseLabel": "Capitalized computer software, gross" } } }, "localname": "CapitalizedComputerSoftwareGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareNet": { "auth_ref": [ "r547" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.", "label": "Capitalized Computer Software, Net", "totalLabel": "Capitalized computer software, net carrying amount" } } }, "localname": "CapitalizedComputerSoftwareNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostAmortization": { "auth_ref": [ "r191" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.", "label": "Capitalized Contract Cost, Amortization", "negatedLabel": "Amortization" } } }, "localname": "CapitalizedContractCostAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionScheduleofChangesinContractCostAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostNet": { "auth_ref": [ "r190" ], "calculation": { "http://med.com/role/RevenueRecognitionScheduleofChangesinContractCostAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.", "label": "Capitalized Contract Cost, Net", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total deferred contract cost assets" } } }, "localname": "CapitalizedContractCostNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionScheduleofChangesinContractCostAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostNetCurrent": { "auth_ref": [ "r190" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 }, "http://med.com/role/RevenueRecognitionScheduleofChangesinContractCostAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_CapitalizedContractCostNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current.", "label": "Capitalized Contract Cost, Net, Current", "terseLabel": "Contract cost assets \u2013 current" } } }, "localname": "CapitalizedContractCostNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail", "http://med.com/role/RevenueRecognitionScheduleofChangesinContractCostAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostNetNoncurrent": { "auth_ref": [ "r190" ], "calculation": { "http://med.com/role/RevenueRecognitionScheduleofChangesinContractCostAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_CapitalizedContractCostNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent.", "label": "Capitalized Contract Cost, Net, Noncurrent", "terseLabel": "Contract cost assets, noncurrent" } } }, "localname": "CapitalizedContractCostNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionScheduleofChangesinContractCostAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostTableTextBlock": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer.", "label": "Capitalized Contract Cost [Table Text Block]", "terseLabel": "Schedule of changes in contract cost assets" } } }, "localname": "CapitalizedContractCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r7", "r85" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets", "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r79", "r85", "r90" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period", "totalLabel": "Cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]", "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r79", "r436" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r18", "r19", "r20", "r93", "r96", "r121", "r122", "r127", "r129", "r131", "r139", "r140", "r141", "r183", "r235", "r239", "r240", "r241", "r244", "r245", "r283", "r284", "r287", "r291", "r297", "r435", "r554" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r40", "r515", "r528" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 5)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r226", "r227", "r228", "r232", "r544" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Class B Common Units" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Common stock, capital shares reserved for future issuance (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r104", "r105", "r432" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r20", "r297" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r20", "r485" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value; 600,000,000 shares authorized, 80,732,286 and 79,734,984 shares issued and outstanding at September\u00a030, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonUnitOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of common units of ownership outstanding of a limited liability company (LLC).", "label": "Common Unit, Outstanding", "terseLabel": "Common units, units outstanding (in shares)" } } }, "localname": "CommonUnitOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment and software" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Schedule of changes in the deferred revenue" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r306", "r307", "r318" ], "calculation": { "http://med.com/role/RevenueRecognitionScheduleofChangesinDeferredRevenueDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Deferred revenue, ending balance", "totalLabel": "Total deferred revenue" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionScheduleofChangesinDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r306", "r307", "r318" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://med.com/role/RevenueRecognitionScheduleofChangesinDeferredRevenueDetails": { "order": 2.0, "parentTag": "us-gaap_ContractWithCustomerLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "periodEndLabel": "Deferred revenue, current", "periodStartLabel": "Deferred revenue, beginning balance", "terseLabel": "Deferred revenue" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets", "http://med.com/role/RevenueRecognitionScheduleofChangesinDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r306", "r307", "r318" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://med.com/role/RevenueRecognitionScheduleofChangesinDeferredRevenueDetails": { "order": 1.0, "parentTag": "us-gaap_ContractWithCustomerLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Long-term deferred revenue" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets", "http://med.com/role/RevenueRecognitionScheduleofChangesinDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r87", "r88", "r89" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Converted", "terseLabel": "Temporary equity stock shares converted into permanent equity (in shares)" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": { "auth_ref": [ "r54", "r55" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_CostOfRevenue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.", "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization", "terseLabel": "Subscription and services" } } }, "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSoldAmortization": { "auth_ref": [ "r59" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_CostOfRevenue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.", "label": "Cost, Amortization", "terseLabel": "Amortization of developed technology" } } }, "localname": "CostOfGoodsAndServicesSoldAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r61", "r96", "r183", "r235", "r236", "r237", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r435" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "totalLabel": "Total cost of revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Revenue [Abstract]", "terseLabel": "Cost of revenues:" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of revenues" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofamortizationexpenserelatedtointangibleassetsDetails", "http://med.com/role/LeasesSummaryofRentExpenseDetails", "http://med.com/role/ShareBasedCompensationSummaryofStockbasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedUsefulLivesandWeightedAverageAmortizationPeriodsforIntangibleAssetsDetail", "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail", "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r92", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r263", "r270", "r271", "r272", "r282" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Long-Term Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r14", "r15", "r16", "r95", "r102", "r246", "r247", "r248", "r249", "r250", "r251", "r253", "r259", "r260", "r261", "r262", "r264", "r265", "r266", "r267", "r268", "r269", "r276", "r277", "r278", "r279", "r448", "r510", "r511", "r522" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail", "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r16", "r273", "r511", "r522" ], "calculation": { "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-Term Debt, Gross", "totalLabel": "Total", "verboseLabel": "2021 Term loan" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail", "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r246", "r276", "r277", "r446", "r448", "r449" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Term loan" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r37", "r275", "r446", "r448" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Interest rate, effective" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail", "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r38", "r95", "r102", "r246", "r247", "r248", "r249", "r250", "r251", "r253", "r259", "r260", "r261", "r262", "r264", "r265", "r266", "r267", "r268", "r269", "r276", "r277", "r278", "r279", "r448" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail", "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredFinanceCostsCurrentNet": { "auth_ref": [ "r447" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Current, Net", "negatedLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsCurrentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r447" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Debt issuance costs, gross" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r259", "r447" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r383", "r384" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred tax assets, net" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r84" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRentCreditNoncurrent": { "auth_ref": [ "r17", "r451", "r473" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of rental payment required by lease over rental income recognized, classified as noncurrent.", "label": "Deferred Rent Credit, Noncurrent", "terseLabel": "Deferred rent" } } }, "localname": "DeferredRentCreditNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r83", "r217" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technology", "verboseLabel": "Developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedUsefulLivesandWeightedAverageAmortizationPeriodsforIntangibleAssetsDetail", "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail", "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorSourceDetails", "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebySolutionTypeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r317", "r320", "r321", "r322", "r323", "r324", "r325", "r326" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorSourceDetails", "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebySolutionTypeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Summary of disaggregation of revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r333", "r334", "r368", "r369", "r371", "r380" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Share-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r56", "r109", "r110", "r111", "r112", "r113", "r118", "r121", "r129", "r130", "r131", "r135", "r136", "r433", "r434", "r517", "r531" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations", "http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Net income (loss) per share:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations", "http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r56", "r109", "r110", "r111", "r112", "r113", "r121", "r129", "r130", "r131", "r135", "r136", "r433", "r434", "r517", "r531" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "verboseLabel": "Diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations", "http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r132", "r133", "r134", "r137" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Income (Loss) Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/NetIncomeLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate reconciliation, percent" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/IncomeTaxesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued payroll and payroll-related expenses" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": { "auth_ref": [ "r367" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost capitalized for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Amount Capitalized", "terseLabel": "Share-based compensation expense capitalized to software additions" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails", "http://med.com/role/ShareBasedCompensationSummaryofStockbasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized stock-based compensation expense, weighted -average period for recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r370" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized stock-based compensation expense, awards other than options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r370" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized stock-based compensation expense related to stock options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Purchase rights committed under the ESPP" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/NetIncomeLossPerShareSummaryofoutstandingpotentiallydilutivesecuritieswereexcludedfromthecalculationofdilutednetlosspercommonunitattributabletocommonunitholdersDetail", "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "terseLabel": "Stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r49", "r50", "r51", "r104", "r105", "r106", "r108", "r114", "r116", "r138", "r184", "r297", "r302", "r374", "r375", "r376", "r392", "r393", "r432", "r437", "r438", "r439", "r440", "r441", "r442", "r474", "r536", "r537", "r538" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_EscrowDeposit": { "auth_ref": [ "r513", "r545" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.", "label": "Escrow Deposit", "terseLabel": "Escrow deposit" } } }, "localname": "EscrowDeposit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Weighted average period before the next renewal or extension (both explicit and implicit) for intangible assets that have been renewed or extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Weighted Average Period before Next Renewal or Extension", "terseLabel": "Weighted Average Remaining Useful Life" } } }, "localname": "FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedUsefulLivesandWeightedAverageAmortizationPeriodsforIntangibleAssetsDetail" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r11", "r212" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Intangible assets, accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.", "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]", "terseLabel": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]" } } }, "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r214" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "2022 (remaining three months)" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]", "terseLabel": "Summary of amortization expense related to intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r214" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r214" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r214" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r207", "r210", "r212", "r215", "r493", "r494" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedUsefulLivesandWeightedAverageAmortizationPeriodsforIntangibleAssetsDetail", "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail", "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r212", "r494" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Intangible assets, gross amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedUsefulLivesandWeightedAverageAmortizationPeriodsforIntangibleAssetsDetail", "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail", "http://med.com/role/BalanceSheetComponentsSummaryofamortizationexpenserelatedtointangibleassetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r207", "r211" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedUsefulLivesandWeightedAverageAmortizationPeriodsforIntangibleAssetsDetail", "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail", "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r212", "r493" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Intangible assets, net", "totalLabel": "Total amortization expense" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedFutureAmortizationofIntangibleAssetsDetail", "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail", "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [ "r208" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.", "label": "Finite-Lived Intangible Assets Acquired", "terseLabel": "Estimated Fair Values" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r83" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "negatedTerseLabel": "Loss on disposal of assets" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r83" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Loss on disposal of fixed assets" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsAdditionalInformationDetail", "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r83", "r280", "r281" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Loss on debt repayment and extinguishment", "terseLabel": "Loss on debt repayment and extinguishment" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows", "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r63" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and administrative expense" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofamortizationexpenserelatedtointangibleassetsDetails", "http://med.com/role/LeasesSummaryofRentExpenseDetails", "http://med.com/role/ShareBasedCompensationSummaryofStockbasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r10", "r193", "r194", "r201", "r205", "r485", "r508" ], "calculation": { "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails": { "order": 6.0, "parentTag": "mlnk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 }, "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryofGoodwillDetails", "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails", "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r195", "r205" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Goodwill additions during period" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r200", "r401" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "Purchase accounting adjustments, goodwill" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r60", "r96", "r161", "r166", "r170", "r173", "r175", "r183", "r235", "r236", "r237", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r435" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "verboseLabel": "IPO" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r53", "r161", "r166", "r170", "r173", "r175", "r507", "r516", "r519", "r532" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income (loss) before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r221", "r223" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofamortizationexpenserelatedtointangibleassetsDetails", "http://med.com/role/LeasesSummaryofRentExpenseDetails", "http://med.com/role/ShareBasedCompensationSummaryofStockbasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofamortizationexpenserelatedtointangibleassetsDetails", "http://med.com/role/LeasesSummaryofRentExpenseDetails", "http://med.com/role/ShareBasedCompensationSummaryofStockbasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r97", "r387", "r390", "r391", "r394", "r396", "r398", "r399", "r400" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r98", "r115", "r116", "r159", "r385", "r395", "r397", "r533" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r21", "r513", "r530" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail": { "order": 4.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income Taxes Receivable, Current", "terseLabel": "Income tax receivable" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r82" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r82" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r82" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r82", "r490" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDepositOtherAssets": { "auth_ref": [ "r82" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.", "label": "Increase (Decrease) in Deposit Assets", "negatedTerseLabel": "Escrow deposit" } } }, "localname": "IncreaseDecreaseInDepositOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r82", "r465" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Initial recognition of operating lease liability" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherDeferredLiability": { "auth_ref": [ "r82" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred obligations classified as other.", "label": "Increase (Decrease) in Other Deferred Liability", "terseLabel": "Deferred rent" } } }, "localname": "IncreaseDecreaseInOtherDeferredLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r82" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Temporary Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInTemporaryEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r52", "r155", "r444", "r447", "r518" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "verboseLabel": "Interest expense, net" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r66", "r268", "r278", "r279" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r77", "r80", "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Operating Leases, Rent Expense", "terseLabel": "Rent expense", "verboseLabel": "Operating leases, rent expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofRentExpenseDetails", "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r469", "r471" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "terseLabel": "Rent expense" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofRentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Summary of rent expense (post ASC 842 adoption)" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Summary of future minimum lease payments (post ASC 842 adoption)" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r470" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r470" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails_1": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r470" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r470" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails_1": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r470" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r470" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "2022 (remaining three months)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r470" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r34", "r96", "r168", "r183", "r235", "r236", "r237", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r424", "r427", "r428", "r435", "r483", "r484" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r26", "r96", "r183", "r435", "r485", "r512", "r526" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r6", "r36", "r96", "r183", "r235", "r236", "r237", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r424", "r427", "r428", "r435", "r483", "r484", "r485" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LimitedLiabilityCompanyLLCMembersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Limited Liability Company (LLC) Members' Equity [Abstract]", "terseLabel": "Stockholders\u2019 Equity" } } }, "localname": "LimitedLiabilityCompanyLLCMembersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Commitment fee rate" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r32" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Revolving credit facility, principal amount" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r32" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Unused revolving credit facility balance" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r32", "r95" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail", "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r16", "r260", "r274", "r276", "r277", "r511", "r524" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "terseLabel": "Total debt, net" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r33" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-Term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt, net of debt issuance costs", "verboseLabel": "Current portion of long term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets", "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r102", "r233", "r265" ], "calculation": { "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail": { "order": 6.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r102", "r233", "r265" ], "calculation": { "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r102", "r233", "r265" ], "calculation": { "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail": { "order": 4.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r102", "r233", "r265" ], "calculation": { "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r102" ], "calculation": { "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail": { "order": 1.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "terseLabel": "2022 (remaining three months)" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtSummaryofFuturePrincipalPaymentsofLongtermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r16" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt, net of debt issuance costs", "verboseLabel": "Total non-current portion of long-term debt, net" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets", "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail", "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r38", "r234" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail", "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r142", "r150" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Organization and Description of Business" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r79" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r79" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r79", "r81", "r84" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r109", "r110", "r111", "r112", "r118", "r119", "r128", "r131", "r161", "r166", "r170", "r173", "r175" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net income (loss) attributable to common stockholders, basic", "totalLabel": "Net income (loss) attributable to common stockholders, basic" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations", "http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r120", "r123", "r124", "r125", "r126", "r128", "r131" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "terseLabel": "Net income (loss) attributable to common stockholders, diluted", "totalLabel": "Net income (loss) attributable to common stockholders, diluted" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations", "http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements Adopted And Not Yet Adopted" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Non-cash investing and financing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionDebtAssumed1": { "auth_ref": [ "r87", "r88", "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of debt that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisition, Debt Assumed", "terseLabel": "Regulation A+ investor note assumed in business combination" } } }, "localname": "NoncashOrPartNoncashAcquisitionDebtAssumed1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncompeteAgreementsMember": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.", "label": "Noncompete Agreements [Member]", "terseLabel": "Non-competition agreements" } } }, "localname": "NoncompeteAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedUsefulLivesandWeightedAverageAmortizationPeriodsforIntangibleAssetsDetail", "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r64" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "negatedTotalLabel": "Total other expense, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other (income) expense, net:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]", "terseLabel": "Office equipment and furniture" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsAdditionalInformationDetail", "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r161", "r166", "r170", "r173", "r175" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r460" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating lease, expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseImpairmentLoss": { "auth_ref": [ "r456" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.", "label": "Operating Lease, Impairment Loss", "terseLabel": "Impairment of right of use assets" } } }, "localname": "OperatingLeaseImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r458" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 }, "http://med.com/role/LeasesSupplementalBalanceSheetInformationAboutTheCompanysLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total operating lease liabilities", "totalLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails", "http://med.com/role/LeasesSupplementalBalanceSheetInformationAboutTheCompanysLeasesDetails", "http://med.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r458" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 }, "http://med.com/role/LeasesSupplementalBalanceSheetInformationAboutTheCompanysLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Lease liability \u2013 current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail", "http://med.com/role/LeasesSupplementalBalanceSheetInformationAboutTheCompanysLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSupplementalBalanceSheetInformationAboutTheCompanysLeasesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r458" ], "calculation": { "http://med.com/role/LeasesSupplementalBalanceSheetInformationAboutTheCompanysLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Noncurrent operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSupplementalBalanceSheetInformationAboutTheCompanysLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.", "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSupplementalBalanceSheetInformationAboutTheCompanysLeasesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r461", "r465" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSupplementalCashFlowInformationAbouttheCompanysLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r457" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Right of use assets", "verboseLabel": "Operating lease ROU assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets", "http://med.com/role/LeasesSupplementalBalanceSheetInformationAboutTheCompanysLeasesDetails", "http://med.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r468", "r471" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r467", "r471" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r450", "r453" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Operating Leases, Future Minimum Payments Due", "totalLabel": "Total future minimum lease payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r450", "r453" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails": { "order": 5.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments Due, Next 12 Months", "verboseLabel": "2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals": { "auth_ref": [ "r454" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contractually required future rental payments receivable on noncancelable subleasing arrangements.", "label": "Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals", "negatedLabel": "Sublease Receipts" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r450", "r453" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Five Years", "terseLabel": "2026" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r450", "r453" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails": { "order": 4.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Four Years", "terseLabel": "2025" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r450", "r453" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Three Years", "terseLabel": "2024" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r450", "r453" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Two Years", "terseLabel": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r450", "r453" ], "calculation": { "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails": { "order": 6.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due Thereafter", "terseLabel": "Thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesRentExpenseSubleaseRentals1": { "auth_ref": [ "r450" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of sublease rental income recognized during the period that reduces the entity's rent expense incurred under operating leases.", "label": "Operating Leases, Rent Expense, Sublease Rentals", "terseLabel": "Sublease rental income" } } }, "localname": "OperatingLeasesRentExpenseSubleaseRentals1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r29", "r485" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Others" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r12" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Commitments [Line Items]", "terseLabel": "Other Commitments [Line Items]" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table]", "terseLabel": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherDepreciationAndAmortization": { "auth_ref": [ "r62", "r83", "r217" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.", "label": "Other Depreciation and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "OtherDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r39" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r84" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other adjustments" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r65" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedLabel": "Other income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "auth_ref": [ "r75" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.", "label": "Payment for Contingent Consideration Liability, Financing Activities", "negatedLabel": "Holdback payment to sellers of MeridianLink" } } }, "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r72" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchases of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfOtherEquity": { "auth_ref": [ "r72" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to reacquire equity classified as other.", "label": "Payments for Repurchase of Other Equity", "negatedLabel": "Repurchases of Units" } } }, "localname": "PaymentsForRepurchaseOfOtherEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForSoftware": { "auth_ref": [ "r68" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.", "label": "Payments for Software", "negatedLabel": "Capitalized software additions" } } }, "localname": "PaymentsForSoftware", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r74" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedLabel": "Payments of debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r76" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payments of deferred offering costs", "verboseLabel": "Payment of stock issuance costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows", "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r72" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedTerseLabel": "Taxes paid related to net share settlement of RSUs", "terseLabel": "Shares withheld with respect to net settlement of RSUs" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessThreeNetOfCashAcquired": { "auth_ref": [ "r69" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with a third acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Business Three, Net of Cash Acquired", "negatedTerseLabel": "Acquisition, net of cash and restricted cash acquired \u2013 StreetShares, Inc." } } }, "localname": "PaymentsToAcquireBusinessThreeNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessTwoNetOfCashAcquired": { "auth_ref": [ "r69" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with a second acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Business Two, Net of Cash Acquired", "negatedLabel": "Acquisition, net of cash and restricted cash acquired \u2013 Saylent Technologies, Inc." } } }, "localname": "PaymentsToAcquireBusinessTwoNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r67", "r417" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Cash consideration, gross" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "http://med.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r67" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisition, net of cash acquired \u2013 TazWorks, LLC" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r68" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r334", "r335", "r336", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r348", "r349", "r350", "r351", "r352", "r353", "r355", "r356", "r358", "r359", "r360", "r361", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r334", "r335", "r336", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r348", "r349", "r350", "r351", "r352", "r353", "r355", "r356", "r358", "r359", "r360", "r361", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "auth_ref": [], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.", "label": "Preferred Stock Dividends, Income Statement Impact", "negatedLabel": "Class A preferred return" } } }, "localname": "PreferredStockDividendsIncomeStatementImpact", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r19", "r283" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r19", "r283" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred sock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r19", "r485" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value; 50,000,000 shares authorized; zero shares issued and outstanding at September\u00a030, 2022 and December 31, 2021" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredUnitsOutstanding": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "The number of preferred units outstanding.", "label": "Preferred Units, Outstanding", "terseLabel": "Preferred units outstanding (in shares)" } } }, "localname": "PreferredUnitsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail", "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r4", "r28", "r188", "r189" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofPrepaidExpensesandOtherCurrentAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r70" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from initial public offering, net of underwriters\u2019 discounts and commissions", "verboseLabel": "Proceeds from issuance initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows", "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": { "auth_ref": [ "r71" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from issuance of long-term debt classified as other.", "label": "Proceeds from Issuance of Other Long-Term Debt", "terseLabel": "Proceeds from long-term debt" } } }, "localname": "ProceedsFromIssuanceOfOtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r70", "r373" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockPlans": { "auth_ref": [ "r70" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the stock plan during the period.", "label": "Proceeds from Stock Plans", "terseLabel": "Proceeds from employee stock purchase plan" } } }, "localname": "ProceedsFromStockPlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r2", "r47", "r48", "r51", "r78", "r96", "r107", "r115", "r116", "r161", "r166", "r170", "r173", "r175", "r183", "r235", "r236", "r237", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r422", "r425", "r426", "r429", "r430", "r434", "r435", "r519" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)", "verboseLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows", "http://med.com/role/CondensedConsolidatedStatementsofOperations", "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsAdditionalInformationDetail", "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r8", "r218" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property plant and equipment gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r220", "r485", "r520", "r527" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail", "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Summary of property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsAdditionalInformationDetail", "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PurchaseObligation": { "auth_ref": [], "calculation": { "http://med.com/role/CommitmentsandContingenciesFutureMinimumPaymentsUnderNonCancelablePurchaseCommitmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.", "label": "Purchase Obligation", "totalLabel": "Total future minimum payments under non-cancelable purchase commitments" } } }, "localname": "PurchaseObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CommitmentsandContingenciesFutureMinimumPaymentsUnderNonCancelablePurchaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueInNextTwelveMonths": { "auth_ref": [], "calculation": { "http://med.com/role/CommitmentsandContingenciesFutureMinimumPaymentsUnderNonCancelablePurchaseCommitmentsDetails": { "order": 2.0, "parentTag": "us-gaap_PurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Purchase Obligation, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "PurchaseObligationDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CommitmentsandContingenciesFutureMinimumPaymentsUnderNonCancelablePurchaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueInSecondYear": { "auth_ref": [], "calculation": { "http://med.com/role/CommitmentsandContingenciesFutureMinimumPaymentsUnderNonCancelablePurchaseCommitmentsDetails": { "order": 3.0, "parentTag": "us-gaap_PurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Purchase Obligation, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "PurchaseObligationDueInSecondYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CommitmentsandContingenciesFutureMinimumPaymentsUnderNonCancelablePurchaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueInThirdYear": { "auth_ref": [], "calculation": { "http://med.com/role/CommitmentsandContingenciesFutureMinimumPaymentsUnderNonCancelablePurchaseCommitmentsDetails": { "order": 1.0, "parentTag": "us-gaap_PurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Purchase Obligation, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "PurchaseObligationDueInThirdYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CommitmentsandContingenciesFutureMinimumPaymentsUnderNonCancelablePurchaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://med.com/role/CommitmentsandContingenciesFutureMinimumPaymentsUnderNonCancelablePurchaseCommitmentsDetails": { "order": 4.0, "parentTag": "us-gaap_PurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchase arrangement to be paid in remainder of current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment.", "label": "Purchase Obligation, to be Paid, Remainder of Fiscal Year", "terseLabel": "2022 (remaining three months)" } } }, "localname": "PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CommitmentsandContingenciesFutureMinimumPaymentsUnderNonCancelablePurchaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r328", "r477", "r478" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r328", "r477", "r478", "r480" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r477" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "verboseLabel": "Related party transaction, cost of sales" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.", "label": "Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party", "terseLabel": "Related party transaction, general and administrative expenses from transactions with related party" } } }, "localname": "RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r328", "r477", "r480", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r475", "r476", "r478", "r481", "r482" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r73" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedTerseLabel": "Payment of Regulation A+ investor note" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfOtherLongTermDebt": { "auth_ref": [ "r73" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.", "label": "Repayments of Other Long-Term Debt", "negatedLabel": "Principal payments of long-term debt" } } }, "localname": "RepaymentsOfOtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r381", "r491", "r548" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofRentExpenseDetails", "http://med.com/role/ShareBasedCompensationSummaryofStockbasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r7", "r90" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted stock awards" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit", "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted stock units (RSUs)", "verboseLabel": "Restricted stock units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit", "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r23", "r302", "r485", "r525", "r539", "r540" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r104", "r105", "r106", "r108", "r114", "r116", "r184", "r374", "r375", "r376", "r392", "r393", "r432", "r536", "r538" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r152", "r153", "r165", "r171", "r172", "r176", "r177", "r178", "r316", "r317", "r492" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenues, net" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations", "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorSourceDetails", "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebySolutionTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r319", "r327" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognition" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r466", "r471" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Operating lease assets obtained in exchange for new operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSupplementalCashFlowInformationAbouttheCompanysLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of stock issue price per share (in dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "auth_ref": [ "r31" ], "calculation": { "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales and Excise Tax Payable, Current", "terseLabel": "Sales tax liability from acquisitions" } } }, "localname": "SalesAndExciseTaxPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Summary of accrued liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/NetIncomeLossPerShareSummaryofoutstandingpotentiallydilutivesecuritieswereexcludedfromthecalculationofdilutednetlosspercommonunitattributabletocommonunitholdersDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Summary of Outstanding Potentially Dilutive Securities were Excluded from the Calculation of Diluted Net Loss Per Common Unit Attributable to Common Unitholders" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/NetIncomeLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r403", "r404", "r409" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsAdditionalInformationDetails", "http://med.com/role/BusinessCombinationsSummaryoftheAllocationofthePurchasePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r38", "r102", "r276", "r278", "r298", "r299", "r300", "r301", "r445", "r446", "r449", "r521" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of long-term debt" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of Calculation of Basic and Diluted Net Income (Loss) Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/NetIncomeLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r365", "r377" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails", "http://med.com/role/ShareBasedCompensationSummaryofStockbasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Summary of stock-based compensation" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.", "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Summary of Fair Value of the Separately Identifiable Finite-Lived Intangible Assets Acquired and Estimated Useful Lives" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r207", "r211", "r493" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedUsefulLivesandWeightedAverageAmortizationPeriodsforIntangibleAssetsDetail", "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail", "http://med.com/role/BalanceSheetComponentsSummaryofamortizationexpenserelatedtointangibleassetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r207", "r211" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Summary of intangible assets, net and estimated useful lives and weighted average amortization periods" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]", "terseLabel": "Summary of future minimum lease payments (pre ASC 842 adoption)" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsSummaryofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Summary of Company's Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "terseLabel": "Summary of future principal payments of long-term debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Schedule of RSU activity" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofPropertyandEquipmentNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Summary of the Allocation of the Purchase Price" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r479", "r480" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRentExpenseTableTextBlock": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of rental expense from operating leases for each period for which an income statement is presented with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included.", "label": "Schedule of Rent Expense [Table Text Block]", "terseLabel": "Summary of rent expense (pre ASC 842 adoption)" } } }, "localname": "ScheduleOfRentExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r161", "r164", "r169", "r202" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r337", "r354", "r357" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Summary of stock option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of estimated future amortization of intangible assets" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Secured Debt" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail", "http://med.com/role/LongTermDebtSummaryofLongtermDebtDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r165", "r166", "r167", "r168", "r170", "r171", "r172", "r173", "r174", "r175", "r178", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r205", "r224", "r225", "r534" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesSummaryofRentExpenseDetails", "http://med.com/role/ShareBasedCompensationSummaryofStockbasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceOtherMember": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, financial service, and other financial service, classified as other.", "label": "Service, Other [Member]", "terseLabel": "Other" } } }, "localname": "ServiceOtherMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionDisaggregationofRevenuebyMajorSourceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r82" ], "calculation": { "http://med.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.", "label": "Share-Based Payment Arrangement, Accelerated Cost", "terseLabel": "Accelerated stock-based compensation expense" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r348", "r349" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Non-vested ending balance (in shares)", "periodStartLabel": "Non-vested beginning balance (in shares)", "terseLabel": "Unvested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of RSUs" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r348", "r349" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Non-vested ending balance (in dollars per share)", "periodStartLabel": "Non-vested beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested (in shares)", "terseLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations", "terseLabel": "RSAs cancelled or forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Weighted Average Remaining Contract Term and Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "terseLabel": "Exercisable at end of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable at end of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r356" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Intrinsic value of options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r372" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r338", "r339" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r338", "r339" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Ending balance (in dollars per share)", "periodStartLabel": "Beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r358" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Aggregate intrinsic value, vested and expected to vest in the future" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Vested and expected to vest in the future (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Vested and expected to vest in the future (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r334", "r335", "r336", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r348", "r349", "r350", "r351", "r352", "r353", "r355", "r356", "r358", "r359", "r360", "r361", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit", "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://med.com/role/ShareBasedCompensationScheduleofRSUActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number", "terseLabel": "Accelerated vesting (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r372" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Aggregate intrinsic value, exercisable at end of period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "verboseLabel": "Weighted average remaining contractual term, exercisable at end of period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual term, vested and expected to vest in the future" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r356" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "terseLabel": "Fair value of options vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Share price (in dollars per share)" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "negatedLabel": "Shares withheld related to net share settlement of RSUs (in shares)" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r91", "r103" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r1", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r165", "r166", "r167", "r168", "r170", "r171", "r172", "r173", "r174", "r175", "r178", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r205", "r222", "r224", "r225", "r534" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/RevenueRecognitionAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r18", "r19", "r20", "r93", "r96", "r121", "r122", "r127", "r129", "r131", "r139", "r140", "r141", "r183", "r235", "r239", "r240", "r241", "r244", "r245", "r283", "r284", "r287", "r291", "r297", "r435", "r554" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r42", "r49", "r50", "r51", "r104", "r105", "r106", "r108", "r114", "r116", "r138", "r184", "r297", "r302", "r374", "r375", "r376", "r392", "r393", "r432", "r437", "r438", "r439", "r440", "r441", "r442", "r474", "r536", "r537", "r538" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows", "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r104", "r105", "r106", "r138", "r492" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows", "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r19", "r20", "r297", "r302" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Issuance of common stock through employee purchase plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit", "http://med.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r19", "r20", "r297", "r302" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of common stock in connection with initial public offering, net of underwriters' discounts and commissions and issuance costs (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r297", "r302" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Vesting of restricted stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r19", "r20", "r297", "r302", "r343" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised (in shares)", "terseLabel": "Issuance of common stock due to exercise of stock options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit", "http://med.com/role/ShareBasedCompensationSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r19", "r20", "r297", "r302" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Issuance of common stock through employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r19", "r20", "r297", "r302" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock in connection with initial public offering, net of underwriters\u2019 discounts and commissions and issuance costs" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r19", "r20", "r297", "r302" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Vesting of restricted stock" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r42", "r297", "r302" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Issuance of common stock due to exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Stock remaining for repurchase under repurchase program" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r19", "r20", "r297", "r302" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Repurchase of stock (in shares)", "terseLabel": "Stock repurchased (in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit", "http://med.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r19", "r20", "r297", "r302" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchase of stock", "terseLabel": "Stock repurchased" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit", "http://med.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r20", "r24", "r25", "r96", "r182", "r183", "r435", "r485" ], "calculation": { "http://med.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedBalanceSheets", "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r94", "r284", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r302", "r305", "r431" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "terseLabel": "Stock split ratio" } } }, "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "pureItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r464", "r471" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease Income", "terseLabel": "Sublease income" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LeasesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r443", "r487" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r443", "r487" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r443", "r487" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r443", "r487" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r486", "r489" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "Balance Sheet Components" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r235", "r239", "r240", "r241", "r244", "r245" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofPreferredUnitsandStockholdersEquityMembersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/BalanceSheetComponentsSummaryofEstimatedUsefulLivesandWeightedAverageAmortizationPeriodsforIntangibleAssetsDetail", "http://med.com/role/BalanceSheetComponentsSummaryofIntangibleAssetsNetDetail", "http://med.com/role/BusinessCombinationsSummaryofFairValueoftheSeparatelyIdentifiableFiniteLivedIntangibleAssetsAcquiredandEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "terseLabel": "Unamortized debt issuance costs" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r382", "r389" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Uncertain tax positions" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/IncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r388" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Penalties and interest on unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/IncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r143", "r144", "r145", "r146", "r147", "r148", "r149" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/LongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r120", "r131" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "verboseLabel": "Diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations", "http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r118", "r131" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations", "http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "terseLabel": "Denominator:", "verboseLabel": "Weighted average common stock outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://med.com/role/CondensedConsolidatedStatementsofOperations", "http://med.com/role/NetIncomeLossPerShareSummaryofcalculationofbasicanddilutednetincomelosspershareDetail" ], "xbrltype": "stringItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r103": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r137": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r228": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r232": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629" }, "r282": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.C)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.F)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770" }, "r305": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r327": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479" }, "r421": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123415192&loc=d3e39927-112707" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r46": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "https://asc.fasb.org/topic&trid=2122208" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r472": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123408481&loc=SL77919140-209958" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r482": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r489": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(2)(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16(a))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(d)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r549": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(2)(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r550": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r551": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r552": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r553": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r554": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r555": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)" }, "r556": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r557": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03" }, "r558": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r559": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r560": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" } }, "version": "2.1" } ZIP 86 0001834494-22-000109-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001834494-22-000109-xbrl.zip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end